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Summary 
In this thesis, studies of the kinetic and mechanism of racemisation of several drug-like 
molecule have been presented. Chapter 1 provides background information on the general 
mechanisms of racemisation of drugs in general, and hydantoin derivatives. In particular 
including reviews of the hydrolysis and the mechanism of base-catalysed racemisation of 
hydantoin derivatives.  
The synthesis of different chiral hydantoins, thiohydantoins, thiazolidine-diones, and 
rhodanines is presented in Chapter 2. Several enantio-enriched 5-substituted 1-acetyl-2-
thiohydantoins and two tri-substituted 2-thiohydantoins have been synthesised. Further 
racemic thiohydantoin derivatives including mono, di, and tri-substituted 2-thiohydantoins 
have also been prepared. 
Chapter 3 focuses on the kinetics and mechanism of hydrolysis of 5-substituted 1-acetyl-2-
thiohydantoins in physiological-like buffers. The key reaction involves de-acetylation and this 
is followed by the hydrolysis of the resulting 5-substituted 2-thiohydantoins. Sodium 
hydroxide and hydrochloric acid have also been used for the hydrolysis of 1-acetyl-5-phenyl-
2-thiohydantoin. Similarly, the hydrolysis of several 5-substituted 2-thiohydantoins has been 
studied. The rate constants for hydrolysis suggest that the 5-substituted 1-acetyl-2-
thiohydantoins hydrolyses faster than the subsequent hydrolysis of 5-substituted 2-
thiohydantoins. 
Chapter 4 focuses on the racemisation of 5-substituted 1-acetyl-2-thiohydantoins and shows 
that substituents at N-1 decelerate racemisation. Racemisation of tri-substituted 2-
thiohydantoins is fast in comparison with 5-substituted 1-acetyl-2-thiohydantoins. The 
substituents at the asymmetric carbon affect the rate of racemisation. The solvent kinetic 
isotope effect on the racemisation were determined for different substituted 2-thiohydantoins 
and supported the SE1 mechanism of racemisation.  
Chapter 5 concerns further confirmation of the mechanism of racemisation by comparing kdeu 
and krac and this confirms the SE1 mechanism for racemisation of 5-substituted 1-acetyl-2-
thiohydantoin as kdeu/krac for all compounds approaches 1. For the racemic 5-substituted 2-
thiohydantoins the rate constants of deuteration have been obtained using 1H-NMR 
spectroscopy and showed fast replacement of hydrogen by deuteron. Assuming kdeu = krac, we 
can order the rate constants for racemisation form high to low as rhodanine > thiohydantoin > 
thiazolidine-2,4-dione > hydantoin.  
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INTRODUCTION 
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1.1 Racemisation 
1.1.1 Enantiomers and racemisation 
 
The geometric property of molecules or drug-like molecules of not being superimposable with 
their mirror images is called chirality.1 The two distinct mirror images of chiral isomers are 
termed enantiomers. Two enantiomers are said to differ in their sense of chirality or 
handedness in the same way as a right hand differs from a left hand.2 Optical activity results 
from the refraction of right and left circularly polarised light to different extents by chiral 
molecules.3 Since enantiomers are usually optically active, they turn the plane of polarised 
light to an equal degree but in opposite directions, which is why enantiomers are also called 
optical isomers.2 Some molecules rotate the plane to the right (clockwise), while others rotate 
the plane to the left (anticlockwise). For example, the two enantiomers (+) and (-) lactic acid 
(Scheme 1.1) are mirror images of each other. They have identical physical and chemical 
properties; for example, both have the same melting points in achiral environments. The 
carbon atom at the centre of lactic acid is attached to four different atoms and is called an 
asymmetric or stereogenic carbon atom.4  
 
 
                       
Scheme 1.1: Structures of (+) and (-) lactic acid 
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1.1.2 Optical rotation 
 
When polarised light passes through (a solution containing) chiral molecules, the medium has 
indices of refraction for both left and right circularly polarised light. The speed of the left 
circularly polarised light is not equal to the speed of the right polarised light (nL ≠ nR). The 
difference in refractive indices is expressed by Fresnel’s equation 1.1.3 
 
𝜑 =  
𝜋
𝜏
 (𝑛𝐿 − 𝑛𝑅) 
Equation 1.1 
 
 
where 𝜑 is the rotation of the plane of polarisation in radians per unit length, 𝜏 is the wave 
length of the incident light, and nL and nR are the indices of refraction for both components of 
polarised light. 
 
1.1.3 Circular dichroism 
 
Optically active compounds have non-zero specific rotation.3 The angle of rotation (α) can be 
measured using a polarimeter and the specific rotation is defined as in equation 1.2.3, 5  
 
[𝛼]𝐷
𝐸 =  
𝛼𝑜𝑏𝑠
𝑙𝑐
 Equation 1.2 
 
where [𝛼]𝐷
𝐸  is the specific rotation determined at temperature E (in °C ) using D-line of 
sodium light, 𝛼𝑜𝑏𝑠 is the observed plane of polarisation, l is the length of the cell in 
decimetres, E is the temperature in °C, and c is the concentration of the substance being 
examined in grams per millilitre of solution. 
The difference in the absorption of right and left circularly polarised light can be expressed as 
‘circular dichroism’ where the molar absorption coefficient (Ԑ) of the R molecule is different 
from the L molecule. 
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1.1.4 Racemisation 
 
An equal amount of two enantiomers is called a racemic mixture. Both enantiomers in equal 
amounts cancel out each other and the mixture is optically inactive.4 The term racemisation 
can be described as the total loss of optical activity of a molecule through the irreversible 
formation of a racemic mixture. The rate of racemisation can be described as the rate of 
formation of a racemate, which has reversible first-order kinetics (Scheme 1.2).6, 7  
 
 
Scheme 1.2: Illustration of enantiomerisation. 
 
The first-order rate law can be written by Equation 1.3 
−
𝑑[𝑆]
𝑑𝑡
=  𝑘1[𝑆] −  𝑘−1[𝑅] 
 
Equation 1.3 
 
 
where [S] and [R] are the concentrations of the enantiomers S and R, kl and k-1 are the 
interconversion constants for the S and R enantiomer respectively, and t is time. Initially, 
when one of the enantiomers dominates, a chiral medium is present and kl may be different 
from k-1. However, if sufficiently dilute, kl = k-1 can be assumed.
6  
When racemisation begins with pure S, under first-order conditions, [S]0-[S]t = [R]t 
 
𝐼𝑛 [
[𝑆]°
2[𝑆]𝑡 − [𝑆]°
] =  2𝑘𝑡 
Equation 1.4 
 
where [𝑆]t and [𝑆]° are the concentrations of enantiomer S at time t and time zero, 
respectively.  
The rate of racemisation can be described as the rate of the formation of a racemate, 
racemisation is an irreversible first-order reaction, contrary to enantiomerisation (Scheme 
1.3). 
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Scheme 1.3: Illustration of racemisation. 
 
When pure enantiomer starts to form a racemate mixture, Equation 1.5 can be used  
 
−
𝑑[𝑆]
𝑑𝑡
=  𝑘′[𝑆]𝑡 
Equation 1.5 
 
 
In the case where [𝑆]° −  [𝑆]𝑡 is equal to 2[𝑆𝑅]𝑡, then Equation 1.5 can be described as  
 
𝐼𝑛 [
[𝑆]°
[𝑆]𝑡
] = 𝐼𝑛 [
[𝑆]°
[𝑆]° −  2[𝑆𝑅]𝑡
] =  𝑘′ 
Equation 1.6 
 
where k’ is the rate constant for racemisation, and [SR] is the concentration of the racemate.6 
 
Following the racemisation by the loss in optical activity can transform Equation 1.6 into 
Equation 1.7.6  
𝐼𝑛 [
𝛼°
𝛼𝑡
] = 𝑘′𝑡 Equation 1.7 
 
where 𝛼𝑡 is the optical activity at time t, and 𝛼° is the optical activity at time zero.  
The observed phenomenological pseudo-first-order rate constants for the loss of ellipticity kɵ 
were obtained by plotting the ellipticity versus time in terms of the first-order-rate equation 
(Equation 1.8). 
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 𝜃𝑡 = 𝜃𝑓𝑖𝑛 +  ∆𝜃 ∗ 𝑒
−𝑘𝜃× 𝑡 Equation 1.8 
 
 
Here, 𝜃𝒕 is the ellipticity at time t, 𝜃finis the final ellipticity, ∆𝜃 represents the difference 
between the ellipticity at time zero and 𝜃fin, and 𝑘𝜃 is the observed pseudo-first-order rate 
constant for loss of ellipticity. 
 
1.1.5 Role of racemisation in optically active drugs 
 
Drug stereoisomerism is recognised as an issue having clinical and regulatory implications in 
drug development. In the case of optically active drugs, the enantiomers can have different 
potency, and/or pharmacological activity. If a non-racemising drug is designed to interact 
with a chiral receptor, then racemic drug mixtures essentially contain 50% of the enantiomer 
that is pharmaceutically active, the so-called “eutomer”.8, 9 Single enantiomers are therefore 
expected to have a better effect than racemate drugs on the body because the effective dose of 
the active drug is higher. The undesired enantiomer may also have undesired effects. In this 
case, administering a single enantiomer becomes crucial. Finally, even if the target of a drug 
is not enantioselective, the pharmacokinetics of the enantiomers may still differ as a result of 
enantioselectivity in the process involved.10 Even if an enantiopure drug is administered, 
however, this drug may still racemise. Therefore, it is important to investigate the single 
enantiomer’s configurational stability.11  
The story of the risk of drug racemisation started with the thalidomide tragedy in the late 
1950s. Thalidomide was taken by pregnant women as an anti-nausea treatment between week 
5 and 8 after conception. Teratogenic effects were caused by side-effects of the S-thalidomide 
(Scheme 1.4).12,13 
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Scheme 1.4: Structures and interconversion of thalidomide enantiomers. 
 
The study of racemic mixtures in drug development is more complicated in pharmacokinetic 
and biological systems than for single enantiomers. The biological activity of two 
enantiomers in a racemic mixture is often different. Because many biomacromolecules are 
chiral and occur as only one enantiomer (e.g. proteins and DNA), these interactions are not 
identical because of diastereomerical binding. For example, if we assume that our target is an 
R enantiomer, the interactions are (R....R) versus (R.....S).14 The difference between the Gibbs 
free energy change involved in the two diastereometrical binding processes is called 
enantiomer-discrimination.14 Due to the stronger binding interaction of one enantiomer with a 
receptor, the difference in Gibbs free energy change upon binding (ΔGɵ) is not equal to zero, 
i.e. ΔRSΔGɵ ≠ 0. To calculate the free energy ΔGɵ change related to each individual 
equilibrium constant, the following equation can be used15,16 
 
ΔGɵ = - 2.303 RT log K 
 
 Equation 1. 9 
  
At the physiological condition (T = 310 K), the equilibrium constant can be observed (in kcal 
mol-1) and ΔGɵ is obtained using Equation 1.9 (ΔGɵ = - 1.4 log K). A drug binding with a Kd 
of 10-4 M  (i.e. K = 104 M-1) at 310 K corresponds to a change in standard molar Gibbs energy 
of  5.6 kcal mol-1 required to dissociate the drug from the receptor.16  
 
1.1.6 Configuration instability and selected examples of racemising drugs 
 
 
It is very important to study drug racemisation because many optically active drugs racemise 
in vivo, which can lead to various side effects.17 Many articles have been published studying 
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drug racemisation and also describing factors affecting racemisation such as pH, temperature, 
solvent and ionic strength. Danel et al.18 studied the racemisation of an N-imidazole 
derivative (Scheme 1.5) in TRIS buffer pH 7.4 at 30, 50 and 70 °C with the corresponding t1/2 
of 117.8, 15.4 and 6.6 h, respectively. Chiral inversion could occur through base-induced 
deprotonation of the labile benzylic proton at the stereogenic carbon, resulting in a planar 
carbanion. For example, it has been shown that adding TEA increases the rate constant for 
racemisation of N-imidazole derivatives. The rate constant for racemisation of thiazole-
substituted 1.2 (when X = S) has been reported to be twice as fast as that for oxazole (when X 
= O) (Scheme 1.5). 
 
 
 
Scheme 1.5: Structures of N-imidazole derivatives 
 
The racemisation of ketorolac (Scheme 1.6) was studied in aqueous buffer solutions at 
different pH and temperature. Brandl et al.19 reported that 20% racemisation of ketorolac 
tromethamine can be achieved after 8 months in 0.04 M of TRIS buffer at pH 7.4 at room 
temperature (25 °C). The proposed mechanism suggests that racemisation occurs with 
acid/base through the formation of an enol following protonation on the ketone on one side 
and transfer of hydrogen on the other.  
 
 
Scheme 1.6: Proposed mechanism for the racemisation of ketorolac.19  
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Mey et al.20 reported the racemisation of (+)- and (−)-diethylpropion (Scheme 1.7 a) in 
aqueous solution under physiological conditions. The racemisation was studied with and 
without cyclodextrins, both in organic solvent and human plasma. In aqueous solution, the 
racemisation of (+)- and (−)-diethylpropion became faster with increasing pH, temperature 
and phosphate buffer concentration, while the rate constant decreased with increasing ionic 
strength. The rate constant of racemisation increased by increasing the polarity of the organic 
solvent in the case of (−)-DEP. The pseudo-first-order rate constant for (+) - and (−)-DEP was 
reported to be unaffected by the presence of cyclodextrins and could be slowed down by 
human plasma. The racemisation of ketoprofen (Scheme 1.7, compound 1.4 b) has been 
suggested to be very fast and to involve reversible chiral inversion in mice.21  
 
 
 
 
Scheme 1.7: Structures of 1.4 a) (R)-diethylpropion, and b) (R)-ketoprofen 
 
Chiral stability and degradation, including the sulphonation of adrenalin (Scheme 1.8), were 
studied by Stepensky et al.22 using chiral HPLC at different pH. It was determined during the 
storage of metabisulphite stabilised adrenaline injections that the degradation process takes 
place for the pharmacologically active L-adrenaline isomer involving racemisation oxidation 
and sulphonation.  
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Scheme 1.8: degradation of L-adrenaline.22 
                     
The base-catalysed racemisation of R,S-2-(4-isobutylphenyl) propionic acid (ibuprofen) 
(Scheme 1.9), which is an important example of non-steroidal anti-inﬂammatory drugs 
“NSAIDs”, has been studied by Xie et al.23 The rate of dynamic equilibrium tautomerism 
leads to racemisation of the ibuprofen isomers in DMSO-water (4:1, v: v). The racemisation 
reaction suggested a pseudo-first-order rate constant which depends on the concentration of 
base catalyst rather than the concentration of the substrate. It has also been reported that using 
DMSO with base catalyst increases the rate constant of racemisation of ibuprofen while the 
single enantiomer is highly stable in DMSO without NaOH. The enantiomeric excess (ee) of 
75.4% after 6 h racemisation reaction was obtained in DMSO-water mixed medium 
containing 80% DMSO at 100 °C. The R-ibuprofen racemisation has been suggested to 
involve keto-enol tautomerism, in which the rate determining step is the enolisation of 
ibuprofen.23  
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Scheme 1.9: Racemisation of ibuprofen enantiomers by keto-enol tautomerism.23 
 
Oğuz and Doğan 24 studied the mechanism of the thermal racemisation of 5,5-dimethyl-1-(o-
aryl)barbituric and 2-thiobarbituric acid derivatives (Scheme 1.10). The keto-enol 
tautomerism and variable tautomerism at different positions were suggested as possible 
mechanisms for the racemisation of the barbituric and 2-thiobarbituric acid derivatives. The 
lower reported activation energy for the racemisation of the thione derivatives compared to 
the oxo derivatives was unexpected. Similarly, the racemisation rate constants of 
thiohydantoin derivatives have been found to be higher than for hydantoin derivatives (vide 
infra). Substituents at the asymmetric carbon greatly influence increases or decreases in 
activation energy. The ring opening of 1.7 (Scheme 1.10) was also expected to compare with 
the racemisation of 3-arylthiazoline-2-thione 1.7 and their oxygen analogue, as suggested by 
Roussel et al. (Scheme 1.10).25  
 
 
 
 
 
 
Scheme 1.10: Possible tautomers of barbituric and 2-thiobarbituric acid derivatives in 
ethanol.24 
 
 
Lambert et al.26 reported the cyclisation and racemisation mechanism for ibutilide (Scheme 
1.11) at 70 °C to involve an intramolecular substitution reaction. Lambert et al. observed 
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acid- and base-catalysis and also suggested that the rate-determining step for this reaction 
changes as a function of pH, as suggested by a U-type rate of racemisation as a function of 
pH. In acidic medium, racemisation takes place by the protonation of the hydroxyl. The 
racemisation of ibutilide is suggested to occur via a carbocation intermediate. The formation 
of a cyclic side product resulting from a nucleophilic attack on the intermediate cation by the 
internal amine is proposed as evidence for the existence of the intermediate carbocation 
(Scheme 1.11a). However, the SN1-type mechanism suggested by reference
26 is unlikely to be 
followed by 1.8 because the carbocation intermediate is likely too high in energy to be a 
viable reaction intermediate. An alternative mechanism can be drawn as shown in scheme 
1.11b. 
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Scheme 1.11: Proposed mechanism for racemisation of ibutilide26 (a) and an alternative 
mechanism for inversion via a cyclic intermediate (b). 
 
 
Yang27 reported the racemisation of temazepam 1.9 (TMZ) (Scheme 1.12) in acidic methanol 
and ethanol. The author reported the rate of racemisation observed by CD spectroscopy and 
the rate of reaction of rac-TMZ to form rac-MeTMZ (or rac-EtTMZ) obtained by ultraviolet-
visible spectrophotometry. Ring opening/closing as a possible mechanism for racemisation of 
R-TMZ 1.9a was reported by Yang in alcoholic solvent. The proposed mechanism involves a 
hydrogen-bonded intermediate 1.9b resulting from solvation, which reacts to form 1.9c by 
opening the C3-N4 bond of the TMZ ring (Scheme 1.12). The rate constant for acid-catalysed 
alcoholysis in ethanol (t 1/2 = 3.0 minutes) was higher than in methanol (t 1/2 = 4.29 minutes) 
containing 0.5 M H2SO4 at 50 °C. However, MeTMZ was reported to be more easily 
decomposed than EtTMZ. It was also indicated that the rate for racemisation of the N4-
protonated form of TMZ increases with increasing acid concentration and the rate of 
racemisation for the un-protonated form of TMZ decreases with increasing acid 
concentration. Therefore, the N4-protonated form of TMZ has a lower rate constant for 
racemisation than the un-protonated form.27 Using strong base for the racemisation study for 
TMZ produces 2-(methylamino)-5-chlorobenzophenone due to hydrolysis of TMZ (Scheme 
1.12).28  
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Scheme 1.12: Proposed mechanism of racemisation of (R)-7-chloro-3-hydroxy-1-methyl-5-
phenyl-1H-benzo[e][1,4]diazepin-2(3H)-one (temazepam TMZ) in alcohol solvent by Yang.27 
 
General-base catalysis of the racemisation of amfepramone and cathinone at pH 7.4 was 
proposed by M. Reist et al.27  
 
 
1.1.7 General mechanisms of racemisation 
 
Good leaving groups which detach from stereogenic centres of optically active compounds 
produce carbocations. The carbocation is achiral because of its planar form and a racemic 
mixture is formed through recombination of the cation with the anion or solvent (Scheme 
1.13).2  
 
 
 
Scheme 1.13: Racemisation mechanism of optically active molecule through formation of a 
planar carbocation intermediate. 
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Compounds that can form a carbanion on the stereogenic centre can also racemise because of  
rapid inversion or planarity of the carbanion. Compounds with a ketone function attached to 
the stereogenic centre can racemise through keto-enol equilibria (Scheme 1.14). In the case 
of keto-enol tautomerism, the proton transfer takes place between carbon and oxygen. The 
interconversion of enantiomers occurs by abstraction of a proton on the stereogenic centre by 
base, resulting in an enolate intermediate which binds a proton with a pair of electrons on the 
enolate oxygen to produce an enol-form species.29  
 
 
 
Scheme 1.14: Keto-enol tautomerism mechanism of racemisation. 
 
The carbanion can be formed in suitable solvents in the absence of base when the proton 
attached to the stereogenic centre is very acidic, for instance in the case of disulphone 
(Scheme 1.15).2 
 
 
 
Scheme 1.15: Carbanion formation of optically active disulphone derivative. 
 
Ketones with attached α-hydrogen may racemise in mineral acid through enol intermediates 
(Scheme 1.16).2 
 
 
 
Scheme 1.16: Acid racemisation mechanism of ketone through intermediate formation. 
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Complete racemisation occurs in the so-called bimolecular SE1 reaction in which hydrogen 
attached to the stereogenic centre is removed first in a rate-determining step to give a planar 
carbanion. Then, an incoming electrophile attaches to either face (Scheme 1.17).7, 29, 30 Each 
carbanion is deuterated with equal rate constants from the front and back side in the case of 
an SE1 reaction. Therefore, kH/D/krac approaches unity (See Section 1.3). 
 
 
 
Scheme 1.17: SE1 mechanism of racemisation. 
 
The ‘push-pull’ mechanism of racemisation is another possible mechanism for optically 
active R1R2R3H compounds. The termolecular SE2 mechanism consists of an incoming 
electrophile (Y+) initiating the reaction from the back, while simultaneously a proton leaves 
the molecule from the front, resulting in a chiral inversion of configuration (Scheme 1.18).2, 7, 
29-31 The H/D exchange rate in an SE2 reaction is half the rate of racemisation and equal to 
the rate of enantiomerisation. Therefore, kH/D/krac = 0.5 (See also Section 1.3). 
 
 
 
Scheme 1.18: SE2 mechanism of racemisation. 
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Two more racemisation mechanisms relying on formation of ion pairs will be discussed in 
Section 1.3. 
 
1.2 Derivatives of hydantoin and structurally related compounds 
 
Several five-membered heterocyclic rings have been recognised as chiral molecules and their 
activity studied by the medicinal chemistry community (Scheme 1.19).  
 
 
 
Scheme 1.19: Structures of 1.10 (a) 2-thiohydantoin, (b) thiazolidine-2, 4-dione (c) 2-
thioxothiazolidin-4-one and (d) hydantoin 
 
1.2.1 Therapeutic agents 
 
The compounds shown in Scheme 1.19 have the ability to interact with a variety of biological 
targets and are so-called “frequent hitters” or privileged scaffolds.32 Substituted five-
membered ring heterocyclic molecules have therefore been used widely in the field of 
therapeutic agents.33 Using a single enantiomer is essential because drug enantiomers differ in 
terms of toxicity, and pharmacodynamics.34 Different hydantoin derivatives have been used in 
the treatment of epilepsy,35 as antiarrhythmic agents36 or anticonvulsants.37 Thiohydantoin 
derivatives are known as being hypolipidemic, anticarcinogenic and antimutagenic and have 
been used in a wide range of applications.38-40 2,4-thiazolidinedione derivatives have been 
marketed as insulin-sensitising agents41 and also for use in the treatment of different 
diseases.42 
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1.2.2 Synthesis  
 
It can be difficult to obtain a high optically active drug-like molecules because racemisation 
can occur during synthesis, particularly if concentrated acid or base conditions and high 
temperature are required.  
The reaction of α-amino acids with isocyanate generally takes place in basic aqueous solution 
to produce ureido acids. The cyclisation occurs by adding mineral acids to obtain the 
corresponding hydantoins 1.11 ( Scheme 1.20).43 
 
 
Scheme 1.20: The condensation of amino acids with isocyanate. 
 
It has also been reported that urea can be used with amino acids to give the corresponding 
hydantoin 1.12 with a yield of 15-20%.43 The condensation of urea with amino acids in the 
absence of solvent needs high temperature. Therefore, the corresponding hydantoin would be 
a mixture of racemic compounds rather than enantiopure hydantoin (Scheme 1.21).    
 
 
Scheme 1.21: The condensation of amino acids with urea. 
 
It is also possible to use thiourea instead of urea to prepare the corresponding 2-
thiohydantoins (Chapter 2).38 High temperature during the reaction leads to racemic 5-
substituted 2-thiohydantoin rather than an enantioenriched product. Narduolo31 has used L- 
amino acid amides with carbonyldiimidazole (CDI) as a coupling agent dissolved in 
19 
 
dichloromethane to prepare (S)-5-benzylhydantoin 1.13 (Scheme 1.22). The author reported 
that (S)-5-benzylhydantoin showed a strong negative Cotton effect in CD spectra at 230 nm.  
 
 
Scheme 1.22: Synthesis of (S)-5-benzylhydantoin as proposed by Narduolo. 
 
The synthesis of 2-thiohydantoin acetylated at the N-1 position has been reported by 
Johnson44, 45 by using amino acid with the ammonium thiocyanate in acetic acid and acetic 
anhydride. This procedure was a successful way to synthesise 5-substituted 1-acetyl-2-
thiohydantoin. However, there was no mention of the optical activity of the product. 
However, in 1932, Csonka and Nicolet46 reported the synthesis of both racemic and D-1-
acetyl-5-methyl-2-thiohydantoin starting from enantiomerically pure D-alanine. The 
temperature during the reaction was not mentioned by the author. The optically active 
compound can be prepared by using 5 parts acetic anhydride containing 10% of acetic acid 
with ammonium thiocyanate. The large excess of acetic anhydride causes the rapid formation 
of azlactone (1.14 a) and produces highly optically active 5-substituted 1-acetyl-2-
thiohydantoin (1.14 b). In the absence of isothiocyanate, the active azlactone racemises 
rapidly in half an hour or less. Therefore, sufficient isothiocyanate in the reaction is necessary 
(Scheme 1.23).46 
 
 
20 
 
 
 
Scheme 1.23: Johnson’s suggested mechanism for the formation of 5-substituted 1-acetyl-2-
thiohydantoins.47 
 
During the reaction, the carboxyl group is activated by the hydrogen of a strong acid used 
with acetic anhydride. The carboxyl group becomes more liable to be attacked by the 
nucleophilic isothiocyanate ion in an acid catalysed reaction. Therefore, ammonium 
thiocyanate is not the best reagent to use without strong acid for the acetylation of 
thiohydantoin.48 
Johnson did not report the optical activity of 1-acetyl-2-thioxoimidazolidin-4-one in his 
publication.  
No articles were found to show the synthesis of enantioenriched 5-substituted thiazolidine-
2,4-diones and 2-thioxothiazolidin-4-ones.  
The condensation of hydantoin with benzaldehyde was first used by Wheeler and Hoffmann 
in 1911 to prepare 5-benzylidene hydantoin.49 This method has been applied successfully to 
achieve the base-catalysed condensation of hydantoin with different aldehydes 1.15 a 
(Scheme 1.24).50,51,31 Similarly, condensation catalysed by bases such as triethylamine or 
piperidine has been used for the synthesis of thiohydantoins with different substituents 1.15 b 
(Scheme 1.24).52,53 
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Scheme 1.24: Synthesis of 5-substituted hydantoins and 2-thiohydantoins 
 
Narduolo used the Knoevenagel condensation of the appropriate aldehydes with hydantoin to 
prepare 5-arylideneimidazolidine-2,4-dione and suggested that the Z isomer for 5-
benzylideneimidazolidine-2,4-dione is formed.31 Similarly, Waldemar et al.54 suggested the 
formation of the Z isomer of 5-benzylidene-2-thioxoimidazolidin-4-one when benzylaldehyde 
reacts with 2-thiohydantoin.  
 
1.2.3 Hydrolysis  
 
Despite the fact that hydantoic acids can cyclise under acidic conditions to produce hydantoin, 
hydantoin can also hydrolyse under basic conditions.55 Bergon and Calmon55 studied the 
alkaline hydrolysis of 5-aryl and 3-arylimidazolidine-2,4-diones to produce 5- and 3-
arylhydantoic acids in aqueous solutions over the pH range 8-14 at 25 °C. The authors 
showed a straight-line correlation of increasing logk versus pH in the pH range from 8 to 12, 
followed by a plateau at pH >12. The ionisation of the substrate and the formation of the 
unreactive anion 1.16b can account for the levelling off of the straight line, resulting in the 
plateau at high pH.55 The hydrolysis takes place by attack of OH- on the unionised substrate 
1.16a to form an intermediate (Scheme 1.25).56 
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Scheme 1.25: Base-catalysed hydrolysis mechanism of 5-substituted hydantoins, as proposed 
by Blagoeva et al.56 
 
Blagoeva et al.56 elucidated the mechanism of alkaline hydrolysis of five ring compounds 
such as hydantoin 1.17 a and 3-methylhydantoin 1.17 b, as well as six-membered rings such 
as 3-methyldihydrouracil 1.18 (Scheme 1.26). The effect of ring size was examined and it was 
shown that angle strain in the ring is important. The rate of the addition of hydroxide to the 
six-membered ring is 2-3 times faster than the rate of the addition to hydantoin and 3-
methylhydantoin.56  
 
 
 
Scheme 1.26: The chemical structures of 1) hydantoin, 2) 5-methylhydantoin, 3) 
dihydropyrimidine-2,4(1H,3H)-dione ( dihydrouracil) and 4) 3-methyldihydrouracil. 
 
At high concentrations of OH-, breakup of the tetrahedral intermediate can be expected as the 
rate-determining step. In this case, the reaction is catalysed by OH- and H2O, which can be 
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interpreted as either a specific acid-base catalysed or a general acid-base catalysed mechanism 
of hydrolysis (section 1.5 and Chapter 3). The same mechanism is expected for the alkaline 
hydrolysis of dihydropyrimidines.57  
Congdon and Edward58 reported the mechanism of base-catalysed hydrolysis of 5-substituted 
1-acetyl-2-thiohydantoins (Scheme 1.27). The acyl linkage degradation for thiohydantoin can 
be related to the base-catalysed deacetylation of polypeptide reported previously. Schlack and 
Kumpf59 published an article in 1926 indicating that the acyl group in polypeptide degrades 
under mild acid or base conditions. 1- acetyl-2-thiohydantoins can ionise as weak acids and 
have pKa values of 6.5-7.0, creating a negative charge at the N-3 position (Scheme 1.27).  
 
 
 
Scheme 1.27: The mechanism of base-catalysed hydrolysis of 5-substituted 1-acetyl-2-
thiohydantoins, as proposed by Congdon and Edward.58 
 
The effect of substituents at the C-5 position on the acid and base-catalysed hydrolysis of 5-
substituted 1-acetyl-2-thiohydantoins has been reported by Congdon and Edward.58 
Substituents at the C-5 position retard the base-catalysed hydrolysis much more than the acid 
catalysed hydrolysis. The authors also suggested the possibility of the hydrogen bond between 
the partially negative sulphur and the hydroxyl group as being important in the mechanism 
(Scheme 1.28).  
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Scheme 1.28: Hydrogen bond formation between the partially negative sulphur and the 
hydroxyl group for 1.19. 
  
The conversion of 2 to 3 (Scheme 1.27) leads to “eclipsing” between the R group at the C-5 
position by the solvated O- and R group of the tetrahedral intermediate (Scheme 1.27). As a 
result, the steric hindrance for the buffer catalysed hydrolysis of 5-substituted 1-benzoyl-2-
thiohydantoins has a large effect on the retardation of the rate of hydrolysis (Table 1.1).60  
 
Table 1.1: Buffer catalysed hydrolysis of 5-substituted 1-benzoyl-2-thiohydantoins in 
aqueous phosphate buffer pH 11.2, 0.45 I, at 25.3 °C. 
1-benzoyl-2-thiohydantoin khydrolysis 
/ 104 s-1  
Unsubstituted 31.40 ± 0.40 
5-methyl 12.70 ± 0.21 
5-phenyl 10.20 ± 0.66 
5-isopropyl 4.77 ± 0.18 
5-isobutyl 6.64 ± 0.15 
5-sec.butyl 4.65 ± 0. 16 
5,5-dimethyl 2.38 ± 0.06 
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Edward and Nielsen61 studied the alkaline hydrolysis of 5-substituted 2-thiohydantoin to 
produce thioureido-acids. Substituents at N-3 speed up hydrolysis because of the lack of 
ionisation of a more acidic hydrogen.61 
Benke62 reported the basic hydrolysis of arylidene-rhodanine 1.20 (Scheme 1.29) supported 
by recent literature63 that interpreted rhodanine hydrolysis as being catalysed by base to 
produce the salt of a thioxo-acid followed by tautomerism to give the thioenolate 1.21 
(Scheme 1.29).  
 
 
 
Scheme 1.29: The hydrolysis product of (Z)-5-benzylidene-2-thioxothiazolidin-4-one. 
 
1.2.4 Racemisation of hydantoin derivatives 
 
Hydantoins and related compounds, including imidazolidine-2,4-dione, 2-thioxoimidazolidin-
4-one (2-thiohydantoin), thiazolidine-2,4-dione and 2-thioxothiazolidin-4-one (rhodanine), 
are subject to racemisation in the presence of a buffer or base. In 1910, Mendel and Dakin64 
published a paper explaining the racemisation of optically active hydantoin in the presence of 
base. The authors proposed that the proton attached to the stereogenic carbon was transferred 
by base and produced a planar carbanion, leading to the tautomeric compound forming 
racemic mixtures.64 Dudley and Bius65 reported the mechanism of the interconversion of 5-
phenylhydantoin by divalent phosphate in vivo without a specific racemase (Scheme 1.30). 
The change in optical rotation was recorded over time using a spectropolarimeter and the 
pseudo-first-order rate constants were obtained in pH range 6.0-7.5. It was determined that the 
rate constant increases linearly with increasing buffer concentration and increasing pH, which 
suggests general-base catalysis. In this article, it was concluded that the abstraction of a 
proton at the asymmetric carbon was the rate-determining step. This was also suggested by 
Dakin.66 After correcting the kinetic data for the ionisation at the N-3 position at each pH, the 
authors suggested that the rate constants for racemisation of 5-phenylhydantoin were almost 
26 
 
the same as those for racemisation of 3-methyl-5-phenylhydantoin. The experimentally 
determined pseudo-first-order rate constant for the racemisation of 5-phenylhydantoin of 
(47.20 ± 1.30).103 /minutes was reported in 0.1 M phosphate buffer (pH 7.5, 0.35 M I). After 
correction, the value was adjusted to (54.90 ± 1.30).103/ minutes (Scheme 1.30) .65 
 
 
 
Scheme 1.30: Mechanism of racemisation of optically active 5-phenylhydantoin or 3-methyl-
5-phenylhydantoin by di-valent phosphate, as proposed by Dudley and Bius.65 
 
Aryl and alkyl groups at the N-1 or N-3 position were suggested by Bovarnic and Clarice67 to 
retard the racemisation, and substituents at both positions may even prevent it. Keto-enol 
tautomerism is essential for hydantoin and thiohydantoin to undergo racemisation. Bovarnic 
and Clarice proposed two possible bond displacements between the nitrogen at the 1 and 3 
positions with the carbonyl at the 2 position and between the hydrogen attached to the 
asymmetric carbon with the carbonyl at the 4 position (Scheme 1.31).  
 
 
 
Scheme 1.31: The keto-enol tautomerism and bond displacement of 5-substituted hydantoins, 
as suggested by Bovarnic and Clarice.67 
 
27 
 
Keto-enol tautomerism has also been detailed for allantoin (5-ureidohydantoin) by Kahn and 
Tipton68 and the SE1 mechanism is expected to be favoured for the base-catalysed 
racemisation of allantoin (vide infra). 
Reist et al.69 studied the racemisation of 5-substituted hydantoins (Scheme 1.32) as a model 
compound in phosphate buffer pH 7.4 at different temperatures. The effect of substituents on 
the rate constants of racemisation at the C-5 position were also discussed. 
 
 
Scheme 1.32: Racemisation of 5-substituted hydantoins studied as a model for chiral drugs by 
Reist et al.69 
 
The pseudo-first-order rate constants of racemisation and H/D exchange were determined for 
compounds 1.22-1.28 and the effect of substituents on the rate constant is quite obvious. A 
general-base catalysed racemisation was also concluded for the 5-substituted hydantoins 
racemisation. Narduolo31 studied the racemisation of hydantoin with different substituents at 
the C-5 and N-3 positions in aqueous solution (Scheme 1.33) and explained the effect of co-
solvents on the rate of racemisation. As can be seen, the methyl group at the N-3 position in 
compound 1.29 (Scheme 1.33) decreased the rate constant of racemisation compared to 
compound 1.25 as reported by Narduolo. This retardation in the rate constant of racemisation 
by the N-3 substituent was also found by Bovarnic and Clarice67 for hydantoin racemisation. 
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Scheme 1.33: Structures of several 3-substituted hydantoins studied with different 5-
substituted hydantoin by Narduolo. 
 
Pseudo-first-order rate constants for racemisation of (167.3 ± 1.3).10-6 s-1 and (114.4 ± 
0.5).10-6 s-1 were reported for compounds 1.25, and 1.29, respectively in H2O phosphate 
buffers (0.25 M, pH 7.2, 0.5 M I, at 60 °C). Similarly, the second-order rate constant for 
racemisation was shown to be lower for compound 1.29 by approximately 34% by Lazarus70 
in comparison with compound 1.25. Lazarus studied the racemisation of 1.25 and 1.29 under 
physiological conditions and proposed general-base catalysed racemisation in which the rate 
constant of racemisation was increased by increasing the concentration of buffer. 
Electronegative substituents on the asymmetric carbon or amino group promote the rate 
constants of racemisation, as suggested previously.66 Therefore, the rate constants of 
racemisation for compounds which have electronegative substituents attached to the 
asymmetric carbon have higher rate constants for racemisation than methyl, isopropyl and 
benzyl substituted compounds. Cabrera et al.71 studied the enantiomerisation of 5-benzyl-3-
phenyl-2-thioxoimidazolidin-4-one 1.33 (Scheme 1.34) using chiral HPLC in methanol-
triethylammonium acetate buffer (pH 4.1) (2:98, v/v), 0.8 ml/min at different temperatures. 
The authors reported the values for the rate constants of enantiomerisation k1 to be 0.0096, 
0.0153 and 0.023 minute-1 at 25, 30 and 35 °C, respectively.  
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Scheme 1.34: Racemic 5-benzyl-3-phenyl-2-thioxoimidazolidin-4-one studied by Cabrera et 
al. 34 
 
Cabordery et al.34 published an important article which reported the mechanism of the 
racemisation of tetrahydroisoquinoline hydantoin and thiohydantoin (Scheme 1.35) studied 
using HPLC and capillary electrophoresis. The rate constants, half-lives and energy barrier for 
racemisation of the different substituted- hydantoin and thiohydantoin compounds were 
reported. The pseudo-first-order rate constants for racemisation of thiohydantoin 1.34a and 
hydantoin 1.34b in ethanolic-aqueous medium show a linear increase with the concentration 
of the phosphate buffer and expected temperature dependence.  
 
 
Scheme 1.35: Tetrahydroisoquinoline a) thiohydantoin, and b) hydantoin studied by 
Cabordery et al.34 
 
The replacement of the oxygen by sulphur increases the rate constant of racemisation, which 
also increases the chiral instability of the enantiomers. Cabordery et al. reported that the 
enantiomer of compound 1.34a needs less than one hour to racemise completely, while the 
enantiomer of compound 1.34b requires 270 days for complete racemisation (Scheme 1.35).  
 
 
 
30 
 
1.3 Comparison of racemisation and H/D exchange kinetics 
 
The carbanion intermediate was first studied by Wilson et al.72, 73 who investigated the 
mechanism of racemisation of l-phenyl-2-methyl-1-butanone by comparing the rate of 
racemisation with the hydrogen-deuterium exchange rate. Wilson observed equal rates for 
racemisation and hydrogen-deuterium exchange of optically active 2-methyl-1-phenyl-1-
butanone in a solution of dioxane-deuterium oxide-sodium deuterium butanone. It was 
proposed that a proton was transferred to the base in the rate-determining step, followed by 
deuteration or protonation of the resulting symmetrical anion on either the oxygen or 
carbon.30 The pyramidal inversion of the optically active tetrahedral carbanion R2R1RC
-
 in the 
racemisation is important to show that both pyramidal configurations are mirror images or 
enantiomers. The cleavage of the proton from the asymmetric carbon by base to form 
carbanion is followed by deuterium exchange in the deuterium containing medium.29, 30 It has 
previously been shown that a comparison of the rate constants for base-catalysed racemisation 
and rate constants for hydrogen-isotope exchange of the optically active carbon acids can be 
used to determine the mechanism of racemisation (Scheme 1.36).30  
 
 
Scheme 1.36: Base-catalysed racemisation and H/D exchange 
 
If a planar carbanion is formed as a result of deprotonation then proton-deuterium exchange 
occurs with complete racemisation because each carbanion is deuterated with equal rate 
constants from the front and from the back. Hence, kH/D/krac approaches unity.
29, 30 Even if the 
anion is not planar the reprotonation rate of the pyramidal configuration of the carbanion is 
typically much slower that the rate of inversion of the carbanion, and deuterium exchange will 
be followed by racemisation. The reaction is therefore expected to follow the SE1 mechanism 
if kH/D is equal to krac (Scheme 1.37).
69
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Scheme 1.37: SE1 mechanism of racemisation. 
 
In the case of exchange with complete net inversion, on the back side, each carbanion will be 
captured simultaneously to deprotonation at the front to produce an inverted molecule. 
Therefore, the exchange rate is half that of racemisation and kH/D/krac = 0.5 (equal that of 
enantiomerisation) (Scheme 1.38).7, 29, 30 
 
 
 
Scheme 1.38: SE2 mechanism of racemisation. 
 
If racemisation in a deuterated solvent occurs without H/D exchange, then kH/D / krac 
approaches 0, also called isoracemisation (Scheme 1.39).74 Isoracemisation was proposed to 
occur in two main ways. First, the proton of the asymmetric carbon might be moved from the 
front side to the backside by external proton donors through intramolecular proton transfer. 
Second, the proton which was attached to the carbon acid becomes reconnected with the 
carbanion and produces a racemic molecule without the isotopic exchange because of the 
absence of sufficiently strong acid to provide protons for the carbanion (Scheme 1.39).30, 75 
For this to occur the carbanion simply rotates 180° while remaining in an ion pair with its 
counterion, i.e. the protonated base (Scheme 1.39). In some cases, moisture can lead to small 
amounts of deuteration to take place. For example, a value of 0.23 was obtained for kH/D/krac 
for 9-deuterio-(or protio)-9-methylfluorene by Cram76 by heating at 145 °C in dry 
tetrahydrofuran containing 0.5 M trimethylamine.30, 77, 78  
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Scheme 1.39: The general mechanism of isoracemisation proposed by Cram.30 
 
Cram indicated that isoracemisation takes place only when k-1 and k2 ≥ k3.30 It can be 
concluded that the reaction medium, including the type of base and solvent used, can change 
the mechanism of racemisation.77 
The exchange process occurs with complete retention if the carbanion is pyramidal and 
protonation is faster than inversion. Complete or predominant retention depends on the 
relative rate of racemisation.29 kH/D / krac approaches infinity for complete retention and kH/D / 
krac > 1 in the predominant retention of configuration. Using ammonia as a base in the 
presence of t-butyl alcohol with optically active compound 1.35 leads to a high retention of 
configuration (kH/D / krac > 50 at 200 °C) (Scheme 1.40).
79 The values of kH/D / krac obtained 
were equal to 10 or higher in the presence of non-dissociating solvents and potassium oxide 
bases used as a catalyst for the racemisation of 2-phenylbutane and 2-( N,N-dimethylamido)-
9-methylfluorene.80 Using a high concentration of ammonia in tetrahydrofuran decreases the 
value of kH/D/krac for 1.35 because ammonia promotes the reaction rate and ion-pair 
dissociation. The retention mechanism occurs when k2 and k-1 > k3. The dissociation of the 
ions becomes faster than ammonium ion rotation if dimethylsulphoxide is used (k3 > k2). This 
can form the symmetrical carbanion, with the value of kH/D / krac going to unity (Scheme 
1.40).30, 79, 80  
33 
 
  
 
 
Scheme 1.40: Mechanism of the retention by ammonium ion rotation proposed by Cram30 
 
 
1.4 Kinetic and equilibrium isotope effects 
 
The contribution of rotational, translational and electronic motion to the overall energy of a 
molecule does not depend significantly on isotopic substitution. On the other hand, the 
vibrational contribution to the energy depends significantly on the isotopic substitution.81 
Therefore, changing the isotope of an atom can have an effect on equilibrium and rate 
constants. Primary kinetic isotope effects take place when a bond involving the isotope is 
broken in the transition state. Secondary kinetic isotope effects occur when the bond 
involving the isotopic substitution is not broken in the transition state, but breaking of another 
(adjacent) bond changes the vibrational frequency of the bond involving the isotope 
substitution. The zero point vibrational energy is given by29, 82 
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𝜀° =  
1
2
 ( hv)                                      Equation 1. 10 
 
where h is Planck’s constant and v is the vibrational frequency of the bond concerned. 
With the vibration frequency v given by Equation 1.11  
v =  
1
2𝜋 √
𝑓
                                      Equation 1. 11 
                       
where f is the force constant of the bond and µ is the reduced mass of the atoms involved in 
the bond. 
The force constants are equal for both isotopes fH = fD and µ is the reduced mass given by 
Equation 1.12. 
𝜇𝐻𝑋 =  
𝑚1  𝑚 2
(𝑚1 + 𝑚2)
  
 
 
           
where m1, and m2 are the masses of the atoms linked by the covalent bond. 
 
From Equation 1.11 and Equation 1.12, the reduced mass of the deuterium attached to a much 
heavier atom becomes 2 and hydrogen attached to a much heavier atom becomes 1. Then the 
frequency ratio becomes 2  (Equation 1.13).  
 
𝑣𝐻𝑋
𝑣𝐷𝑋
=  √
DX  
HX
  4.12  Equation 1. 13 
 
The kinetic isotope effect is obtained from the ratio between the rate constants of two 
reactions that differ in the isotope composition of the reactants (Equation 1.14).83 
 
 
 
 
Equation 1. 12 
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           KIE =  
𝑘light
𝑘heavy
                      Equation 1. 14 
                    
where klight is the rate constant for the reaction of the light isotope and kheavy is the rate 
constant for reaction of the heavy isotope.  
In the solvent kinetic isotope effect, the vibration frequencies of H2O and H3O
+ are different 
from those of D2O and D3O
+. When the solvent is involved in the reaction mechanism, a 
kinetic isotope effect can arise. The isotope effect can be primary, secondary, normal or 
inverse depending on the role of the solvent. As a result of D3O
+ being a stronger acid than 
H3O
+, reactants in D2O solution are protonated more at the same acid concentration (pD) than 
reactants in H2O at the same acid concentration (pH). Therefore, a reaction requiring a 
protonated substrate proceeds faster in D2O than in H2O. The ratio kH2O / kD2O < 1, therefore an 
inverse solvent kinetic isotope effect is observed. Inverse solvent kinetic isotope effects 
happen when solvent is not involved as a proton donor in the rate determining step in the 
reaction. However, the reaction in H2O will be observed to be faster than D2O when the 
proton abstraction is part of the rate determining step and obtain the normal kinetic isotope 
effect.84 Normal solvent kinetic isotope effects happens when the proton transfer is part of the 
rate –determining step and the reaction is faster in H2O than D2O.85 
Proton abstraction from carbon acids in hydantoin and thiohydantoin derivatives has been 
studied previously. Reist et al.69 observed a small solvent kinetic isotope effect for the 
racemisation of 5-substituted hydantoins. Solvent kinetic isotope effect values (1.13 ± 0.05) 
and (1.24 ± 0.08) were observed for the racemisation of (S)-5-phenylimidazolidine-2,4-dione 
(1.22) and (S)-5-benzylimidazolidine-2,4-dione (1.25), respectively, in a 50/50 (v/v) mixture 
of phosphate buffer and DMSO. A negligible solvent kinetic isotope effect on racemisation 
was also obtained for 1.22 and 1.25 by Narduolo31 in D2O- and H2O-phosphate buffers (0.25 
M, 0.5 M I, at 60 °C). Solvent and primary kinetic isotope effects were also determined by 
Narduolo for the compounds shown in Scheme 1.41.  
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Scheme 1.41: (S)-5-H- and (S)-5-D- pyridin-2-ylmethyl)imidazolidine-2,4-dione (1.36, and 
1.37), and (S)-5-H- and (S)-5-D- (1-methyl-1H-pyrrol-2-yl)methyl)imidazolidine-2,4-dione 
(1.38, and 1.39) studied by Narduolo. 
 
Negligible solvent kinetic isotope effects were obtained for compounds 1.36 and 1.38. 
Normal primary kinetic isotope effects for racemisation of 1.36 and 1.38 were observed 
suggesting breaking of the C-H(D) bond in the rate-determining step (Table 1.2).  
 
Table 1.2: Rate constants for racemisation of hydantoins 1.36-1.39 in H2O- and D2O- 
phosphate buffers 0.5 M, 1 M I, pH and pH* 7.2, at 60 °C, and related primary kinetic 
isotope effects studied by Narduolo. 
Buffer 
 
kɵ
a) / 10-6 s-1 Ratio 
1.36 1.37  
H2O 494.0 ± 16.0
 ---------  
 D2O 498.8 ± 6.1 150.5 ± 4.9 3.3 ± 0.1 
Buffer kɵ / 10
-6 s-1 
1.38 1.39  
H2O 208.0 ± 10.0   
D2O 303.5 ± 5.3 61.9 ± 7.2 4.9 ± 0.6 
a) kɵ is the rate constant for the loss of ellipticity determined by CD spectroscopy (See 
chapter 4). 
 
Cabordery et al.34 obtained the value of the solvent kinetic isotope effect ( kH2O / kD2O) of 0.78 
for 2-(3-(benzyl(methyl)amino)propyl)-3-thioxo-2,3,10,10a-tetrahydroimidazo[1,5-
b]isoquinolin-1(5H)-one 1.34a (Scheme 1.35) in 33 mM of H2O- and D2O-phosphate buffer 
and EtOH and EtOD 75/25 (v/v), pH, and pH* 2.5, and 2.6, respectively, at 15 °C. As 
mentioned, Narduolo observed the absence of significant solvent kinetic isotope effects for 
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the general-base catalysed racemisation of substituted hydantoin, which suggests no 
involvement of the solvent in proton abstraction or donation. 
 
1.5 Acid and base catalysis of reactions involving proton transfer 
 
Acid and base catalysis are important in racemisation and other reactions of drug-like 
molecules involving proton transfer. There are two major types of acid/base catalysis, namely 
specific and general catalysis. 
 
1.5.1 Acid catalysis hydrolysis and racemisation 
 
The hydrolysis of 5-substituted 1-acetyl-2-thiohydantoin was studied by Congdon and 
Edward86 in sulphuric acid. The acid-catalysed hydrolysis takes place by a mechanism named 
A2. Deprotonation may take place for the tetrahedral intermediate to produce the neutral 
tetrahedral intermediate. There is also another possibility to reprotonate the other oxygen 
giving a charged intermediate by direct intramolecular proton transfer.87 This type of 
mechanism is called specific acid catalysis and is reported for the hydrolysis of ethyl 
acetate,87 amide hydrolysis and the cleavage of primary ethers.82 The observed pseudo-first-
order rate constants kobs in specific-acid catalysis has been observed to be linearly dependent 
upon hydronium ion concentration [H3O
+] (Equation 1.15). 
 
  −
d[E]
dt
=  𝑘°[E] + 𝑘H [H3O
+][E]                   Equation 1. 15 
 
 
which can be rewritten as a first-order rate law (Equation 1.16). 
 
      −
d[E]
dt
=  𝑘obs[E]                            Equation 1. 16 
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The specific-acid catalysed rate constant can then be calculated using Equation 1.17. 
 
          𝑘obs = 0k + Hk [H3O
+]                     Equation 1. 17 
 
where kobs is the experimental pseudo-first-order rate constant, k0 is the first-order rate 
constant for the uncatalysed reaction and kH is the second-order catalytic rate constant for the 
reaction catalysed by H3O
+. 
In a general-base catalysed reaction, the reaction is catalysed not only by H3O
+ but also by 
any additional weak acid A-H (Equation 1.18).  
 
     𝑘obs = 0k + Hk [H3O
+] +  ]AH[
AH
 k              Equation 1. 18 
 
where kobs is the experimental pseudo-first-order rate constant, k0 is the first-order rate 
constant for the un-catalysed reaction, kH is the second-order catalytic constant for the 
reaction catalysed by H3O
+
, kAH is the second-order catalytic constant for the reaction 
catalysed by the general acid AH, and ΣkAH [AH] is the sum over the contributions of all 
catalytically active acids present. 
General-acid catalysis can occur when rate determining proton transfer takes place from acids 
other than from the solvated proton.84 Acid-catalysed racemisation of catecholamines 1.40 
(Scheme 1.42) was reported by Venter88 who suggested that racemisation occurs via the 
formation of a quinoidal intermediate rather than via an SN1-type reaction. The proposed 
mechanism involves the loss of the hydroxide group resulting in the formation of a highly 
stable achiral intermediate and thus loss of optical activity. Stabilisation of the compound may 
occur by the formation of a quinonoid intermediate.88  
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Scheme 1.42: Acid-catalysed racemisation mechanism of (S)-2-hydroxy-2-(4-
hydroxyphenyl)-N-methylethan-1-aminium (1.40a) and (S)-N-(2-hydroxy-2-(4-
methoxyphenyl)ethyl)propan-2-aminium (1.40b), proposed by Venter. 
 
For comparison, the mechanism shown in Scheme 1.8 was also proposed for the acid-
catalysed racemisation of the structurally similar L-adrenaline 1.5 (Scheme 1.8).88 
 
1.5.2 Base catalysis in selected hydrolysis and racemisation reactions 
 
The first-order rate constants for a reaction undergoing specific-base catalysis, i.e. the reaction 
is not catalysed by any other bases, vary linearly with [OH-] according to Equation 1.19.  
 
𝑘obs = 0k +  𝑘OH[OH
−]                   Equation 1.19 
 
where kobs is the experimental pseudo-first-order rate constant, k0 is the first-order rate 
constant for the uncatalysed reaction and kH is the second-order rate constant for the reaction 
catalysed by OH-.  
Reaction involving fast proton transfer from the molecule to a base, followed by a slow step 
involving the deprotonated substrate molecule exhibits a specific-base catalysis rate law.87 
 In the general-base catalysis of hydrolysis and racemisation, the reaction is catalysed by OH- 
and any base B.84 The observed rate constant for a reaction undergoing general-base catalysis 
is given by Equation 1.20. 
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𝑘obs = 0k +  𝑘OH[OH
−] +  ]B[
B
k               Equation 1. 20 
 
where kobs is the experimental pseudo n-th order rate constant, k0 is the rate constant for the 
uncatalysed reaction, kOH is the catalytic constant of the hydroxide catalysed reaction, kB is the 
catalytic constant of the reaction catalysed by general base B, and ΣkB.[B] is the sum over the 
contributions of all catalytically active bases present.87 The base-catalysed hydrolysis of the 
hydantoin and thiohydantoin derivatives have been reported previously.58, 89, 90 The base-
catalysed racemisation of substituted hydantoins and thiohydantoins has also been studied in 
buffer which catalyses the abstraction of the acidic hydrogen at the asymmetric carbon and 
buffer therefore racemises the compounds.31, 34, 69, 70  
 
1.5.3 Brønsted plots  
 
The proton transfer of the carbon has an important role in racemisation which depends on the 
acidity of the CH which in turn depends on the polar reaction involving the charge 
delocalisation, bond formation and cleavage.91 The enolisation of hydantoin derivatives is 
subject to general-base catalysis as mentioned by Lazarus70 and the catalysing power of the 
base is related to the equilibrium base strength, as expressed by Equation 1.21.  
 
log𝑘𝐵 = 𝛽 ×  p𝐾𝑎 + 𝐶 
 
Equation 1. 21 
 
  
where kB is the second-order catalytic constant for the reaction catalysed by the general base 
B, β is the Brønsted parameter associated with the reaction catalysed by general-bases which 
show the sensitivity of the reaction to change in structure of the catalysing base, and pKa is the 
dissociation constant of the conjugate acid of the catalytic base B.92  
The values of α and β in general-acid and base catalysis, respectively, can be determined from 
the slope of the logarithm of observed rate constant versus pKa of the conjugated-acid or base. 
The Brønsted coefficient is typically interpreted as the degree of proton transfer in the 
transition state, falling between 0 and 1 for most reactions.82, 84 When the Brønsted coefficient 
equals 0, it suggests that the transition state is close to the reactant; when it is equal to 1, it 
suggests a transition state close to the product.82 As mentioned before, isotope effects also 
probe proton transfer and can be considered alongside the Brønsted coefficient to show if 
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proton transfer is involved in the rate-determining step or not. In the solvent kinetic isotope 
effect, kH2O / kD2O can be obtained as normal or inverse based on the mechanism of the proton 
transfer. In the normal kinetic isotope effect, the proton transfer is part of the rate determining 
step and rapid equilibrium protonation in the inverse kinetic isotope effect. Lazarus70 reported 
a β-value of 0.59 for the base-catalysed racemisation of L-5-benzylhydantoin and 0.51 for L-
5-benzyl-3-methylhydantoin. These values suggest that the proton is only half-transferred in 
the rate determining step. Narduolo31 obtained a β-value for L-5-benzyl-3-methylhydantoin of 
0.57 and 0.59 at 25 and 60 °C, respectively.  
The Brønsted coefficient and solvent kinetic isotope effect have been calculated for acetone 
enolisation at 25 °C.92 A correlation between β and kH2O/kD2O was reported with the largest 
isotope effects associated with values of β close to 0.5 and the smallest isotope effect 
correlated with β equal to 0.82.92  
A general Marcus-type mechanism can be proposed for proton abstraction in aqueous solution 
in which formation of a hydrogen bond between the acid and base formally preceeds proton 
transfer. Following proton transfer, the conjugate base of the acid and the protonated base are 
hydrogen bonded. Reaction is completed by breaking this hydrogen bond (HBC1 and HBC2 in 
Scheme 1.43).93  
 
 
 
Scheme 1.43: proton transfer mechanism. 
 
The observed rate constant of the proton transfer in Scheme 1.43 from HA to B is given by 
equation 1.22.93 
 
𝑘obs =
𝑘1 𝑘2 𝑘3
[𝑘−1(𝑘−2 + 𝑘3) + 𝑘2 𝑘3]
 
 
 
Equation 1. 22 
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Assuming the intermediates are present in low concentration, two main mechanisms are 
possible. First, when k2 > k-2, the formation of H1 is the rate-determining step and kobs = k1, 
when k2 < k-2, the kobs for the cleavage of hydrogen bond (HBC1 and HBC2 in Scheme 1.43) is 
kobs = (k1/k-1) (k2/k-2) k3. In this case, the proton transfer between the HBC1 and HBC2 is fast. 
Second, proton abstraction is the rate-determining step when the interconversion of the 
complex is slow; then k2 < k-1 and k3 > k-2, and therefore, kobs = (k1/k-1) k2 (Scheme 1.44).
93   
 
 
Scheme 1.44: Standard free energy change of proton abstraction reaction and transition state 
structure differences.93 
 
From Schemes 1.43 and 1.44, the reaction becomes exothermic when HA is a much stronger 
acid than BH+, and the transition state lies towards the reactant, with G≠ closer to 𝐺𝑅
°
 than to 
𝐺𝑝 
°. Then, the deprotonation reaction will have a Brønsted β of 0. On the other hand, the 
reaction would be endothermic if HA is a much weaker acid than BH+ and the transition state 
lies to the product with G≠ closer to 𝐺𝑝
°  . In this case the reaction catalysed by A- will have β = 
1.94  
ΔGR° < 0 
ΔGR° > 0 
ΔGR° = 0 
≠
  
≠
  
≠
  
≠
  
≠
  
Δ𝐺𝑅
°  
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Since β= 1-α, 𝛥𝐺≠ =  𝐺≠ −  𝐺𝑅
°   and 𝛥𝐺° =  𝐺𝑝 
° − 𝐺𝑅
° , the Brønsted coefficient can be 
expressed as a function of the free energy according to Equations 1.23, 1.24 and 1.25 to 
obtain 1.26. 
 
𝛿𝐺≠ = 𝛼 𝛿𝐺𝑝 
° +  𝛽 𝛿𝐺𝑅
° 
 
Equation 1. 23 
  
𝛿𝐺≠ =  𝛼 𝛿𝐺𝑝 
° +  𝛿𝐺𝑅
° −  𝛼 𝛿𝐺𝑅
° Equation 1. 24 
 𝛿𝐺≠ −  𝛿𝐺𝑅
° =  𝛼 (𝛿𝐺𝑝 
°  −  𝛿𝐺𝑅
° ) 
 
Equation 1. 25 
  
𝛼 or 𝛽 = (𝛿𝛥𝐺≠)/(𝛿𝛥𝐺° ) 
 
Equation 1. 26 
  
where 𝛥𝐺° is the free energy of the reaction and 𝛥𝐺≠ is the free energy of activation. 
When the acidity strength of HA and BH+ is similar, then α and β values will be between 0 
and 1. Therefore, changing the strength of B changes 𝛥𝐺°and 𝛥𝐺𝑅
°, and according to 
Equation 1.19, the values of α and β will also change. It can be concluded from Scheme 1.44 
that for the symmetrical proton transfer when 𝛥𝐺𝑅
° = 0 , the value of β = 0.5, for 𝛥𝐺𝑅
° < 0, 
the value of β will be less than 0.5, and β will be higher than 0.5 in the case of 𝛥𝐺𝑅
° > 0.93 
 
1.5.4 Enzyme catalysed hydrolysis and racemisation of hydantoin derivatives 
 
5-Substituted hydantoins can be considered as amino acids that are cyclised (vide supra). 
Some enzymes can hydrolyse the substituted hydantoins to the carbamoyl amino acid and in 
some cases produce amino acids.95, 96 Some bacteria can be used to prepare enantiopure amino 
acids from racemic 5-substituted hydantoins (Scheme 1.45).97 The rate constant of 
racemisation plays an important role in the production of enantiopure L- and D-N-carbamoyl 
amino acids followed by the formation of L- and D-amino acids. If the rate constant of 
hydantoin racemisation is quite slow in comparison with the rate constant of the hydrolysis, 
then the optically active hydrolysed compound can be prepared.98 On the other hand, the 
optically active hydrolysed compounds are impossible to prepare when the racemisation 
process takes place faster than the hydrolysis. Therefore, the substituents at the C-5 position 
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have an important role in controlling the rate constant of racemisation rather than hydrolysis 
as discussed for the racemisation and hydrolysis rate constant of thiohydantoin derivatives 
(Scheme 1.45).  
 
Scheme 1.45: Synthesis of optically active α-amino acids with enantioselective 
hydantoinase–carbamoylase with in situ racemisation, proposed by Servi et al.97 
 
Lee and Fan98 studied the enzymatic hydrolysis and racemisation of 5-phenylhydantoin and 5-
(p-hydroxyphenyl)hydantoin to produce N-carbamoyl amino acid, as catalysed by 
hydantoinase. The authors observed an increase in the rate constant for hydrolysis with 
increasing pH. It has also been observed that the rate constant for racemisation of 5-(p-
hydroxyphenyl)hydantoin is higher than the 5-phenylhydantoin racemisation rate constant. 
The enzymatic synthesis of hydantoin is documented as a well-established process to prepare 
optically active hydantoin without a toxic chemical compound. The keto-enol tautomerism 
was also mentioned to be affected by more electronegative hydroxyl substituents at the para 
position which can stabilise the enolate structure and promote the rate constant of the 
racemisation.  
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1.6 Mechanistic studies of racemisation reactions 
 
Narduolo31 reported a krac / kH/D between 1.2-1.3 for S-5-benzylhydantoin which supports the 
SE1 rather than the SE2 mechanism (25 °C using 0.1 and 0.5 M of D2O-phosphate buffer, pH* 
7.2, 1 M I). The SE1 mechanism is illustrated in Scheme 1.46. 
 
 
Scheme 1.46: Proposed SE1 mechanism for hydantoin derivatives. 
 
Cabordery et al.34 proposed the SE1 mechanism for Tic-hydantoin (1.34 b) racemisation in 33 
mM, pD 7.3 deuterated-phosphate buffers / EtOD- 75/25 (v/v) at 25 °C which kH/D / krac ~ 1 
and the deuteration occurring with complete racemisation (Scheme 1.35). Similarly, the 
racemisation of amfepranone and cathinone have been reported to proceed via the SE1 
mechanism in D2O-phosphate buffer (pD 7.4, 0.43 M I).
99  
Reist et al.,69 found kH/D / krac for 5-benzylhydantoin (1.25) (Scheme 1.32) to vary between 0.6 
and 0.7 in a mixture of D2O-phosphate buffer (pD 7.4, 0.1 M, 0.22 M I) with 1:1 D6-DMSO 
(v:v) between 50 °C to 80 °C. Cabordery et al.34 proposed the SE2 mechanism for 
thiohydantoin 1.34 a (Scheme 1.35) in 33 mM, pD 2.6 deuterated phosphate buffers / EtOD-
75/25 (v/v) at 15 °C based on the observation that the rate constant for deuteration was about 
half the rate constant for racemisation, suggesting that deuteration occurs with an inversion of 
conﬁguration. The push-pull SE2 mechanism for thiohydantoin proposed by Reist et al. is 
show in Scheme 1.47 where H or D can be transferred by base or OD on one side and attack 
by the H or D from the other side, producing the inverted configuration (Scheme 1.47). 
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Scheme 1.47: proposed SE2 mechanism for thiohydantoin and hydantoin derivatives. 
 
The kinetics and mechanism of allantoin racemisation was reported by Kahn and Tipton68 in 
D2O-phosphate buffer at pH between 5.7 and 10 at 22 °C. The authors proposed three 
possible mechanisms for the racemisation of (S)-5-ureido-hydantoin (1.40): SE1, SE2 and SN2. 
The rate constants for H/D exchange (kH/D) increase with increasing phosphate buffer 
concentration. There was no clear explanation to favour the SE1 mechanism over the SE2 
mechanism or vice versa by Kahn and Tipton for allantoin racemisation. Therefore, only a 
general SE mechanism was suggested which could be either SE1 or SE2 for the general-base 
catalysed racemisation of allantoin 1.41 (Scheme 1.48). This was in agreement with the SE1 
mechanism proposed by Narduolo31 and Cabordery et al.34 and also the SE2 mechanism 
suggested by Reist et al.69 for the racemisation of substituted-hydantoin (vide supra). 
Allantoin can racemise via an SN2-like mechanism, as shown in Scheme 1.48, via the 
formation of a symmetrical bicyclic intermediate formed between the primary amide and C4. 
This mechanism is not possible for other 5-substituted hydantoins because of the absence of 
suitable substituents at the C-5 position of hydantoin.  
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Scheme 1.48: The racemisation mechansim of allantoin, proposed by Kahn and Tipton68 
  
There is no practical evidence available to show the mechanism of the racemisation of 
thiazolidine-2,4-dione (1.10 b) and 2-thioxothiazolidin-4-one (1.10 c) (Scheme 1.19). Jamali 
et al.100 reported keto-enol tautomerism, an unsurprising way to convert R enantiomers to S 
enantiomers and vice versa for 5-substituted thiazolidine-2,4-dione (Scheme 1.49). Similarly, 
the keto-enol tautomerism has also been suggested for hydantoin, as mentioned in 1912 by 
Dakin.101 
 
 
Scheme 1.49: The keto-enol tautomerism of 5-substituted- thiazolidine-2,4-dione. 
 
A theoretical study of the racemisation mechanism and the factors which promote the base- 
catalysed racemisation of thiazolidine-2,4-dione (1.10 b) was conducted by Bharatam and 
Khanna.102 The authors suggested that the possibility of keto-enol tautomerism of 
thiazolidine-2,4-dione is very low in comparison with acetaldehyde. It is known that the 
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sulphur, phosphorus and electron-withdrawing groups at the α-carbon accelerate H/D 
exchange and stabilise carbanion formation.29 Computationally, it has been illustrated that the 
thiazolidine-2,4-dione ring is liable to be planar and deprotonated at the asymmetric carbon 
through increased π-delocalisation.102 The sulphur can be oxidised, which increases the 
acidity of substituted thiazolidine-2,4-dione. Furthermore, different tautomeric formations of 
substituted thiazolidine-2,4-dione have been suggested by Bharatam and Khanna which are 
less favourable in acid-base catalysed racemisation (Scheme 1.50). 
 
 
Scheme 1.50: Oxidation and keto-enol tautomerism of substituted-thiazolidine-2,4-dione. 
 
Taxak et al.103 have also suggested that S-oxidation for thiazolidine-2,4-dione increases the 
acidity of the asymmetric carbon and promotes racemisation. This sulphur-oxidation increases 
the rate constant of racemisation, which is a major factor for promoting racemisation (Scheme 
1.51). 
  
 
 
 
Scheme 1.51: Oxidation and keto-enol tautomerism proposed by Taxak et al. 
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Scheme 1.51 illustrates that direct keto-enol tautomerism from C to D is more likely to take 
place for the racemisation of 5-substituted thiazolidine-2,4-dione than B to A as expected by 
Taxak et al. No H/D exchange rate constant studies have been carried out for 5-substituted 
thiazolidine-2,4-diones and 2-thioxothiazolidin-4-ones to compare with the rate constants of 
racemisation. Hence, it has been thus far impossible to assign a mechanism for these reactions 
similar to Narduolo’s31 work on hydantoin and Reist et al.69 Jamali et al.100 studied the 
racemisation of the enantiomers of pioglitazone 1.42 and rosiglitazone 1.43 in 25 mM 
phosphate buffer (pH 2.5, 7.4, and 9.3 at 37 °C). Full racemisation was observed for 1.42 and 
1.43 within 48 hours at pH 7.4 and 24 hours at pH 9.3 (Scheme 1.52). 
 
 
 
Scheme 1.52: Structures of pioglitazone and rosiglitazone studied by Jamali et al.100 
 
Welch et al.104 studied the racemisation of 5-arylthiazolidine-2,4-dione (Scheme 1.53) in 
different solvents and observed fast racemisation of compound 1.44 in various media 
including dog plasma.  
 
 
 
Scheme 1.53: 5-Arylthiazolidine-2,4-dione studied by Welch et al.104 
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The racemisation half-life, t1/2, of 1.44 in ethanol at 10-14 hours showed rapid racemisation to 
reach 50% ee. Using 0.2 eq of trimethylamine caused 1.44 to racemise in a few minutes. 
However, using 0.2 eq. of acetic acid increases the half-life t1/2 > 20 h, and in chloroform the 
compound needs more than a week to racemise. The racemisation of 1.44 has also been 
studied in a mixture of ethanol and pH 9 buffer, where 1.44 can be racemised in less than 2 h.  
 
1.7 Aims and Objectives 
 
The main goal of this work is to measure the racemisation rate constants for 2-
thioxoimidazolidin-4-ones (thiohydantoins), 2-thioxoimidazolidin-4-ones, and 2-
thioxothiazolidin-4-ones (rhodanines) as drug-like molecules under physiological conditions. 
The hydrolysis of these molecules is one of the possible side reactions which may affect the 
observed kinetics and it is therefore important to study and compare the hydrolysis with the 
racemisation reaction. There are many factors influencing the rate of racemisation and 
hydrolysis that should be studied, such as temperature, pH, and the presence of acids and 
bases. The effect of various substituents at the asymmetric carbon and different position of the 
molecules on the rate of racemisation and hydrolysis will be investigated. The H/D exchange 
reaction of the molecules will be studied. The observed rate constants for H/D exchange can 
be divided by the corresponding rate constants for racemisation. Together with solvent kinetic 
isotope effects, the kinetic data will allow us to propose a mechanism for the racemisation of 
chiral substituted 2-thioxoimidazolidin-4-ones (thiohydantoins), 2-thioxoimidazolidin-4-ones, 
and 2-thioxothiazolidin-4-ones (rhodanines). 
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related compounds 
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2.1 Introduction 
2.1.1 Five-membered heterocyclic rings in medicine 
 
Five-membered multi-heterocyclic rings play important roles in medicinal chemistry and 
many have biological activity.1,2,3 Drugs based on five-membered heterocycles include 
hydantoins, 2-thiohydantoins, thiazolidine-2,4-dione and thioxothiazolidin-4-one, and these 
motifs are widely used in drug discovery (Scheme 2.1).3  
 
 
 
Scheme 2.1: Structures of (a) 2-thiohydantoin1a) (2-thioxoimidazolidin-4-one), (b) 
thiazolidine-2, 4-dione1b) (c) 2-thioxothiazolidin-4-one1c) (rhodanine), and (d) hydantoin1d) 
(imidazolidine-2,4-dione). 
 
For many drugs, it is known that their biological activity is related to their chirality. 
Therefore, both the synthesis and configurational stability of single enantiomers of drugs are 
important for investigation in research studies.4,5  
 
1) In this thesis, various nomenclatures for the studied compounds have been used, viz.  
the common and IUPAC names as follows: 
a) 2-Thioxoimidazolidin-4-one is the same as 2-thiohydantoin. 
b) 2-Thioxothiazolidin-4-one is the same as rhodanine.  
c) Thiazolidine-2,4-dione is always mentioned called as such.  
d) Hydantoin is the same as imidazolidine-2,4-dione. 
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2.1.2 Synthesis of thiohydantoins 
 
The simplest preparation of thiohydantoin involves heating the hydrochloride salt of ethyl 
amino acetate with potassium thiocyanate at 140-150 °C and was reported by Peter Klason in 
1890.6 The resulting product is a basic thiohydantoin which has been used as a starting 
material in reactions with different aldehydes to prepare 5-arylidene-2-thiohydantoins 
(Scheme 2.2).7  
 
 
 
 
Scheme 2.2: Condensation and reduction process of 2-thiohydantoin.  
 
Different aromatic aldehydes have been condensed with thiohydantoin in the presence of 
triethylamine or triethanolamine to prepare arylidene derivatives.8,7 The reduction of such 
arylidene thiohydantoin derivatives (Scheme 2.2) has been carried out using Pd / C dissolved 
in THF. However, for thiohydantoins, this reaction typically produces poor yields, in contrast 
to hydantoin derivatives. Instead, using zinc dust in acetic acid to reduce the double bond has 
been successful in the preparation of a wide range of racemic 5-substituted 2-thiohydantoins 
with good yields, as reported by Garst.9 Furthermore, 5-substituted 2-thiohydantoins have 
been synthesised, including with alkyl substituents at the 5-position by mixing various amino 
acids with thiourea and melting together at 180 °C in a solvent-free process.10 Using high 
temperatures to melt the reactants led to formation of non-optically active products.  
The acetylation of 2-thiohydantoin at the N-1 position was developed by Johnson in 1911.11 
Johnson et al. published an initial article showing the preparation of 1-acetyl-2-thiohydantoin 
using the amino acid glycine and ammonium thiocyanate in the presence of acetic acid, and 
acetic anhydride produces 1-acetyl-2-thiohydantoins (Scheme 2.3). Further amino acids were 
used to prepare 1-acetyl-2-thiohydantoin subsequently.12,13,14, 15  
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Scheme 2.3: Johnson’s suggested mechanism for the formation of 1-acetyl-2-thiohydantoin 
 
The reaction between amino acids and acetic anhydride produces acetyl amino acids, as 
suggested by Johnson13. These are transformed directly during the reaction to the 
corresponding lactone-anhydrides by reacting with extra acetic anhydride (Scheme 2.3). The 
corresponding lactone-anhydride then reacts with the thiocyanic acid which is formed from 
ammonium thiocyanate by the action of acidic anhydride to produce the corresponding acyl 
isothiocyanate. Finally, 1-acetyl-2-thiohydantoin is obtained by the intramolecular 
rearrangement of unstable acyl isothiocyanate (Scheme 2.3).13, 15, 16 On the other hand, 
Johnson did not mention the optical activity of his compounds which is important for the 
research described in this thesis. Csonka and Nicolet17 prepared an optically active 1-acetyl-5-
methyl-2-thioxoimidazolidin-4-one by following Johnson‘s method, using acetic anhydride 
and acetic acid. Furthermore, racemic 3,5-disubstituted 1-acetyl-2-thiohydantoins can also be 
prepared followed LeTiran’s method,18 as confirmed by Reyes and Burgess.14  
The cyclisation process is one of the most interesting ways to prepare a library of hydantoins 
or thiohydantoins substituted at all three sites. A range of aromatic aldehydes in the presence 
of phenyl isothiocyanate and methyl esters of various amino acids together with triethylamine 
and tri-acetoxyborohydride were used to obtain the corresponding substituted 2-
thiohydantoins with substituents at the 1,3, and 5 positions.19 This method has been reported 
for the preparation of a library of 1,3,5 trisubstituted 2-thiohydantoins by cyclative cleavage 
in solid phase synthesis.19,20  
The condensation reaction between different aromatic aldehydes with thiazolidine-2,4-dione 
and 2-thioxothiazolidin-4-one was performed by the Knoevenagel condensation.21 
Commercially available thiazolidine-2,4-dione and 2-thioxothiazolidin-4-one were condensed 
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with aldehydes in ethanol, containing piperidine, to prepare several 5-arylidenethiazolidine-
2,4-diones and 5-arylidene-2-thioxothiazolidin-4-ones.22 
The reductions of 5-arylidenethiazolidine-2,4-diones were carried out using zinc dust in acetic 
acid.9 Garst et al.9 prepared 5-benzyl-2-thioxoimidazolidin-4-one from 5-benzylidene-2-
thioxoimidazolidin-4-one. Lithium borohydride in THF in the presence of pyridine was also 
used to reduce (Z)-5-arylidenethiazolidine-2,4-dione to prepare the corresponding chiral 
compounds.23,24 
 
2.2 Results and discussion 
2.2.1 Synthesis of 5-substituted derivatives of 2-thioxoimidazolidin-4-one 
 
5-Benzylidine-2-thiohydantoin was synthesised following the methods previously used for 5-
benzylidinehydantoin by using commercially available hydantoin dissolved in ethanol in the 
presence of benzaldehyde and triethylamine (this was done following the success of a test 
reaction).25, 8 The same procedure was used to prepare different substituted thiohydantoins at 
the 5-position by using different aldehydes (Scheme 2.4).9 
 
 
Scheme 2.4: Synthesis of 5-substituted 2-thiohydantoins 
 
Several aromatic aldehydes were used with commercially available 2-thiohydantoin and the 
procedure was employed to prepare unsaturated 5-substituted 2-thiohydantoin (see 
experimental section).  
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2.2.2 Synthesis of 5-substituted derivatives thiazolidine-2,4-dione and 2-
thioxothiazolidin-4-one 
 
The Knoevenagel condensation was also used for the condensation of aldehydes with 
thiazolidine-2,4-dione26,21 in ethanol in the presence of piperidine to prepare (Z)-5-
benzylidenethiazolidine-2,4-dione, (Z)-5-(pyridin-2-ylmethylene)thiazolidine-2,4-dione and 
(Z)-5-(4-methoxybenzylidene)thiazolidine-2,4-dione (Scheme 2.5, X=O). Likewise, the 
Knoevenagel condensation was successfully applied to commercially available 
thioxothiazolidin-4-one with benzaldehyde and 2-pyridine-carboxaldehyde to synthesise the 
corresponding 5-substituted- 2-thioxothiazolidin-4-ones (X=S) (Scheme 2.5). 
 
 
Scheme 2.5: Knoevenagel condensation reaction of aromatic aldehydes with thiazolidine-2,4-
dione and 2-thioxothiazolidin-4-one 
 
The Z isomer of 5-(pyridin-2-ylmethylene)-2-thioxothiazolidin-4-one was obtained through a 
Knoevenagel condensation reaction in the present work. The 3D structure of representative 5-
(pyridin-2-ylmethylene)-2-thioxothiazolidin-4-one was determined using X-ray crystal 
structure analysis (Figure 2.1). 
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Figure 2.1: The molecular structure of compound 18 determined by X-ray crystallography. 
 
Many derivatives of 2-thioxoimidazolidin-4-one, thiazolidine-2,4-dione and 2-
thioxothiazolidin-4-one with substituents at the 5-position were prepared. 1H-NMR spectra 
for all compounds showed a typical signal for the hydrogen on the double bond (CH=C) in the 
range of 5.6-7.6 ppm for thioxoimidazolidin-4-one, and in the range of 7.75-7.9 ppm for 
thiazolidine-2,4-dione and 2-thioxothiazolidin-4-one. No overlaps were seen in 1H-NMR 
spectra between a typical signal for the hydrogen on the double bond and aromatic ring 
signals for thiazolidine-2,4-dione and 2-thioxothiazolidin-4-one. 
 
2.2.3 The reduction reaction of 5-substituted derivatives of 2-thiohydantoin, 
thiazolidine-2,4-dione and 2-thioxothiazolidin-4-one 
 
The reduction of the double bond in (Z)-5-benzylidene-2-thioxoimidazolidin-4-one was 
carried out using Pd/C as a catalyst and THF as a solvent.8 The product was obtained, but in 
poor yield. The use of Zn dust with acetic acid was previously used just for (Z)-5-
benzylidene-2-thioxoimidazolidin-4-one.9 Using this procedure, we were able to reduce not 
only compound 1 but also all other unsaturated 2-thioxoimidazolidin-4-ones, except 
compound 7 (Scheme 2.6). 
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Scheme 2.6: Synthesis of racemic 5-substituted 2-thiohydantoins. 
 
The reduction procedure in Scheme 2.6 was used for compound 7; however, we obtained an 
unknown product. The reduction procedure by zinc and acetic acid was repeated using a 
longer reaction time to reduce compound 7. Despite this, no clear result was obtained 
(Scheme 2.7). 
 
 
Scheme 2.7: Attempted synthesis of compound 7. 
 
Fortunately, the adjacent hydrogen on the stereogenic centre and diastereotopic protons on the 
CH2 for all compounds, except compound 7, were clearly visible in 
1H-NMR spectra, 
confirming the reduction process, and thus generation of the stereogenic centre. 
Similarly, the catalysed reduction using zinc dust was also tried for 5-substituted thiazolidine-
2,4-diones. However, its success depends on the types of substituents involved. The reduction 
process by zinc dust was not accomplished for 5-benzylidenethiazolidine-2,4-dione 12 in the 
attempted synthesis of 13 (Scheme 2.8).  
 
 
Scheme 2.8: Attempted synthesis of compound 13. 
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The reduction process by zinc and acetic acid was successful for 5-(pyridin-2-ylmethylene) 
thiazolidine-2, 4-dione 14 and pure 15 was obtained in good yield. The zinc acid catalysed 
reduction also worked for 16 and 18 to produce compounds 17 and 19, respectively (Scheme 
2.9). 
 
 
 
Scheme 2.9: Reduction of compounds 14, 16 and 18. 
 
As an alternative, reduction using LiBH4 in THF was tried for (Z)-5-benzylidenethiazolidine-
2,4-dione 12. The reduction of the double bond at room temperature and purification by 
column chromatography produced the desired 5-benzylthiazolidine-2, 4-dione 13 (Scheme 
2.10). 
 
 
Scheme 2.10: Reduction of 5-benzylidenethiazolidin-2,4-dione. 
 
Finally, microwave heating (300 W, 120 °C, max pressure 300 psi) was also used to 
synthesise 5-benzylthiazolidine-2,4-dione using the LiBH4 procedure, as previously 
reported,23 and this procedure was successful. 
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2.2.4 Synthesis of 5-substituted 2-thiohydantoin under solvent free conditions 
 
The condensation of thiourea with different amino acids serves as an excellent starting point 
in the preparation of 5-substituted 2-thiohydantoins.27,10 We have used several amino acids 
with thiourea to synthesise the corresponding 5-substituted 2-thioxoimidazolidin-4-ones under 
solvent free conditions. Compounds 20-25 were synthesised using thermal heating between 
180-200 °C, i.e. in liquid thiourea. The required reaction time ranged from 15 to 25 min, with 
14.0- 42.0 % yields obtained (Scheme 2.11). 
 
 
 
Scheme 2.11: Conditions proposed by Wang and co-workers for the synthesis of racemic 5-
substituted 2-thiohydantoins10 
 
The use of high temperature during the reaction resulted in all products being non-optically 
active compounds, i.e. racemic mixtures. We tried quenching the products in organic solvent 
without adding water, followed by washing with water at room temperature and evaporation 
of the organic solvent. Our efforts failed to produce enantioenriched compounds, although the 
literature suggested this should be possible10 by the condensation of thiourea with enantiopure 
amino acids under solvent free conditions. The authors reported that this procedure is safe to 
prepare, even for enantiopure 5-substituted 2-thiohydantoins, but this was reported without 
the confirmation of optical activity. Unfortunately, all products prepared were non-optically 
active compounds, as confirmed by either polarimetry or CD spectroscopy. All 5-substituted 
2-thiohydantoins were characterised by 1H-NMR, 13C-NMR and MS.  
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2.2.5 Synthesis of 5-substituted 1-acetyl-2-thiohydantoin 
We started the synthesis of 5-substituted 1-acetyl-2-thiohydantoin from different amino acids 
and ammonium thiocyanate with acetic acid and acidic anhydride, as previously reported 
(Scheme 2.12, and see section 2.1.2).9,7 
 
Scheme 2.12: Synthesis of 5-substituted 1-acetyl-2-thiohydantoins by the reaction of amino 
acid derivatives with ammonium thiocyanate including acetic acid and acetic anhydride. 
 
We follow the post-1907 nomenclature for 2-thiohydantoins according to which the acetyl 
group in Scheme 2.12 is substituted at the N-1 position. The same compound, 1-acetyl-2-
thioxoimidazolidin-4-one, has also been named 3-acetyl-2-thioxoimidazolidin-4-one by Davis 
et al.28 who used the same synthetic procedure as Johnson. 2-D COSY NMR spectroscopy 
confirmed that the acetyl group was substituted at the NH-1 rather than the NH-3. 
Unfortunately, the change in nomenclature has affected several publications where an 
incorrect nomenclature is used.9, 28  
We followed the procedure of Csonka and Nicolet17 for the synthesis of optically active 5-
substituted 1-acetyl-2-thioxoimidazolidin-4-ones, with various changes (see Chapter 1). 
However, the temperature of the reaction was not indicated by the authors. Generally, the 
same amount of acetic anhydride and acetic acid was used to prepare several 5-substituted 1-
acetyl-2-thiohydantoins by using the corresponding enantiopure amino acids and different 
reaction times. Essentially, the temperature and the reaction time were decreased to synthesise 
as much as possible of the high optically active compounds (Scheme 2.13). 
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Scheme 2.13: Synthesis of optically active 5-substituted 1-acetyl-2-thioxoimidazolidin-4-
ones. 
 
L-phenyl alanine, L-valine, L-tryptophan and L-methionine were reacted gently with 
ammonium thiocyanate, acetic anhydride and acetic acid to produce the corresponding 
optically active 5-substituted 1-acetyl-2-thioxoimidazolidin-4-ones (See experimental 
section). Using L-phenyl glycine produces racemic 1-acetyl-5-phenyl-2-thioxoimidazolidin-4-
one. All reactions involving amino acids as starting material were successful in producing 
products, although as the racemates. The reaction involving histidine failed to produce the 
required product altogether. The preparation of thiohydantoin from histidine was 
unsuccessful, despite trying different temperatures and concentrations of ammonium 
thiocyanate, acetic anhydride and acetic acid. This procedure was previously tried by Swan29 
in 1952, who used histidine and N-acetyl histidine and warming with acetic anhydride and 
ammonium thiocyanate to produce an unstable compound. At the end, the unstable products 
are converted by dilute acetic acid into a mono-acetyl compound, such as 5-(1-acetyl-4-
iminazolyimethyl)-2-thiohydantoin, rather than 1-acetyl compounds.11 Using an excess of 
acetic anhydride causes racemisation and produces racemic compounds,30 and the formation 
of lactone anhydride (azlactone) destroys the second mole of acetic anhydride (see Scheme 
2.3). Therefore, active intermediate azlactone might prevent the racemisation if formed 
rapidly.17 Column chromatography was performed over silica gel using hexane and diethyl 
ether as eluents to purify the compounds. The structures of all compounds prepared by my 
own procedure and those of Johnson were confirmed by 1H-NMR, 13C-NMR, FTIR and MS. 
Furthermore, for further verification, the GC-MS was recorded. The spectra obtained showed 
products to be pure with the correct molecular structures. 
The deacylation process was done for compound 27 by dissolving in 12 M HCl and heating 
for 1 hour at 60 °C. Pure 2 was collected (Scheme 2.14).31 
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Scheme 2.14: The deacetylation of compound 27 to prepare compound 2. 
 
The product was extracted by ethyl acetate and then dried. There was no acetyl peak observed 
in 1H-NMR and 13C-NMR spectra and the yield was 73.5% 5-benzyl-2-thiohydantoin. 
  
2.2.6 The enantiomeric excess and intensity of enantioenriched compounds 
 
The specific rotations of 27-32 were recorded using a polarimeter and were found to be 
different from one another. During the synthesis of 5-substituted 1-acetyl-2-thiohydantoins 
from the corresponding amino acids, acetic acid and acetic anhydride with ammonium 
isothiocyanate was used. Csonka and Nicolet17 reported the high specific rotation of 
compound 29 (
20
D][  = 118.5°) in 1% alcohol solution for white light filtered through 2 cm by 
using a similar procedure to the one we used with some modification. However, the specific 
rotation we found was lower (
20
D][ = + 83.9°), recorded in 0.3% acetonitrile solution. 
However, it should be noted that Csonka and Nicolet used a higher concentration of 29 in 
their measurements. The specific rotations of 27-32 at different concentrations are shown in 
Table 2.1. 
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Table 2.1: Specific rotation of 27-32 in different solvents and at different concentrations 
determined by polarimetry.  
 
Substrate  
 
20
D][  
Concentration 
27  +94.5° 0.25 g / l00 ml (Acetonitrile) 
29  +83.9° 0.29 g / l00 ml (Acetonitrile) 
30  +116.8° 0.40 g / l00 ml (Acetone) 
31  +94.5° 0.4 g / l00 ml (Acetone) 
32  +118.6° 0.40 g / l00 ml (Acetone) 
 
Reetz et al.32 described how to determine enantiomeric excess (ee %) by using the anisotropy 
factor obtained by dividing the ellipticity by absorbance ( Equation 2.1).  
 
𝑔 =
𝜃
𝐴
 
Equation 2. 1 
 
where g is the anisotropy factor, is the ellipticity and A is the UV absorbance.33 
By using Equation 2.1, the anisotropy factor was calculated for 27-32 by using the maximum 
ellipticity and absorbance in 10 % water and 90 % of 0.2 M phosphate buffer (0.9 M I, pH 
7.4) and 37 °C (Table 2.2). 
 
Table 2.2: The specific rotation of 27-32 in different solvents and at different concentrations 
determined by polarimetry. The compounds were dissolved in 10 % water and 90 % 0.2 M 
phosphate buffer (0.9 M I, pH 7.4) at 37 °C. 
 Substrate Con./ mM Maximum Ellipticity Absorbance g/ factors 
27 0.081 -15.722 (265 nm) 1.013 (291 nm) -15.528 
29 0.017 -7.216 (262 nm) 0.925 (288 nm) -7.800 
30 0.025 -9.910 (266 nm) 0.758 (288 nm) -13.067 
31 0.012 -5.590 (260 nm) 0.716 (287 nm) -7.696 
32 0.011 -4.953 (263 nm) 0.855 (290 nm) -5.796 
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The enantiomeric excess of 27-32 (Table 2.2) is unknown and pure enantiomers were not 
identified by either HPLC or GC-MS. Therefore, it is impossible to determine the 
enantiomeric excess for 27-32.  
 
2.2.7 Synthesis of racemic 5-substituted 3-phenyl-2-thiohydantoin 
 
For studies of the effect of substituents at the N-3 position of 2-thiohydantoin, several di-
substituted 2-thiohydantoins were required. These have been prepared from the corresponding 
amino acids esters. The substituent at the 3-position originating from the use of phenyl 
isothiocyanate or allyl isothiocyanate with phenylalanine methyl ester HCl using the 
procedure was previously reported for the synthesis of 3-benzyl-5-methyl-2-
thioxoimidazolidin-4-one.14 The reaction between hydrochloride salts of amino acid methyl 
ester and phenyl or alkyl isocyanate / isothiocyanate (X = O or S) in the presence of 
triethylamine or pyridine proceeds in two steps. The first step is a condensation process which 
produces 3-substituted (thio) ureido-phenyl acetic acid. The following step is the cyclisation 
of the acid derivative upon refluxing in basic medium (Scheme 2.15).34 
 
 
 
Scheme 2.15: Synthesis of racemic 5-substituted 3-phenyl-2-thioxoimidazolidin-4-ones by 
the reaction of amino acid methyl ester HCl derivatives with phenyl isothiocyanate in basic 
medium. 
 
This procedure was used to synthesise the 3,5-disubstituted 2-thiohydantoins 33-36 in this 
project in good yields. All these thiohydantoin derivatives were optically inactive products if 
prepared under basic conditions. It is difficult to dissolve amino acid methyl ester HCl in 
DCM, but by adding triethylamine the mixture becomes completely soluble. To address this, 
acidified water was used to remove the excess of trimethylamine and amino acid methyl ester 
HCl, while hexane is a very good solvent to remove the remaining phenyl isothiocyanate from 
the solution.  
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Very good yields of 84.0- 96.8% were obtained for compounds 33-35 and a yield of 46.3% 
was obtained for 36 using this procedure. Clear analytical NMR, MS and FTIR data was 
obtained. 
 
2.2.8 Synthesis of tri-substituted 2-thiohydantoin 
2.2.8.1 Synthesis of rac-tri-substituted 2-thiohydantoin 
 
Sim and Ganesan35 prepared a library of trisubstituted 2-thiohydantoins from α-amino ester, 
aromatic aldehydes and phenyl isothiocyanate, which was followed in the present work to 
prepare compounds 37-41. The reductive amination reaction of amino esters with aromatic 
aldehydes in the presence of sodium triacetoxyborohydride containing triethylamine was done 
in the first step. After one hour stirring, the cyclisation was carried out by adding 
isothiocyanate and extra triethylamine for another hour under stirring. The product was 
purified by column chromatography (Scheme 2.16).  
 
 
Scheme 2.16: Synthesis of racemic trisubstituted 2-thiohydantoin19 
 
The α-amino acid ester reacts with the aromatic aldehyde to produce an iminium ion followed 
by reduction using sodium triacetoxyborohydride (Scheme 2.17). The electron-withdrawing 
capacity and steric effects of the three acetoxy groups stabilise the boron-hydrogen bond and 
both properties are responsible for the reduction process.36 Compound I reacts with 
isothiocyanate to form compound II in the presence of base (Scheme 2.16) after the reductive 
amination process (Scheme 2.17). 
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Scheme 2.17: The reduction process of imine to form the corresponding amine. 
 
Several compounds were prepared by this procedure showing clear analytical data by using 
different aromatic aldehydes. There was no obvious product from the reaction using DL-
serine methyl ester HCl with 4(5)-imidazolecarboxaldehyde in the attempt to synthesis 
cyclised trisubstituted 2-thiohydantoin. Unfortunately, all thiohydantoin derivatives were 
optically inactive under these conditions. Adding extra triethylamine resulted in the product 
being optically inactive without finding a critical time to end cyclisation. An alternative way 
to synthesise optically active trisubstituted 2-thiohydantoin is presented in the next section. 
 
2.2.8.2 Synthesis of enantiomerically-enriched trisubstituted 2-thiohydantoin 
 
(S)-5-isopropyl-3-phenyl-1-(pyridin-2-ylmethyl)-2-thioxoimidazolidin-4-one 38 was 
synthesised following Sim and Ganesan’s procedure35 by slightly changing the amount of 
reagents and reaction time. A mixture of products 38 and 34 was detected by GC-MS 
spectroscopy. The products were separated using column chromatography (Scheme 2.18). 
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Scheme 2.18: Synthesis of enantiomerically-enriched 38 and racemic 34 
 
The mixture of 38 and 34 was separated using column chromatography. Compounds 38 and 
34 were collected separately after purification with yields of 60.4 and 18.1 %, respectively. 
Unfortunately, thiohydantoin 34 is completely optically inactive. On the other hand, 
compound 38 is optically active and has been used for kinetic studies. The formation of 34 in 
this procedure shows that the reaction between α-amino ester derivatives I with isothiocynate 
(Scheme 2.15) occurs on the same timescale as the cyclisation of intermediate I (Scheme 
2.16). The ring closed compounds 34 and 38 racemise much faster in the presence of 
triethylamine than the compounds before cyclisation.  
Similarly, (R)-5-benzyl-3-phenyl-1-(pyridin-2-ylmethyl)-2-thioxoimidazolidin-4-one 37 
(Scheme 2.19) has been prepared by a variation of the method of Sim and Ganesan35 by 
decreasing the reaction time and amount of triethylamine. It was found that adding 
triethylamine, which causes the product to be racemic, is not essential in both steps. However, 
triethylamine was just added in the first step, and instead of stirring for two hours in both 
steps, the solution was stirred for 35 minutes. TLC showed that the reaction had finished 
(Scheme 2.19). 
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Scheme 2.19: Combination synthesis of enantiomerically-enriched compound 37 
 
GC-MS showed that 37 was pure. In comparison, the NMR and MS data for racemic 37, 
which had been prepared previously (Scheme 2.16), and enantioenriched thiohydantoin were 
similar (for CD data for enantioenriched 37, see Chapter 4). 
 
 
2.3 Conclusions 
 
2-Thioxoimidazolidin-4-ones derivatives with substituents at the 1, 3 and 5 positions have 
been prepared as racemic and enantioenriched compounds by different procedures (Chapter 
2). Knoevenagel condensation worked successfully to react different aldehydes with 2-
thioxoimidazolidin-4-ones to prepare the corresponding unsaturated 5-substituted-2-
thioxoimidazolidin-4-ones derivatives. Knoevenagel condensation was also successful in 
preparing unsaturated 5-substituted thiazolidine-2,4-diones and 5-substituted 2-
thioxothiazolidin-4-one derivatives. To prepare saturated 5-substituted 2-thioxoimidazolidin-
4-ones, zinc and acetic acid were used to reduce the double bond to a single bond and prepare 
racemic 5-substituted 2-thioxoimidazolidin-4-ones. The reduction process worked well for all 
unsaturated 2-thioxoimidazolidin-4-ones prepared, except for (Z)-5-(furan-2-ylmethylene)-2-
thioxoimidazolidin-4-one 7, which produced an unknown product. Zn/acetic acid were also 
successful in reducing (Z)-5-(pyridin-2-ylmethylene)thiazolidine-2,4-dione 14, but not (Z)-5-
benzylidenethiazolidine-2,4-dione 12, the reason being unclear. As an alternative, LiBH4 in 
the presence of pyridine, for catalytic reduction in THF, was tried for (Z)-5-
benzylidenethiazolidine-2,4-dione 12 and found to be successful. The reduction process was 
successful in preparing racemic 5-substituted 2-thioxothiazolidin-4-one by using zinc/acetic 
acid on one hand, and LiBH4 with pyridine as a catalytic reduction in THF on the other. Our 
attempts to prepare enantioenriched 5-substituted 2-thioxoimidazolidin-4-ones derivatives 
starting from enantiopure amino acids with thiourea failed because of the high reaction 
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temperature. However, several enantioenriched 5-substituted 1-acetyl-2-thioxoimidazolidin-4-
one derivatives were synthesised using the corresponding amino acids with ammonium 
thiocyanate, including acetic acid and acetic anhydride. Several racemic tri-substituted 2-
thioxoimidazolidin-4-ones were prepared using the pure enantiomer of amino acid methyl 
ester HCl. Using the same procedure for racemic tri-substituted 2-thioxoimidazolidin-4-ones 
with various changes to reaction time and amount of base, two enantioenriched tri-substituted 
2-thioxoimidazolidin-4-ones were prepared. In this way, N-acetyl substituted 2-
thioxoimidazolidin-4-ones could be obtained with some enantiomeric excess.  
 
2.4  Experimental section 
Chemicals 
 
All reagents were purchased from Fisher Scientific, Sigma-Aldrich, Alfa Aesar, Fluorochem, 
Acros Organic, Applichem, BDH, and Lancaster Synthesis and used without purification. 
 
2.5  Experimental techniques 
 
Infra-Red spectra (IR) 
Infrared spectra were recorded in the range 4000-600 cm-1 using a SHIMADZU CORP series 
FTIR instrument. Samples were either thin films or powders. All absorptions are quoted in 
cm-1. 
 
Nuclear Magnetic Resonance (NMR) 
1H-NMR and 13C-NMR spectra were recorded on a Bruker DPX 400 (400 MHz) or DPX 500 
(500 MHz) spectrometer. Chemical shifts are expressed in parts per million downfield from 
tetramethylsilane as an internal standard. NMR spectra were recorded in solutions in 
deuterated-dimethylsulfoxide (DMSO-d6) or chloroform (CDCl3). HMBC and HSQC 
experiments were used on the same spectrometers to confirm assignments when necessary. 
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Melting Point 
Melting points were recorded using a Gallenkamp Melting Point Apparatus. 
Mass spectrometry 
LCMS experiments were performed using a Waters 2790 liquid chromatography system and a 
Waters ZQ mass spectrometer. Samples were loaded using a Gilson 232XL auto-sampler. 
Low-resolution mass spectrometric data were determined using a Fisons VG Platform II 
quadrupole instrument using electrospray ionisation (ES), unless otherwise stated. High-
resolution mass spectrometric data were obtained in electrospray (ES) mode unless otherwise 
reported, on a Waters Q-TOF micro-mass spectrometer. 
  
Polarimetry 
 
Optical rotations were measured with a Schmidt-Haensch Polartronic I in a 5.00 cm path 
length cell. The solvent and concentration (expressed in g/100 ml) of the solutions used for 
the measurements are reported in the individual sections. 
 
X-ray crystallography 
 
A Bruker CCD diffractometer with graphite-mono-chromatised Mo-K radiation (λ =0.71073 
Å) was used for X-Ray crystallographic studies, carried out at by the X-Ray Crystallography 
Service. The structures were solved by direct methods and refined using the SHELXTL 
software package.  
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2.6 Methods 
All compounds were prepared according to one of the following general methods. 
 
Method 1 
Commercially available 2-thiohydantoin was placed with the required aldehydes in a round 
bottom flask equipped with a magnetic stirrer and reflux condenser under a nitrogen 
atmosphere in triethylamine and water. The mixture was stirred overnight at room 
temperature and the pH was adjusted to 3 by adding 3 M HCl. The solid product was filtered 
off and washed with diethyl ether and water. The pure compounds were collected and dried. 
 
Method 2 
Thiazolidine-2, 4-dione or 2-thioxothiazolidin-4-one and the appropriate aldehydes were 
added to 20 ml ethanol containing piperidine. The mixture was refluxed under nitrogen for 3 
h. The precipitate was filtered off, washed with ethanol and dried. 
 
Method 3 
The compounds used in method 2 were dissolved in 10 ml anhydrous THF containing 10 ml 
pyridine at room temperature. Lithium borohydride was slowly added to the mixture causing 
bubbles to form during the addition. The stirred mixture was refluxed for 4 days. When the 
reaction was finished, the mixture was cooled on an ice bath to 5 ◦C and 8 ml of 12 N 
hydrochloric acid and 50 ml of deionised water were added. The mixture was refluxed again 
for 1 h. The residue formed after evaporation of the solvent was dissolved in chloroform, 
washed with 3 x 150 ml of water and dried over MgSO4. 
 
Method 4 
The condensation products prepared according method 1 and 2 were dissolved in acetic acid 
in a round bottom flask under nitrogen atmosphere, stirrer and refluxed. Zinc dust was added 
to the solution and the mixture was heated for 3 hours at 130 °C under reflux. The mixture 
77 
 
was then allowed to cool down to 50 °C and 50 ml of methanol was added to the solution. The 
temperature was then returned to 115 °C for about 5 minutes. The mixture was allowed to 
cool to 63 °C and filtered. The liquid was concentrated under reduced pressure. The resulting 
paste was mixed with 3:7 isopropanol DCM and filtered again. The solution was washed with 
100 ml of water and 50 ml of brine. The combined organic layer was filtered through filter 
paper and the solvent was evaporated under reduced pressure. The product was dried under 
high vacuum. 
 
Method 5a 
Acetylated 2-thiohydantoins were synthesised by reacting ammonium thiocyanate with 
several amino acids. The amino acids were mixed with ammonium isothiocyanate and 
dissolved in 9:1 acetic anhydride / acetic acid at 100 °C under nitrogen atmosphere and 
refluxed for 30 minutes. The solution was poured into 20 ml of an ice/water mixture and 
stored in a fridge overnight. The solid was filtered and dried using a freeze dryer. Racemic 
products were obtained. 
 
Method 5b 
Enantioenriched 5-substituted 1-acetyl-2-thiohydantoins were synthesised by the method 
described above (method 5a) with the slight variation of dissolving the mixture at 70 °C in a 
sonication bath for 5 -10 minutes and reducing the temperature to 35 °C. The mixture was 
heated at 35 °C for a further 25 minutes. The mixture was cooled down, washed with 50 ml of 
water and mixed with ethyl acetate. The reaction mixtures were washed twice with brine. All 
compounds were purified by column chromatography over silica using 50:50 diethyl ether 
and hexane. Significant optical activity was found for the resulting products. 
 
Method 6 
In a round bottom flask, 1:2 amino acid and thiourea was mixed together under reflux and 
nitrogen atmosphere at 180 °C using an oil bath. When the mixture started to melt, the 
temperature was increased to 190 °C and a yellow vapour was observed inside the condenser. 
The mixture was allowed to heat under reflux at the same temperature for 25 minutes. Water 
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was then added to the mixture after reducing the temperature to about 80 °C. The mixture was 
then put in a refrigerator for the product to precipitate.  
 
Method 7 
Different α-amino acid methyl esters HCl were dissolved in a mixture of CH2Cl2 and 
triethylamine. Phenyl isothiocyanate was slowly added to the solution and stirred for 1 hour at 
25 °C. The temperature was then raised to 40 °C under reflux and continued to be stirred for 
another hour. The solution was cooled down to room temperature and evaporated under 
reduced pressure. The residue was redissolved in CH2Cl2 and washed twice with acidified 
water (pH 3.0) to remove triethylamine and amino acid methyl ester HCl. The solution was 
then washed with brine and dried over Na2SO4. The solid product was triturated with hexane 
until an excess of phenyl isothiocyanate was removed. 
 
Method 8 
 
Different amino acid methyl ester hydrochlorides were dissolved in a mixture of CH2Cl2 (10 
ml) and triethylamine. Aldehyde and sodium triacetoxyborohydride were added to the 
solutions and stirred at room temperature (ca. 20 °C). Phenyl isothiocyanate or 
allylisothiocyanate were added to the mixture and stirred for another hour. The solution was 
treated with glycine solution and extracted with CH2Cl2. The organic solvent was evaporated 
and an oily compound was obtained. All compounds were purified by column 
chromatography over silica. 
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Synthesis of 5-benzilidine-2-thiohydantoin (1) 
 
 
 
Utilising method 1, thiohydantoin (2.0 g, 17.2 mmol), trimethylamine (4.9 ml, 37 mmol) and 
benzaldehyde (1.9 ml, 19 mmol) were added to 50 ml of water. 
 
Yield= 69.9 %, Mp 270-272 °C, HRMS calculated for C10H8N2OS m/z [M+H]
+ 204.0358; 
found 204.0358; 1H-NMR (400 MHz, DMSO-d6): δ 12.41 (s, H, NH), δ 12.19 (s, H, NH), δ 
7.74 (d, J = 7.4 Hz, 2H, phen), δ 7.45-7.37 (m, 3H, phenyl), δ 6.49 (s, H, CH=C).13C-NMR 
(101 MHz, d6-DMSO): δ 177.3 (C=S), δ 164.0 (CO), δ 130.5 (C=CH), δ 128.6 (2xCH), δ 
127.3 (C), δ 127.0 (2xCH), δ 126.0 (CH), δ 109.7 (CH=C). IR (neat): vmax= 3225 cm-1 
(NH), 1723 cm-1 (C=O), 1475 cm-1 (C=S), 1643 cm-1 (C=C). (File reference: NMR: 
400_HA_exp 1A DFA).  
 
Synthesis of 5-benzyl-2-thiohydantoin (2) 
 
 
 
Utilising method 4, 5-benzilidine-2-thiohydantoin (1.5 g, 7.4 mmol) was dissolved in acetic 
acid (10 ml, 175 mmol) and zinc dust (1.18 g, 18 mmol) was added. 
 
Yield= 29.5 %, Mp 168-170 °C, HRMS calculated for C10H10N2OS m/z [M+H]
+ 206.0517; 
found 206.0517; 1H-NMR (400 MHz-d6-DMSO): δ 11.45 (s, 1H, NH), δ 10.10 (s, 1H, NH), 
δ 7.34 – 7.16 (m, 5H, phenyl), δ 4.56 (apparent t, J = 5.3 Hz, 1H, CH), δ 2.99 (m, 2H, 
CH2).
13C NMR (101 MHz, DMSO): δ 182.5 (C=S), δ 176.1 (CO), δ 135.39 (C), δ 130.3 
(2XC), δ 128.5 (2xC), δ 127.2 (CH), δ 61.7 (CHCH2), δ 36.0 (CHCH2). IR (neat): vmax = 
1738 cm-1 (C=O), 1543 cm-1 (C=S). (File reference: NMR: 400_HA_exp 1B DFA). 
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Synthesis of (Z)-5-(pyridin-2-ylmethylene)-2-thioxoimidazolidin-4-one (3) 
 
 
Utilising method 1, thiohydantoin (2.0 g, 17.2 mmol), triethylamine (4.8 ml, 37 mmol) and 2-
pyridinecarboxyaldehyde (1.8 ml, 22 mmol) were added to 50 ml of water. 
 
Yield= 86.7 %, M.p. 262-263 °C, HRMS calculated for C9H7N3OS m/z [M+H]
+ 205.0310; 
found 205.0311; 1H-NMR (400 MHz, DMSO): δ 8.74 (d, J = 3.8 Hz, 1H, CHN), δ 7.89 (td, J 
= 7.7, 1.8 Hz, 1H, CHCHCHN), δ 7.72 (d, J = 7.9 Hz, 1H, CHCN), δ 7.38 (dd, J = 7.6, 4.9 
Hz, 1H, CHCHCHN), δ 6.61 (CH=). 13C-NMR (101 MHz, d6-DMSO): δ 179.2 (C=S), δ 
165.8 (CO), δ 153.6 (CN), δ 150.2 (CHN), δ 137.7 (C=CH), δ 131.4 (CHCHCN), δ 126.3 
(CHCN), δ 123.9 (CHCHN), δ 107.5 (CH=C).IR (neat): vmax=1719 cm-1 (C=O), 1660 cm-1 
(C=C), 1489 cm-1 (C=S). File reference: 1H-NMR: 400_hiwa-5PT-333.13C-NMR: 
400_HA_exp 3A DFA 1).  
 
 
Synthesis of 5-(pyridin-2-ylmethyl)-2-thioxoimidazolidin-4-one (4) 
 
Utilising method 4, (Z)-5-(pyridin-2-ylmethylene)-2-thioxoimidazolidin-4-one (1.5 g, 7.3 
mmol) was dissolved in 30 ml of methanol and acetic acid (12 ml, 210 mmol) and zinc dust 
(1.0 g, 15.3 mmol) were added (the product was recrystallised using ethanol). 
 
Yield= 30.5 %, M.p. 211-213 °C, HRMS calculated for C9H9N3OS m/z [M+H]
+ 207.0466; 
found 207.0463; 1H-NMR (400 MHz DMSO): δ 11.62 (s, 1H, NH), δ 9.96 (b, 1H, NH), δ 
8.49 (d, J = 4.3 Hz, 1H, CHN), δ 7.77 (td, J = 7.7, 1.8 Hz, 1H, CHCHCHN), δ 7.30 (dd, J = 
11.2, 6.4 Hz, 2H, CHCN and CHCHN), δ 4.66 (apparent t, J = 5.4 Hz, 1H, CHCH2CN), δ 
3.20 (qd, J = 14.9, 5.8 Hz, 2H, CHCHACHBCN). 
13C-NMR (101 MHz, d6-DMSO): δ 183.0 
81 
 
(C=S), δ 176.7 (CO), δ 156.0 (CN), δ 149.4 (CHN), δ 136.9 (CHCHCHN), δ 124.6 (CHCN), 
δ 122.4 (CHCHN), δ 60.4 (CHCH2), δ 38.2 (CHCH2). IR (neat): vmax=1711 cm-1 (C=O), 
1519 cm-1 (C=S). File reference: 1H-NMR: 400_HA_exp 3B_5pt_FDA.13C-NMR: 400_hiwa-
5PT-444).  
 
 
Synthesis of (Z)-5-(1-methyl-1H-pyrrol-2-yl) methylene)-2-thioxoimidazolidin-4-one (5) 
 
 
 
Utilising method 1, thiohydantoin (2.3 g, 19.8 mmol), triethylamine (5.9 ml, 42.3 mmol) and 
1-methyl pyrrole-2-carboxaldehyde (2.0 ml, 18.6 mmol) were added to 50 ml of water. 
 
Yield = 64.3 %, M.p. 263-265 °C, HRMS calculated for C9H9N3OS m/z [M+H]
+ 207.0466; 
found 207.0463; 1H-NMR (400 MHz, DMSO): δ 7.24 (dd, J=4.03, 1.28 Hz, 1H, CHN), δ 
7.08 (t, J = 2.2 Hz, 1H, CHCHN), δ 6.43 (s, 1H, CH=C), δ 6.20 (dd, J = 3.9, 2.6 Hz, 1H, 
CHCN), δ 3.71 (s, 3H, H3CN).13C-NMR (126 MHz, d6-DMSO): δ 177.3 (C=S), δ 165.92 
(CO), δ 128.5 (CCHCNCH3), δ 125.8 (CNCH3), δ 122.9 (CHNCH3), δ 115.3 (CHCNCH3), δ 
110.1 (CH=), δ 101.7 (CHCHNCH3), δ 33.4 (CH3N). IR (neat): vmax=1712 cm-1 (C=O), 
1633 cm-1 (C=C), 1431cm-1 (C=S). File reference: 1H-NMR: 400_hiwa-5MPT-555.13C-NMR: 
500_HA_ exp 4 A C13). 
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Synthesis of 5-((1-methyl-1H-pyrrol-2-yl) methyl)-2-thioxoimidazolidin-4-one (6) 
 
 
 
Utilising method 4, 5-((1-methyl-1H-pyrrol-2-yl) methyl)-2-thioxoimidazolidin-4-one (2.0 g, 
7.3 mmol) was dissolved in 75 ml of methanol, acetic acid (30 ml, 524 mmol) and Zn dust 
(1.2 g, 18.4 mmol) was added. 
 
Yield= 27.3 %, M.p. 203-205 °C, HRMS calculated for C9H9N3OS m/z [M+H]
+ 209.0623; 
found 209.0622; 1H-NMR (500 MHz DMSO): δ 10.01 (b, 1H, NH) δ 6.59 (t, J = 2.2 Hz, 1H, 
CHNCH3), δ 5.84 (t, J = 3.1 Hz, 1H, CHCNCH3), δ 5.77 (m, 1H, CHCN), δ 4.66 (apparent t, 
J = 4.9, Hz, 1H, CHCH2CN), δ 2.97 (d, J = 4.9 Hz, 1H, CHCHACHBCN).13C-NMR (126 
MHz, d6-DMSO): δ 182.2 (C=S), δ 175.3 (CO), δ 125.8 (CNCH3), δ 121.9 (CHN), δ 107.5 
(CHCHNCH3), δ 106.3 (CHCNCH3), δ 60.7 (CHCH2), δ 33.3 (CH3N), δ 26.3 (CH2CH). IR 
(neat): vmax=1737 cm-1 (C=O), 1548 cm-1 (C=S). File reference: 1H-NMR: 500_HA_exp 4 
B.13C-NMR: 500_HA_ exp 4B C13F). 
 
Synthesis of (Z)-5-(furan-2-ylmethylene)-2-thioxoimidazolidin-4-one (7) 
 
 
Utilising method 1, thiohydantoin (2.0 g, 17.2 mmol), triethylamine (5.7 ml, 40.9 mmol) and 
furan-2-carbaldehyde (1.8 ml, 21.7 mmol) were added to 25 ml of water. 
 
Yield= 92.9 %, M.p. 223-225 °C, HRMS calculated for C8H6N2O2S m/z [M+H]
+ 194.0150; 
found 194.0150; 1H-NMR (400 MHz DMSO): δ 7.85 (d, J = 1.5 Hz, 1H, CHO), δ 7.12 (d, J= 
3.51 Hz, 1H, CHCO), δ 6.76 (dd, J = 3.5, 1.8 Hz, 1H, CHCHO), δ 6.76 (s, 1H, CH=C). 13C-
NMR (101 MHz, d6-DMSO): δ 178.4 (C=S), δ 165.7 (CO), δ 149.2 (CHCO), δ 146.2 
(C=CH), δ 125.8 (CHCHO), δ 115.9 (CHCHO), δ 113.6 (CHCO), δ 99.4 (CH=). IR (neat): 
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vmax=1722 cm-1 (C=O), 1651 cm-1 (C=C), 1592 cm-1 (C=S). File reference: 1H-NMR: 
400_HA_exp 5A_DF.13C-NMR: 400_hiwa-5-furT-7777). 
 
Synthesis of (Z)-5-(4-methoxybenzylidene)-2-thioxoimidazolidin-4-one (8) 
 
 
Utilising method 1, thiohydantoin (2.0 g, 17.2 mmol), triethylamine (6.0 ml, 43.0 mmol), and 
4-methoxybenzaldehyde (2.6 ml, 21.3 mmol) were added to 25 ml of water. 
 
Yield= 52.73 %, M.p. 267- 269 °C, HRMS calculated for C11H10N2O2S m/z [M+H]
+ 
234.0463; found 234.0467; 1H-NMR (400 MHz, DMSO): δ 7.73 (2 x CH, d, J = 8.7 Hz, 2H, 
CHCOCH, δ 6.99 (2x CH, d, J = 8.7 Hz, 2H, CHCCH), δ 6.47 (s, 1H, CH=C), δ 3.81 (s, 3H, 
CH3) .13C-NMR (101 MHz, d6-DMSO): δ 179.1 (C=S), δ 165.9 (CO), δ 160.7 (H3CCO), δ 
132.2 (2xC, CHCOCH), δ 125.9 (C=CH), δ 124.9 (CHCCH), δ 114.4 (CHCCH), δ 112.2 
(CH=C), δ 55.4 (OCH3). IR (neat): vmax=1723 cm-1 (C=O), 1645 cm-1 (C=C), 1596 cm-1 
(C=S). File reference: NMR: 400_hiwa-anis-BT-999). 
 
Synthesis of 5-(4-methoxybenzyl)-2-thioxoimidazolidin-4-one (9) 
 
 
 
 
Utilising method 4, (Z)-5-(4-methoxybenzylidene)-2-thioxoimidazolidin-4-one (1.5 g, 6.4 
mmol) was dissolved in 50 ml of methanol, and acetic acid (23 ml, 401.8 mmol) and Zn dust 
(1.0 g, 15.3 mmol) were added. 
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Yield= 37.7%, M.p. 192-194 °C, HRMS calculated for C11H12N2O2S m/z [M+H]+ 236.0619; 
found 236.0617;1H-NMR (400 MHz DMSO): δ 11.43 (s, 1H, NH), δ 10.07 (s, 1H, NH), δ 
7.086 (2x CH, d, J = 8.8 Hz, 2H, CHCOCH), δ 6.82 (2 x CH, d, J = 8.5 Hz, 2H, CHCCH), δ 
4.49 (apparent t, J = 4.6 Hz, 1H, CHCH2C), δ 3.60 (s, 3H, OCH3), δ 2.92 (d, J = 4.7 Hz, 2H, 
CHACHBCH). 
13C-NMR (101 MHz, d6-DMSO): δ 182.7 (C=S), δ 176.3 (CO), δ 158.4 
(H3CCO), δ 131.3 (2 x CHCO), δ 127.1 (CCH2CH), δ 113.9 (2 x CHC), δ 62.0 (CHCH2), δ 
55.5 (OCH3), δ 34.8 (CHCH2). IR (neat): vmax=1727 cm-1 (C=O), 1523 cm-1 (C=S). File 
reference: 1H-NMR: 400_HA_exp 6B DFA1.13C-NMR: 400_hiwa-5-anis-BT-101010). 
 
 
Synthesis of (Z)-5-((tetrahydrofuran-3-yl) methylene)-2-thioxoimidazolidin-4-one (10) 
 
 
Utilising method 1, thiohydantoin (3.0 g, 25.9 mmol), triethylamine (5.5 ml, 39.5 mmol) and 
tetrahydrofuran-3-carbaldehyde (4.0 ml, 42.4 mmol) were added to 25 ml of water. 
 
Yield= 39.1%, M.p. 223-225 °C, HRMS calculated for C8H10N2O2S m/z [M+H]
+ 198.0463; 
found 198.0466;1H-NMR (400 MHz DMSO): δ 5.61 (d, J = 10.2 Hz, 1H, CH=), δ 3.86 - 3.79 
(m, 2H, CHCHAHBO + CH2CHAHBO), δ 3.72 (dd, J = 14.9, 7.6 Hz, 1H, CHCHAHBO), δ 
3.41-3.26 ( m, 2H, CHCHAHBO+CH2CHAHBO), δ 2.16-2.08 ( m, 1H, CHCHAHBCH2), δ 1.77 
(m, 1H, CHCHAHBCH2). 
13C-NMR (101 MHz, d6-DMSO): δ 178.6 (C=S), δ 164.7 (CO), δ 
131.5 (C=CH), δ 116.9 (CH=C), δ 72.2 (CH2O), δ 67.8 (CH2O), δ 37.2 (CH2CH), δ 32.9 
(CH2CH). IR (neat): vmax = 1725cm
-1 (C=O), 1672 cm-1 (C=C), 1534 cm-1 (C=S). File 
reference: 1H-NMR: 400_hiwa-5-hydro-fur-yl-2-thiohydamntoin.13C-NMR: 400_hiwa-hydro-
f-111111). 
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Synthesis of 5-((tetrahydrofuran-3-yl) methyl)-2-thioxoimidazolidin-4-one (11) 
 
 
 
Utilising method 4, (Z)-5-((tetrahydrofuran-3-yl)methylene)-2-thioxoimidazolidin-4-one (2.0 
g, 10.0 mmol) was dissolved in 50 ml methanol, and acetic acid (10 ml, 174.6 mmol) and zinc 
dust  (1.0 g, 15.3 mmol) were added. 
 
Yield= 24.8 %, M.p. 166-168 °C, HRMS calculated for C8H12N2O2S m/z [M+H]
+ 200.0619; 
found 200.0621; 1H-NMR (400 MHz, DMSO-d6): δ 11.74 (s, 2x1H, NH), δ 10.11, 10.07 (2 x 
s, 2 x 1H, NH), δ 4.26-4.21 (m, 2 x 1H, COCHCH2), δ 3.77- 3.67 (m, 2 x 2H, CHCHAHBO + 
CH2CHAHBO), δ 3.63-3.57 (m, 2 x 1H, CH2CHAHBO), δ 3.25 (t, J = 7.8 Hz) and 3.18 (t, J = 
7.8 Hz) (CHCHAHBO), δ 2.30-2.20 (m, 2 x 1H, CH2CHCH2O), δ 2.01-1.94 (m, 2 x 1H, 
CH2CHAHBCH), δ 1.74-1.63 (m, 2 x 2H, CHCHAHBCH), δ 1.52-1.41 (m, 2 x 1H, 
CH2CHAHBCH).
13C-NMR (126 MHz, d6-DMSO): δ 182.2 (2 x C=S), δ 176.3, 176.2 (2 x 
CO), δ 72.0, 71.7 (2 x OCH2CH), δ 66.7, 66.5 (OCH2CH2), δ 59.7 (br, 2 x COCHCH2), δ 
34.8, 34.7 (2 x CH2CHCH2), δ 33.8, 33.6 (2 x CHCH2CH), δ 31.9, 31.2 (2 x CH2CH2CH). Rf 
= 1.5 (ethyl acetate: dichloromethane 2:1); FTIR vmax = 1747 cm-1 (C=O), 1531 cm-1 (C=S). 
File reference: 1H-NMR: 400_HA_exp 14 DFA.13C-NMR: 500_hiwa 5 THf M 2 
thiohydantoin 500). 
 
Synthesis (Z)-5-benzylidenethiazolidine-2, 4-dione (12) 
 
 
Utilising method 2, benzaldehyde (0.95 ml, 9.35 mmol) and thiazolidine-2, 4-dione (1.0 g, 
8.53 mmol) were together suspended in ethanol (20 ml). Piperidine (0.2 ml, 2.02 mmol) was 
then added. 
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Yield= 74.5 %, M.p. 195-197°C, HRMS calculated for C10H7NO2S m/z [EI]
+ 205.0198; found 
2045.0196; 1H-NMR (500 MHz DMSO): δ 7.79 (s, 1H, HC=C), δ 7.60 (d, J = 7.5 Hz, 2H, 
CHCCH), δ 7.53 ( t, J = 7.5 Hz, 2H, CHCHCH), δ 7.48 ( t, J = 7.1 Hz, 1H, CHCHCH).13C-
NMR (126 MHz, d6-DMSO): δ 167.8 (SC=O), δ 167.3 (CCO), δ 133.0 (C=CH), δ 133.0 
(C=CHC), δ 130.4 (CH), δ 130.0 (2 x CH), δ 127.0 (2 x CH), δ 129.3 (CH=C). IR (neat): 
vmax=1750 cm-1 (C=O), 1700 cm-1 (C=O), 1608 cm-1 (C=C). File reference: NMR: 
500_EXP1 BT_DOBbond). 
 
Synthesis 5-benzylthiazolidine-2,4-dione (13) 
 
 
Utilising method 3, (Z)-5-benzylidinethiazolidine-2, 4-dione (0.65 g, 3.17 mmol) was 
dissolved in the mixture of 10 ml of pyridine and 10 ml of anhydrous tetrahydrofuran (THF) 
at room temperature. Lithium borohydride (0.154 g, 6.98 mmol) was slowly added to a stirred 
solution. 
 
Yield= 55.0 %, M.p. 98-100 °C, HRMS calculated for C10H9NO2S m/z [EI]
+ 207.0354; found 
207.0353; 1H NMR (400 MHz, CDCl3); δ 7.26 – 7.11 (m, 5H, phenyl), δ 4.43 (dd, J = 9.9, 3.9 
Hz, 1H, CH), δ 3.44 (dd, J = 14.0, 3.8 Hz, 1H, CHCHACHB), δ 3.03 (dd, J = 14.0, 9.9 Hz, 
1H, CHCHACHB).
13C NMR (101 MHz, CDCl3), δ 172.9 (CO), δ 169.2 (CO), δ 134.7 (C), δ 
128.1 (2 X C), δ 127.9 (2 x C), δ 126.7 (CH), δ 52.4 (CHCH2), δ 37.6 (CHCH2). IR (neat): IR 
(neat): vmax=1745 cm-1 (C=O), 1682 cm-1 (C=O). File reference: 1H-NMR: 400_BT1.13C-
NMR: 400_BT c13). 
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Synthesis (Z)-5-(pyridin-2-ylmethylene) thiazolidine-2,4-dione (14) 
 
 
 
Utilising method 2, 2-pyridine carboxaldehyde (1.9 ml, 19.97 mmol) and thiazolidine-2, 4-
dione (2.0 g, 17.07 mmol) were together suspended in ethanol (40ml). Piperidine (0.3 ml, 
3.03 mmol) was added to the mixture. 
 
Yield= 64.0 %, M.p. 258-260 °C, HRMS calculated for C9H6N2O2S m/z [EI]
+ 206.0150; 
found 206.0155; 1H-NMR (500 MHz DMSO): δ 8.76 (d, J = 4.4 Hz, 1H, CHN), δ 7.94 (td, J 
= 7.7, 1.8 Hz, 1H, CHCHCHN), δ 7.85 (d, J = 7.8 Hz, 1H, CHCN), δ 7.82 (s, 1H, CH=), δ 
7.42 (ddd, J = 7.6, 4.8, 1.1 Hz, 1H, CHCHN).13C-NMR (126 MHz, d6-DMSO): δ 171.9 (CO), 
δ 167.4 (CO), δ 151.3 (CN), δ 149.3 (CHN), δ 137.5 (C=CH), δ 128.0 (CHCHCN), δ 27.8 
(CHCN), δ 127.7 (CHCHN), δ 123.9 (CH=C). IR (neat): vmax = 1740 cm-1 (C=O), 1680 cm-1 
(C=O), 1620 cm-1 (C=C). File reference: 1H-NMR: 500_HA exp108pythi.13C-NMR: 
500_HA-exp 106 C13). 
 
Synthesis 5-(pyridin-2-ylmethyl) thiazolidine-2,4-dione (15) 
 
 
 
Utilising method 4, (Z)-5-(pyridin-2-ylmethylene) thiazolidine-2, 4-dione (1.25 g, 60.07 
mmol) was dissolved in 50 ml of acetic acid under nitrogen atmosphere. Zinc dust (1.5 g, 
22.94 mmol) was added to the mixture at 130 ◦C. 
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Yield= 72.1 %, M.p. 98-100 °C, HRMS calculated for C9H8N2O2S m/z [EI]
+ 208.0306; found 
208.0309; 1H-NMR (500 MHz DMSO): δ 12.10 (s, 1H, NH), δ 8.54 (d, J = 4.2 Hz, 1H, 
CHN), δ 7.81 (td, J = 7.7, 1.8 Hz, 1H, CHCHCHN), δ 7.39 (d, J = 7.8 Hz, 1H, CHCN), δ 
7.33 (dd, J = 7.1, 5.2 Hz, 1H, CHCHN), δ 4.99 (dd, J = 10.1, 3.9 Hz, 1H, CH), δ 3.69 (dd, J = 
16.0, 3.9 Hz, 1H, CHCHACHB), δ 3.44 (dd, J = 16.0, 10.1 Hz, 1H, CHCHACHB).13C-NMR 
(126 MHz, d6-DMSO): δ 176.5 (CO), δ 172.8 (CO), δ 156.7 (CN), δ 148.8 (CHN), δ 136.7 
(CHCHCN), δ 123.6 (CHCN), δ 122.0 (CHCHN), δ 49.7 (CHCH2), δ 21.1 (CHCH2). IR 
(neat): vmax = 3010 cm-1 (NH), 1689 cm-1 (C=O), 1668 cm-1 (C=O). File reference: 1H-NMR: 
500_ha-EXP 108 hmbc.13C-NMR: 500_HA_exp 108 CH2). 
 
Synthesis (Z)-5-benzylidene-2-thioxothiazolidin-4-one (16) 
 
 
 
Utilising method 2, benzaldehyde (3.82 ml, 37.61 mmol) and 2-thioxothiazolidin-4-one (5.0 
g, 37.60 mmol) were suspended in ethanol (100 ml). Piperidine (1.0 ml, 10.12 mmol) was 
added to the mixture. 
 
Yield= 90.0 %, Mp: 190-192°C, HRMS calculated for C10H7NOS2 m/z [EI]+ 220.9969; found 
220.9969; 1H-NMR (500 MHz, DMSO): δ 7.64 (s, 1H, HC=C), δ 7.61-7.48 (m, 5H, phenyl). 
13C-NMR (126 MHz, d6-DMSO): δ 195.6 (C=S), δ 169.4 (CO), δ 132.9 (C=CH), δ 131.6 
(C=CHC), δ 130.7 (CH), δ 130.4 (2 x CH), δ 129.4 (2 x CH), δ 125.5 (CH=C). IR (neat): 
vmax = 1699 cm-1 (C=O), 1660 cm-1 (C=S), 1587 cm-1 (C=C). File reference: NMR: 500_ 
EXP1 BR_DOUBLEBOND). 
 
 
 
 
 
89 
 
Synthesis 5-benzyl-2-thioxothiazolidin-4-one (17) 
 
 
 
Utilising method 4, (Z)-5-benzylidene-2-thioxothiazolidin-4-one (0.5 g, 2.22 mmol) was 
dissolved in 50 ml of acetic acid under nitrogen atmosphere. Zinc dust (1.5 g, 22.94 mmol) 
was added to the mixture at 130 ◦C. 
 
Yield= 60.0 %, HRMS calculated for C10H9NOS2 m/z [ES]
- 222.0047; found 222.0043; 1H 
NMR (400 MHz, CDCl3); δ 7.30-7.14 (m, 5H, phenyl), δ 4.54 (dd, J = 10.1, 4.0 Hz, 1H, CH), 
δ 3.48 (dd, J = 14.1, 4.0 Hz, 1H, CHCHACHB), δ 3.09 (dd, J = 14.1, 10.1 Hz, 1H, 
CHCHACHB).
13C NMR (101 MHz, CDCl3): δ 199.2 (CS), δ 175.7 (CO), δ 134.6 (C), δ 128.0 
(2 X C), δ 128.2 (2 x C), δ 126.8 (CH), δ 55.7 (CHCH2), δ 37.3 (CHCH2). IR (neat): vmax = 
1745 cm-1 (C=O), 1682 cm-1 (C=S). File reference: NMR: 400_HA_benzylrhodanine_ZN). 
 
Synthesis (Z)-5-(pyridin-2-ylmethylene)-2-thioxothiazolidin-4-one (18) 
 
 
 
Utilising method 2, 2-pyridinecarboxaldehyde (1.5 ml, 15.76 mmol) and 2-thioxothiazolidin-
4-one (2.0 g, 15.04 mmol) were together suspended in ethanol (60 ml). Piperidine (0.2 ml, 
2.02 mmol) was added to the mixture. 
 
Yield= 85.0 %, M.p. 258-261 °C, HRMS calculated for C9H6N2OS2 m/z [MS EI]
+ 221.9922; 
found 221.9920; 1H-NMR (500 MHz, DMSO): δ 13.68 (s, 1H, NH), δ 8.78 (d, J = 4.6 Hz, 
1H, CHN), δ 7.94 (td, J = 7.6, 1.7 Hz, 1H, CHCHCHN), δ 7.88 (d, J = 7.8 Hz, 1H, CHCN), δ 
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7.66 (s, 1H, CH=), δ 7.43 (ddd, J = 7.5, 4.8, 1.2 Hz, 1H, CHCHN).13C-NMR (126 MHz, d6-
DMSO): δ 201.9 (CS), δ 169.3 (CO), δ 151.0 (CN), δ 149.5 (CHN), δ 137.6 (C=CH), δ 129.7 
(CHCHCN), δ 128.1 (CHCN), δ 127.4 (CHCHN), δ 124.0 (CH=C). IR (neat): vmax = 1720 
cm-1 (C=O), 1610 cm-1 (C=S), 1579 cm-1 (C=C). NMR: 500_EXP1 PYR_DouBond) 
 
Synthesis 5-(pyridin-2-ylmethyl)-2-thioxothiazolidin-4-one (19) 
 
 
Utilising method 4, (Z)-5-(pyridin-2-ylmethylene)-2-thioxothiazolidin-4-one (0.5 g, 2.25 
mmol) was dissolved in 50 ml of acetic acid under nitrogen atmosphere. Zinc dust (0.8 g, 
12.23 mmol) was added to the mixture at 130 °C. 
Yield= 68.0 %, M.p. 100-102 °C, HRMS calculated for C9H8N2OS2 m/z [MS ES]
- 223.0002; 
found 223.0000; 1H-NMR (500 MHz CDCl3): δ 8.46 (dd, J = 5.7, 1.5 Hz, 1H, CHN), δ 7.58 
(tt, J = 4.5, 2.3 Hz, 1H, CHCHCHN), δ 7.13 (dd, J = 7.6, 4.5 Hz, 2H, CHCN + CHCHN), δ 
4.85 (dd, J = 10.5, 3.9 Hz, 1H, CH), δ 3.73 (dd, J = 16.1, 3.9 Hz, 1H, CHCHACHB), δ 3.38 
(dd, J = 16.1, 10.5 Hz, 1H, CHCHACHB).
13C-NMR (126 MHz, d6-DMSO): δ 205.0 (CS), δ 
178.6 (CO), δ 156.4 (CN), δ 148.7 (CHN), δ 136.8 (CHCHCN), δ 123.5 (CHCN), δ 122.2 
(CHCHN), δ 52.5 (CHCH2), δ 38.2 (CHCH2). IR (neat): vmax = 1699 cm-1 (C=O), 1593 cm-1 
(C=S). File reference: 1H-NMR: 500_HA_IBRpyrrhod.13C-NMR: 
500_HA_IBRpyrrhod_DMSO). 
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Synthesis of 5-methyl-2-thioxoimidazolidin-4-one (20) 
 
 
 
Utilising method 6, 1:3 L-alanine (1.0 g, 11.22 mmol) and thiourea (2.56 g, 33.67 mmol) were 
mixed together and heated under stirring. 
 
Yield= 30.0%, M.p. 138-140 °C, HRMS calculated for C4H6N2OS m/z [EI]
+ 130.0201; found 
130.0199; 1H-NMR (400 MHz DMSO): δ 10.02 (s, 1H, NH), δ 4.24 (q, J = 7.0 Hz, 1H, CH), 
δ 1.24 (d, J = 7.0 Hz, 3H,CH3). 13C-NMR (101 MHz, d6-DMSO): δ 182.5 (C=S), δ 177.9 
(CO), δ 56.8 (CHCH3), δ 16.27 (CHCH3). IR (neat): vmax = 1740 cm-1 (C=O), 1544 cm-1 
(C=S). (File reference: 1H-NMR: 400_HA-exp 42_16-9 long.13C-NMR: 400_ha_EXP 42 
_12_9).  
 
Synthesis of 5-isopropyl-2-thioxoimidazolidin-4-one (21) 
 
 
 
Utilising method 6, 1:3 L-valine (1.0 g, 8.53 mmol) and thiourea (1.95 g, 25.60 mmol) were 
mixed together and heated under stirring. 
 
Yield= 14.0 %, M.p. 122-123 °C, HRMS calculated for C6H10N2OSm/z [EI]
+ 158.0507; found 
158.0514; 1H-NMR (400 MHz DMSO): δ 11.76 (s, 1H, NH), δ 10.07 (s, 1H, NH), δ 4.12 (dd, 
J = 3.6, 1.1 Hz, 1H, CH), δ 2.10 (m, 1H, H3CCHCH3), δ 0.96 (d, J = 7.0 Hz, 3H, CH3), δ 0.81 
(d, J = 6.8 Hz, 3H,CH3).13C-NMR (101 MHz, d6-DMSO): δ 183.3 (C=S), δ 176.3 (C=O), δ 
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66.0 (NHCHCH), δ 30.4 (H3CCHCH3), δ 18.4 (H3CCHCH3), δ 16.6 (H3CCHCH3). IR (neat): 
vmax=1723 cm-1 (C=O), 1524 cm-1 (C=S). (File reference: NMR: 400_EXp52FD)  
 
 
Synthesis of 5-((1H-indol-3-yl) methyl)-2-thioxoimidazolidin-4-one (22) 
 
 
 
Utilising method 6, L-tryptophan (1.0 g, 4.89 mmol) and thiourea (1.11 g, 14.58 mmol) were 
mixed together and heated under stirring. 
 
Yield= 26.7 %, M.p. 112-113°C, HRMS calculated for C12H11N3OSm/z [ES]
- 244.05465; 
found 244.0540; 1H-NMR (400 MHz DMSO): δ 11.28 (s, 1H, NH), δ 10.93 (s, 1H, HCNH), δ 
10.08 (s, 1H, NH), δ 7.54 (d, J = 7.9 Hz, 1H, CHCC), δ 7.32 (d, J = 8.1 Hz, 1H, CHCNH), δ 
7.10 (d, J = 2.4 Hz, 1H, CHN), δ 7.05 (t, J = 7.0 Hz, 1H, CHCHCNH), δ 6.97 (t, J = 6.9 Hz, 
1H, CHCHCC), δ 4.53 (apparent t, J = 4.7 Hz, 1H,CHCH2), δ 3.12 (qd, J = 15.1, 4.7 Hz, 2H, 
CHACHBCH).
13C-NMR (101 MHz, d6-DMSO): δ 182.4 (C=S), δ 176.3 (CO), δ 135.6 
(CNH), δ 127.6 (CCNH), δ 124.0 (CHNH), δ 121.0 (CHCHCNH), δ 118.5 (CHCHCC), δ 
111.3 (CHCC), δ 109.4 (CHCNH), δ 107.4 (CCHNH), δ 61.8 (CHCH2), δ 27.4 (CHCH2). IR 
(neat): vmax = 1744 cm-1 (C=O), 1524 cm-1 (C=S). (File reference: 1H-NMR: 400_ha_EXP 
54df2.13C-NMR: 400_HA_exp 54).  
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Synthesis of 3-thioxohexahydro-1H-pyrrolo [1, 2-c] imidazol-1-one (23) 
 
 
 
 
Utilising method 6, 1:3 L-proline (1.4 g, 12.16 mmol) and thiourea (2.8 g, 36.48 mmol) were 
mixed together and heated under stirring. 
 
Yield = 42.2 %, M.p. 133-135 °C, HRMS calculated for C6H8N2OS m/z [MS EI]
+ 156.0357; 
found 156.0361, 1H-NMR (500 MHz DMSO): δ 4.39 (dd, J = 10.01, 6.3 Hz, 1H, NCHCH2), δ 
3.74-3.65 (m, 1H, CHAN), δ 3.43 (ddd, J = 11.4, 8.2, 2.9 Hz, 1H, CHBN), δ 2.18-2.02 (m, 3H, 
CHACHBCH2N + CHACHBCH), δ 1.72-1.57 (m, 1H, CHACHBCH).13C-NMR (126 MHz, d6-
DMSO): δ 186.30 (C=S), δ 175.58 (CO), δ 66.55 (NCHCH2), δ 47.59 (CH2N), δ 27.02 
(CH2CH2N), δ 26.16 (CH2CHN). IR (neat): vmax = 1750 cm-1 (C=O), 1554 cm-1 (C=S). (File 
reference: NMR: 500_hiwa_proline 2thio last).  
 
 
Synthesis of 5-(2-(methylthio) ethyl)-2-thioxoimidazolidin-4-one (24) 
 
 
 
Utilising method 6, 1:3 L-methionine (1.4 g, 12.16 mmol) and thiourea (2.8 g, 36.48 mmol) 
were mixed together and heated under stirring. 
 
Yield= 25.0 %, M.p. 81-82°C, HRMS calculated for C6H10N2OS2 m/z [MS EI]
+ 190.0235; 
found 190.02235;1H-NMR (500 MHz DMSO): δ 11.70 (s, 1H, NH), δ 10.80 (s, 1H, NH), δ 
4.30 (dd, J = 7.5, 4.9 Hz, 1H,CHCH2), δ 2.56 – 2.52 (m, 2H, CH2S), δ 2.03 (s, 3H, CH3S), δ 
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1.99 (m, 1H, CHACHBCH), δ 1.96 (m, 1H, CHACHBCH).13C-NMR (126 MHz, d6-DMSO): δ 
183.0 (C=S), δ 176.4 (CO), δ 59.5 (CHCH2), δ 30.2 (CH2CH2S), δ 28.5 (CH2CH2S), δ 14.40 
(SCH3). IR (neat): vmax= 1738 cm
-1 (C=O), 1541 cm-1 (C=S). (File reference: NMR: 
500_HA_exp 58 _C13).  
 
Synthesis of 5-((1H-imidazol-4-yl) methyl)-2-thioxoimidazolidin-4-one (25) 
 
 
 
 
Utilising method 6, D-histidine (0.5 g, 3.22 mmol) and thiourea (1.0 g, 13.13 mmol) were 
mixed together and heated under stirring. 
 
Yield= 16.0 %, HRMS calculated for C7H8N4OS m/z [MS EI]
+ 196.0419; found 196.0413; 
1H-NMR (500 MHz DMSO): δ 11.57 (s, 1H, SCNH), δ 9.92 (s, 1H, HCNH), δ 7.71 (s, 1H, 
NHCHN), δ 6.87 (s, 1H, NHCHC), δ 4.45 (apparent t, J = 5.5 Hz, 1H, CHCH2C), δ 2.98 (dd, 
J = 15.2, 5.0, 1H, CHCHA CHBC), δ 2.89 (dd, J = 15.2, 6.0, 1H, CHCHA CHBC). 13C-NMR 
(126 MHz, d6-DMSO): δ 182.8 (C=S), δ 176.2 (CO), δ 134.8 (NHCHN), δ 131.5 (CHCH2C), 
δ 116.3 (NHCHC), δ 60.6 (CHCH2C), δ 28.20 (CHCH2C). (File reference: 1H-NMR: 
500_hiwa histidin dilute_2.13C-NMR: 500_hiwa_histidin 2 thio 0005).  
 
Synthesis of 1-acetyl-2-thioxoimidazolidin-4-one (26) 
 
 
 
Utilising method 5a, glycine (1.0 g, 13.3 mmol) and NH
4
SCN (1.038 g, 13.3 mmol) were 
ground together. A mixture of 9 ml acetic anhydride and 1 ml of acetic acid was added. 
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Yield= 73.28 %, M.p. 170-172°C, HRMS calculated for C5H6N2O2S m/z [MS EI]
+ 158.0150; 
found 158.0150; 1H-NMR (400 MHz DMSO): δ 4.40 (s, 2H, CH2), δ 2.68 (s, 3H, CH3). 13C-
NMR (101 MHz, d6-DMSO): δ 181.9 (C=S), δ 170.0 (CO), δ 168.9 (H3CCO), δ 51.7 (CH2), 
δ 26.1 (H3CCO). IR (neat): vmax = 1755 cm-1, 1661 cm-1 (C=O), 1645 cm-1 (C=S). (File 
reference: NMR: 400_HA_exp 16 DFA).  
 
Synthesis of (S)-1-acetyl-5-benzyl-2-thioxoimidazolidin-4-one (27) 
 
 
 
Utilising method 5b, L-phenyl alanine (1.0 g, 6.0 mmol) and NH
4
SCN (1.0 g, 13.2 mmol) 
were ground together. A mixture of 4.5 ml of acetic anhydride and 0.5 ml of acetic acid was 
added. 
 
Yield= 35.9 %, M.p. 124-125 °C, 
20
D][ = +94.5° (0.25 g/l00 ml in acetonitrile), HRMS 
calculated for C12H12N2O2S m/z [M+H]+ 248.0619; found 248.0624; 
1H-NMR (500 MHz 
DMSO): δ 7.30-7.23 (m, 3H, phen), δ 6.99 - 6.97 (m, 2H, phen), δ 4.99 (dd, J = 5.9, 2.57 Hz, 
1H, CH), δ 3.41-3.37 (dd, J = 13.9, 5.8 Hz, 1H, CHACHBCH), δ 3.14-3.11 (dd, J = 13.9, 2.57 
Hz, 1H, CHACHBCH), δ 2.69 (s, 1H, CH3).13C-NMR (126 MHz, d6-DMSO): δ 182.1 (C=S), 
δ 172.3 (CO), δ 169.8 (H3CCO), δ 134.2 (CCH2), δ 129.0 (2XCHCH), δ 128.2 (2 x CHC), δ 
127.05 (CH), δ 63.30 (CHCH2), δ 34.3 (CHCH2), δ 27.0 (H3CCO). IR (neat): vmax = 1761 
cm-1, 1699 cm-1 (C=O), 1456 cm-1 (C=S). (File reference: 1H-NMR: 
500_hiwa_acetyl_5_benzyl_2_thiohydantoin. 13C-NMR: 500_hiwa_acetyl_5BT1001).  
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Synthesis of (S)-1-acetyl-5-phenyl-2-thioxoimidazolidin-4-one (28) 
 
 
 
Utilising method 5b, L-phenyl glycine (1.0 g, 6.0 mmol) and NH
4
SCN (1.0 g, 13.2 mmol) 
were ground together. A mixture of 4.5 ml of acetic anhydride and 0.5 ml of acetic acid was 
added. 
 
Yield= 64.0%, 
20
D][ = +14.0° (0.43 g/l00 ml in methanol), HRMS calculated for 
C11H10N2O2S m/z [EI]
+ 234.0463; found 234.0463; 1H-NMR (400 MHz DMSO): δ 7.44-7.33 
(m, 3H, phen), δ 7.26 (d, J = 7.3 Hz, 2H, phen), δ 5.71 (s, 1H, CH), δ 2.72 (s, 1H, CH3). 13C-
NMR (101 MHz, d6-DMSO): δ 183.0 (C=S), δ 171.7 (CO), δ 169.5 (H3CCO), δ 134.8 
(CCH), δ 129.3 (2 x CHCH), δ 128.8 (2 x CHC), δ 126.7 (CH), δ 66.4 (CHCH2), δ 27.6 
(H3CCO). IR (neat): vmax = 1761 cm
-1, 1699 cm-1 (C=O), 1456 cm-1 (C=S). (File reference: 
1H-NMR: 400_HA_exp49 last in DMSO.13C-NMR: 400_HA_exp 49).  
 
 
Synthesis of (S)-1-acetyl-5-methyl-2-thioxoimidazolidin-4-one (29) 
 
 
Utilising method 5b, L-alanine (1.0 g, 11.2 mmol) and NH
4
SCN (1.0 g, 13.2 mmol) were 
ground together. A mixture of 4.5 ml of acetic anhydride and 0.5 ml of acetic acid was added. 
 
Yield= 14.6 %, M.p. 161-162 °C, 
20
D][ = +83.9° (0.29 g/l00 ml in acetonitrile), HRMS 
calculated for C6H8N2O2S m/z [M+H] + 171.0228; found 171.0223, 
1H-NMR (500 MHz, d6-
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DMSO): δ 12.62 (s, 1H, NH), δ 4.69 (q, J = 6.8 Hz, 1H,CHCH3), δ 2.72 (S, 1H, COCH3), δ 
1.44 (d, J = 6.9 Hz, 1H,CHCH3).13C-NMR (126 MHz, d6-DMSO): δ 182.5 (C=S), δ 174.2 
(CO), δ 169.7 (H3CCO), δ 58.9 (CHCH3), δ 27.3 (H3CCO), δ 15.9 (CHCH3). (File reference: 
1H-NMR: 500_HA_exp 46 DFD.13C-NMR: 500_HA_exp 46 CDF3).  
 
 
Synthesis of (S)-1-acetyl-5-isopropyl-2-thioxoimidazolidin-4-one (30) 
 
 
 
Utilising method 5b, L-valine (1.0 g, 8.5 mmol) and NH
4
SCN (1.0 g, 13.2 mmol) were ground 
together. A mixture of 4.5 ml of acetic anhydride and 0.5 ml of acetic acid was added. 
 
Yield= 35.0%, M.p. 96-97°C, 
20
D][ = +116.8° (0.40 g/l00 ml in acetone), HRMS calculated 
for C8H12N2O2S m/z [AP]
- 199.0535; found 199.0541; 1H-NMR (400 MHz, d6-DMSO): δ 
12.64 (s, 1H, NH), δ 4.57 (d, J = 3.4 Hz, 1H,CH), δ 2.71 (s, 3H, H3CCO), δ 2.45-2.39 (m, 1H, 
H3CCHCH3), δ 1.08 (d, J = 7.1 Hz, 3H, CH3), δ 0.75 (d, J = 6.9 Hz, 3H, CH3).13C-NMR (101 
MHz, d6-DMSO): δ 182.6 (C=S), δ 171.9 (CO), δ 169.5 (H3CCO), δ 66.3 (CHCH2), δ 28.7 
(H3CCHCH3), δ 27.6 (H3CCO), δ 17.2 (H3CCHCH3), δ 15.2 (H3CCHCH3). IR (neat): vmax 
= 1757 cm-1 (C=O), 1703 cm-1 (C=O), 1460 cm-1 (C=S). (File reference: NMR: 400_HA_exp 
47 DFM).  
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Synthesis of 5-((1H-indol-3-yl) methyl)-1-acetyl-2-thioxoimidazolidin-4-one (31) 
 
 
 
 
 
Utilising method 5b, L-tryptophan (0.5 g, 2.4 mmol) and NH
4
SCN (0.5 g, 6.6 mmol) were 
ground together. A mixture of 2250 µl of acetic anhydride and 250 µl of acetic acid was 
added. 
 
Yield= 42.0 %, M.p. 153-154 °C, 
20
D][  = +94.5° (0.4 g/l00 ml in acetone), HRMS calculated 
for C14H13N3O2S m/z [ES]
- 286.0650; found 286.0640; 1H-NMR (400 MHz, d6-DMSO): δ 
12.29 (s, 1H, NH), δ 10.95 (s,1H, HCNH), δ 7.35 (d, J = 7.9 Hz, 1H, CHCC), δ 7.31 (d, J = 
8.1 Hz, 1H, CHCNH), δ 7.07-7.031 (t, J = 7.5 Hz, 1H, CHCHCNH), δ 6.98 (m, 2H, 
CHCHCC + CHNH), δ 4.99 (dd, J = 5.5, 2.6 Hz, 1H, CHCH2), δ 3.57-3.52 (dd, J = 14.6, 5.6 
Hz, 1H, CHACHBCH), δ 3.29 (dd, J = 14.8, 3.8 Hz, 1H, CHACHBCH), δ 2.68 (s, 3H, 
H3CCO).13C-NMR (101 MHz, d6-DMSO): δ 181.3 (C=S), δ 171.8 (CO), δ 169.0 (H3CCO), δ 
134.6 (CNH), δ 126.0 (CCNH), δ 122.8 (CHNH), δ 120.0 (CHCHCNH), δ 117.5 
(CHCHCC), δ 117.9 (CHCC), δ 110.2 (CHCNH), δ 104.9 (CCHNH), δ 63.6 (CHCH2), δ 
27.3 (CHCH2), δ 24.6 ( H3CCO). IR (neat): vmax = 1750 cm-1 (C=O), 1688 cm-1 (C=O), 1456 
cm-1 (C=S). (File reference: NMR: 400_HA_exp 53 DFM).  
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Synthesis of (S)-1-acetyl-5-((methylthio) methyl)-2-thioxoimidazolidin-4-one (32) 
 
 
 
 
Utilising method 5b, L-methionine (0.5 g, 3.4mmol) and NH
4
SCN (0.5 g, 6.6 mmol) were 
ground together. A mixture of 2250 µl of acetic anhydride and 250 µl of acetic acid was 
added. 
 
Yield= 38.0 %, M.p. 81-82°C, 
20
D][ = +118.6° (0.40 g/l00 ml in acetone), HRMS calculated 
for C8H12N2O2S2 m/z [MS ES]
- 231.0262; found 231.0266; 1H-NMR (400 MHz, d6-DMSO): 
δ 12.69 (s, 1H, NH), δ 4.76 (dd, J = 7.1, 3.2 Hz, 1H, CHCH2), δ 2.68 (s, 3H, OCCH3), δ 2.51 
– 2.41 (m, 1H, overlapped with DMSO, CHACHBS), δ 2.34 (m, 1H, CHACHBS), δ 2.24 – 2.06 
(m, 2H, CH2CH), δ 1.96 (s, 3H, SCH3).13C-NMR (101MHz, d6-DMSO): δ 183.3 (C=S), δ 
173.5 (CO), δ 170.3 (H3CCO), δ 61.8 (CHCH2), δ 28.4 (CH2S), δ 27.9 (CH2CH2CH), δ 27.81 
(CH3CO), δ 14.80 (SCH3). IR (neat): vmax = 1761 cm-1 (C=O), 1704 cm-1 (C=O), 1446 cm-1 
(C=S). (File reference: 1H-NMR: 400_HA_exp 57 after CC_01.13C-NMR: 400_HA_exp 57 
DFCH).  
 
Synthesis of 5-benzyl-3-phenyl-2-thioxoimidazolidin-4-one (33) 
 
 
 
Utilising method 7, to a mixture of L-phenyl alanine methyl ester hydrochloride salt (1.0 g, 
4.35 mmol) and Et3N (1.5 ml, 10.76 mmol) in 25 ml of CH2Cl2, phenylisothiocyanate (1.5 ml, 
12.56 mmol) was slowly added. 
  
100 
 
Yield= 84.0 %, M.p. 178-179°C, HRMS calculated for C16H14N2OS m/z [EI]
+ 282.0827; 
found 282.0825; 1H-NMR (500 MHz, d6-DMSO): δ 10.62 (s, 1H, NH), δ 7.42-6.76 (m, 10H, 
phenyl), δ 4.78 (apparent t, J = 4.5, 1H, CH), δ 3.13 (d, J = 4.5 Hz, 2H, CHACHBCH). 13C-
NMR (126 MHz, d6-DMSO): δ 181.9 (C=S), δ 173.3 (CO), δ 134.0 (CN), δ 132.8 (CCH2), δ 
129.4 (2 x CH), δ 128.6 (2 x CH), δ 128.5 (CH), δ 128.0 (2 x CH), δ 127.7 (2 x CH), δ 126.6 
(CHCHCHC), δ 59.7 (CHCH2), δ 35.7 (CHCH2). IR (neat): vmax = 1746 cm-1 (C=O), 1494 
cm-1 (C=S). (File reference: NMR: 500_hiwa_5benz3phe2thio).  
 
Synthesis of 5-isopropyl-3-phenyl-2-thioxoimidazolidin-4-one (34) 
 
 
 
Utilising method 7, to a mixture of L-valine methyl ester hydrochloride salt (1.0 g, 5.96 
mmol) and Et3N (1.5 ml, 10.76 mmol) in 25 ml of CH2Cl2, phenylisothiocyanate (1.5 ml, 
12.56 mmol) was slowly added. 
Yield= 90.5 %, M.p. 159-161 °C, HRMS calculated for C12H14N2OS m/z [EI]
+ 234.0827; 
found 234.0832; 1H-NMR (400 MHz, d6-DMSO): δ 10.59 (s, 1H, NH), δ 7.52-7.22 (m, 5H, 
phenyl), δ 4.33 (d, J = 3.6 Hz, 1H, CH), δ 2.19 (m, 1H, H3CCHCH3), δ 1.05 (d, J = 6.9 Hz, 
3H, CH3), δ 0.92 (d, J = 6.6 Hz, 3H, CH3).13C-NMR (126 MHz, d6-DMSO): δ 182.6 (C=S), δ 
173.4 (CO), δ 133.1 (CN), δ 129.6 (2 x CH), δ 128.5 (2 x CH), δ 129.1 (CH), δ 64.1 
(CHCH2), δ 30.3 (H3CCHCH3), δ 17.9 (H3CCHCH3), δ 15.9 (H3CCHCH3). IR (neat): vmax 
= 1756 cm-1 (C=O), 1514 cm-1 (C=S). (File reference: NMR: 500_hiwa_5 valin 3 phenyl 2 
thio).  
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Synthesis of 5-methyl-3-phenyl-2-thioxoimidazolidin-4-one (35) 
 
 
 
Utilising method 2, to a mixture of L-alanine methyl ester hydrochloride salt (1.0 g, 7.16 
mmol) and Et3N (1.4 ml, 10.04 mmol) in 25 ml of CH2Cl2, phenylisothiocyanate (1.5 ml, 
12.56 mmol) was slowly added. 
 
Yield= 96.8%, M.p. 154- 156 °C, HRMS calculated for C10H10N2OS m/z [MS EI]
+ 206.0514; 
found 206.0518; 1H-NMR (400 MHz, d6-DMSO): δ 10.53 (s, 1H, NH), δ 7.54-7.25 (m, 5H, 
phenyl), δ 4.47 (q, J = 6.7 Hz, 1H, CHCH3), δ 1.40 (d, J = 6.8 Hz, 3H, CHCH3).13C-NMR 
(101 MHz, d6-DMSO): δ 182.0 (C=S), δ 174.9 (CO), δ 133.5 (CN), δ 128.8 (2 x CH), δ 128.6 
(2 x CH), δ 128.4 (CH), δ 55.0 (CHCH3), δ 16.1 (CHCH3). IR (neat): vmax= 1750 cm-1 
(C=O), 1498 cm-1 (C=S). (File reference: 1H-NMR: 400_HA_exp 25 C13).  
 
Synthesis of 3-allyl-5-benzyl-2-thioxoimidazolidin-4-one (36) 
 
 
 
Utilising method 7, to a mixture of L-alanine methyl ester hydrochloride salt (0.2 g, 0.87 
mmol) and Et3N (0.2 ml, 1.44 mmol) in 5 ml of CH2Cl2, phenylisothiocyanate (0.2 ml, 2.0 
mmol) was slowly added. 
 
Yield= 46.3 %, M.p. 107-108 °C, HRMS calculated for C13H14N2OS m/z [MS EI]
+ 245.0749; 
found 245.0742; 1H-NMR (400 MHz, d6-DMSO): δ 10.45 (s, 1H, NH), δ 7.31-7.09 (m, 5H, 
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phenyl), δ 5.50 – 5.37 (m, 1H, CH=CHACHB), δ 4.85 (dd, J = 10.4, 1.3, 1H, CH=CHACHB), δ 
4.65 (dd, J = 4.8, 3.7 Hz, 1H, CHCH2), δ 4.48 (dd, J = 17.3, 1.3, 1H, CH= CHACHB), δ 4.08 
(m, 2H, CH2CH= CHACHB), δ 3.04 (d, J = 4.8 Hz, 2H, CH2CH). 13C-NMR (101 MHz, d6-
DMSO): δ 182.5 (C=S), δ 174.0 (CO), δ 135.0 (CCH2CH), δ 131.6 (CH=CHACHB), δ 130.2 
(2 x CH), δ 128.6 (2 x CH), δ 127.3 (CH), δ 116.4 (CH=CH2), δ 59.9 (CCH2CH), δ 45.9 
(NCH2CH=CH2), δ 36.0 (CHCH2). IR (neat): vmax = 1739cm-1 (C=O), 1495 cm-1 (C=S). 
(File reference: 1H-NMR: 400_HA_exp 200 dry HV.13C-NMR: 400_HA_exp 200_13C1).  
 
Synthesis of (R)-5-benzyl-3-phenyl-1-(pyridin-2-ylmethyl)-2-thioxoimidazolidin-4-one 
(37) 
 
 
 
Utilising method 8, D-phenylalanine methyl ester hydrochloride salt (0.25 g, 1.16 mmol) was 
dissolved in dichloromethane (5 ml) in the presence of triethylamine (0.08 ml, 0.57 mmol). 2-
pyridinecarboxaldehyde (0.15 ml, 1.6 mmol) and sodium triacetoxyborohydride (0.40 g, 1.89 
mmol) were added and the mixture allowed to stir for 10 minutes at room temperature. Phenyl 
isothiocyanate (0.15 ml, 1.26 mmol) was added to the mixture and stirred for another 25 
minutes. The solution was washed with acidic water 3 times to remove the base and amino 
acid methyl ester. The organic phase was evaporated under reduced pressure and 3x10 ml of 
hexane was added to the solid to extract all impurities. The product was dried by high vacuum 
and NMR spectra were recorded. 
Yield= 46.2%, Mp. 104-105 °C, 
20
D][ = +55.0° (0.41 g/l00 ml in acetone), HRMS calculated 
for C22H19N3OS m/z [EI]
+ 374.1327; found 374.1320; 1H-NMR (500 MHz, CDCl3): δ 8.52 (d, 
J = 4.0 Hz, 1H, CHN), δ 7.7 (t, J = 7.6 Hz, 1H, CHCHN), δ 7.5 (d, J = 7.8 Hz, 1H, CHCN), δ 
7.31-7.18 (m, 7H, phenyl+ pyridine), δ 7.07 (m, 2H, phenyl), δ 6.71 (m, 2H, phenyl), δ 5.81 
(d, J = 15.1 Hz, 1H, CHACHBN), δ 4.75 (apparent t, J = 4.3 Hz, 1H, CHCH2), δ 4.63 (d, J = 
15.1 Hz, 1H, CHACHBN), δ 3.42 (dd, J = 14.5, 4.4 Hz, 1H, CHACHBCH), δ 3.25 (dd, J = 
14.5, 4.1 Hz, 1H, CHACHBCH). 
13C-NMR (126 MHz, CDCl3): δ 182.4 (C=S), δ 173.1 (CO), 
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δ 155.4 (CH2CN), δ 149.8 (CHN), δ 137.4 (CNCS), δ 134.5 (CHCHCN), δ 133.8 (CCH2CH), 
δ 130.0 (2 x CH), δ 129.3 (2 x CH), δ 128.9 (4 x CH), δ 127.5 (CH), δ 123.3 (CHCN), δ 
122.9 (CHCHN), δ 63.9 (CHCH2), δ 49.6 (NCH2), δ 34.4 (CHCH2). IR (neat): vmax = 1746 
cm-1 (C=O), 1593 cm-1 (C=S). (File reference: NMR: 500_hiwa_exp 33 CC 002).  
 
Synthesis of (S)-5-isopropyl-3-phenyl-1-(pyridine -2-ylmethyl)-2-thioxoimidazolidin-4-
one (38) 
 
  
 
Utilising method 8, L-valine methyl ester hydrochloride salt (1.00 g, 5.97 mmol) was 
dissolved in dichloromethane (40 ml) in the presence of triethylamine (0.91 ml, 6.52 mmol). 
2-pyridinecarboxaldehyde (0.62 ml, 6.56 mmol) and sodium triacetoxyborohydride (1.9 g, 
8.96 mmol) were added to the mixture, allowing stirring for 1 hour at room temperature. 
Phenyl isothiocyanate (0.97 ml, 6.56 mmol) and triethylamine (0.83 ml, 5.97 mmol) were 
added to the mixture and allowed to stir for another hour. The yellow oily product was 
washed with ethanol (4 x 10 ml) and subjected to column chromatography (40% acetone: 
60% hexane). The mixture of compounds 34 (Rf = 1.8) and 38 (Rf= 1.3) was collected and 
characterised by GC-MS. The mixture was again subjected to column chromatography (90% 
diethyl ether: 10% hexane). The pure compounds of 34 and 38 were collected separately with 
yields of 18.1 % and 60.4 %, respectively.  
 
Yield= 60.4%, M.p. 88- 89°C, 
20
D][  = -27.0° (0.37 g/l00 ml in acetone), HRMS calculated 
for C18H19N3OS m/z [ES]
- 324.1171; found 324.1164; 1H-NMR (400 MHz, CDCl3): δ 8.49 (d, 
J = 4.8 Hz, 1H, CHN), δ 7.6 (dd, J = 7.7, 5.9 Hz, 1H, CHCHN), δ 7.4-7.10 (m, 7H, phenyl+ 
pyridine), δ 5.69 (d, J = 15.4 Hz, 1H, CHACHBN), δ 4.60 (d, J = 15.4 Hz, 1H, CHACHBN), δ 
4.2 (d, J = 3.4 Hz, 1H, CHCHCH3), δ 2.45 (m, 1H, CH3CHCH3), δ 1.17 (d, J = 7.0 Hz, 1H, 
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CH3CHCH3), δ 0.86 (d, J = 6.9 Hz, 1H, CH3CHCH3). 13C-NMR (101 MHz, CDCl3): δ 183.0 
(C=S), δ 172.0 (CO), δ 155.1 (CH2CN), δ 150.2 (CHN), δ 137.0 (CNCS), δ 133.8 
(CHCHCN), δ 129.8 (2 x CH), δ 129.0 (CH), δ 128.5 (2 x CH), δ 123.1 (CHCHCN), δ 122.9 
(CHCHN), δ 67.6 (CHCHCH3), δ 50.1 (CHCHCH3), δ 28.8 (NCH2), δ 17.6 (CH3CHCH3), δ 
15.8 (CH3CHCH3). IR (neat): vmax = 1750 cm
-1 (C=O), 1618 cm-1 (C=S). 
 
Yield= 18.1 %; 1H-NMR (400 MHz, CDCl3): δ 7.47-7.37 (m, 3H, phenyl), δ 7.25-7.20 (m, 
2H, phenyl), δ 4.11 (d, J = 3.7, 1.1 Hz, 1H, CH), δ 2.32 (m, 1H, H3CCHCH3), δ 1.08 (d, J = 
7.0 Hz, 3H, CH3), δ 0.98 (d, J = 6.8 Hz, 3H, CH3).13C-NMR (101 MHz, CDCl3): δ 184.7 
(C=S), δ 173.5 (CO), δ 133.0 (CN), δ 129.8 (2 x CH), δ 129.7 (2 x CH), δ 128.6 (CH), δ 65.3 
(CHCH2), δ 31.6 (H3CCHCH3), δ 19.3 (H3CCHCH3), δ 16.6 (H3CCHCH3). File reference: 
NMR: 400_HA_exp 51A spot 1).  
 
Synthesis 1-(furan-2-ylmethyl)-5-isopropyl-3-phenyl-2-thioxoimidazolidin-4-one (39) 
 
 
 
Utilising method 8, L-valine methyl ester hydrochloride salt (1.00 g, 5.97 mmol) was 
dissolved in dichloromethane (30 ml) in the presence of triethylamine (0.62 ml, 4.44 mmol). 
2-furancarboxaldehyde (0.51 g, 5.3 mmol) and sodium triacetoxyborohydride (1.9 g, 8.96 
mmol) were added to the mixture, allowing stirring for 1 hour at room temperature. Phenyl 
isothiocyanate (0.83 ml, 6.94 mmol) and triethylamine (0.80 ml, 5.73 mmol) were added and 
the mixture was stirred for another hour. 
 
Yield= 53.0 %, M.p. 90-92°C, HRMS calculated for C17H18N2O2S m/z [ES]
- 313.1011; found 
313.1015; 1H-NMR (400 MHz, CDCl3): δ 7.46 –7.31 (m, 4H, phenyl + CHO furan), δ 7.22- 
7.15 (m, 2H, phen), δ 6.38 (d, J = 3.1 Hz, 1H, CHCHO), δ 6.31 (dd, J = 3.2, 1.9 Hz, 
1H,CHCO), δ 5.65 (d, J = 15.7 Hz, 1H, NCHACHBCO), δ 4.46 (d, J = 15.7 Hz, 1H, 
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NCHACHBCO), δ 3.97 (d, J = 3.4 Hz, 1H, CHCHCH3), δ 2.45 (m, 1H, CH3CHCH3), δ 1.17 
(d, J = 7.0 Hz, 3H, CH3CHCH3), δ 0.91 (d, J = 6.9 Hz, 3H, CH3CHCH3). 13C-NMR (101 
MHz, CDCl3): δ 183.0 (C=S), δ 172.3 (CO), δ 148.7 (CHCO), δ 143.4 (CHO), δ 133.8 (CN), 
δ 129.7 (CHCHCHCN), δ 129.6 (2 x CH), δ 128.9 (2 x CH), δ 111.2 (CHCO), δ 110.6 
(CHCHO), δ 66.7 (CHCHCH3), δ 41.8 (CH2N), δ 29.8 (CH3CHCH3), δ 17.8 (CH3CHCH3), δ 
16.1 (CH3CHCH3). IR (neat): vmax = 1749 cm
-1 (C=O), 1499 cm-1 (C=S). (File reference: 
NMR: 400_HA_exp 51 D).  
 
Synthesis 1-benzyl-5-isopropyl-3-phenyl-2-thioxoimidazolidin-4-one (40) 
 
 
 
Utilising method 8, L-valine methyl ester hydrochloride salt (1.00 g, 5.97 mmol) was 
dissolved in dichloromethane (40 ml) in the presence of triethylamine (0.91 ml, 6.52 mmol). 
Benzaldehyde (0.67 ml, 6.56 mmol) and sodium triacetoxyborohydride (1.9 g, 8.96 mmol) 
were added and the mixture was allowed to stir for 1 hour at room temperature. Phenyl 
isothiocyanate (0.97 ml, 6.95 mmol) and triethylamine (0.83 ml, 5.97 mmol) were added and 
the mixture was stirred for another hour. 
 
Yield= 71.7%, M.p. 124-125 °C, HRMS calculated for C19H20N2OS m/z [ES]
- ; found; 1H-
NMR (400 MHz, CDCl3): δ 7.50 –7.22 (m, 10H, phenyl), δ 5.89 (d, J = 15.1 Hz, 1H, 
NCHACHBCCH), δ 4.33 (d, J = 15.1 Hz, 1H, NCHACHBCCH), δ 3.84 (d, J = 3.4 Hz, 1H, 
CHCHCH3), δ 2.40-2.30 (m, 1H, CH3CHCH3), δ 1.12 (d, J = 7.1 Hz, 3H, CH3CHCH3), δ 
0.92 (d, J = 6.9 Hz, 3H, CH3CHCH3). 
13C-NMR (101 MHz, CDCl3): δ 183.6 (C=S), δ 172.4 
(CO), δ 135.3 (CNCS), δ 133.9 (CNCH2N), δ 129.6 (CH), δ 129.6 (2 x CH), δ 129.5 (2 x 
CH), δ 128.9 (2 x CH), δ 128.8 (CH), δ 128.7 (2 x CH), δ 65.9 (CHCHCH3), δ 48.9 (CH2), δ 
29.7 (CHCHCH3), δ 17.8 (H3CCHCH3), δ 16.3 (H3CCHCH3). IR (neat): vmax = 1748 cm-1 
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(C=O), 1501 cm-1 (C=S). (File reference: 1H-NMR: 400_HA_exp 51B.13C-NMR: 
400_HA_exp 51B _C13).  
 
Synthesis 3-(3, 5-bis(trifluoromethyl)phenyl)-5-methyl-1-((1-methyl-1H-pyrrol-2-
yl)methyl)-2-thioxoimidazolidin-4-one (41) 
 
 
 
Utilising method 8, L-alanine methyl ester hydrochloride salt (1.00 g, 7.16 mmol) was 
dissolved in dichloromethane (16 ml) in the presence of triethylamine (0.93 ml, 6.3 mmol). 1-
methyl-1H-pyrrole-2-carbaldehyde (0.80 ml, 7.40 mmol) and sodium triacetoxyborohydride 
(2.1 g, 9.91 mmol) were added and the mixture, allowing stirring over night at room 
temperature. 1-isothiocyanato-3,5-bis (trifluoromethyl) benzene (2.60 ml, 14.23 mmol) and 
triethylamine (0.20 ml, 1.43 mmol) were added and the mixture was stirred for another hour. 
 
Yield= 64.0 %, M.p. 173-174°C, HRMS calculated for C17H12F6N3OS m/z [EI]
+ 435.0840; 
found 435.0840; 1H-NMR (500 MHz, CDCl3): δ 7.86 (s, 1H, CHCF3), δ 7.79 (s, 2H, 
CHCCH), δ 6.61 (t, J = 3.2 Hz, 1H, CHNCH3), δ 6.16 (dd, J = 3.5, 1.7 Hz, 1H, 
CHCHNCH3), δ 6.04 (t, J = 3.2 Hz, 1H, CHCNCH3), δ 5.69 (d, J = 15.6 Hz, 1H, CHACHBN), 
δ 4.49 (d, J = 15.6 Hz, 1H, CHACHBN), δ 3.98 (q, J = 7.2 Hz, 1H, CHCH3), δ 3.60 (s, 3H, 
NCH3), δ 1.51 (d, J = 7.2 Hz, 3H, CHCH3), 13C-NMR (126 MHz, CDCl3): δ 179.3 (C=S), δ 
172.5 (CO), δ 134.3 (CNCH3), δ 132.2 (CHN), δ 124.3 (2xCHN), δ 124.2 (CHCCF3), δ 
122.7 (CHCHN), δ 121.7 (CHCN), δ 111.3 (2 x CCF3), δ 107.7 (2 x CF3), δ 57.2 (CHCH3), δ 
40.8 (NCH3), δ 34.8 (CH2NCH3), δ 15.5 (CHCH3). IR (neat): vmax = 1756 cm-1 (C=O), 1480 
cm-1 (C=S). 1H-NMR: 500_hiwa_exp 34 13C.13C-NMR: 500_HIWA_EXP 34 003).  
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Chapter 3 
 
 
 
 
 
 
 
 
 
 
 
Hydrolysis of substituted 2-thiohydantoins and 
related compounds 
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3.1 Introduction 
3.1.1 Hydrolysis of hydantoins 
 
Hydantoin derivatives decompose either by base-catalysed or acid-catalysed hydrolysis to the 
urido-acid. Enzyme catalysis is another way to hydrolyse hydantoin in particular, and other 
drugs more generally, in the body (Scheme 3.1).1  
 
 
Scheme 3.1: Enzyme hydrolysis of hydantoin derivatives.2 
 
3.1.2 Hydrolysis of 1-acetyl 2-thiohydantoins 
 
5-Substituted 1-acetyl-2-thiohydantoins are hydrolysed by acid- or base-catalysed processes. 
De-acetylation is the first step to produce 5-substituted 2-thiohydantoins by acid 3,4 or base.5 
Cleavage of 5-substituted 1-acetyl-2-thiohydantoins was originally reported by Schlack and 
Kumpf, followed by Nicolet6 in connection with the degradation of peptides and proteins 
under basic conditions. Congdon and Edward5 reported that 1-acetyl-5-methyl-2-
thiohydantoin starts to be hydrolysed under alkaline conditions and the negative charge on the 
3-position N- is not delocalised over the 1-acetyl-carbonyl group, allowing hydrolysis to take 
place (Scheme 3.2). Similarly, Kjaer and Eriksen7 reported the hydrolysis of 1-acetyl-2-
thiohydantoin and 1-benzoyl-2-thiohydantoin by using dilute base which was deacetyled 
rapidly to form 2-thiohydantoin. 
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Scheme 3.2: Mechanism of base-catalysed hydrolysis of 5-substituted 1-acetyl-2-
thiohydantoins, as suggested by Congdon8 
 
The negative charge at N-3 position (2) (Scheme 3.2) can reduce the reactivity of 5-
substituted 1-acetyl-2-thiohydantoin because the hydrolysis must proceed by the attack of the 
hydroxide ion on anion. Congdon8  reported the hydrolysis of some 1-acetyl-2-thiohydantoins 
and 1-benzoyl-2-thiohydantoins which were slowly hydrolysed at low pH and rapidly 
hydrolysed at high pH. It has been explained that the benzoyl on the N-1 position is lost as a 
result of hydrolysis more quickly than acetyl because of the co-planarity effect of acetyl. The 
acyl carbonyl and the thiocarbonyl groups can be in a coplanar conformation, but will be 
separated as much as possible (the parallel coplanar conformation involves strong dipolar 
repulsion). On the contrary, to avoid the dipolar repulsion in 1-benzoyl-2-thiohydantoin, the 
benzene ring twists about 90° out of the plane of the acyl group. Congdon and Edward5 
reported the pseudo-first-order rate constant of 1-benzoyl-2-thiohydantoins with C-5 
substituent in phosphate buffer (pH 11.2, 0.45 M I, at 25 °C). The authors reported the 
pseudo-first-order rate constants for different 1-benzoyl-2-thiohydantoins and the effect of C-
5 substituents on the hydrolysis in the order un-substituted>5-methyl>5-phenyl>5-isobutyl>5-
isopropyl.5 
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3.1.3 Hydrolysis of 2-thiohydantoin 
 
The following step after the deacetylation process of 1-acetyl-2-thiohydantoin involves 
converting 5-substituted 2-thiohydantoin to thioureido-acids9 which are finally hydrolysed to 
amino acids.10 The base-catalysed hydrolysis of peptides proceeds to form substituted 2-
thioureidopropanoic acid, reducing the yield of C-terminal thiohydantoin derivatives (Scheme 
3.3).11 Edward and Nielsen12 suggested the mechanism for the base-catalysed hydrolysis of 5-
substituted 2-thiohydantoins to produce thioureido-acids. 
 
 
 
Scheme 3.3: Mechanism of base-catalysed hydrolysis of 5-substituted 2-
thiohydantoins proposed by Edward and Nielsen.12 
 
3.2 Results and discussion 
3.2.1 Kinetics and mechanism of base-catalysed hydrolysis of 5-substituted 
1-acetyl-2-thiohydantoins 
3.2.1.1 UV-visible spectroscopy  
 
Several acetylated 2-thiohydantoins were selected to study their kinetics and mechanism of 
hydrolysis (Scheme 3.4). 
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Scheme 3.4: The chemical structure of compounds 3.1-3.7 
 
To study the hydrolysis of 5-substituted 1-acetyl-2-thiohydantoins, different concentrations of 
phosphate buffer were used (pH 7.4, 0.9 M I at 37 °C). The kinetics of hydrolysis for all 
compounds was studied in aqueous solution without the use of a co-solvent. The acetyl group 
at the N-1 position is deacetyled to form 5-substituted 2-thiohydantoin and acetic acid. The 
UV-visible spectrum of 5-substituted 1-acetyl-2-thiohydantoins 3.1-3.7 exhibits a strong 
absorption band at around 287-291 nm. In the presence of different concentrations of buffer, 
the absorption spectrum of the compounds decrease as a function of time and the new 
absorption spectrum increases in intensity (Figure 3.1).  
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Figure 3.1: Typical UV–visible spectra of (S)-1-acetyl-5-methyl-2-thioxoimidazolidin-4-one 
3.7 at 37 °C, recorded during a kinetic run in non-deuterated phosphate buffer, pH 7.4, 0.27 
M, 0.9 M I. 
 
Figure 3.1 shows that the absorbance at 255 and 290 nm of 3.7 decreases as a function of time 
in non-deuterated buffer solution (pH 7.4, 0.27 M, 0.9 M I). There is no clear isosbestic point 
between the peaks at 190 nm and 255 nm, suggesting that more than one hydrolysis process 
has taken place (vide infra). Nevertheless, the largest absorbance band at 290 nm decreases in 
intensity in a process following a first-order rate law. We therefore attribute this absorbance 
to 1-acetyl-2-thiohydantoins with negligible contributions from potential downstream reaction 
intermediates and products. This assignment is in agreement with the UV-visible spectra 
observed for the deacetylated compounds (see section 3.2.2). The absorbance spectra of 3.7 in 
different phosphate buffers (0.045, 0.09, 0.18, 0.27 and 0.36, pH 7.4, 0.9 M I, at 37 °C) were 
plotted versus time to obtain the pseudo-first-order rate constants for hydrolysis (Figure 3.2). 
Similarly, the absorbance spectra of 3.1-3.6 were plotted versus time (see appendix). 
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Figure 3.2: Fits of experimental data from hydrolysis experiments of (S)-1-acetyl-5-methyl-2-
thioxoimidazolidin-4-one 3.7 hydrolysis at 290 nm in (■) 0.045 M, (●) 0.09 M, (▲) 0.18 M, 
(▼) 0.27 M, and () 0.36 M, non-deuterated phosphate buffer (pH 7.4, 0.9 M I, at 37 °C). 
 
Figure 3.2 shows the hydrolysis of 3.7 in 0.045, 0.09, 0.18, 0.27 and 0.36 M phosphate buffer 
(pH 7.4, 0.9 M I at 37 °C) and a fit of the data with a pseudo-first-order kinetic rate law. 
Similarly, the same conditions were used for compounds 3.1-3.6, with a decrease in 
absorbance as a function of time also observed.  
The decrease of absorbance with time at the selected wavelengths was reproduced well by the 
pseudo-first-order kinetic rate law (Equation 3.1).13 
 
𝐴t = 𝐴fin + ∆𝐴e
−𝑘𝑜𝑏𝑠𝑡 Equation 3. 1 
  
Here At is the absorbance at time t, Afin is the final absorbance, ΔA represents the difference 
between the absorbance at time zero and Afin, and kobs is the observed pseudo-first-order rate 
constant for hydrolysis. 
Equation 3.1 was used to obtain pseudo-first-order rate constants for hydrolysis of 3.1-3.7 at 
every single concentration of buffer. The data for 3.1-3.7 were reproduced very well by the 
pseudo-first-order rate law (see appendix). 
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The rate constants for hydrolysis of 3.1-3.7 were plotted versus the concentration of the basic 
component of phosphate buffer in different total concentrations of phosphate buffer (pH 7.4, 
0.9 M I, at 37 °C) (Figure 3.3)  
 
 
Figure 3.3: Observed rate constants of hydrolysis of a) (■) 3.1, (●) 3.2, (▲) 3.3, (▼) 3.4 and 
b) (▲) 3.5, (●) 3.6, (■) 3.7 as a function of the concentration of the basic component of H2O-
based phosphate buffer (37 °C, 0.9 M I, pH 7.4) with total phosphate concentration of 0.45 M, 
0.36 M, 0.27 M, 0.18 M and 0.09 M. 
 
Figure 3.3 shows a linear increase in the first-order rate constants for hydrolysis of 3.1-3.7 as 
a function of the concentration of the basic component of the buffer, i.e. HPO4
2-
, at pH 7.4. 
The data show that not only is the concentration of base important, but also that the linear 
increase suggests that the hydrolysis reaction is subject to general-base catalysis by the 
phosphate dianion. The experimentally observed rate constants follow the rate law given by 
Equation 3.2. 
 
𝑘𝑜𝑏𝑠 =  𝑘° + 𝑘OH−[𝑂𝐻
−] + 𝑘H3O+[𝐻3𝑂
+] + 𝑘buffer[𝐻𝑃𝑂4
2−] 
 
Equation 3. 2 
 
where k0 is the rate constant of the non-catalysed reaction, kOH
- and kH3O+ are the rate constants 
for the catalysed reaction by hydroxide and hydronium ion, respectively, obtained together 
from the intercept (kin), kbuffer is the second-order rate constant for buffer catalysed hydrolysis 
obtained from the slope, and kobs is the observed rate constant for hydrolysis.  
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The observed second-order rate constants for the HPO4
2--catalysed hydrolysis of 3.1-3.7 khyd 
and the observed rate constant kin obtained from the slope and intercept, respectively, are 
shown in Table 3.1.  
 
Table 3.1: Second-order rate constants for hydrolysis khyd of 3.1-3.7 in H2O-phosphate buffer 
at 0.36 M, 0.27 M, 0.18 M, 0.09 M and 0.045 M total phosphate buffer, and 0.29 M, 0.22 M, 
0.14 M, 0.072 M and 0.036 M HPO4
2-, respectively, with ionic strength of 0.9 M I, pH 7.4 at 
37 °C. 
 
 
 
 
 
 
Substrate R 
khyd 
 / 10-6 s-1 M-1 
kin  
/ 10-6 s-1 
3.1 H 73.2 ± 7.1 11.3 ± 0.9 
3.2 Bz 10.2 ± 0.5 4.5 ± 0.07 
3.3 Ph 20.2 ± 0.3 4.6 ± 0.04 
3.4 3-Met-indole 10.5 ± 0.6 3.7 ± 0.09 
3.5 i-Pr 23.3 ± 0.08 4.8 ± 0.1 
3.6 CH2CH2SCH3 30.7 ± 0.7 6.6 ± 0.09
 
3.7 Me 29.9 ± 1.0 9.9 ± 0.2 
 
Table 3.1 shows the differences in the second-order rate constants khyd for 3.1-3.7. The 
presence of substituents on C-5 was found to affect the rate of hydrolysis and decrease the 
reactivity.12 The substituents might impede the change from trigonal 2 to tetrahedral 3 by a 
non-bonded interaction (Scheme 3.2). Compound 3.1, which is non-substituted at position 5, 
is hydrolysed faster than the other C-5 substituted 1-acetyl-2-thiohydantoins 3.2-3.7. The rate 
constants in Table 3.1 thus show the steric hindrance for attack on the acetyl group at the N-1 
position exerted by different groups at the C-5 position.5 
The order of decreasing rate constants for base-catalysed hydrolysis, and thus increasing 
stability in Table 3.1 is 3.1, 3.6, 3.7, 3.5, 3.3, 3.4 and 3.2. The highest rate constant is found 
for 3.1, which does not carry any group substituents on the 5-position, as a result of the 
absence of steric effects compared with the 5-substituted 1-acetyl-2-thiohydantoins (Table 
3.1).  
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The reaction proceeds by attack of OH- on the acetyl moiety and the hydrolysis rate is 
decreased due to an increase of the steric strain for the tetrahedral intermediate in combination 
with a hindered approach of the nucleophile. The comparison between aromatic substituents 
on the 5-position and aliphatic substituents is obvious. The linear aliphatic substituents on the 
5-position of 1-acetyl-2-thiohydantoins 3.6 and 3.7 display the highest rate constants for 
hydrolysis after the non-substituted compound, showing the effect of substituent size and 
steric hindrance. The branched isopropyl group in 3.5 leads to a slower reaction than observed 
for 3.6 and 3.7 with unbranched the aliphatic substituents. The phenyl group in 3.3 appears to 
have a similar effect as the isopropyl group in 3.5 which is not unreasonable considering the 
similar “branching” and the fact that the reaction centre is not in direct conjugation with the 
aromatic ring. When larger groups are attached to the C-5 position it becomes more difficult 
for the nucleophile to reach the carbonyl carbon to produce the tetrahedral intermediate.14 
Compounds 3.2 and 3.4 are therefore hydrolysed more slowly than the other compounds. An 
additional effect of substituents may affect the acidity of the reactant. It has been shown that 
1-acetyl-2-thiohydantoin is able to ionise to produce compound 2 (Scheme 3.2), with pKa 
values of 6.5-7.0.5 The rate constant of hydrolysis will be different when base-catalysed attack 
takes place on the un-ionised compound (1) and ionised compound (2) (Scheme 3.2). The rate 
constant of hydrolysis is faster by factor 103 when the base attacks the unionised compound 
(1) rather than the ionised compound (2), as previously reported.8 pKa values of 7.03 and 6.95 
for 3.1 and 3.7 have been reported in water, respectively. N-1-acetylated thiohydantoins 
compounds 3.1 and 3.7 are thus slightly stronger acids than the corresponding non-acetylated 
hydantoins.8, 15 Similarly, the pKa of 2-thiohydantoin is 8.5, making it a slightly stronger acid 
than corresponding hydantoin (pKa = 9.0).
15, 16  
 
3.2.1.2  Determination of the rate constant for hydrolysis of 1-acetyl-5-isopropyl-2-
thiohydantoin by NMR spectroscopy 
 
The absence of an isosbestic point in the overlay spectra for hydrolysis (Figure 3.1) suggests 
that multiple reactions are occurring. To explore this behaviour further, we plotted the 
absorbance at 260 nm as a function of time (Figure 3.4). 
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Figure 3.4: Absorbance of 3.5 as a function of time at 260 nm in deuterated-phosphate buffer 
(pH* 7.4, 0.36 M, 0.9 M I).  
 
Figure 3.4 shows that at 260 nm, the absorbance increased and subsequently decreases. This 
suggests that two reactions occur. 
To confirm if the process followed in Section 3.2.1.1 corresponds to a loss of acetate, the 
hydrolysis of compound 3.5 was also studied using 1H-NMR spectroscopy in 0.36 M 
phosphate buffer (0.9 M ionic strength at 37 °C). It was noticed during 1H-NMR studies that 
one of the hydrolysis products of 3.5 is not soluble in aqueous solution and precipitates. In 
order to observe the peak of 3.5 in 1H-NMR, a higher concentration of compound compared 
to that used in the UV-visible studies was used. Therefore, the precipitation was noticed 
during the hydrolysis process. The hydrolysis of 3.5 is slow and the area of all peaks relative 
to methyl and CH in 3.5 decreases during the hydrolysis. Therefore, tetramethylammonium 
bromide was used as an internal reference with the peak at 3.02 ppm (Figure 3.5). 
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Figure 3.5: Time resolved 1H-NMR spectra of 3.5 by using 0.36 M of total D2O-phosphate 
buffer (0.9 M I, pH 7.4 at 37 °C with no d3-acetonitrile). 
 
Figure 3.5 shows the disappearance of peaks for 3.5 and the appearance of new peaks for new 
compounds. It is clear that the acetyl peak has decreased over time and a new peak of acetate 
is observed at 1.75 ppm. To confirm that the new peak belongs to acetate, sodium acetate was 
added to the solution after the hydrolysis reaction had taken place. The 1H-NMR spectrum of 
the resulting solution confirmed that the new peak corresponded to acetate. The relative area 
of the peak for the methyl group in the acetylated thiohydantoin at 2.65 ppm decreases and 
the relative area of the peak for the methyl at 1.75 ppm increases. Both peaks are referenced 
against tetramethylammonium bromide. The relative peak areas were plotted as a function of 
time and suggest pseudo-first-order behaviour of hydrolysis of 3.5 (Figure 3.6).  
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Figure 3.6: The hydrolysis process of 3.5 in 0.36 M D2O-phosphate buffer (0.9 M I, pH 7.4 at 
37 °C). a) (■) the relative area 3H of H3CCO decreases over time, and (●) the relative area of 
3H of H3CCO (one hydrogen disappears with integration) increases over time.  
 
Figure 3.6 shows the plot for the relative integration of decreasing acetyl CH3 at the N-1 
position of 3.5 at 2.65 ppm and increasing the acetate CH3 at 1.75 ppm as a function of time. 
Both peaks were fitted to the pseudo-first-order rate constant and the rate constant of 
hydrolysis obtained by using Equation 3.1. It is important to note that the integration of three 
hydrogens has appeared at 2.65 ppm from 0 hour in 1H-NMR (Figure 3.6). However, the 
peak of CH3 of acetate after hydrolysis at 152 hours at 1.75 ppm shows just two hydrogens 
which might be because of the precipitation of acetate or evaporation of acetic acid. An 
alternative reason for the reduced relative signal observed for acetate formed in the hydrolysis 
reaction might be an additional H/D exchange process on the acetyl methyl group. This H/D 
exchange process, if occurring, would presumably take place before hydrolysis because the 
negative charge on the acetate anion would strongly inhibit the H/D exchange process after 
hydrolysis. The pseudo-first-order rate constants for the hydrolysis of 3.5 by 1H-NMR are 
shown in Table 3.2 by the relative area of the disappearance and appearance of the methyl 
group during the deacetylation process. 
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Table 3.2: Pseudo-first-order rate constants for hydrolysis khyd of (S)-1-acetyl-5-isopropyl-2-
thioxoimidazolidin-4-one (3.5) in D2O-phosphate buffer at 0.36 M total phosphate buffer with 
ionic strength of 0.9 M I, pH 7.4 at 37 °C (No d3-acetonitrile), and using 80% of 0.01 M of 
total phosphate buffer, 0.9 M I, pH 7.4 at 37 °C, with 20% of d3-acetonitrile, determined by 
1H-NMR spectroscopy. 
Con./M k hyd (D2O) 
/ 10-6 s-1 (■) 
 
k hyd (D2O) 
/ 10-6 s-1 (●) 
0.36 11.3 ± 0.4 9.9 ± 0.3 
0.008 0.5 ± 0.03 0.5 ± 0.03 
 
Table 3.2 shows the pseudo-first-order rate constants for hydrolysis khyd in aqueous 0.36 M 
total phosphate buffer with precipitation. In order to solve the precipitation problem, a 
solution of 20 % d3-acetonitrile with 80% 0.01 M D2O-phosphate buffer pH 7.4, 1 M I, was 
used (Table 3.2) (see appendix). Interestingly, though the amount of precipitation decreased, 
solid particles were still observed indicating that the hydrolysis product of 3.5 has limited 
solubility in aqueous solution. The isopropyl and methyl substituents at the C-5 position of 1-
acetyl-2-thiohydantoin have higher solubility than other substituents such as benzyl and 
phenyl. Therefore, experiments with further compounds were not attempted.  
 
3.2.1.3  Brønsted plot for hydrolysis of (S)-1-acetyl-5-methyl-2-thioxoimidazolidin-4-one 
 
The hydrolysis of 3.7 was studied in aqueous solution in a series buffers with different pKa. 
Pseudo-first-order rate constants for hydrolysis were determined as before (Section 3.2.1.1). 
The hydrolysis was studied using acetate, phosphate, TRIS, borate and methylamine buffers 
over the pH range 5.0-9.7 at 37 °C. The second-order rate constants for hydrolysis in the 
different buffers were determined by plotting the pseudo-first-order rate constants of 
hydrolysis versus the concentration of the basic component of each buffer (Figure 3.7). 
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Figure 3.7: Observed pseudo-first-order rate constants for the hydrolysis of 3.7 in 0.45 M, 
0.36 M, 0.27 M, 0.18 M and 0.09 M of total acetate, phosphate, TRIS and methyl amine, 0.9 
M I of a) (■) acetate buffer pH 5.0 (●), phosphate buffer pH 7.4 (▲) TRIS buffer pH 8.2 and 
b) (■) methyl amine pH 9.7, all buffers are H2O-based and experiments were carried out at 37 
°C; data are plotted as a function of the concentration of the basic buffer component. 
 
A good linear correlation between khyd with the basic component of the buffer is observed. 
This linear correlation suggests general base catalysis of hydrolysis. The second-order rate 
constants for hydrolysis were obtained using Equation 3.2 for every buffer at constant ionic 
strength from Figure 3.6 a, and b and these are reported in Table 3.3. 
 
Table 3.3: The pKa and the second-order rate constants for hydrolysis khyd of 3.7 in acetate, 
phosphate, TRIS, and methyl amine buffers at 0.9 M I, pH 5.0, 7.4, 8.2 and 9.7, respectively, 
at 37 °C. 
Buffers 
 
pKa pH khyd  
/ 10-6 s-1 M-1 
kin  
/ 10-6 s-1 
Acetate 
0.0166 
4.59(a 5.0 0.4 ± 0.1 2.6 ± 0.02 
phosphate 6.8(b 7.4 
..4 
29.9 ± 1.0 9.9 ± 0.2 
TRIS 
0.02496 
7.88(a 8.2 187 ± 14 9.8 ± 1.2 
Methyl amine 
0.0116115 
10.4(a 9.7 24100 ± 1140 -14.9 ± 28.1 
a) pKa at 37 °C.
17,18 
b) The value reported previously at 37 °C.19, 20 
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Table 3.3 shows that the second-order rate constants for hydrolysis increase with increasing 
buffer pKa, as expected for general-base catalysis. 
To measure the sensitivity of the reaction to the basicity of the catalytic base, the following 
equation was used:21 
log𝑘𝑜𝑏𝑠 = 𝛽 ∗  𝑝𝐾𝑎 + 𝐶 
 
Equation 3. 3 
 
 
where, logkobs is the logarithm of the observed second-order rate constant khyd in different 
buffers determined using UV-visible spectroscopy, pKa is the dissociation constant of the 
acidic component of every buffer for the given ionic strength at 37 °C and β is the measure 
of the sensitivity of the hydrolysis reaction to change in the strength of the base. 
The logarithm of second-order rate constants for the hydrolysis of 3.7 in acetate, phosphate, 
TRIS and methylamine was plotted versus the pKa of acetate, phosphate, TRIS and methyl 
amine buffers (Figure 3.8). 
 
Figure 3.8: Brønsted plot for the base-catalysed hydrolysis of 3.7 (data from Table 3.3). 
 
The least-squares-calculated values of the intercept (C) and the Brønsted slope (β) were found 
to be -10.03 ± 0.091 and 0.81 ± 0.011, respectively. The intercept (C) has no physical 
significance beyond an intrinsic reactivity, which is not relevant here. The slope in Figure 3.7 
corresponds to β14 and is close to unity, which suggests that the proton is almost fully 
transferred in the transition state.22 Unless the reaction takes place by nucleophilic catalysis, 
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at least one water molecule is involved in the transition state in general-base catalysed 
hydrolysis reactions (Scheme 3.5).23  
 
 
 
Scheme 3.5: Proton transfer mechanism for general-base catalysis of hydrolysis of 1-acetyl-2-
thioxoimidazolidin-4-one 3.7 
 
The high value of Brønsted β of 0.81 ± 0.011 suggests that proton-transfer in the rate-
determining step of hydrolysis of 3.7 is almost complete. From the mechanism in Scheme 3.5 
it can be surmised that the tetrahedral intermediate is formed by the general-base catalysed 
nucleophilic attack of a water molecule on 3.7. The unstable intermediate (3) breaks down to 
the product (5) (Scheme 3.5).  
 
3.2.1.4  Kinetics of acid- and base-catalysed hydrolysis of 1-acetyl-5-phenyl-2-
thioxoimidazolidin-4-one 
 
The deacetylation process discussed in Chapter 2 was done using 12 M HCl to remove the 
acetyl group and obtain 5-substituted 2-thioxoimidazolidin-4-ones. To study in more detail 
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the acid and base catalysis of hydrolysis of 3.3, acyl cleavage was followed 
spectrophotometrically at different concentrations of HCl and NaOH at 37 °C (Figure 3.9).  
 
  
Figure 3.9: a) UV–visible spectra of 1-acetyl-5-phenyl-2-thioxoimidazolidin-4-one 3.3 
recorded in 0.9576 M HCl at 37 °C and b) fits of the first-order rate law to experimental data 
from hydrolysis experiments of 1-acetyl-5-phenyl-2-thioxoimidazolidin-4-one at 37 °C in (■) 
0.24 M, (●) 0.48 M, (▲) 0.72 M and (▼) 0.96 M HCl. 
 
Figure 3.8 shows a clear drop in the intensity of the band at 279 nm and the formation of a 
new band at 260 nm. The presence of isosbestic points suggests that only one reaction is 
taking place and this reaction is expected to produce 5-phenyl-2-thioxoimidazolidin-4-one. 
For comparison, in base-catalysed hydrolysis using buffer (vide supra) and sodium hydroxide 
(vide infra), an increase in absorbance at 260 nm followed by a decrease was observed, 
indicating that (at least) two reactions were taking place. The apparent rate constant for 
hydrolysis of 3.3 was determined by taking the maximum absorbance at 279 nm and plotting 
it as a function of time. The pseudo-first-order rate constant of hydrolysis was determined by 
fitting Equation 3.1 to the data, as shown in Table 3.4. . 
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Table 3.4: Pseudo-first-order rate constants for hydrolysis khyd determined using UV-visible 
spectroscopy for 1-acetyl-5-phenyl-2-thioxoimidazolidin-4-one (3.3) in 0.96 M, 0.72 M, 0.48 
M and 0.24 M HCl at 37 °C. 
Acid concentrations 
 /M 
khyd  
/ 10-6 s-1 
0.24 89.7 ± 1.8 (± 0.6)a 
0.48 197.0 ± 3.9 (± 0.2)a 
0.72 296.5 ± 5.9 (± 0.7)a 
0.96 395.9 ± 7.9 (± 0.8)a 
a) Where the error from the data fit is reported to be less than 2% of the rate constant, an 
error of 2% was assumed. The values in brackets are the errors from the data fit, which 
are less than 2%. 
 
Table 3.4 shows that the pseudo-first-order rate constants for hydrolysis increase with 
increasing concentration of hydrochloric acid, suggesting acid catalysis. The second-order 
rate constant for hydrolysis was obtained by plotting the pseudo-first-order rate constants 
against the concentrations of hydrochloric acid (Figure 3.10). 
 
Figure 3.10: Observed pseudo-first-order rate constants for hydrolysis of 3.3 in acid versus 
hydrochloric acid concentration at 37 °C. 
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The straight line in Figure 3.10 suggests acid catalysis for the hydrolysis of 3.3 with HCl. The 
observed second-order rate constant for hydrolysis was determined from the slope of the 
straight line fit in Figure 3.10 using Equation 3.4. 
 
𝑘𝑜𝑏𝑠 = 𝑘° + 𝑘hyd,H[𝐻𝐶𝑙] Equation 3.4 
  
Where kH is the rate constant for the hydrogen ion catalysed reaction and 𝑘° is the 
uncatalysed rate constant of hydrolysis. 
The second-order rate constant for the hydrolysis of 3.3 is shown in Table 3.5 at 37 °C. 
 
Table 3.5: Second-order rate constant of the acid catalysed hydrolysis khyd, H of 3.3 in different 
concentrations of HCl at 37 °C. 
Substrate khyd, H HCl  
/ 10-6 s-1 M-1 
kin  
/ 10-6 s-1 
3.3 431.5 ± 6.3 -13.1 ± 2.4 
 
The rate constant for the uncatalysed reaction kin of 3.3 is a negative value, which is 
impossible. We assume that an apparently significant negative value has been obtained due to 
underestimating the margin of error margin for the first-order rate constants (Figure 3.10). 
To study the differences between acid catalysis and base-catalysed hydrolysis of 3.3, different 
concentrations of sodium hydroxide were used (Figure 3.11).  
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Figure 3.11: a) Typical UV–visible spectra of 1-acetyl-5-phenyl-2-thioxoimidazolidin-4-one 
3.3 recorded during a kinetic run in 0.0025 M NaOH at 37 °C, and b) the absorbance of a 
solution of 3.3 as a function of time at (■) 290 and (●) 260 nm in 0.0025 M of NaOH at 37 
°C.  
 
Figure 3.11 shows that the absorbance of 3.3 decreases as a function of time at 290 nm and 
initially increases at 260 nm. This suggests deacetylation in the first step to produce 5-phenyl-
2-thioxoimidazolidin-4-one. There is a second decrease at 260 nm after the initial de-
acetylation process which indicates that the base has further hydrolysed the 5-phenyl-2-
thioxoimidazolidin-4-one. Similarly, the increase and decrease of the peak at 260 nm is also 
seen when using phosphate buffer (vide supra), suggesting two reactions take place during the 
hydrolysis reaction.  
The absorbance at 290 nm corresponding to the deacylation process for different 
concentrations of NaOH was plotted versus time (Figure 3.12). 
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Figure 3.12: Fits of experimental data from hydrolysis experiments of 1-acetyl-5-phenyl-2-
thioxoimidazolidin-4-one 3.3 at 37 °C in (■) 0.0017 M, (●) 0.0025 M, (▲) 0.0033 M, (▼) 
0.0042 M and () 0.005 M NaOH at 290 nm. 
 
Figure 3.12 shows that the plots for all concentrations are reproduced well by the pseudo-
first-order rate law. The pseudo-first-order rate constants for the hydrolysis of 3.3 were 
obtained using Equation 3.1 (Table 3.6). 
 
Table 3.6: Rate constants for hydrolysis khyd of 1-acetyl-5-phenyl-2-thioxoimidazolidin-4-one 
(3.3) in 0.005 M, 0.0042 M, 0.0033 M, 0.0025 M and 0.0017 M sodium hydroxide at 37 °C, 
determined by UV-visible spectroscopy. 
Base concentration/ M khyd / 10
-6 s-1  
0.0017 514 ± 10 (± 1.2)a 
0.0025 669 ± 13 (± 0.5)a 
0.0033 983 ± 20 (± 1.4)a 
0.0042 1176 ± 24 (± 2.3)a 
0.0050 1390 ± 28 (± 2.2)a 
a) Where the error from the data fit is reported to be less than 2% of the rate constant, an 
error of 2% was assumed. The values in brackets are the errors from the data fit which are less 
than 2%. 
b) . 
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As can be seen from Table 3.6, upon increasing the concentration of sodium hydroxide, the 
rate constants of hydrolysis increase. This agrees with both base catalysis and direct 
nucleophilic attack by OH-. The second-order rate constant for basic hydrolysis was 
determined by plotting the observed pseudo-first-order rate constants for hydrolysis versus the 
concentration of sodium hydroxide (Figure 3.13).  
 
Figure 3.13: Observed pseudo-first-order rate constants of hydrolysis of 3.3 in sodium 
hydroxide obtained from Table 3.6 at 37 °C versus the concentrations of sodium hydroxide. 
 
The second-order rate constant of hydrolysis for compound 3.3 was expressed using the 
following equation: 
 
𝑘obs = 𝑘H[H
+] + 𝑘° + 𝑘hyd,OH[OH
−] Equation 3. 5 
  
where kH is the rate constant for the hydronium ion catalysed reaction, 𝑘° is the rate constant 
for uncatalysed hydrolysis and kOH is the rate constant for the hydroxide catalysed reaction. 
The second-order rate constant for the base-catalysed hydrolysis khyd was determined from the 
slope and the combined rate constant for hydronium catalysed hydrolysis and uncatalysed 
hydrolysis of 3.3 kin was obtained from the intercept (Table 3.7).  
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Table 3.7: Second-order rate constants of the hydrolysis khyd of 3.3 in different concentrations 
of sodium hydroxide at 37 °C. 
Substrate 
khyd, OH  
/ 10-6 s-1 M-1 
kin  
/ 10-6 s-1 
3.3 267471 ± 9295 53 ± 53 
 
Table 3.7 shows that the second-order rate constant for base-catalysed hydrolysis of 3.3 is 
significantly higher than the rate constant for acid catalysed hydrolysis. As the intercept is 
zero within error, in the presence of base, deacetylation will be catalysed by base and depends 
on the strength of the base or acid. 
 
3.2.2 Kinetics and mechanism of base-catalysed hydrolysis of 5-substituted 
2-thioxoimidazolidin-4-ones 
 
To study the continued hydrolysis of the non-acetylated 2-thioxoimidazolidin-4-one, different 
5-substituted 2-thioxoimidazolidin-4-ones (Scheme 3.6) have been prepared (Chapter 2).  
 
 
 
Scheme 3.6: Structures of compounds 3.8-3.15 
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Scheme 3.6 shows the structures of the different 5-substitituted 2-thioxoimidazolidin-4-ones 
which allow us to analyse the effect of the groups attached to C-5 on the base-catalysed 
hydrolysis of 3.8-3.15. In alkaline solution, 5-substituted thioxoimidazolidin-4-ones act as 
weak acids and ionise. The 5-substituted 2-thioxoimidazolidin-4-ones are also quite slowly 
hydrolysed to produce the salt of thioureido-acids.12, 24, 25 The change in absorption spectrum 
was used to determine the rate constant of hydrolysis (Figure 3.14). 
 
Figure 3.14: UV-visible spectra recorded for a solution of (S)-5-methyl-2-thioxoimidazolidin-
4-one 3.14 at 37 °C in non-deuterated-phosphate buffer (pH 7.4, 0.36 M, 0.9 M I). 
 
Figure 3.14 shows a decrease at 260 and an increase at 235 nm in the absorbance of 
compound 3.14 over time. The obvious presence of isosbestic points for the hydrolysis is in 
contrast to the base-catalysed hydrolysis of 5-substituted 1-acetyl-2-thioxoimidazolidin-4-
ones which did not show any (Figure 3.1). For example, for compound 3.7 (Figure 3.1), the 
band at 260 nm first increases and then decreases at 260 nm while the band at 235 nm 
increases. The spectra here confirm that compound 3.7 has hydrolysed quite fast to produce 
3.14 and that the hydrolysis has continued to produce thioureido-acids. 
The absorbances at 260 nm for the hydrolysis of 3.14 in the presence of different 
concentrations of phosphate buffer (pH 7.4, 1 M I) were plotted versus time (Figure 3.15). 
Similarly, the absorbances of 3.8, 3.9, 3.10, 3.11, 3.12, 3.13, and 3.15 at various wavelengths 
were plotted as a function of time in different concentrations of phosphate buffer (pH 7.4, 1 M 
I) (see appendix). 
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Figure 3.15: Fits of a first-order rate law to the experimental data from hydrolysis khyd 
experiments of (S)-5-methyl-2-thioxoimidazolidin-4-one 3.14 at 37 °C in non-deuterated 
phosphate buffer, pH 7.4, (■) 0.045, (●) 0.09, (▲) 0.18, (▼) 0.27, and (◄) 0.36 M total 
phosphate concentration (0.9 M I) at 264 nm. 
 
The first-order rate constants for the hydrolysis of 3.14 in Figure 3.15 were determined using 
Equation 3.1. The values of pseudo-first-order rate constants for the hydrolysis of 3.8-3.15 are 
summarised in the appendix. The second-order rate constants for the hydrolysis of 3.8-3.15 
were determined by plotting the pseudo-first-order rate constants for hydrolysis against the 
concentration of the basic component of the phosphate buffer according to Equation 3.2 
(Figure 3.16). 
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Figure 3.16: Observed rate constants for hydrolysis khyd of a) (■) 3.8, (●) 3.9, (▲) 3.10, and 
(▼) 3.11, and b) (■) 3.12, (●) 3.13,(▲) 3.14, and (▼) 3.15 versus the concentration of the 
basic components of H2O-based phosphate buffer at 37 °C, 0.9 M I, pH 7.4 ( 0.45 M,0.36 M, 
0.27 M, 0.18 M, and 0.09 M total phosphate concentration). 
 
Equation 3.2 was used to determine the second-order rate constants for the HPO4
2--catalysed 
hydrolysis khyd of 3.8-3.15 from the slope and       OHkOHkk OHOH 30 3  from the 
intercept (Table 3.8). The linear correlation of pseudo-first-order rate constants and the 
concentration of the basic component of the buffer for compounds 3.8-3.15 are not as a good 
as the linear correlation observed for the deacetylation of compounds 3.1-3.7. 
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Table 3.8: Second-order rate constants for hydrolysis khyd of 3.8-3.15 in H2O-phosphate 
buffer at 0.36 M, 0.27 M, 0.18 M, 0.09 M and 0.045 M total phosphate buffer and 0.29, 0.22, 
0.14, 0.072 and 0.036 M of HPO4
2-, respectively, with ionic strength of 0.9 M I, pH 7.4 at 37 
°C. 
 
 
 
 
 
 
Substrate khyd 
/ 10-6 s-1 M-1 
kin 
/ 10-6 s-1 
3.8 124 ± 31 22.6 ± 4.1 
3.9 76.8 ± 8.7 9.9 ± 1.1 
3.10 36.0 ± 13.0 10.6 ± 1.9 
3.11 26.0 ± 2.4 39.0 ± 0.4 
3.12 17.7 ± 4.5 7.0 ± 0.8 
3.13 27.8 ± 1.1 51.9 ± 0.2 
3.14 82.0 ± 12.8 15.6 ± 1.7 
3.15 65.3 ± 9.2 10.6 ± 1.2 
 
Table 3.8 shows that substituted 2-thioxoimidazolidin-4-ones undergo base-catalysed 
hydrolysis more slowly than the parent compound 3.8. Table 3.8 shows that 2-
thioxoimidazolidin-4-ones with aliphatic substituents on the C-5 have higher second-order 
rate constants khyd for HPO4
2--catalysed hydrolysis than khyd for 2-thioxoimidazolidin-4-ones 
with aromatic substituents on the 5-position. It has previously been mentioned that 
substitution, particularly in the 5-position of 5-membered ring compounds, such as 
hydantoins, and thiohydantoins, leads to decreased reactivity.26 The substituents in the 5-
position impede the change from a trigonal to tetrahedral configuration at the C-4 of 
thiohydantoin by non-bonded interactions.27 The effect of steric hindrance and size attached 
substituents at the C-5 position as observed for hydrolysis leading to deacetylation of 3.1-3.7, 
also plays a role in the hydrolysis of compounds 3.8-3.15. Some factors should be taken into 
consideration for the hydrolysis of hydantoins, dihydrouracils and open-chain acylurea 
including the configuration of the open chain derivative and angle strain in the ring systems.28 
In the case of hydantoin and thiohydantoin, as explained before, N-3 can be deprotonated 
forming an anion because it is more acidic than N-1.15, 29 There is another possibility to 
deprotonate both hydrogens on O-H in the tetrahedral intermediate, as mentioned previously 
for the base-catalysed hydrolysis of allantoin (Chapter 1).28, 30 For this mechanism, the plot of 
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the rate constant of hydrolysis of hydantoin and allantoin has been reported to display a 
plateau in the intermediate region.  
 
 
Scheme 3.7: Mechanism for base-catalysed hydrolysis of 5-substituted 2-thiohydantoin 
mechanism based on the slow breakdown of the tetrahedral intermediate as a mono and di-
anion to the product. 
 
3.2.3 Kinetics and mechanism of base-catalysed hydrolysis of 3,5-di-
substituted 2-thiohydantoins 
 
To avoid complications resulting from deprotonation at N-3, the rate constants for hydrolysis 
of 3.16 were also studied using UV-visible spectroscopy (Scheme 3.8). 
 
 
 
Scheme 3.8: The chemical structure of 3.16 
 
Because the H/D exchange of compound 3.16 was extremely fast by 1H-NMR spectroscopy 
(See chapter 5) in comparison with compounds 3.1-3.5, low concentrations of buffers were 
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used in the studies of the hydrolysis of 3.16 so that the data also serve to compare with the 
H/D exchange process. The absorbance of 3.16 decreases over time at different concentrations 
of phosphate buffer (pH 7.4, 0.9 M I) (Figure 3.17). 
 
  
Figure 3.17: Typical UV–visible spectra of 3.16 in non-deuterated phosphate buffer, pH 7.4, 
0.009 M total phosphate buffer, 0.9 M I at 37 °C, and b) the absorbance of 3.16 as a function 
of time at (■) 265 and (●) 248 nm in non-deuterated phosphate buffer (pH* 7.4, 0.009 M, 0.9 
M I, 37 °C). 
 
As can be seen from Figure 3.17, the absorbance of 3.16 gradually decreases at 265 nm over 
time and simultaneously increases at 248 and 375 nm. The absorbance increase at 375 nm is a 
new observation which has not been seen for compounds 3.1-3.15. The decrease in 
absorbance for the hydrolysis of 3.16 at 265 nm has been plotted versus time at different 
concentrations of phosphate buffers (pH 7.4, 1 M I) (Figure 3.18).  
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Figure 3.18: Fits of the first-order rate law to experimental data for hydrolysis of 5-benzyl-3-
phenyl-2-thioxoimidazolidin-4-one 3.16 at 37 °C in non-deuterated phosphate buffer in pH 
7.4, (■) 0.009 M, (●) 0.018 M, (▲) 0.027 M, and (▼) 0.036 M total phosphate buffer (0.9 M 
I) at 265 nm. 
 
The pseudo-first-order rate law was fitted to the data in Figure 3.17 and as can be seen, the 
rate constants increase with increasing concentration of phosphate buffer. The observed 
pseudo-first-order rate constants of hydrolysis were plotted versus the concentration of the 
basic component of the phosphate buffer (Figure 3.19). From the slope, the second-order rate 
constant for the HPO4
2--catalysed hydrolysis of 3.16 was observed and 
      OHkOHkk OHOH 30 3  was obtained from the intercept using Equation 3.2, as done 
previously (Figure 3.19). 
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Figure 3.19: Observed rate constants for hydrolysis of 3.16 as a function of the concentration 
of H2O-based phosphate buffer at 37 °C, 0.9 M I, pH 7.4, basic phosphate concentrations 
correspond to (0.045 M, 0.036 M, 0.027 M, 0.018 M, and 0.009 M total phosphate). 
  
The observed rate constants are (19.6 ± 3.8). 10-6 s-1 for kin and (1030.0 ± 202). 10
-6 M-1s-1 for 
the second-order rate constant for HPO4
2-
 catalysed hydrolysis.  
The second-order rate constant for the hydrolysis of 5-benzyl-3-phenyl-2-thioxoimidazolidin-
4-one 3.16 is approximately 14 times higher than the rate constant for the hydrolysis of 5-
benzyl-2-thioxoimidazolidin-4-one 3.9. The substituents on 2-thioxoimidazolidin-4-ones 
clearly have an effect on the reactivity of the neutral molecule possibly through eliminating 
ionisation leading to a change in the rate of hydrolysis.12 The alkaline hydrolysis of 2-
thioxoimidazolidin-4-ones substituted at the N-3 position might be comparable with the 
hydrolysis of dihydropyrimidines31 substituted at the 3-position to form a tetrahedral 
intermediate and breakdown to the product (Scheme 3.9). 
 
 
 
 
0.000 0.005 0.010 0.015 0.020 0.025 0.030 0.035 0.040
0.0
8.0x10
-6
1.6x10
-5
2.4x10
-5
3.2x10
-5
4.0x10
-5
4.8x10
-5
5.6x10
-5
6.4x10
-5
k
h
y
d
ro
ly
si
s/
s-
1
[HPO
4
2-
]/M
141 
 
 
 
Scheme 3.9: Mechanism of base-catalysed hydrolysis of 3,5-di-substituted 2-thiohydantoin. 
 
The methyl group on N-3 alone decreases the rate constant of hydrolysis in five-membered 
rings such as hydantoin but increases the rate constant of hydrolysis in six-membered rings 
such as 3-methyldihydrouracil.28 Steric hindrance is expected to affect the rate of hydrolysis. 
Furthermore, the endocyclic bond angles of the tetrahedral intermediate become smaller, 
leading to the methyl group being shifted away from the neighbouring oxygen.28 The second-
order rate constants for hydrolysis of 3,5-di-substituted 2-thiohydantoin were found to be 
higher than 5-substituted 2-thiohydantoin. Despite the substitution at N-3 stabilising the 
neutral molecule, the lack of ionisation at N-3 leads to an increase in the hydrolysis of 3-
substituted 2-thiohydantoin.12 
 
3.3 Conclusions 
 
The kinetics of hydrolysis of compounds 3.1-3.16 with different substituents at C-5, N-1, and 
N-3 with mono-, and di- substitution were studied in buffers mimicking physiological 
conditions. The pseudo-first-order and second-order rate constants of hydrolysis were 
obtained. From these results and comparison with different substituted 2-thiohydantoins, the 
following conclusions can be made.  
First, the acetyl substituent on the N-1 position can be removed by acid or base rapidly. Two 
processes were identified to have taken place during the hydrolysis of 3.1-3.7 using buffer:  
deacetylation to form 5-substituted 2-thiohydantoins followed by further hydrolysis. 
Second, the various substitutions on the C-5 of 2-thiohydantoin also have a strong influence 
on the rate constant of hydrolysis. The rate constant of hydrolysis is lower in comparison to 
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the C-5 of un-substituted 2-thiohydantoin. C-5 substituents impede the conversion from 
trigonal to tetrahedral configuration by non-bonded interaction at C-4. 
Third, the second-order rate constants for hydrolysis of 3.3 are significantly higher when 
using sodium hydroxide compared to hydrochloric acid. 
Fourth, compound 3.16 was hydrolysed more rapidly than 3.9 and 3.7. This shows the effect 
of the phenyl at the N-3 position on the rate constant of hydrolysis. This result shows that rate 
constants of hydrolysis can be increased by phenyl substituents at the N-3 position. 
 
3.4 Experimental 
General Experimental 
Materials 
All chemicals and reagents were purchased from commercial sources and used without further 
purification. Sodium dihydrogen orthophosphate and sodium hydroxide were purchased from 
Fisher Scientific. Sodium hydroxide was purchased from BDH and anhydrous sodium acetate 
was purchased from CALBIOCHEM. Tris-(hydroxymethyl)-aminomethane (molecular 
biology grade, >99.9%) was purchased from Melford. CAPS buffer was purchased from 
Sigma Aldrich. Methyl amine 40 wt. % in H2O was purchased from Sigma Aldrich. Water 
used for the preparation of buffers and solutions was demineralised by means of a PureLab 
Option water purification system from Elga. 
 
Buffer preparation 
 
H2O-phosphate buffers (pH 7.4) were prepared by dissolving the appropriate amounts of 
sodium di-hydrogen ortho-phosphate dihydrate and sodium chloride in water followed by 
adjusting the pH to 7.4 by adding sodium hydroxide. Sodium acetate tri-hydrate was 
dissolved to prepare acetate buffers (pH 5.0) with 1 M I and acetic acid used to adjust the pH. 
Tris-(hydroxymethyl)-amino methane was used to prepare TRIS buffer (pH 8.2, 1 M I), the 
pH was adjusted to the desired value by the addition of hydrochloric acid. To prepare borate 
buffers (pH 9.3, 1 M I), the appropriate amount of sodium tetraborate-decahydrate was 
dissolved and hydrochloric acid was added to adjust the pH. The CAPS buffer (pH 9.7, 1 M I) 
was prepared by dissolving N-cyclohexyl-3-aminopropanesulphonic acid in water and sodium 
hydroxide was added to adjust to the desired pH. A 40% methyl amine solution in water was 
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used to prepare methyl amine buffer (pH 9.7, 1 M I) and the pH was adjusted to the desired 
value by adding HCl. Sodium chloride was used for all buffer solutions to adjust the ionic 
strength. The basic and acidic component of buffers were calculated by using the Henderson–
Hasselbalch equation. 
 
General kinetic measurements 
 
Hydrolysis experiments were carried out by preparing stock solutions of compounds 3.1-3.15 
in water. All compounds had enough absorbance in water to allow UV-visible spectroscopy to 
be used for the kinetic studies, except compound 3.16, which has low absorbance and is 
difficult to dissolve in water. An ultrasonic bath sonicator was used to speed up dissolution of 
all compounds in water. The stock solutions were transferred to plastic Eppendorfs and 
centrifuged for 7 minutes two times at 13.3 rpm on a Jencons-pls Spectrafuge 24.D centrifuge. 
The clear supernatant was transferred to a new vial and diluted to appropriate absorbance for 
UV-visible spectroscopy. The stock solution of thiohydantoins was then mixed with the 
concentration of buffer in a 10%-90% (v-v) ratio. Experiments were carried out in 1 cm path 
length quartz cuvettes containing 3.4 ml of the aqueous solution of interest. The hydrolysis 
reactions were followed at 286, 289, 291, 283, 288, 290 and 290 nm for 3.1-3.7, and at 264, 
263, 264, 262, 264, 262,260, 263 and 265 nm for 3.8-3.16, respectively, at 37 °C. For 1H-
NMR studies, a stock solution of compound 3.5 in D2O was prepared by dissolving 0.0106 g 
of 3.5 in 100 µl D2O and 900 µl of deuterated-phosphate buffer (0.4 M, 1 M I, pH
* 7.55). The 
solution was transferred to the ultrasound sonicator bath to dissolve and was centrifuged for 7 
minutes two times to avoid precipitation during the kinetic experiments. The solution was 
placed in an NMR tube and kept at 37 °C in a Fisher Scientific circulating water bath. 1H-
NMR spectra were recorded over time. 
 
Instruments 
 
Hydrolysis reactions were monitored by parallel kinetic measurements using a JASCO V650 
UV-visible spectrophotometer with an Auto Peltier thermostatting unit with six-position cell 
changer PAC-743R. A JASCO V630 UV-visible spectrophotometer was also used for some 
experiments. Materials were weighed on an analytical balance Fisher Brand PS-100 (Max 100 
g, d=0.1 mg). Volumes of solutions were measured by means of Gilson or Eppendorf 
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Research micropipettes. pH measurements were carried out at room temperature using a 
Hanna Instruments pH 210 pH meter. The pH meter was calibrated before each measurement 
with certified traceable NIST buffers at pH 7.00+0.01 (at 25 °C) (from Fisher), pH 
10.01+0.02 (at 25 °C) (from Fisher) and pH 4.00+0.01 (at 25 °C) (from Fisher). A 
thermostatic water bath Julabo MB-5 Heating Circulator (temperature stability ± 0.2 °C) was 
used to control the temperature of solutions if not kept in thermostated cell holders in the 
NMR machine.  
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Chapter 4 
 
 
 
 
 
 
 
 
 
Kinetics and mechanism for racemisation of 
substituted 2-thiohydantoins 
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4.1 Introduction 
 
Enantiomers of drugs may exhibit different pharmacological profiles and toxicity, e.g. one 
enantiomer may be active while the other is inactive or even toxic.1,2-4 Single enantiomer 
drugs improve the clinical effect and decrease drug toxicity. Indeed, in 1997, 54 % of the 
world’s best-selling drugs were single enantiomers.5 For chiral drugs the potential for 
racemisation should be studied in order to determine if enantiomers are configurationally 
stable under physiological conditions.6 Substituted hydantoins, thiohydantoins, thiazolidines 
and rhodanines are molecules of pharmaceutical interest which are characterised by the 
presence of a stereogenic centre at the C-5 position. Reist et al.7 and Narduolo8 have studied 
the kinetics and mechanism of racemisation of 5-substituted hydantoin under physiological-
like conditions. Cabordery et al.6 studied the kinetics and mechanism of racemisation of  Tic-
hydantoins, including Tic-thiohydantoin, while Cabera et al.9 determined the 
enantiomerisation barrier of 3-phenyl-5-benzyl-2-thiohydantoin. Typically, substituents at the 
stereogenic carbon in the chiral molecule have a strong effect on the reactivity in racemisation 
reactions. Previous authors reported that the chemical racemisation of hydantoin proceeds via 
keto-enol tautomerism10, 11 by forming a planar enolate intermediate (Scheme 4.1).  
 
 
 
Scheme 4.1: Proposed keto-enol tautomerism of 5-subsituted 2-thiohydantoin.12 
 
Mendil and Dakin12 proposed keto-enol tautomerism as the mechanism for hydantoin 
racemisation forming optically inactive hydantoin (see Chapter 1). During the keto-enol 
tautomerism, the labelled hydrogen on the α-carbon is lost to form an inactive tautomeric-
enolate salt which is reprotonated to produce racemised products.13 Tian et al.14 reported the 
role of water to facilitate proton transfer and act as a catalyst to reduce the enantiomerisation 
barrier by ≈ 30 kcal mol-1.  
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Divalent phosphate catalysis as reported by Dudley and Bius15 (Chapter 1) for the mechanism 
of racemisation of 5-phenylhydantoin is also a possibility for racemisation of thiohydantoin 
derivatives in vivo without a specific racemase (Scheme 4.2).  
 
 
Scheme 4.2: Possible mechanism for the racemisation of 5-substituted 1-acetyl-2-
thiohydantoins by divalent phosphate for hydantoin based on the mechanism proposed by 
Dudley and Bius15 for 5-phenylhydantoin. 
 
 
4.2 Results and discussion 
4.2.1 Racemisation of 5-substituted 1-acetyl-2-thiohydantoins 
4.2.1.1 Determination of rate constants for loss of ellipticity 
 
In order to study the racemisation of chiral thiohydantoins, enantioenriched 5-substituted 1-
acetyl-2-thiohydantoins were synthesised from the corresponding amino acids (Chapter 2). 
The loss of optical activity, as quantified by the loss of ellipticity of compounds 4.1-4.5 
(Scheme 4.3), was monitored using circular dichroism spectroscopy in aqueous systems under 
mimicked physiological conditions using different concentrations of buffer at pH 7.4.  
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Scheme 4.3: The chemical structures of compounds 4.1-4.6 
 
As Scheme 4.3 shows, compounds 4.1-4.6 have different substituents at the stereogenic centre 
and an acetyl group at the N-1 position. Each compound was dissolved in water or D2O and 
the resulting solution mixed with phosphate buffer and centrifuged two times to avoid 
precipitation. Kinetic studies of the loss of ellipticity for all enantioenriched compounds 4.1-
4.5 was carried out in different concentrations of both non-deuterated and deuterated 
phosphate buffers using CD spectroscopy at pH 7.4 and 0.9 M I at 37 °C. Changes in 
ellipticity as a function of time for 4.1-4.5 in 0.27 M non-deuterated-phosphate buffer (pH 
7.4, 0.9 M I at 37 °C) are shown in Figure 4.1. For all further experiments of 4.1-4.5 in H2O- 
and D2O-phosphate buffers pH 7.4
a) and pH* 7.4a) and 0.9 M I at 37 °C, see the Appendix. 
 
 
a) Buffers pH 7.4: A series of concentrations of phosphate buffer in H2O were prepared by 
adjusting pH20°C to 7.4. Buffers pH* 7.55: the H2O-phosphate buffers were evaporated three 
times and D2O subsequently added to prepare deuterated-phosphate buffers with pH
20°C 7.55. 
This procedure ensures that the buffer ratio is the same in our H2O based and D2O based 
buffers.  
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Figure 4.1: Change in ellipticity over time for solutions of a) 4.1, b) 4.2, c) 4.3, d) 4.4, and c) 
4.5 at 37 °C. For every experiment, 10 vol% of a stock solution of each compound in water 
was mixed with 90 vol% of a 0.3 M non-deuterated-phosphate buffer (pH 7.4, 1 M I). 
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Figure 4.1 shows that the ellipticity of solutions of compounds 4.1-4.5 decreased as a function 
of time. The ellipticities at the wavelength of maximum ellipticity of compounds 4.1-4.5 in 
0.27 M of phosphate buffer (pH 7.4, 1 M I at 37 °C) were plotted versus time (Figure 4.2). 
For kinetic traces at other buffer concentrations, see Appendix.  
 
 
 
 
Figure 4.2: The ellipticities of a) 4.1 at 262 nm, b) 4.2 at 265 nm, c) 4.3 at 268 nm, d) 4.4 at 
290 nm and e) 4.5 at 263 nm versus time. Solid lines are fits in terms of the first-order rate 
law. 
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Figure 4.2 shows that the first-order rate law reproduces the data for all compounds well. The 
observed phenomenological pseudo-first-order rate constants for loss of ellipticity kɵ were 
obtained by plotting the ellipticity versus time in terms of the first-order-rate equation 
(Equation 4.1). 
 
 𝜃𝑡 = 𝜃𝑓𝑖𝑛 +  ∆𝜃 ∗ 𝑒
−𝑘𝜃𝑡 Equation 4.1 
 
 
Here 𝜃𝒕 is the ellipticity at time t, 𝜃finis the final ellipticity, ∆𝜃 represents the difference 
between the ellipticity at time zero and 𝜃fin, and 𝑘𝜃 is the observed pseudo-first-order rate 
constant for loss of ellipticity. 
Using Equation 4.1, the pseudo-first-order rate constants kɵ for loss of ellipticity of 
compounds 4.1-4.5 in aqueous solution were determined and these are listed in the Appendix. 
By using different concentrations of buffer (pH 7.4, 0.9 M I), it was found that by increasing 
the concentration of buffer the rate constant kɵ also increases. Therefore, the racemisation 
proceeds via a general-base catalysed pathway (Equation 4.2).  
 
      buffer30
3
bufferOHOHobs
kOHkOHkkk   
 
 Equation 4.2 
  
where k0 is the rate constant for the non-catalysed reaction, kOH
- and kH3O
+ are the rate 
constants for the catalysed reaction by base and hydronium, respectively, which is obtained 
from the intercept (kin), while kbuffer is the second-order rate constant for the buffer catalysed 
loss of ellipticity, which is obtained from the slope, and kobs is the rate constant for the 
observed reaction.  
 
4.2.1.2 Relation between base-catalysed hydrolysis and racemisation 
  
The rate constants for the loss of ellipticity of acetylated 2-thiohydantoins were determined by 
CD spectroscopy in phosphate buffer. The acetyl group on the N-1 position is liable to be 
hydrolysed even in mild acid and base medium. During the racemisation process, it was 
noticed that the absorbance of enantioenriched compounds 4.1-4.5 in CD spectroscopy 
decreases over time (Figure 4.3). Therefore, it was important to study the hydrolysis under the 
same conditions as those used for the racemisation studies (Chapter 3).  
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Figure 4.3: Time-resolved a) ellipticity and b) absorbance of 4.4. 
 
From Figure 4.3 it is clear that the loss of ellipticity is complete before the hydrolysis process 
is completed. Furthermore, the rate constant for loss of ellipticity is higher than the rate 
constant for hydrolysis of 4.1, 4.2, 4.4 and 4.5. However, the loss of ellipticity of 4.3 is quite 
slow, though still faster than its hydrolysis. Scheme 4.4 illustrates the relation between the 
racemisation and hydrolysis processes. 
 
 
Scheme 4.4: Competition between hydrolysis and racemisation. 
 
From Chapter 3, it has been explained that compounds 4.1-4.6 undergo base-catalysed 
hydrolysis to produce 5-substituted 2-thiohydantoin (B) and these continue to undergo 
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hydrolysis to obtain a ring-opened compound (C) (Scheme 4.4). In fact, the rate constants of 
racemisation of 5-substituted 2-thiohydantoins (B) are much faster than those of the 5-
substituted 1-acetyl-2-thiohydantoins (A) krac (TH) >> krac (AcTH).
16 To identify the real rate 
constants of racemisation of each 5-substituted 1-acetyl-2-thiohydantoin, the rate constants 
for the loss of ellipticity, which have been obtained by CD spectroscopy, have to be corrected 
for the effect of the hydrolysis process. For krac (TH) >> krac (AcTH), kɵ is the sum of the rate 
constants of racemisation and the rate constants of hydrolysis (Equation 4.3). 
 
𝑘
θ
=  𝑘𝑟𝑎𝑐 + 𝑘ℎ𝑦𝑑 Equation 4. 3 
  
From Equation 4.3 
 
𝑘rac = 𝑘 θ −  𝑘hyd Equation 4. 4 
  
Where kɵ is the rate constant for the loss of ellipticity, corresponding to racemisation and 
hydrolysis together, krac is the rate constant for racemisation and khyd is the rate constant for 
hydrolysis. 
Using Equation 4.1, the pseudo-first-order rate constants for loss of ellipticity in different 
concentrations of phosphate buffer kɵ and the rate constant of hydrolysis khyd at the same 
conditions were determined. Equation 4.4 was subsequently used to calculate krac for every 
single concentration of phosphate buffer by calculating the margin of error. krac for 4.1-4.5 
were then plotted versus the concentration of the basic component of the H2O-phosphate 
buffer to determine the slope and intercept by fitting a straight line to the data (Figure 4.4). 
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Figure 4.4: Observed pseudo-first-order rate constants for racemisation of 4.4 calculated by 
Equation 4.4 for every single concentration of buffer, and plotted versus the concentration of 
the basic component of H2O-phosphate buffer (0.9 M I, pH 7.4 at 37 °C). 
 
The pseudo-first-order rate constants kɵ, krac and khyd for 4.1 were plotted versus the basic 
component of phosphate (Figure 4.5). In the previous section the kɵ in H2O and D2O-
phosphate buffers were plotted, therefore here the kɵ in D2O is not included. However, Figure 
4.5 shows that krac is determined by kɵ for 4.1. The same is true for 4.2-4.5. 
 
Figure 4.5: The relation between rate constants of (■) kɵ, (●) krac and (▲) khyd for buffer 
catalysed racemisation of 4.1 in H2O phosphate buffers (0.9 M I, pH 7.4 at 37 °C). 
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Figures 4.4 and 4.5 show that the rate constants for the loss of ellipticity kɵ, racemisation krac 
and hydrolysis khyd increase linearly versus the concentration of the basic component of 
phosphate buffer (0.9 M I, pH 7.4 at 37 °C). The hydrolysis process discussed in Chapter 3 
for 4.1, 4.2, 4.4 and 4.5 are slow in comparison with the racemisation. This is obvious from 
Figure 4.5 in that krac is slightly less than kɵ for 4.1 and the same is true for 4.2, 4.4 and 4.5. 
On the other hand, the rate constants for racemisation, krac, of 4.3 is quite low in comparison 
with the rest of the 5-substituted 1-acetyl-2-thiohydantoins, and the difference between the 
rate constants for hydrolysis and racemisation is less. The second-order rate constants kɵ, khyd 
and krac(=kobs-khyd), which were determined from the slopes for 4.1-4.5, and kin from the 
intercept of krac, are shown in Table 4.1. 
 
 
Table 4.1: Second-order rate constants kɵ, khyd and krac for buffer HPO4
2- catalysed loss of 
ellipticity, hydrolysis and racemisation, respectively, and the combined uncatalysed, 
deuteroxide catalysed and hydronium catalysed kin for 4.1-4.5 in H2O-phosphate buffers 
(0.9 M I, pH 7.4 at 37 °C). 
Substrate 
kɵ (H2O) 
/ 10-6 s-1 M-1 
khyd, H2O 
/ 10-6 s-1 M-1 
krac, H2O 
/ 10-6 s-1 M-1 
kin (rac.) 
/ 10-6 s-1 
4.1 763 ± 29 29.9 ± 1.0 735 ± 30 (a 
 
 
6.5 ± 2.5 
4.2 1356 ± 86 10.2 ± 0.5 1347 ± 86 (a 
 
 
9.3 ± 6.7 
4.3 61.3 ± 9.4 23.3 ± 0.08 45.0 ± 9.0 (a 
 
 
0.4 ± 1.7 
 4.4 646 ± 19.4 10.5 ± 0.6 636 ± 19 (a 
 
5.7 ± 1.4 
4.5 2495 ± 131 30.7 ± 0.7 2465 ± 131(a 
 
 
35.0 ± 9.0 
a) Standard errors calculated according to Equation 4.8 
  
From Table 4.1, the hydrolysis processes are being affected by substituents at the C-5 position 
which is explained in terms of the effect of steric hindrance on the hydrolysis.17 There is a big 
difference between the rate constants for base-catalysed hydrolysis and base-catalysed 
racemisation of 4.1-4.5, as can be seen in Table 4.1. Generally, because the rate constants for 
loss of ellipticity are much higher than the rate constants for hydrolysis, the rate constants for 
racemisation similarly increase or decrease depending on substituents. The order of the rate 
constants for racemisation krac is 4.5>4.2>4.1>4.4>4.3. For comparison, the order of the rate 
constants for hydrolysis is 4.1>4.5>4.4>4.3>4.2.  
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Because the acetyl group at the N-1 position is present on all compounds, the effect of acetyl 
on the racemisation for all compounds is similar. However, the variable substituents on the 
stereogenic centre have an effect on the rate constant for loss of ellipticity, as can be clearly 
seen in Table 4.2. The rate constants for racemisation is also dependent on the bulkiness and 
electronic effect of substituents at the stereogenic centre. The combined effects of substituents 
are analogous to the effects on the rate constants for the racemisation of amino acids which 
follow the order Ala>Leu>Ile>Val.18  
Compounds 4.1 and 4.3 with methyl and isopropyl substituents at the C-5 position, 
respectively, display rate constants for racemisation 4.1 > 4.3, which is similar to the order for 
corresponding amino acids Ala > Val. The compoundracemising fastest is 4.5, which is also 
substituted with an aliphatic substituent with the presence of a sulphur atom. It is clear that the 
sulphur atom promotes the racemisation of compound 4.5 during the proton transfer reaction 
in the presence of base. The sulphur will accelerate the deprotonation because of its inductive 
electronegative contribution.19 Likewise, sulphur can promote C-H acidity, as reported by 
Barber and Jones20 for base-catalysed racemisation of methionine. The authors also explained 
the reason for the increase in racemisation by sulphur in methionine by proposing that the π 
orbital of the delocalised enolate overlaps with the d orbital of sulphur.19, 20  
Benzyl-substituted thiohydantoin 4.2 racemises two times faster than 4.4. The aryl group, 
substituted at the 5-position, can act as an electron sink to stabilise the developing carbanion 
in the transition state, reducing ∆H≠.21 Unfortunately, compound 4.6 racemised during the 
preparation, confirming how the different substituent groups affect the racemisation. The 
phenyl group on the asymmetric α-carbon accelerates the racemisation because of resonance 
processes which stabilise the carbanion.22  
The H/D exchange process for compound 4.6 was studied using 1H-NMR spectroscopy and 
was shown to be much faster than for other compounds (vide infra). Reist et al.7 reported the 
rate constants for racemisation of 5-phenylhydantoin in deuterated-phosphate buffer to be 
188, 342 and 1883 times faster than 5-benzyl-, 5-methyl- and 5-isopropylhydantoin, 
respectively. The kin for 4.1, 4.2, 4.4 and 4.5 are zero within the margin of error in deuterated-
phosphate buffer pH* 7.4. 4.3 racemises too slowly and kin is not so different from the values 
found for the other compounds in the series. Therefore, specific base catalysis can be 
discounted in deuterated phosphate buffer pH* 7.4. However, the kin is significant within the 
margin of error in the non-deuterated phosphate buffer pH 7.4 and higher than in the 
deuterated phosphate buffer pH* 7.4.  
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4.2.1.3 Solvent kinetic isotope effects  on the racemisation of 5-substituted 1-acetyl-2-
thiohydantoins 
 
The solvent kinetic isotope effect for the racemisation of hydantoins has been reported 
previously.7, 8 The rate constants for loss of ellipticity of compounds 4.1-4.5 were determined 
using CD spectroscopy in different concentrations of phosphate buffer at pH 7.4 in both H2O 
and D2O. The pseudo-first-order rate constants for loss of ellipticity were obtained using 
varying concentrations of buffer. Upon increasing the concentration of buffer, the rate 
constant k increased, confirming general-base catalysis for loss of ellipticity. The solvent 
kinetic isotope effect can be estimated by dividing the second-order rate constants for loss of 
ellipticity in non-deuterated phosphate buffer (kH2O)) by the second-order rate constants for 
loss of ellipticity in deuterated phosphate buffer (k(D2O)), for compounds where khyd<< k.  
Therefore, the second-order rate constants for loss of ellipticity were obtained by plotting the 
observed rate constants of racemisation versus the concentration of the basic component of 
phosphate buffer in H2O and D2O based buffers (Figure 4.6). 
 
 
 
Figure 4.6: Second-order rate constants for the buffer catalysed loss of ellipticity for 4.4 in 
(■) H2O and (●) D2O phosphate buffers (0.9 M I, pH and pH* 7.4 at 37 °C). 
 
Figure 4.6 shows the linear increases of pseudo-first-order rate constants kɵ for 4.4 against the 
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4.4 and the rest of the compounds in H2O and D2O phosphate buffer represent the second-
order rate constants kɵ (figures shown in Appendix of Chapter 4). The intercept gives the sum 
of the contribution of kin =       OHkOHkk 3OHOH0 3  which represent the uncatalysed, 
specific-base-catalysed, and specific-acid-catalysed rate constants for the loss of optical 
activity. The comparison of rate constants in non-deuterated and deuterated medium 
illustrates the solvent kinetic isotope effect on racemisation of 4.1-4.5, as shown in Table 4.2. 
For the results of the solvent kinetic isotope effect, we used the phenomenological rate 
constants kɵ to approximate the mechanistic rate constants krac.  
 
Table 4.2: Second-order rate constants for buffer catalysed loss of ellipticity for the combined 
uncatalysed, deuteroxide catalysed and hydronium catalysed racemisation of 4.1-4.5 in H2O 
and D2O phosphate buffers (0.9 M I, pH and pH
* 7.4 at 37 °C). 
Subs
. 
kɵ H2O 
/ 10-6 s-1 M-1 
kin H2O 
/ 10-6 s-1 
kɵ D2O 
/ 10-6 s-1 M-1 
kin D2O 
/ 10-6 s-1 
kɵ, H2O/ 
kɵ, D2O 
 
4.1 763 ± 29 16.5 ± 2.3 811.44± 66.37 8.86 ± 8.38 0.94 ± 0.03a 
 
 
4.2 1356 ± 86 14.0 ± 6.7 1579 ±78 -10.2 ± 9.2 0.86 ± 0.02a 
 4.3 61.3 ± 9.4 6.6 ± 1.5 53.5 ± 4.0 3.4 ± 0.8 1.15 ± 0.20a 
 4.4 646 ± 19 9.3 ± 1.4 715 ± 43 4.9 ± 4.9 0.90 ± 0.03a 
 4.5 2495 ± 131 41.7 ± 9.0 3007 ± 19 -2.4 ± 2.0 0.83 ± 0.04a 
 a) Standard errors calculated using Equation 4.7 
 
Table 4.2 shows small inverse solvent kinetic isotope effects for compounds 4.1, 4.2, 4.4 and 
4.5 and a small normal kinetic isotope effect for 4.3 with a bigger margin of error than for the 
rest of the compounds. The solvent kinetic isotope effect describes the involvement of the 
solvent in the rate determining step of the reaction. The rate constants of racemisation in 
deuterated phosphate buffer and non-deuterated phosphate buffer had been determined for 5-
substituted hydantoin previously.23, 8, 7 
Narduolo8 has reported the pseudo-first-order rate constants for racemisation of 5-
benzylhydantoin in non-deuterated and deuterated phosphate buffer pH and pH* 7.2 (Table 
4.3). The phenomenological rate constants kɵ for hydantoins can be assumed to be equal to the 
mechanistic rate constants krac for racemisation of substituted hydantoin because no hydrolysis 
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process has been identified during the racemisation of substituted hydantoin, as reported by 
Reist et al. and Narduolo. 
 
Table 4.3: Rate constants of racemisation of (S)-5-benzylhydantoin in D2O and H2O 
phosphate buffers pH and pH* 7.2, respectively (0.25 M, 0.5 M I, at 60 °C).8 
 
Hydantoin C(5) Substituent  
kracH  
/ 10-6 s-1 
 
kracD  
/ 10-6 s-1 
kH/kD 
PhCH2  167.3 ± 1.3
  175.0 ± 0.2 0.96 ± 0.01 
 
 
Table 4.2 and 4.3 show small differences for the rate constants of thiohydantoin and 
hydantoin in non-deuterated and deuterated phosphate buffers. Reist et al.7 reported the 
solvent kinetic isotope effect (kH2O / kD2O) to be 1.13 ± 0.05 and 1.24 ± 0.08 for (S)-5-
phenylhydantoin and (S)-5-benzylhydantoin, respectively, in a 50/50 (v/v) mixture of 
phosphate buffer and DMSO. The inverse solvent kinetic isotope effects for 4.1-4.5 in Table 
4.2 indicate no involvement of solvent as a proton donor in the rate determining step in the 
reaction, indicating that the SE2 mechanism is unlikely.  
 
4.2.1.4  Brønsted plot for proton transfer  
 
The proton transfer from the chiral carbon of thiohydantoin to the base and the effect of buffer 
strength on the rate constants for racemisation of 4.1 were studied. The racemisation was 
studied using acetate, phosphate, TRIS, borate and methyl amine buffer over the pH 5.0-9.7 at 
37 °C. Furthermore, racemisation was studied in the same conditions as those used to study 
hydrolysis for 4.1 (Chapter 3). Pseudo-first-order rate constants for racemisation were 
determined in the same conditions as those used for non-deuterated phosphate buffer (0.9 M I, 
pH 7.4 at 37 °C). The second-order rate constants for loss of optical activity were obtained 
using Equation 4.2. Equation 4.4 was used to determine the rate constants for racemisation 
corrected for hydrolysis (Chapter 3) in acetate pH 5.0, phosphate pH 7.4, TRIS buffer pH 8.2 
and methyl amine pH 9.7. Pseudo-first-order rate constants of racemisation, obtained by 
Equation 4.1, were plotted versus the concentration of basic component of acetate, phosphate, 
TRIS and methyl amine buffers (Figure 4.7).  
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Figure 4.7: Dependence of the apparent first-order rate constants of 4.1 on the concentration 
of the basic component of (■) acetate (pH 5.0), (●) phosphate (pH 7.4) (▲) TRIS (pH 8.2) 
and (▼) methyl amine (pH 9.7) buffers. 
 
Figure 4.7 shows that the pseudo-first-order rate constants for the racemisation of 4.1 plotted 
versus the concentration of the basic component of acetate, phosphate, TRIS and methylamine 
buffers increase linearly with straight line fits passing through the origin. This indicates that 
general-base catalysis of racemisation occurs in all four buffers. The second-order rate 
constants for racemisation krac were determined for acetate, phosphate and TRIS buffer from 
the slope of the linear plot using Equation 4.2 (Table 4.4). Equation 4.4 could not be used to 
determine krac in methyl amine buffer (pH 9.7) because khyd was slightly higher than kɵ. 
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Table 4.4: The pKa and second-order rate constants for racemisation 4.1 in acetate, phosphate, 
TRIS and methyl amine buffers (0.9 M I) at, pH 5.0, 7.4, 8.2 and 9.7, respectively 
Buffers 
Con./ mM 
pKa 
krac (H2O)  
/ 10-6 s-1 M-1 
kin  
/ 10-6 s-1 
Acetate 
0.0166 
4.59(a 253.5 ± 13.0 -0.9 ± 2.3 
phosphate 6.8(b 735± 30 6.5 ± 2.5 
TRIS 
0.02496 
7.88(a 1248 ± 139 10.2 ± 9.3 
a) pKa at 1 M ionic strength at 37 °C.
24, 25 
b) As reported previously.11, 26 
 
To quantify the sensitivity of the general-base catalysis to changing the strength of the 
catalytic base, the Brønsted equation (Equation 4.5) was used. 
 
log𝑘𝑜bs = 𝛽 ×  𝑝𝐾𝑎 + 𝐶 
 
Equation 4.5 
 
 
where logkobs is the logarithm of the observed second-order rate constant in different buffers 
determined using CD spectroscopy, pKa is the dissociation constant of every buffer at ionic 
strength 0.9 M, according to Table 4.4 at 37 °C, and β is the measure of the sensitivity of the 
racemisation reaction to change in the strength of the base. Therefore, the logarithm of the 
second-order rate constants for racemisation of 4.1 in acetate, phosphate, TRIS and 
methylamine were plotted versus the dissociation constants of 4.1 in these same buffers 
(Figure 4.9).  
The second-order rate constants for ellipticity loss of 4.1 and for hydrolysis in acetate, 
phosphate, TRIS and methyl amine buffers were plotted versus the dissociation constant of 
the buffers (Figure 4.8).  
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Figure 4.8: Brønsted plot for base catalysis for (■) loss of ellipticity and (●) hydrolysis of 4.1 
(0.9 M I, 37 °C). 
 
Figure 4.8 shows overlapping of the second-order rate constants for ellipticity loss and the 
second-order rate constant of hydrolysis at pH 9.7 in trimethylamine buffer. Therefore, 
Equation 4.4 gives negative results for the determination of the second-order rate constant of 
racemisation in methyl amine buffer. The logarithm of the second-order rate constants of 
racemisation of 4.1 in acetate, phosphate and TRIS were plotted versus the dissociation 
constants of acetate, phosphate and TRIS buffers (Figure 4.9). 
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Figure 4.9: Brønsted plot for base-catalysed racemisation of 4.1. 
 
Figure 4.9 shows an increase in second-order rate constants for racemisation with increasing 
pKa. A Brønsted β of 0.21 ± 0.0008 was determined from the slope of the second-order rate 
constants for racemisation versus pKa of buffers. A β-value of 0.21 ± 0.0008 indicates an early 
transition state. Lazarus11 reported a β-value of 0.59 for the base-catalysed racemisation of L-
5-benzylhydantoin and 0.51 for L-5-benzyl-3-methylhydantoin. Narduolo obtained β-values 
for L-5-benzyl-3-methylhydantoin of 0.57 and 0.59 at 25 and 60 °C, respectively. Our value is 
thus significantly lower, which we attribute to deprotonation of thiohydantoin at the N-3 
position. The β-value for neutral 4.1 will be calculated in the next section according to the 
dissociation constant of 4.1. 
Different concentrations of borate buffer were used and the rate constants for racemisation of 
4.1 were determined. The pseudo-first-order rate constant for loss of ellipticity were plotted 
versus the concentration of the basic component of borate buffer (Figure 4.10).  
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Figure 4.10: First-order rate constants for racemisation against the basic component of borate 
buffer for 4.1 in H2O-phosphate buffers (0.9 M I, pH 9.3 at 37 °C). 
 
Figure 4.10 shows that the racemisation is apparently not catalysed by the basic components 
of borate buffer; in fact we obtained a slope of (-6.301 ± 2.972) x 10-5 s-1 M-1. In contrast, 
general-base catalysis was observed for substituted hydantoin by Narduolo8 in borate buffer.  
 
4.2.1.5 The effect of ionisation at the N-3 position on the rate constant of racemisation  
 
The reason for the low Brønsted β for the racemisation of 4.1 may be due to the acidity of the 
N-3 of thiohydantoin, leading to the possibility of ionisation (Scheme 4.5). Lazarus27 has 
described the kinetic equivalence of general-base catalysis of the neutral form and rate 
determining protonation of the anionic form of 5-benzylhydantoin, which must be taken into 
consideration.11 
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Scheme 4.5: Ionisation of 5-substituted 1-acetyl-2-thiohydantoins at the N-3 position.  
 
In Scheme 4.5, the negative charge at N-3 impedes racemisation compared to the protonated 
compound and the acidity of the proton at the stereogenic centre decreases because of the 
presence of the negative charge.17 All second-order rate constants of racemisation in acetate, 
phosphate, TRIS and methyl amine were determined without taking deprotonation into 
account. The dissociation constant pKa
NH of 6.95 has been previously reported for 4.1 in 
water, which was used in the present work.17 This value was used to correct krac for the 
deprotonation of thiohydantoin (Table 4.5). 
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Table 4.5: The pKa and second-order rate constants for racemisation of total and protonated 
4.1 in acetate, phosphate, TRIS and methyl amine buffers (0.9 M I) at pH 5.0, 7.4, 8.2 and 
9.7, respectively. 
Buffer  
pKa 
pH krac 
/ 10-6 s-1 M-1 
Fraction 
protonated 
 
krac, corrected  
/ 10-6 s-1 M-1 
 4.59(a 5.0 253.5 (c ± 13.0 (d 98.9% 256.3 ± 13.2 
6.8(b 7.4 734.8 (c ± 30.1(d 26.2% 2806 ± 115 
7.88(a 8.2 1248(c ± 139(d 5.3% 23400 ± 2600 
a) pKa at 1 M ionic strength at 37 °C.
31, 32 
b) The value reported previously.11, 26 
 
 
 
c) Values obtained using Equation 4.4. 
d) Standard errors according to Equation 4.8. 
  
The methyl amine buffer was not used in Table 4.5 because Equation 4.4 cannot be applied 
when the second-order rate constant of hydrolysis is higher than the rate constant of loss of 
ellipticity. Therefore, the logarithm of the corrected second-order rate constants for 
racemisation of neutral 4.1 were plotted as a function of buffer pKa for acetate, phosphate and 
TRIS only (Figure 4.11). 
 
Figure 4.11: Brønsted plot for base-catalysed racemisation of protonated 4.1. 
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The Brønsted β for racemisation of the protonated form of 4.1 was found to be 0.51 ± 0.085, 
in agreement with general-base catalysis of racemisation and suggests that the proton at the 5-
position is half way between thiohydantoin and the buffer in the transition state (Scheme 4.6). 
 
 
 
Scheme 4.6: Transition state of general-base catalysis of 4.1 based on the Brønsted β-value 
from Figure 4.11. 
 
4.2.2 Racemisation of tri-substituted 2-thiohydantoins 
 
In order to show the effects of the different substituents on the three positions of 
thiohydantoin on the rate constants for racemisation, different substituted 2-thiohydantoins 
were prepared (Chapter 2). The previous literature reported that the N3-H group on hydantoin 
and thiohydantoin is more acidic than N1-H.28, 29 Therefore, the substituents on the N-3 or N-
1 or both change the pKa and the observed rate constants of racemisation. The solvent kinetic 
isotope effect of tri-susbtituuted 2-thiohydantoin was also studied. 
 
4.2.2.1 Determination of the rate constant for racemisation 
 
Two enantioenriched trisubstituted thiohydantoin derivatives were prepared to study the rate 
of racemisation in deuterated and non-deuterated buffer (Scheme 4.7).  
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Scheme 4.7: The chemical structures of compounds 4.7-4.8 
 
To deal with the lack of solubility of both thiohydantoins 4.7 and 4.8, 10 vol-% acetonitrile 
and acetonitrile-d3 were used to be able to observe sufficient signals in CD spectroscopy. The 
kinetics for the loss of ellipticity for 4.7 and 4.8 were followed using a physiological buffer at 
pH and pH* 7.4 (0.9 M ionic strength at 37 °C). Low concentrations of total phosphate buffer 
were used because if the same conditions were used as those for compounds 4.1-4.5, 4.7 and 
4.8 would racemise extremely fast. The kinetic study of all enantioenriched compounds was 
carried out in non-deuterated and deuterated phosphate buffer in mixtures consisting of  90 
vol-% phosphate buffer (0.01M, 0.02 M, 0.03 M, 0.04 M, and 0.05 M total phosphate buffer, 
pH and pH* 7.4) or 10 vol-% of acetonitrile or acetonitrile-d3. Reactions were monitored at 37 
°C using CD spectroscopy (Figure 4.12). 
 
 
 
Figure 4.12: CD spectra observed for racemisation of a) 4.7 and b) 4.8. A stock solution of 
each compound in acetonitrile and 0.01 M non-deuterated phosphate buffer (10 vol-% and 90 
vol-% ratio, respectively; pH 7.4, 1 M I) were mixed and the ellipticity was followed at 37 °C 
as a function of time. 
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Figure 4.12 shows that ellipticity decreases over time. The ellipticity at 248 and 272 nm for 
compound 4.7 and at 247 and 271 nm for 4.8 were plotted versus time for every buffer 
concentration according to Equation 4.1 (Figure 4.13 and Appendix 3). 
 
 
 
Figure 4.13: Ellipticity as a function of time for compounds a) 4.7 at (■) 248 and (●) 272 nm 
and b) 4.8 at (■) 247 and (●) 271 nm by using 10 % acetonitrile and 90 % 0.01 M non-
deuterated phosphate buffer (pH 7.4, 1 M I, at 37 °C). 
 
Figure 4.13 shows that the ellipticity at 248 and 272 nm of compound 4.7 decreases over 
time. For compound 4.8, the ellipticity at 247 and 271 nm increases with time. Pseudo-first-
order rate constants kɵ were determined for the five different concentrations of 0.009 M, 0.018 
M, 0.027 M, 0.036 M and 0.045 M total phosphate buffer (0.9 M I, pH and pH* 7.4 of non-
deuterated and deuterated phosphate buffer). The second-order rate constants were determined 
by plotting the pseudo-first-order rate constants versus the basic component of the phosphate 
buffers, as discussed below. 
 
4.2.2.2 Solvent kinetic isotope effect of racemisation 
 
The kinetics of racemisation of compounds 4.7 and 4.8 were studied in non-deuterated and 
deuterated phosphate buffer to study the mechanism of proton transfer. The racemisation took 
place rapidly in comparison with compounds 4.1-4.5 if the same phosphate buffer 
concentrations were used (pH 7.4, 09 M I, at 37 °C). Therefore, lower concentrations of 
phosphate buffer were used with constant ionic strength at 37 °C. The pseudo-first-order rate 
constants for racemisation in non-deuterated and deuterated phosphate buffer pH and pH* 7.4, 
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(0.9 M I at 37 °C) were obtained according to Equation 4.1 (Section 4.2.2.1). The second-
order rate constants of racemisation were determined by plotting the observed rate constants 
for loss of ellipticity in non-deuterated and deuterated phosphate buffer versus the 
concentration of the basic component of the phosphate buffers (Figure 4.14).  
 
   
Figure 4.14: Pseudo first-order rate constants for loss of ellipticity for a) 4.7 and b) 4.8 in (■) 
H2O and (●) D2O phosphate buffers (0.9 M I, pH and pH* 7.4 at 37 °C). 
 
Figure 4.14 shows a linear correlation of the observed pseudo-first order rate constants for 
racemisation of 4.7 and 4.8 with the concentration of the basic component of phosphate 
buffer, suggesting general-base catalysis of racemisation. The solvent kinetic isotope effect 
was obtained by dividing the second-order rate constants for racemisation in deuterated and 
non-deuterated phosphate buffer (Table 4.6). 
 
Table 4.6: Second-order rate constants for buffer-catalysed loss of ellipticity kɵ of 4.7 and 
4.8 at 272 and 271 nm, respectively, in H2O and D2O phosphate buffers (0.9 M I, pH and 
pH* 7.4 at 37 °C) and the solvent kinetic isotope effect. 
Substrate 
kɵ H2O 
/ 10-6 s-1 M-1 
kɵ D2O 
/ 10-6 s-1 M-1 
kH/kD 
4.7 78700 ± 12700 72400 ± 9800 1.09 ± 0.23
(a 
 
 
4.8  60 ± 980 4650 ± 320 1.17 ± 0.22
(a 
 
 
a) Standard errors calculated using Equation 4.7 
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Table 4.6 shows significant second-order rate constants for loss of ellipticity for 4.7 and 4.8 
which are drastically higher than the corresponding rate constants for 4.1-4.5. The high rate 
constants indicate the effect of substituents at the N-3 position, which is free of substituents in 
4.1-4.6. It is also interesting to note that the isopropyl substituent at the C-5 position of 4.8 
has a strong rate-retarding effect in comparison with the benzyl substituent of 4.7. This 
stronger rate-retarding effect of isopropyl over benzyl was also observed for the rate constant 
of loss of ellipticity for 4.2 (1356 ± 86). 10-6 s-1 M-1, which was much higher than the rate 
constant for 4.3 ((61.3 ± 9.4). 10-6 s-1 M-1) (Table 4.1). Compound 4.7, with an additional 
substituent at the 3-position loses ellipticity 58 times faster than di-substituted 4.2. Compound 
4.8 loses ellipticity 89 times faster than 4.3. Bovarnick and Clarke30 suggested the possibility 
of conjugation influencing the ease of racemisation.30 
The solvent kinetic isotope effects for racemisation of 4.7 and 4.8 are 1.09 ± 0.2 and 1.2 ± 0.2, 
respectively, both are within error from 1. As shown before, the solvent kinetic isotope effects 
on the racemisation of compounds 4.1, 4.2, 4.4 and 4.5 were inverse kinetic isotope effects 
due to (de) protonation at N-3. The main difference between compounds 4.1-4.5 on the one 
hand and 4.7-4.8 on the other hand is that the more acidic position N-H is free of the 
substituent for 4.1-4.6, while in compound 4.7 and 4.8 the N-H position is substituted by a 
phenyl group. The partial deprotonation of 4.1-4.5 causes the rate of racemisation in H2O 
phosphate buffer to be slower and shows an inverse solvent kinetic isotope effect. Similarly, 
Cabordery et al.23 reported a solvent kinetic isotope effect of 0.77 for 2-(3-
(benzyl(methyl)amino)propyl)-3-thioxo-2,3,10,10a-tetrahydroimidazo[1,5-b]isoquinolin-
1(5H)-one in 75/25 phosphate buffer pH 2.5 and pD 2.6 and ethanol at 15 °C. There is no 
depronation at the N-3 position in 4.7 and 4.8 in H2O-phosphate buffer, therefore, no inverse 
solvent kinetic isotope effects were observed. In an attempt to explore the significance of the 
kinetic isotope effect even further, the weighted average of the second-order rate constant for 
loss of ellipticity as studied at 248 and 271 nm for compound 4.7 and as studied at 247 and 
271 for compound 4.8 were calculated. The weighted average of the second-order rate 
constants kɵ in H2O and D2O phosphate buffer at 248 and 272 nm for 4.7 are (83800 ± 8900). 
10-6 s-1 M-1and (70700± 7700). 10-6 s-1 M-1, respectively. The solvent kinetic isotope effect for 
loss of ellipticity then become 1.18 ± 0.18 i.e. within error margin of 1. This observation 
suggests no involvement of a proton transfer from water or from the buffer to the substrate in 
the rate determining step. 
From previous literature, the rate constants for racemisation of hydantoin have been reported 
at both different pH and temperature. It is interesting to compare the rate constants of 
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substituted 2-thiohydantoin racemisation in the present work with substituted hydantoin rate 
constants of racemisation from previous work. It has been reported that the sulphur atom in 
thiohydantoin increases the chiral instability of the enantiomer.23 Narduolo8 reported the rate 
constants of racemisation for various substituted hydantoins in D2O phosphate buffer (pH 7.2 
at 60 °C) (Scheme 4.8). 
 
 
Scheme 4.8: Substituted hydantoin studied by Narduolo. 
 
The racemisation of 4.9 was also studied by Reist et al.7 Narduolo reported the second- order 
rate constants for racemisation of 4.9-4.13 in deuterated phosphate buffer (pH 7.2, 1 M I, at 
60 °C) (Table 4.7).  
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Table 4.7: Rate constants for buffer catalysed and for the combined uncatalysed and 
deuteroxide catalysed racemisation of substituted hydantoins 4.9-4.13 in D2O phosphate 
buffer (pH 7.2, 1 M I, at 60 °C). 
Substrate 
kɵ D2O 
/ 10-6 s-1 M-1 
kin  
/ 10-6 s-1 
4.9 542.2 ± 2.5 17.7 ± 0.5 
4.10 342.6 ± 0.9 15.1 ± 0.1 
4.11 231.2 ± 1.7 8.6 ± 0.5 
4.12 2127.0 ± 9.0 51.1 ± 0.8 
4.13 1106.0 ± 19.0 58.3 ± 2.8 
 
From Table 4.7, it is clear that the methyl group substituted at the N-3 position of hydantoin 
in 4.10 retards racemisation in comparison with unsubstituted hydantoin 4.9. Similarly, the 
hydrogen replacement of N-3 by (2-methoxyethyl) (4.11) and (2-(dimethylamino) ethyl) 
(4.12) also reduces the rate of racemisation. The phenyl substituent on the N-3 position 
enhances the rate of racemisation of hydantoin, as previously reported.30  
Reist et al.7 also determined the pseudo-first-order rate constants for racemisation of 
compounds 4.9 and 4.14 in H2O and D2O phosphate buffer with 50% DMSO (Table 4.8). 
 
Table 4.8: Pseudo-first-order rate constants for buffer catalysed racemisation of 4.9 and 
4.14 in 50 % H2O and D2O phosphate buffers (0.1 M, 0.22 M I, pH and pH
* 7.4 and 50% 
of dimethyl-sulphoxide at 50 °C). 
 
k rac (bffer) H2O 
/ h-1  
krac (bffer) D2O 
/ h-1  
kH/kD 
4.9 0.12 ± 0.006 0.09 ± 0.02 1.27 ± 1.26 
 
 
4.14 23.7 ± 3.0 21.1 ± 1.4 1.12 ± 1.12 
 
 
 
It is obvious that 4.14 (with phenyl substituent) racemises 199 times faster than 4.9, showing 
the differences between the benzyl and phenyl group on the asymmetric carbon. There is also 
no solvent kinetic isotope effect within the margin of error for 4.9 and 4.14.  
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4.2.2.3 Relation between base-catalysed hydrolysis and racemisation 
 
For compounds 4.1-4.6, rate constants for racemisation were determined from the rate 
constants for loss of ellipticity by correcting for the effect of hydrolysis. For compound 4.7, 
the absorbance was not noted to decrease during the kinetic experiments because the decrease 
of ellipticity over time was extremely fast. However, the ellipticity of compound 4.8 
decreases more slowly in the buffer at 37 °C, and therefore, the decrease of absorbance in the 
CD measurements was noted (Figure 4.15). The rate constants for hydrolysis have therefore 
also been measured by UV-visible spectroscopy under the same conditions as those used for 
racemisation.  
 
  
  
Figure 4.15: CD observation for loss of ellipticity of 4.7 (a) and 4.8 (c) and absorbance of 4.7 
(b), and 4.8 (d) as a function of time. A solution of each compound in 10 % acetonitrile was 
mixed with 90% 0.01 M phosphate buffer (pH 7.4, 1 M I at 37 °C) over time. 
 
Figure 4.15 shows very slow hydrolysis for compounds 4.7 and 4.8 during the loss of 
ellipticity in phosphate buffer (pH 7.4, 0.9 M I at 37 °C). The rate constants of hydrolysis 
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were determined for compounds 4.7 and 4.8 by following the reaction using UV-visible 
spectroscopy under the same conditions as those used in CD measurements. 
The rate constants for the loss of ellipticity krac were plotted for 4.7 and 4.8 versus the 
concentration of the basic component of phosphate buffer to determine the slope and intercept 
by fitting the straight line (Figure 4.16). 
 
  
Figure 4.16: Pseudo-first-order rate constant krac determined by Equation 4.4 for a) 4.7 and b) 
4.8 without the effect of hydrolysis and in H2O phosphate buffers (0.9 M I, pH 7.4 at 37 °C). 
 
Compounds 4.7 and 4.8 lose optical activity drastically fast in comparison with compound 
4.1-4.5 in phosphate buffer (pH 7.4, 0.9 M I, at 37 °C) and with only slight hydrolysis during 
the process (Table 4.9). The second-order rate constants for loss of ellipticity kɵ and second-
order rate constants for hydrolysis khyd are compared in Table 4.9. 
 
Table 4.9: Second-order rate constants kɵ and khyd for 4.7 and 4.8 in H2O phosphate buffers 
(0.9 M I, pH and pH 7.4 at 37 °C). 
 
kɵ  
/ 10-6 s-1 M-1 
khyd 
/ 10-6 s-1 M-1 
4.7 78700 ± 12700 372 ± 63 
4.8 5460 ± 970 167 ± 25 
 
Table 4.9 suggests that the hydrolysis has a negligible effect on the rate constant for the loss 
of ellipticity. 
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4.2.2.4 Activation parameters for the racemisation of (R)-5-benzyl-3-phenyl-1-(pyridin-
2-ylmethyl)-2-thioxoimidazolidin-4-one 
 
The kinetic study of compound 4.7 was carried out at different temperatures in phosphate 
buffer (pH 7.4, 0.9 M I) and the activation parameters for racemisation were determined using 
the Eyring equation. 31 
 
 
where krac is the second-order rate constant for racemisation which is assumed to be equal to 
the second-order rate constant for loss of ellipticity kɵ (in s
-1 M-1), h is Planck's constant, kb is 
the Boltzmann constant, R is the gas constant and T is the absolute temperature (in K). 
The pseudo-first-order rate constants kɵ were determined in different non-deuterated 
phosphate buffer concentration (pH 7.4) at 15, 20, 25, 30 and 37 °C, while the second-order 
rate constants were calculated according to Equation 4.2. The rate constants for the loss of 
ellipticity were observed to increase with increasing temperature. The pseudo-first-order rate 
constants for the loss of ellipticity were observed by CD spectroscopy at 15, 20, 25, 30 and 37 
°C and plotted versus the basic component of phosphate buffer (pH 7.4, 0.9 M I) (Figure 
4.17).  
 
In (
𝑘rac. ℎ
𝑘B . 𝑇
) = − 
Δ𝐻‡o
𝑅. 𝑇
+  
∆𝑆‡o
𝑅
 
  Equation 4.6 
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Figure 4.17: Pseudo-first-order rate constants for buffer catalysed racemisation for 4.7 versus 
basic component of H2O phosphate buffers (pH 7.4, 0.9 M I) at (■) 15, (●) 20, (▲) 25, (▼) 
30 and () 37 °C. 
 
Figure 4.17 shows that the loss of ellipticity for 4.7 is highly temperature dependent; the 
second-order rate constants are reported in the Appendix of Chapter 4. The second-order rate 
constants for loss of ellipticity were calculated by the weighted average value at 272 and 248 
nm by using Equation 4.9 and 4.10. The activation parameters were then determined by 
plotting In (
𝑘rac.ℎ
𝑘B .𝑇
) versus 1/T using Equation 4.6 to determine the standard enthalpy change 
for activation ΔH‡ and standard entropy for activation ΔS‡o (Figure 4.18).  
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Figure 4.18: Eyring plot for racemisation of 4.7 in H2O phosphate buffer (0.9 M I, pH 7.4) at 
15, 20, 25, 30 and 37 °C. 
 
From the slope and intercept of Figure 4.18, the enthalpy (ΔH‡o) and entropy of activation 
(ΔS‡o) for general-base catalysed racemisation in H2O phosphate buffer pH 7.4 were 
calculated using Equation 4.6 (Table 4.10). 
 
Table 4.10: Standard activation parameters for racemisation of 4.7 in H2O-phosphate 
buffers (0.9 M I, pH 7.4). 
 
ΔH‡o  
/ kJ mol-1 
ΔS‡o 
/ J K-1 mol-1 
∆G‡o 
/kJ mol-1 
4.7  
 
47.6 ± 6.2 
 
-112 ± 21 
 
82 ± 22 
 
The relatively low value of ΔH‡o suggests simultaneous breaking and forming of bonds in the 
activated complex.32 The large negative value for the entropy of activation, ΔS‡o, for 
racemisation of 4.7 indicates significant loss of translational, vibrational, and/or rotational 
degrees of freedom and is in line with a bimolecular reaction. In comparison with the 
racemisation of amino acids, aliphatic amino acids have higher enthalpies of activation than 
aromatic amino acids. However, for entropy, this trend is the opposite, as can be seen in the 
3.2x10
-3
3.3x10
-3
3.4x10
-3
3.4x10
-3
3.5x10
-3
-33.6
-33.2
-32.8
-32.4
-32.0
ln
 (
k

* 
h
 /
 K
B
*T
)
1/T (K
-1
)
180 
 
previous literature.18 It is attractive to compare the activation parameters of the present study 
with those for the deuteration of 5-substituted hydantoins, reported previously by Testa et al. 
(Table 4.11).7 
 
Table 4.11: Activation parameters for deuteration of 5-monosubstituted hydantoins from 
Reist et al.7 
Hydantoin  
ΔH‡o  
/ kJ mol-1 
ΔS‡o  
/ J K-1 mol-1 
ΔG‡o 
 / kJ mol-1 
-Ph 72.3 ± 4.0 -68.2 ± 5.0 94.6 ± 11.7 
-CH2OH 76.7 ± 2.8 -86.6 ± 4.6 105.0 ± 9.6 
-NHONH2 94.1 ± 2.1 -39.3 ± 1.3 106.7 ± 5.4 
-CH2Ph 94.3 ± 2.5 -43.1 ± 1.7 108.4 ± 6.7 
-CH3 85.3 ± 2.1 -77.0 ± 2.9 110.0 ± 6.7 
-CH2COOH 98.4 ± 3.2 -42.3 ± 2.1 112.1 ± 11.7 
-CH(CH3)2 80.7 ± 3.0 -105.4 ± 6.7 114.6 ± 11.7 
 
Table 4.11 shows that the enthalpy of activation is between 72.3 ± 4.0 and 98.4 ± 3.2 kJ mol-1 
and the entropy for activation is between -39.3 ± 1.3 and -105.4 ± 6.7 J K-1 mol-1 for 5-
substituted hydantoin. Unfortunately, Reist et al. used the pseudo-first-order rate constant for 
deuteration to calculate activation parameters rather than second-order rate constants which 
are used in the present work, so we can only compare ΔH‡o rather than ΔS‡o. It should be 
noted that the values in Table 4.11 were observed by Reist et al. for 5–substituted hydantoins 
by using DMSO and phosphate buffer in a 1:1 proportion. Reist et al. indicated the partial 
responsibility of inductive and resonance effects on the transition state, which is reflected in 
the change of   ΔH‡o.33 In particular, the entropy of activation affects the rate of racemisation 
and deuteration strongly which prevented the author from deriving a general rule to anticipate 
the effect of substituents on the chiral stability of 5-subsituted hydantoins. Table 4.11 shows a 
large negative ΔS‡ for 5-isopropylhydantoin, which might indicate the effect of steric 
hindrance on racemisation. It is also important to mention that racemisation of 4.3 is quite 
slow in comparison with compounds 4.1, 4.2, 4.4 and 4.5 because of the steric effect (Table 
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4.1). Using 50% DMSO to obtain the rate of deuteration at different temperatures has also an 
effect on the entropy of activation.  
Narduolo8 reported the values of activation parameter for base-catalysed racemisation of 
hydantoins with different groups at the N-3 position of hydantoin (Table 4.12). 
 
Table 4.12: Activation parameters for base-catalysed racemisation of 4.10, 4.11 and 
4.13 in D2O phosphate buffer (pH 7.2, 1 M I) from Narduolo.
8 
Hydantoin N- Substituent 
ΔH‡o  
/ kJ mol-1 
ΔS‡o 
/ J K-1 mol-1 
4.10  83.7 ± 0.8  -55.2 ± 2.9 
4.11  87.9 ± 2.9  -44.8 ± 10.0 
4.13  93.7 ± 2.1  -13.4 ± 6.7 
 
From Table 4.12, it is clear that the type of substituent at the N-3 position changing the 
activation parameter is important as it can be seen comparing 5-benzylhydantoin 4.9 and 3-
methyl-5-benzylhydantoin 4.10. The rate constant of racemisation decreased for compounds 
4.10 and 4.11 in comparison with 5-benzylhydantoin 4.9 and the enthalpy of activation is also  
reduced. It has been argued that there is no simple relationship between the effects of 
substituents and the enthalpies of activation.18  
For compound 4.7, we found a higher negative value for the entropy of activation and a lower 
enthalpy of activation with bigger margins of error than those reported for 5-substituted 
hydantoins7 or even disubstituted hydantoins.8 The highly negative activation entropy for 
racemisation of 4.7 suggests the loss of translational and rotational degrees of freedom 
associated with the highly ordered transition state32 which can be interpreted as bulkiness of 
the substituents at the C-5, N-1 and N-3 positions. ΔH‡o for thiohydantoin is lower than for 
hydantoin while ΔS‡o is more negative for thiohydantoin than for hydantoin. 
 
4.2.2.5 Effect of co-solvents on the kinetics of racemisation 
 
Compounds 4.1-4.5 are sufficiently soluble to be able to see their peaks using CD 
spectroscopy. To study the effect of added co-solvent on the rate constants for racemisation of 
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4.2 and 4.3 the second-order rate constants for loss of ellipticity were also obtained in 
aqueous solution in the presence and absence of 10 vol-% acetonitrile. Solutions were 
prepared mixing 10 vol-% H2O or D2O containing either 4.2 or 4.3 with 90 vol-% H2O and 
D2O-phosphate buffers. On the other hand, solutions were also prepared in 10 vol-% 
acetonitrile or acetonitrile-d3 and mixed with 90 vol-% H2O and D2O-phosphate buffers 
(Table 4.13).  
 
 
a) A solution of each compound contains 10 vol-%  H2O or 10 vol-%  D2O with 90% 0.1 
M phosphate buffer (pH or pH* 7.4, 1 M I at 37 °C). 
b) A solution of each compound contains 10 vol-% acetonitrile or 10 vol-% acetonitrile-
D3 with 90% 0.1 M phosphate buffer (pH or pH
* 7.4, 1 M I at 37 °C). 
 
As can be seen in Table 4.13, the rate constant for the loss of ellipticity kɵ in 100 % H2O 
phosphate buffer is approximately 1.1 and 1.15 times faster than kɵ in 10% acetonitrile and 
90% H2O phosphate for 4.2 and 4.4, respectively. As mentioned before, water may catalyse 
and enhance proton transfer, reducing the enantiomerisation barrier by approximately 30 kcal 
mol-1.14 Tian et al.14 also suggested that the hydroxide ion can further reduce the energy 
barrier to about 24 kcal mol-1 under basic conditions by accelerating the proton transfer. The 
literature also reports how water can catalyse the interconversion of thalidomide by promoting 
the proton transfer where a one-dimentional water chain can act as a water bridge through the 
Grotthuss mechanism34 for the proton transfer.14 These mechanisms may also play a role in 
the (small) rate retardation observed here. 
The kinetic studies of racemisation for 4.7 and 4.8 were undertaken by dissolving the 
compound in acetonitrile or acetonitrile-d3 and subsequently mixing with H2O and D2O 
phosphate buffer. To investigate the effect of different co-solvents on the rate of racemisation, 
Table 4.13: Pseudo first-order rate constants for loss of ellipticity of 4.2 and 4.4 in the 
absence and presence of 10 vol-%   acetonitrile and acetonitrile-D3. 
Su. 
kɵ ACN
(a 
 / 10-6 s-1 
 
kɵ ACN-d3
(a 
/ 10-6 s-1 
 
SKIE 
 
kɵ H2O 
(b  
/ 10-6 s-1 
 
kɵ D2O
(b  
/ 10-6 s-1 
 
 
SKIE 
4.2 96.0 ± 1.9 96.7 ± 1.9 0.99 ±0.03 
 
105.6 ±2.1 
 
 
105.3 ± 2.1 1.00 ±0.03 
 4.4 50.7 ± 1.3 48.7± 1.0 1.04 ±0.03 
 
58.5 ±1.2 57.1 ±1.2 1.02 ±0.03 
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other co-solvents were also used to compare with the effect of 90% acetonitrile 0.01 M 
phosphate buffer (pH 7.4, 1 M I at 37 °C). The pseudo-first-order rate constants kɵ in buffers 
with 10 vol-% of MeCN, DMSO, EtOH, MeOH, IPA and TFE were obtained under otherwise 
identical conditions (Figure 4.19). 
 
 
Figure 4.19: CD observation as a function of time at 272 nm for racemisation of 4.7. 10 vol-
% of compound 4.7 in acetonitrile (■), DMSO (●), ethanol (▲), isopropanol (▼), methanol 
(♦) trifluoroethanol (◄) was mixed with 90 vol-% 0.01 M phosphate buffer (pH 7.4, 1 M I at 
37 °C). 
 
The pseudo-first-order rate constants for loss of ellipticity kɵ were determined according to 
Equation 4.1. All pseudo-first-order rate constants kɵ were plotted versus co-solvent to show 
the effect of co-solvent on the rate constant for ellipticity loss. There is no pseudo-first-order 
rate constant kɵ in aqueous solution without added co-solvents because compound 4.7 does 
not dissolve in water (Figure 4.20). 
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Figure 4.20: Comparison of pseudo-first-order rate constants for ellipticity loss of 4.7 in a 
solution of 10 vol-% MeCN, DMSO, EtOH, IPA, MeOH and TFE, mixed with 90 vol-% 0.01 
M phosphate buffer (pH 7.4, 1 M I at 37 °C). 
 
From Figure 4.20, the rate constants in the presence of different co-solvents are higher than 
those in the presence of acetonitrile. The highest rate constant kɵ was obtained using 10 % 
trifluoroethanol with 90 vol-% buffer (3.55 times higher than acetonitrile). DMSO and 
methanol increase the rate kɵ by about 1.35 and 1.30 times, respectively. Ethanol and 
isopropanol have less effect on racemisation, with rate constants which are higher than those 
in the presence of acetonitrile by approximately 1.1 and 1.08 times when using ethanol and 
isopropanol, respectively (Table 4.14).  
 
 
 
 
 
ACN DMSO EtOH IPA MeOH TFE
0.0
2.0x10
-3
4.0x10
-3
6.0x10
-3
8.0x10
-3
1.0x10
-2
1.2x10
-2
k 
 /
s-
1
185 
 
Table 4.14: Pseudo-first-order rate constants for racemisation of 4.7. 10 vol-% of a solution 
of each compound in acetonitrile, DMSO, ethanol, isopropanol, methanol and tri-
fluoroethanol was mixed with 90 vol-% 0.01 M phosphate buffer (pH 7.4, 1 M I at 37 °C). 
 
kɵ (ACN) 
/ 10-6 s-1 
  
kɵ (DMSO) 
/ 10-6 s-1  
 
kɵ (EtOH)  
/ 10-6 s-1 
 3005 ± 96 3951 ± 137 3363 ± 88 
kɵ (MeOH) 
 / 10-6 s-1 
 
kɵ (IPA) 
/ 10-6 s-1 
 
kɵ (TFE ) 
/ 10-6 s-1 
 3936 ± 116 3246 ± 87 10680 ± 575 
 
 
 
 
The effect of DMSO on the racemisation of different optically active compounds has been 
reported previously;35,8, 36 DMSO typically accelerates racemisation. The rate of racemisation 
increases by increasing the volume of DMSO, which is attributed to the reduced efficiency of 
the solvation of the dianion in DMSO containing buffers.37 The anions in aprotic polar 
solvents are partially blocked and strong solvation deactivates the role of anions as basic 
catalyst in the racemisation process.38  
It is interesting to compare the effect of co-solvent on racemisation of thiohydantoin with that 
on racemisation of hydantoin. Narduolo8 has used different co-solvents with non-deuterated 
and deuterated phosphate buffers for 4.9-4.11 and 4.13 (Table 4.15). 
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Table 4.15: Rate constants for racemisation of hydantoins 4.9-4.11 and 4.13, at 60 °C, in 
mixtures composed of 50 volume-% H2O and D2O phosphate buffers 0.5 M, 1 M / and 50 
volume-% of H2O or mixtures 1:1 (v:v) of H2O non-deuterated co-solvent and D2O or 
mixtures 1:1 (v:v) of D2O-deuterated co-solvent, respectively, to give a total concentration 
of co-solvent of 25 volume-% (v:v).8  
H2O buffer pH25 °C 7.2 
hydantoin 
 
kɵ / 10
-6 s-1 
no co-solvent 2-propanol TFE dioxane 
4.9 167.3 ± 1.3 129.9 ± 1.0 208.0 ± 1.8 134.8 ± 1.5 
 
 
4.10 114.5 ± 0.5 76.3 ± 0.7 128.7 ± 1.0 89.3 ± 0.4 
4.11 78.4 ± 0.6 48.8 ± 0.2 95.5 ± 0.3 57.6 ± 0.2 
4.13 524.1 ± 13.4 808.5 ± 14.7 676.2 ± 30.1 947.8 ± 29.6 
D2O buffer (pH* 7.3) 
hydantoin kɵ / 10
-6 s-1 
no co-solvent 2-propanol TFE dioxane 
4.9 175.0 ± 1.5 134.8 ± 1.9 191.4 ± 2.4 140.5 ± 1.2 
4.10 112.8 ± 0.4 77.4 ± 0.4 107.3 ± 0.6 86.7 ± 0.6 
4.11 77.0 ± 0.3 46.7 ± 0.1 82.5 ± 0.3 56.1 ± 0.3 
4.13 539.7 ± 15.1 896.9 ± 15.5 615.4 ± 17.0 968.8 ± 21.6 
 
It is obvious from Table 4.15 that trifluoroethanol accelerates and isopropanol decelerates the 
rate of ellipticity loss both in deuterated and non-deuterated phosphate buffer. The effect of 
trifluoroethanol on increasing the rate of racemisation was also found for compound 4.7 in 
H2O phosphate buffer (pH 7.4). Narduolo
8 also reported that the pH of the phosphate buffer 
appeared to be higher by using 25 vol-% co-solvent increasing from 7.24 to 7.78 (IPA), 7.91 
(dioxane) and 8.28 (DMSO). Furthermore, adding 25 % TFE with 75% phosphate buffer 
increased the pH of phosphate buffer from 7.24 to just 7.32.  
 
4.2.3 Racemisation of 5-substituted 2-thiohydantoins 
 
As described in Chapter 2, we were not able to synthesise enantioenriched 5-substituted 2-
thiohydantoin. Even pure enantiomers of amino acids have been tried as starting material. 
Several racemic 5-substituted 2-thiohydantoins have been synthesised from the corresponding 
amino acids and aldehydes. The chirobiotic T column was tried in chiral HPLC for 
enantioseparation for several 5-substituted 2-thiohydantoins in different conditions (see 
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Chapter 2). The enantiomers of the two compounds were collected by chiral column HPLC 
(Scheme 4.9).  
 
 
Scheme 4.9: The chemical structure of 5-benzyl-2-thioxoimidazolidin-4-one (4.15) and 5-
(pyridin-2-ylmethyl)-2-thioxoimidazolidin-4-one (4.16) 
 
We collected multiple enantioenriched fractions of 4.15 and 4.16 to have enough absorbance 
and ellipticity to be measurable in CD spectroscopy. To confirm separation of the 
enantiomers, we recorded CD spectra to confirm the inverse peaks for both enantiomers. Both 
enantiomers of 4.16 were observed by CD spectroscopy which showed opposite CD spectra 
for both enantiomers with low intensity. Unfortunately, it was found that 4.15 and 4.16 
racemised completely during the process of HPLC sample collection and subsequent solvent 
evaporation. Bovarnick and Clarke30 have explained that the replacement of hydrogen at the 
N-1 position of hydantoin by substituents will decrease the rate constants of racemisation. It is 
notable that the acetyl group on the N-1 retards the rate of ellipticity loss for 4.1-4.5. 
 
4.3   Conclusion 
 
The kinetics of racemisation of thiohydantoins were studied in physiological like buffer to 
obtain the rate constants of racemisation. Firstly, it was observed that the acetyl group 
substituted at the N-1 position has a rate retarding effect on racemisation. It is known that 
during racemisation, the cleavage of the acetyl bond occurs which influences the observed 
rate constant for ellipticity loss. Therefore, the rate constant for ellipticity loss determined 
using CD spectroscopy is higher than the rate constant for racemisation. Secondly, the solvent 
kinetic isotope effect was also studied and suggested negligible solvent kinetic isotope effect 
for the racemisation of 4.1-4.5, 4.7 and 4.8. Thirdly, the corresponding amino acid 
substituents on the asymmetric C-5 carbon influenced the rate of racemisation of 
thiohydantoin, which varied between increasing and decreasing the rate of 4.1-4.5. Finally, 
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our data suggest the SE1 mechanism for the racemisation of thiohydantoin rather than the SE2 
mechanism.  
 
4.4  Experimental 
4.4.1 General Experimental 
 
4.4.1.1 Apparatus 
 
All solvents used were HPLC grade and purchased from Fischer Scientific or Sigma Aldrich. 
All materials used were weighed out on an analytical Fisher Brand PS-100 balance (Max 100 
g, d=0.1 mg). For every buffer concentration, the required buffer was mixed with a freshly 
prepared stock solution of thiohydantoin. The volumes for all stock solutions were measured 
by Gilson or Eppendorf Research micropipettes. The stock solutions of thiohydantoin were 
centrifuged three times to avoid precipitation inside the stock solution. The pH measurements 
for all concentrations of buffer in non-deuterated and deuterated buffer were carried out at 20 
°C using a Hanna Instruments pH 210 pH meter. The pH meter was calibrated before each 
measurement with certified traceable NIST buffers at pH 10.01+0.02 (at 20 °C) (from Fisher) 
and pH 4.00+0.01 (at 20 °C) (from Reagecon). Kinetic experiments of racemisation were 
carried out on a Chirascan CD spectrometer equipped with a temperature controlled sample 
holder for circular dichroism (temperature stability: ± 0.02 °C) in 1.00 cm path length quartz 
cuvettes, unless otherwise stated.  
 
4.4.1.2 Preparation of solutions 
 
All non-deuterated buffers were prepared by the procedures described in Chapter 3. 
Deuterated phosphate buffers were prepared by evaporating the different concentrations of 
H2O phosphate buffer (pH* 7.4, 1 M I) by freeze dryer and adding D2O three times to 
guarantee the exchange of deuteron. The measurement of pH of the above described solutions 
gave values of pH*20°C (D2O) = 7.55 and pH
20°C (H2O) = 7.44. For the stock solutions, 5-
substituted 1-acetyl-2-thiohydantoins were dissolved in H2O and D2O and placed in an 
ultrasonic bath sonicator for approximately 5 minutes. The solutions were subsequently put in 
plastic Eppendorfs and centrifuged for 8 minutes at 13.3 rpm on a Jencons-pls Spectrafuge 
24.D centrifuge. Every buffer concentration was mixed with a freshly prepared stock solution 
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of thiohydantoin. The supernatants were transferred to new Eppendorfs and centrifuged 2 
times. The supernatants were collected and measured in a UV-visible spectrophotometer to 
confirm appropriate absorbance even with the dilution.  
 
4.4.1.3 Error calculation 
 
Error propagation in the present work was calculated in different ways. For the pseudo-first 
and second-order rate constants, the errors were obtained using the Origin 9.0 program. For 
the slope and intercept, the errors appeared in origin without having to calculate manually. 
However, the errors of solvent kinetic isotope effect (kH2O/kD2O) on racemisation and rate 
constants in deuterated phosphate buffer divided by hydrogen-deuterium exchange process 
(kD2O/kHD) were calculated using the following equation
39, 40 
 
𝐸𝑟𝑟𝑜𝑟𝑘𝐻/𝑘𝐷 = √(
1
𝑘𝜃
𝐷)
2. (𝑒𝑟𝑟𝑜𝑟𝑜𝑛𝑘𝜃
𝐻)2 + [
𝑘𝜃
𝐻
(𝑘𝜃
𝐷)2
]2. (𝑒𝑟𝑟𝑜𝑟𝑖𝑛𝑘𝜃
𝐷)2 
Equation 4.7 
 
 
kɵH and kɵD were determined using CD spectroscopy in different concentrations of non-
deuterated and deuterated phosphate buffer. The error in kɵH and kɵD were obtained in Origin 
9.0.  
The error margins for kkhyd were calculated using the following equation40 
 
𝐸𝑟𝑟𝑜𝑟(𝑘𝜃 − 𝑘hyd) = √(1)2(𝑒𝑟𝑟𝑜𝑟 𝑖𝑛 𝑘𝜃)2 + (−1)2(𝑒𝑟𝑟𝑜𝑟 𝑖𝑛 𝑘ℎ𝑦𝑑)2 
Equation 4.8 
  
The errors in the kɵ and khyd were obtained using Origin 9.0. 
Weighted averaged data were used to calculate the rate constant for loss of ellipticity at 
different wavelengths for 4.7 (see Section 4.2.2.2). Two rate constants for racemisation of 4.7 
were observed at different wave length. To calculate the weighted average of two rate 
constants, the following equation was used40 
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Weight Average rate =
(
1
(error 𝑘1)2
∗ k1) + (
1
(error 𝑘2)2
∗ k2)
(
1
(error k1)2
+
1
(error k2)2
)
 
 
  
Equation 4.9 
 
 
Here, all rate constants were obtained using either CD spectroscopy, with the exception of kHD 
for H/D exchange which was obtained using 1H-NMR spectroscopy. The error margins for 
individual k in the equation were obtained using Origin 9.0. 
To calculate the error margin of the weight average, the following equation was used40 
 
Error of weight average rate constant = √
1
1
(𝑒𝑟𝑟𝑜𝑟𝑘1)2
+
1
(𝑒𝑟𝑟𝑜𝑟𝑘2)2
 
Equation 4.10 
 
 
Here, all errors for the rate constants were obtained in Origin 9.0. 
The error propagation equation has been used for the data in the Eyring plots to obtain the 
error margins on activation enthalpy and entropy.40,41 
 
4.4.1.4     Standard state 
 
The usual choice of 1 mol dm-3 has been used as the reference state for concentration. 
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Chapter 5 
 
 
 
 
 
 
 
 
Kinetics of H/D exchange and racemisation 
for substituted 2-thiohydantoins and related 
compounds 
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5.1 Introduction 
 
The mechanism of racemisation can be studied by comparing the rate constant of 
racemisation krac with the rate constant of hydrogen-deuterium exchange kdeut. Wilson et al.
1 
proposed the mechanism of racemisation of optically active 2-methyl-1-phenyl-1-butanone in 
this way. If kdeu/krac approaches unity, the exchange occurs with complete racemisation.
2 SE1 
and SE2 mechanisms have been suggested for the racemisation of 5-substituted hydantoins by 
Narduolo3 and Reist et al.4 Narduolo3 reported krac / kH/D to be between 1.2 and 1.3 for S-5-
benzylhydantoin (25 °C using 0.1 and 0.5 M of D2O-phosphate buffer, pH
* 7.2, 1 M I), which 
is close to unity, therefore indicating SE1 rather than SE2. This was further supported by a 
wealth of additional data. The racemisation of amfepranone and cathinone have also been 
reported to proceed via the SE1 mechanism in D2O-phosphate buffer (pH
* 7.4, 0.43 M I).5 
However, Reist et al. suggested the SE2 mechanism for the racemisation of 5-substituted 
hydantoins in 50% DMSO and 50% buffer with rate constants of deuteration half those of 
racemisation, and kdeut / krac approaching 0.5. Cabordery et al.
6 proposed the SE2 mechanism 
for the racemisation of thiohydantoin (33 mM, pD 2.6 deuterated phosphate buffers / EtOD- 
75/25 (v/v) at 15 °C), where the rate constant for deuteration was about half that for 
racemisation, suggesting that deuteration occurs with inversion of conﬁguration. Both SE1 and 
SE2 mechanisms were suggested for the racemisation of 5-substituted hydantoin by Narduolo 
and Reist et al., respectively, as shown in Scheme 5.1.  
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Scheme 5.1: SE1 and SE2 mechanisms of racemisation  
 
The SE2 mechanism was suggested for thiohydantoin racemisation by Cabordery et al.
6 
because the isotopic exchange occurring with kdeut/ krac is equal to 0.68 at pH 2.6 with 
complete net inversion of configuration (Scheme 5.2).2  
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Scheme 5.2: SE2 mechanism for thiohydantoin racemisation proposed by Cabordery et al.
6  
 
5.2 Results and discussion 
5.2.1 The hydrogen/deuterium exchange of 5-substituted 1-acetyl-2-
thiohydantoin 
5.2.1.1 Determination of hydrogen/deuterium exchange of 5-substituted 1-acetyl-2-
thiohydantoin 
 
To study the mechanism of racemisation, 1H-NMR experiments in D2O-phosphate buffers 
(pH* 7.4, 0.9 M I, at 37 °C) were performed for the deuteration of labile hydrogen at the chiral 
centre of compounds 5.1-5.5 (Scheme 5.3) to complement the racemisation experiments 
described in Chapter 4. 
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Scheme 5.3: The chemical structures of compounds 5.1-5.6 
  
Scheme 5.3 shows different groups attached at the C-5 position with acetyl substituted at N-1. 
Their racemisation was discussed in Chapter 4 in non-deuterated and deuterated phosphate 
buffer pH (pH* 7.4, 0.9 M I, at 37 °C). Compounds 5.1 and 5.3 had sufficient solubility in 
aqueous buffers for peaks in their 1H-NMR spectra to be observed. Different concentrations 
of D2O-phosphate buffer were used for 5.1 and 5.3 and 
1H-NMR spectra were recorded as a 
function of time (Figure 5.1). Because of the lack of solubility in aqueous solution of 
compounds 5.2, 5.4 and 5.5, 10 vol-% of d3-acetonitrile was used to dissolve sufficient 
quantities of these compounds.  
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Figure 5.1: 1H-NMR spectra of 5.3 between 0 and 167 h in 0.36 M D2O-phosphate buffer 
(pH* 7.4, 0.9 M I, at 37 °C). 
 
Figure 5.1 shows hydrolysis and a decrease in the signal for the labile hydrogen at the 
stereogenic centre for compound 5.3. This is in agreement with the observation for the loss of 
ellipticty of 5.1-5.5 in Chapter 4. We discussed how the rate constants for the loss of 
ellipticity are not equal to the rate constants for racemisation because hydrolysis occurs 
during the reaction. Therefore, to determine krac, the equation kɵ-khyd = krac was used to obtain 
the rate constants of racemisation of 5.1-5.5 (vide supra) in H2O and D2O-phosphate buffer. 
Similarly, the rate constant observed from the decrease of the relative integration of the 
hydrogen at the stereogenic centre over time does not represent the rate constants for H/D 
exchange because of the hydrolysis of 5.1-5.5, as can be seen in Figure 5.1. As a result, the 
equation kH, obs - khyd = kH/D can be used to obtain the rate constants for H/D exchange kH/D. 
However, we have not carried out hydrolysis experiments for 5.1-5.5 in D2O-phosphate buffer 
using UV-visible spectroscopy (as we did to determine khyd in H2O-phosphate buffer, Chapter 
4). Therefore, kH/D cannot be compared with krac but can be compared with kɵ. Nevertheless, 
kH, obs is represented as kH/D in this chapter, i.e. kH, obs ≈ kH/D. 
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1H-NMR spectroscopy, using tetramethylammonium bromide as a reference, indicates that the 
signal for the labile hydrogen on the stereogenic centre decreases for 5.3 in deuterated-
phosphate buffer (pH* 7.4) (Figure 5.1). The reason for using tetramethylammonium bromide 
as a reference is because the kH, obs of 5.3 is low, approximately twice khyd.  
In contrast, the kH, obs are much higher than khyd for the rest of compounds 5.1, 5.2, 5.4 and 5.5 
(vide infra). The reaction was followed using 1H-NMR spectroscopy in D2O-phosphate buffer 
pH* 7.4 for compounds 5.1, 5.2, 5.4, 5.5 and 5.6. The integrated peak areas, relative to a 
reference signal, for the hydrogens at the stereogenic centres were calculated over time (see 
appendix).  
For these compounds, integrations were normalised relative to a signal for non-exchanging 
protons in the compounds themselves. The relative integration areas of the hydrogen signal 
were plotted versus time for 5.1-5.6 to determine the pseudo-first-order rate constants of H/D 
exchange (Figure 5.2 and Appendix). 
  
Figure 5.2: a) The relative area of labile hydrogen on the stereogenic centre of 5.3 over time 
in 0.36 M D2O-phosphate buffer (pH
* 7.4, 0.9 M I, at 37 °C), and b) the relative integration 
area (●) increasing and (■) decreasing of the acetyl methyl group over time in 0.36 M D2O- 
phosphate buffer (pH* 7.4, 0.9 M I, at 37 °C). Solid lines are fits in terms of the first order 
rate law. 
 
 
 
The pseudo-first-order rate constant for H/D exchange, kH/D, of 5.3 (21.1 ± 0.5). 10
-6 s-1 
(Figure 5.2 a) is higher than khyd   for 5.3 as quantified by both the rate constant for loss of the 
N-acetyl-CH3 of (11.3 ± 0.4).10
-6 s-1 and the rate constant observed for formation of the 
acetate-CH3 of (9.9 ± 0.3). 10
-6 s-1 (Figure 5.2 b). Rate constants for hydrolysis in D2O-
phosphate buffer were not determined for every compound by UV-visible spectroscopy (only 
H2O-phosphate buffers were used in Chapter 3). There are two possibilities for the signal of 
the proton at the stereogenic centre in the hydrolysed product:1) it overlaps with the signal of 
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the starting material or 2) it is found elsewhere. However, considering that H/D exchange for 
the deacetylated compound is much faster than for the acetylated compound, the signal is 
unlikely to contribute significantly to the relative integral for the proton on the stereogenic 
centre in 5.3. Therefore, the rate constant of H/D exchange here also contains the rate constant 
for hydrolysis. The highest rate constant of hydrolysis of 5.3 was observed by 1H-NMR 
spectroscopy in D2O-phosphate buffer, which is approximately half of the rate constant of 
H/D exchange (Figure 5.2 b). This value can be considered reasonable because in the case of 
the racemisation in H2O-phosphate buffer, khyd also approaches half of the rate constant for the 
racemisation (see appendix).  
The pseudo-first-order rate constants for H/D exchange were determined for 5.1 and 5.3 by 
using Equation 5.1 (Experimental Section) in different concentrations of D2O-phosphate 
buffer (pH* 7.4 at 37 °C) without using co-solvent. However, 10% d3-ACN was used with the 
D2O–phosphate buffer for compounds 5.2, 5.4, 5.5 and 5.6 to record 1H-NMR data. From 
Figure 5.2a for 5.3, the data is reproduced well by the pseudo-first-order rate law. Similarly, 
the pseudo-first-order rate law was fit to the data for the H/D exchange of the rest of the 
compounds, as illustrated in the Appendix. To show the effect of the basic component of the 
buffer on the hydrogen-deuterium replacement, different concentrations of D2O-phosphate 
buffer were used for 5.1 and 5.3. The second-order rate constants for H/D exchange were 
obtained by plotting the pseudo-first-order rate constant versus the concentration of the basic 
component of the phosphate buffers (Figure 5.3).  
 
 
Figure 5.3: First-order rate constants for buffer catalysed H/D exchange of a) 5.1 and b) 5.3 
in D2O-phosphate buffers (0.9 M I, pH
* 7.4 at 37 °C). 
 
Figure 5.3 shows a good linear correlation, confirming general-base catalysis for H/D 
exchange. The rate constants of racemisation for 5.1-5.6 also increased by increasing the 
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buffer concentration (Chapter 4). The second-order rate constants for 5.1 and 5.3, observed in 
D2O-phosphate buffer (pH
* 7.4 at 37 °C), are shown in Table 5.1.  
 
Table 5.1: Second-order rate constants of H/D exchange kH/D of 5.1 and 5.3 in D2O-phosphate 
buffer measured by 1H-NMR spectroscopy at 0.36, 0.27, 0.18 and 0.09 M total phosphate and 
0.2877, 0.2158, 0.1438, 0.0719 and 0.0360 M basic phosphate, respectively (0.9 M I, pH* 7.4 
at 37 °C). 
 
 
 
 
 
 
Substrate 
kH/D 
/ 10-6 s-1 M-1 
kin 
/ 10-6 s-1 
5.1  880 ± 12 
 
 
19.8 ± 1.7 
 
5.3  60.4 ± 13.3 
 
2.8 ± 2.6 
 
 
Moreover, it is obvious that the substituents at the chiral centre have an influence on the rate 
of racemisation. It should also be noted from Table 5.1 that the substituents at the C-5 
position affect the H/D exchange in a similar way to racemisation. It was reported that the 
aliphatic and aromatic groups at the C-5 also increase or decrease the acidity of C-H because 
of the inductive effect, which is not the only effect but indeed can be considered important.7  
  
5.2.1.2 Comparison of the rate constant of racemisation and H/D 
exchange 
 
The hydrogen-deuterium exchange process can be considered a useful probe in the 
investigation of carbanions.8 Comparison between the rate constant of H/D exchange and that 
of racemisation can support a proposed mechanism of racemisation. The SE1 mechanism for 
hydantoin racemisation was previously suggested.3, 6 The SE1 mechanism occurs in the 
racemisation when kdeu / krac approaches unity and deuteration takes place with complete 
racemisation.6 The base-catalysed hydrogen exchange reaction of 5-substituted 1-N-acetyl-2-
thiohydantoin is proposed to proceed via the SE1 mechanism, as shown in Scheme 5.4.  
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 Scheme 5.4: The proposed SE1 mechanism for thiohydantoin racemisation. 
 
The rate constants for the loss of optical activity kɵ were obtained using CD spectroscopy in 
different concentrations of deuterated-phosphate buffer, as mentioned in Chapter 4. Under the 
same conditions, the pseudo-first-order rate constants for H/D exchange of 5.1 and 5.3 were 
determined from 1H-NMR spectroscopic data in various concentrations of phosphate buffer 
(Equation 5.1). The second-order rate constants of H/D exchange were determined at pH* 7.4 
at 37 °C (Equation 5.2) (Table 5.2).  
 
Table 5.2: Second-order rate constants for H/D exchange kH/D of 5.1 and 5.3 in D2O 
phosphate buffer measured by 1H-NMR spectroscopy (ionic strength 0.9 M I, pH* 7.4 at 37 
°C). 
 
 
 
 
 
 
Compound 
kɵ (D2O) 
/ 10-6 s-1 M-1 
kH/D 
 / 10-6 s-1 M-1 
kɵ D2O/kH/D 
5.1 811 ± 66 
 
 
880 ± 12 
 
 
0.92 ± 0.08 
 
5.3 53.5 ± 4.0 
 
60.4 ± 13.3 
 
0.89 ± 0.21 
 
 
 
From Table 5.2, the second-order rate constant for the loss of ellipticity of both 5.1 and 5.3 in 
D2O-phosphate buffer divided by the second-order rate constant for H/D exchange are 
approximately equal to unity. For compound 5.1 and 5.3, the value of krac/kdeut is 
approximately equal to unity within the margin of error, confirming SE1 rather than SE2 is the 
mechanism for thiohydantoin racemisation.  
Compounds 5.1, 5.2, 5.4, and 5.6 were studied in 0.09 M phosphate buffer without and with 
10 vol-% d3-acetonitrile, respectively while compounds 5.3 and 5.5 were studied in 0.36 M 
phosphate buffer with and without 10 vol-% d3-acetonitrile, respectively. The presence of d3-
203 
 
acetonitrile increased the solubility of the sample allowing us to obtain the pseudo-first-order 
rate constants for H/D exchange (Table 5.3).  
 
Table 5.3: Pseudo-first-order rate constants for the loss of ellipticity kɵ for solutions of 5.1, 
5.2 and 5.4 and for H/D exchange kH/D of 5.2, 5.4 and 5.6 in D2O-phosphate buffer measured 
by 1H-NMR spectroscopy at 0.09 M total phosphate (0.072 M basic phosphate), and kɵ and 
kH/D at 0.36 M total phosphate (0.29 M basic phosphate) for 5.3 and 5.5 (ionic strength of 0.9 
M I, pH* 7.4 at 37 °C). 
 
 
 
 
 
 
Compound 
kɵ (D2O) 
/ 10-6 s-1  
kH/D  
/10-6 s-1 
kɵ (D2O)/kH/D 
5.1 68.5 ± 1.4 (a 
 
83.5 ± 3.2(a 
 
0.82 ± 0.04 
 
5.2 96.7 ± 1.2(b 
 
 
111.9 ± 3.6(b 
 
0.86 ± 0.03 
 
5.4 48.7 ± 1.0 (b 
 
45.3 ± 1.5 (b 
 
1.08 ± 0.04 
 
5.6 ------------- 521 ± 13
(b 
 
--------------- 
5.3 19.0 ± 0.4(a 
 
21.1 ± 0.4 ( a 0.90 ± 0.03 
5.5 870 ± 28 (a 
 
866 ± 30 (b 
 
0.97 ± 0.05 
 
a) No d3-acetonitrile used. 
b) 10% acetonitrile used. 
 
It is clear that the ratios of the rate constants of racemisation with the rate constants of H/D 
exchange are closer to unity than to 0.5 or 2 for 5-substituted 1-acetyl-2-thiohydantoins. The 
value of krac / kHD approaching unity confirms SE1 rather than SE2, with the proposed 
mechanism illustrated in Scheme 5.2.  
The rate constant for H/D exchange of the racemic compound 5.6 (Table 5.3) is the highest 
measured. This suggests a high rate constant for racemisation as well. Therefore, during the 
preparation, the compound racemised; this was not noticed for the other enantioenriched 5-
substituted 1-acetyl-2-thiohydantoins. Similarly, it was reported that 5-phenylhydantoin 
racemised significantly faster (t1/2: 0.3 h) than 5-benzylhydantoin (t1/2: 5 h), and 5-
isopropylhydantoin (t1/2: 56 h).
9 The highest rate constant for racemisation and H/D exchange 
for 5.6 is in agreement with the results of Reist et al.4 and Narduolo,3 which showed high rate 
constants for H/D exchange of 5-phenylhydantoin compared with other substituted 
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hydantoins. The phenyl group on the stereogenic centre of thiohydantoin and hydantoin 
stabilise the intermediate carbanion by resonance.10 
 
5.2.2 The H/D exchange process of 5-substituted 2-thiohydantoins 
 
As mentioned before, the separation of enantiomers of 5.8 and 5.12 was attempted using 
chiral HPLC. However, before kinetic studies could be carried out, 5.8 and 5.12 had already 
racemised during solvent evaporation. We also attempted to study the racemisation of 5-
(pyridin-2-ylmethyl)-2-thioxoimidazolidin-4-one 5.12, after the separation of both 
enantiomers by chiral HPLC without evaporating the eluent used in the HPLC separation and 
observed that racemisation was quite fast in comparison with compounds 5.1-5.5. Similarly, 
compounds 5.7-5.14 (Scheme 5.5) could not be obtained in enantioenriched form. As 
mentioned in the last section, there is a strong relationship between the racemisation and H/D 
exchange process, with krac approximately equal to kH/D for substituted 1-acetyl-2-
thiohydantoins. We therefore decided to use 1H-NMR spectroscopy as an alternative way to 
obtain rate constants related to the rate constants for racemisation.  
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Scheme 5.5: The chemical structures of compounds 5.7-5.14 
 
Such rapid racemisation indicates that the hydrogen attached to the stereogenic centre of 5-
substituted 2-thiohydantoins is replaced by deuterium more rapidly than in the case of 
hydantoin, as reported previously.3, 4  
When the concentrations of buffer used in 1H-NMR spectroscopic experiments were as used 
for compounds 5.1-5.6, there were not enough data points obtained for 5.7-5.14 to plot the 
relative area versus time and obtain a rate constant. Use of lower concentrations of buffer 
was essential to obtain enough data points to plot relative integration areas of hydrogen on 
the stereogenic carbon versus time. 1H-NMR spectroscopy was used to obtain the H/D 
exchange rate constants of 5.7-5.14 in 10% d3-ACN and 90% 0.01 M D2O-phosphate buffer 
(pH* 7.4, 1 M I, at 37 °C). 
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Figure 5.4: 1H-NMR spectra for 5.7 from 12 to 89 min in 10 % d3-acetonitrile and 90% 0.01 
M D2O-phosphate buffer (pH
* 7.4, 1 M I, at 37 °C). 
 
From Figure 5.4, it is clear that the signal for the hydrogen on the stereogenic carbon (at 4.6 
ppm) decreases over time and the relative integration areas of the hydrogen were plotted 
versus time to determine the pseudo-first-order rate constants for H/D exchange (Figure 5.5). 
Unfortunately, the peaks for the hydrogen at the asymmetric carbons for several of the 
compounds synthesised (Chapter 2) overlapped with the water peak of the solvent. Therefore, 
the H/D exchange process could not be measured for several of the 5-substituted 2-
thiohydantoins reported in Chapter 2. 
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Figure 5.5: Relative integrals for the proton on the stereogenic centre of a) 5.7 and b) 5.8 in 
10% d3-acetonitrile and 90% 0.01 M D2O-phosphate buffer (pH
* 7.4, 1 M I, at 37 °C). Solid 
lines are fits to the first order rate law. 
 
 
Figure 5.5 shows the pseudo-first-order rate law fit to the data for the H/D exchange process 
in 10% d3-ACN with 90% D2O-phosphate buffer (pH
* 7.4, 0.01 M, 1 M I, at 37 °C). 
Fortunately, there was no precipitation while mixing the co-solvents (10%) such as d3-ACN 
and d6-DMSO with the deuterated-phosphate buffer (90%) (pH
* 7.4, 0.01 M, 1 M I, at 37 °C) 
for 5-substituted 2-thiohydantoins. The temperature of the NMR machine was set to 37 °C 
and the number of scans decreased to reduce the measurement time and obtain a higher 
number of points. It is also important to note that the time between zero minutes and the first 
integration is long in comparison with the other points because it was impossible to shorten 
the time required for the shimming of the NMR machine at the beginning. The other figures 
for the compounds shown in Scheme 5.6 are illustrated in the Appendix. The pseudo-first- 
order rate constants were obtained by using Equation 5.1 for compound 5.7-5.14 and these are 
summarised in Table 5.4.  
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Table 5.4: Pseudo-first-order rate constants for H/D exchange, kH/D, determined using 
1H-
NMR spectroscopy of 5.7-5.14 in D2O-phosphate buffer at 0.009 M total phosphate (ionic 
strength of 0.9 M I, pH* 7.4 at 37 °C). 
Substrate Total phosphate 
/M 
Basic phosphate  
/ M 
kH/D (D2O) 
/ 10-6 s-1  
5.7 0.009 0.0072 789 ± 23(a  
5.8 0.009 0.0072 1550 ± 103 (a  
5.9 0.009 0.0072 202.9 ± 2.4(b  
5.10 0.009 0.0072 705 ± 24(b  
5.11 0.009 0.0072 2880 ± 230(b  
5.12 0.009 0.0072 3010 ± 220(b  
5.13 0.009 0.0072 3020 ± 250(b  
5.14 0.009 0.0072 1312 ± 90(a  
a 10% d3-acetonitrile and 90% 0.01 M D2O-phosphate buffer (pH
* 7.4, 1 M I, at 37 °C). 
b10% d6-DMSO and 90 % 0.01 M D2O-phosphate buffer (pH
* 7.4, 1 M I, at 37 °C). 
 
The rate constants for H/D exchange of 5.7-5.14 in Table 5.4 strongly depend on the 
substituent at the 5-position, as shown also by the rate constants of racemisation for these 
compounds (vide supra). As explained before, steric hindrance has a significant effect on the 
promotion or retardation of racemisation. Compound 5.9, with an isopropyl substituent at C-5, 
has the slowest rate constant for H/D exchange, analogous to the low rate constant for 
racemisation of 1-acetyl-5-isopropyl-2-thiohydantoin. The presence of a benzyl group in 5.8 
increases the acidity of the hydrogen on the asymmetric carbon. The highest rate constants of 
H/D exchange were obtained for compounds 5.11-5.13 which contain oxygen, sulphur and 
nitrogen in the substituent at the asymmetric carbon. The protonation of the pyridine 
substituent of compound 5.12 makes the compound much more electron-withdrawing in 
comparison with 5.8 and increases the rate constant for racemisation and H/D exchange.  
The rate constant for H/D exchange has previously been studied for 5-substituted hydantoins 
at different concentrations of buffer and at different temperatures. Reist et al.4 reported the 
rate constants for H/D exchange for various 5-substituted hydantoins at 50 °C, while the rate 
constants of H/D exchange for 5-phenylhydantoin and 5-benzylhydantoin have been reported 
at different temperatures. The buffer concentrations and temperatures in these studies are not 
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similar to the present work, making it difficult to compare the thiohydantoin and hydantoin 
derivatives (Table 5.5).  
 
a determined in a mixture of D2O phosphate buffer (pD 7.4, 0.1 M, I = 0.22) and d6-DMSO in 
a 1:1 (v/v) proportion at 50 °C.  
b determined in a mixture of phosphate buffer (pH* 7.4, 0.01 M, 1 M I) and d6-DMSO and d3-
ACN in a 9:1 (v/v) proportion at 37 °C. 
 
Table 5.5 shows that the pseudo-first-order rate constants for H/D exchange of 5-substituted 
hydantoin in the higher concentration of buffer, lower ionic strength and higher temperature 
are lower than the kH/D of the corresponding 5-substituted-2-thiohydantoin. Unfortunately, 
there are no exact conditions that have been reported previously for hydantoin to compare 
with the present conditions used for thiohydantoin. This indicates that the role of the sulphur 
atom in the increase in the rate of racemisation and H/D exchange occurs through increasing 
the stability of the carbanion.6  
 
 
 
Table 5.5: Comparison of the pseudo-first-order rate constants of H/D exchange kH/D of 
5-substituted hydantoin determined by Testa et al.4 and the 5-subsituted 2-thiohydantoin 
in the present work. 
 
 
 
kH/D
(a 
/ 10-6 s-1 
R group 
kH/D
(b 
/ 10-6 s-1 
 
 
3140 ± 530 Ph ------ 
16.7 ± 1.1 CH2Ph 1550 ± 103 
77.8 ± 15.3 CH2OH ------- 
32.8 ± 1.7 NH2(O)NH ------- 
(1) 9.2 ± 0.3 CH3 789 ± 23 (2) 
 
4.7 ± 0.3 CH2COOH -------  
1.7 ± 0.2 CH(CH3)2 202.9 ± 2.4 
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5.2.3 The H/D exchange process of 3-phenyl-5-benzyl-2-thiohydantoin 
 
As mentioned in Chapter 3, the presence of substituents at the N-3 position increased the rate 
constant for hydrolysis. However, it has been reported that replacing one of the hydrogen 
atoms at the N-3 or N-1 position may retard racemisation. Furthermore it has been reported 
that replacement of both hydrogens should prevent a decrease in the rate of racemisation.11 
For compounds 5.16 and 5.17, the pseudo-first-order rate constants for H/D exchange were 
reported by Narduolo3 who showed the effect of substituents at the N-3 position. Narduolo3 
and Lazarus12 reported that when the N-3 hydrogen of hydantoin was replaced by a methyl 
group, H/D exchange became slower (Scheme 5.6). 
 
 
 
Scheme 5.6: The chemical structures of compounds 5.15-5.17 
 
Using 10 % d3-ACN or d6-DMSO caused the precipitation of 5.15 with 90 % phosphate 
buffer (pH* 7.4, 0.01 M, 1 M I). Sufficient concentrations of compound 5.18 were required to 
observe the peak in 1H-NMR spectra. Therefore, 20 % d3-ACN was used with 80 % D2O-
phosphate buffer to avoid precipitation from taking place. The relative areas of the signal for 
the hydrogen at the stereogenic carbon was followed over time to determine the pseudo-first-
order rate constant for H/D exchange of 5.15 (Figure 5.6). 
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Figure 5.6: Relative integrals for the proton on the stereogenic centre for 5.15 in 20% d3-
acetonitrile and 80% 0.01 M D2O-phosphate buffer (pH
* 7.4, 1 M I, at 37 °C). 
 
The line in Figure 5.6 is a fit of the pseudo-first-order law to the data for H/D exchange. 
Equation 5.1 was used to observe the rate constant kH/D. It is interesting to compare the rate 
constant for H/D exchange, kH/D, for 5.15 (containing a 3-N-phenyl substituent) with kH/D for 
5.8 (which is unsubstituted on N-3) to show the effect of a substituent at the N-3 position on 
the racemisation process (Table 5.6). 
  
a determined in D2O-phosphate buffer (0.5 M, 1 M I, kept constant with KC1, pH
* 7.2, at 25 
°C). 
b determined in a mixture of phosphate buffer (pH* 7.4, 0.01 M, 1 M I) and d6-DMSO or d3-
ACN in a 9:1 (v/v) proportion at 37 °C. 
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Table 5.6: Comparison of the pseudo-first-order rate constants of H/D exchange kH/D of 5-
benzyl-3-phenylimidazolidine-2,4-dione and 5-benzylimidazolidine-2,4-dione determined by 
Narduolo3, and 5-benzyl-3-phenyl-2-thioxoimidazolidin-4-one and 5-benzyl-2-
thioxoimidazolidin-4-one in the present work. 
Substrate kH/D  
/ 10-6 s-1 
Substrate kH/D  
/ 10-6 s-1 
5.15 707 ± 28(a 5.8 1550 ± 103 (a 
5.17 3.4 ± 0.1(b 5.16 5.4 ± 0.4 (b 
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Table 5.6 shows that the introduction of substituents at N-3 retards H/D exchange for both 
hydantoins and 2-thiohydantoins. The results in Table 5.6 are in agreement with the 
suggestion of Bovarnic and Clarice that the substituent at the N-3 position decreases the rate 
constant for racemisation krac. The krac was found to be similar to kH/D in the previous section 
for 5.1-5.4 (indicating an SE1 mechanism). Therefore, the substituent at the N-3 position 
retards the rate constant kH/D in a similar way to the racemisation as expected by Bovarnic. 
Unfortunately, there has been no data for H/D exchange reported for hydantoin derivatives 
under similar conditions to compare with the thiohydantoins in the present work.  
 
5.2.4 The H/D exchange process of 5-substituted thiazolidine-2,4-diones 
 
The racemisation of the three glitazones (also called thiazolidine-2,4-dione) balaglitazone, 
pioglitazone and rosiglitazone (Scheme 5.7) were reported previously.13  
 
 
Scheme 5.7: Structure of the three glitazones: (5.18) balaglitazone, (5.19) pioglitazone and 
(5.20) rosiglitazone. The marked carbon atom with the star (*) shows the chiral centre.13 
 
The C-5 stereogenic centre is anticipated to be relatively acidic because deprotonation induces 
sp2 character to C-5 and increasesπ-delocalisation. Therefore, base-catalysed ionisation of 
thiazolidine-2,4-dione is anticipated to play an important role in the racemisation process.14 
Jamali et al.15 reported that keto-enol tautomerism is the expected pathway to convert the R 
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enantiomer to its S enantiomer (and vice versa) for 5-substituted thiazolidine-2,4-dione, as 
explained also in Chapter 1 (Scheme 5.8).  
 
 
Scheme 5.8: The keto-enol tautomerism of 5-substituted- thiazolidine-2,4-dione 
  
5-Substituted thiazolidine-2,4-dione derivatives have also been prepared as racemic 
compounds. There is a close relation between the rate constants for H/D exchange (kH/D) and 
racemisation processes (krac) (vide supra). No optically active 5-substituted thiazolidine-2,4-
diones could be prepared to study the kinetics of racemisation using CD spectroscopy. 
Therefore, the H/D exchange process was studied as an alternative to obtaining the rate 
constants for racemisation (Scheme 5.9).  
 
 
Scheme 5.9: The chemical structures of compounds 5.21 and 5.22 
 
Similar conditions as those used for kinetic studies of compounds 5.1-5.5 were used for 5.21 
and 5.22 because 5-substituted thiazolidine-2,4-dione racemised more slowly than 5-
substituted 2-thioxothiazolidin-4-one (thiohydantoin). The relative area of the 1H-NMR signal 
for hydrogen at C-5 was followed over time in D2O-phosphate buffer (0.09, 0.18 and 0.27 M 
total phosphate buffer, 0.9 M I, pH* 7.4, at 37 °C). The integrated areas were plotted against 
time to determine the pseudo-first-order rate constant for H/D exchange kH/D (Figure 5.7). 
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Figure 5.7: Relative integrals for the proton on the stereogenic centre of 5.24 and 5.25 in 10 
vol-% d3-acetonitrile and 90 vol-% (0.2 M D2O-phosphate buffer pH
* 7.4, 1 M I, at 37 °C). 
 
In Figure 5.7, the lines are fits of the pseudo-first-order rate law to the rate constant for H/D 
exchange kH/D. The pseudo-first-order rate constants kH/D at 0.27 M, 0.18 M, and 0.09 M of 
total D2O-phosphate (0.9 M I, pH
* 7.4 and 37 °C) are shown in Table 5.7. 
 
Table 5.7: Pseudo-first-order rate constants kH/D determined using 
1H-NMR spectroscopy of 
5-benzylthiazolidine-2,4-dione (5.21) and 5-(pyridin-2-ylmethyl)thiazolidine-2,4-dione 
(5.22) in D2O-phosphate buffer at 0.27, 0.18, and 0.09 M total phosphate and 0.22, 0.14, and 
0.072 M HPO4
2-, respectively (0.9 M I, pH* 7.4 and 37 °C) using 10% d3-ACN. 
 5.21  5.22 
Total Buffer 
/ M 
 
kH/D (D2O)
(a 
/10-6 s-1 
 
kH/D (D2O)
(a 
/10-6 s-1 
0.09 
 
411± 16 
 
1269 ± 25 
0.18 619 ± 19 1651 ± 49  
0.27 800 ± 40 1918 ± 98  
a The data were collected by Ibrahim Bala16 
 
The kH/D for 5.21 and 5.22 increased by increasing the concentration of D2O-phosphate buffer. 
The pseudo-first-order rate constants for H/D exchange of 5.24 and 5.25 were plotted against 
the concentration of the basic component of deuterated-phosphate buffer (pH* 7.4, 0.9 M I, at 
37 °C) (Figure 5.8).  
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Figure 5.8: First-order rate constants for buffer-catalysed H/D exchange followed using 1H-
NMR spectroscopy of a) 5.21 and b) 5.22 in D2O-phosphate buffer (0.9 M I, pH
* 7.4 at 37 
°C). 
 
  
Figure 5.8 shows a linear correlation between the first-order rate constants and the basic 
component of the phosphate buffer. Equation 5.2 was used to obtain the second-order rate 
constant kH/D for 5.21 and 5.22. The uncatalysed, specific acid and base-catalysed rate 
constants are combined in the intercept and the bimolecular rate constant kH/D is obtained 
from the slope in Figure 5.8. The values are listed in Table 5.8. 
 
Table 5.8: Second-order rate constants for H/D exchange kH/D of 5.21 and 5.22 in D2O- 
phosphate buffer determined using 1H-NMR spectroscopy at 0.27, 0.18, and 0.09 M total 
phosphate and 0.22, 0.14, and 0.072 M basic phosphate, respectively, (0.9 M I, pH* 7.4 at 37 
°C) using 10 % d3-ACN. 
 
 
 
 
 
 
 Substrate 
kH/D 
/ 10-6 s-1 M-1 
kin  
/ 10-6 s-1  
5.21 2780 ± 250 
 
 
214 ± 30 
 
 5.22 4880 ± 450 
  
 
922 ± 45 
 
 
It is obvious from Table 5.8 that the compound with the 5-(pyridin-2-ylmethyl) substituent at 
the C-5 position has a higher rate constant kH/D than its homologue with benzyl substituents, as 
also observed for the thiohydantoin derivatives.  
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5.2.5  The H/D exchange process of 2-thioxothiazolidin-4-one  
 
No previous studies are available for the racemisation or H/D exchange process of 2-
thioxothiazolidin-4-ones. The H/D exchange process of racemic 5-substituted 2-
thioxothiazolidin-4-ones 5.23 and 5.24 (Scheme 5.10) were compared with imidazolidine-2,4-
dione, 2-thioxoimidazolidin-4-one and thiazolidine-2,4-dione.  
 
Scheme 5.10: The chemical structures of compounds 5.23 and 5.24 
 
It can be expected that the 2-thioxothiazolidin-4-one derivative also racemises by keto-enol 
tautomerism similar to imidazolidine-2,4-dione, 2-thioxoimidazolidin-4-one and thiazolidine-
2,4-dione (Scheme 5.8). The presence of the sulphur atom next to the asymmetric carbon is 
similar for 2-thioxothiazolidin-4-one and thiazolidine-2,4-dione and might accelerate the 
enolisation. We tried to study the H/D exchange for compounds 5.23 and 5.24 but during the 
shim of the NMR, i.e. 5-10 minutes, the reaction has finished (D2O-phosphate buffer at 0.09 
M total phosphate with ionic strength of 0.9 M I, pH* 7.4 and 37 °C, using 10 vol-% of d3-
CAN as a cosolvent). Therefore, we could not collect any points to construct a plot between 
relative integration area and time. It can be concluded from the fast deuteration that the 
sulphur atom attached to the asymmetric carbon not only accelerates the racemisation and 
deuteration. The thiocarbonyl is also important because 2-thioxoimidazolidin-4-one 
(thiohydantoin) with thiocarbonyl and a nitrogen atom at the 1-position racemises faster than 
2- thiazolidine-2,4-dione with carbonyl and sulphur at the 1-position. Therefore, 
thioxoimidazolidin-4-ones (compounds 5.23 and 5.24) containing both thiocarbonyl and 
sulphur have higher rate constants for deuteration and racemisation than compounds 5.1-5.22. 
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5.3 Conclusions 
 
Racemisation and H/D exchange were studied. The kdeut / krac values of approximately 1 in the 
present work for compounds 5.1-5.5 indicates the SE1 mechanism for racemisation rather than 
the SE2 mechanism. The H/D exchange of compound 5.6 with a phenyl substituent at the C-5 
position was determined with its kH/D value found to be higher than the kH/D values for 5.1-5.5. 
This is because of the resonance stabilisation of the anion in 5.6.  
The rate constants for H/D exchange were obtained by using 1H-NMR for racemic 5-
substituted 2-thiohydantoins 5.7-5.14. The values of kH/D depend on the substituents at the C-5 
position, which have a major influence on the rate constant of racemisation and H/D 
exchange.  
The phenyl substituent at the N-3 position in 5.15 decreases the rate constant for H/D 
exchange in comparison with 5-substituted 2-thiohydantoins. 
The H/D exchange for the 5-substituted thiazolidine-2,4-diones (5.21 and 5.22) was also 
studied and the rate constants for H/D exchange kH/D were determined. The 2-thiohydantoins, 
with thiocarbonyl at the 2-position and nitrogen at the 1-position, have higher rate constants 
kH/D than thiazolidine-2,4-dione, with carbonyl at the 2-position and sulphur at the 1-position.  
For 2-thioxothiazolidin-4-ones, with thiocarbonyl at the 2-position and sulphur at the 1-
position, it was impossible to collect even one data point because the H/D exchange reactions 
for 5.23 and 5.24 were found to finish in less than 10 minutes. 
From the present study it can be concluded that the rate constants of racemisation and H/D 
exchange increase by increasing the sulphur atoms either with thiocarbonyl or bound to the 
asymmetric carbon. 
The comparison of the present work with previous studies suggests decreasing rate constants 
in the order 2-thioxothiazolidin-4-one (rhodanine) > 2-thioxoimidazolidin-4-one (2-
thiohydantoin) > thiazolidine-2,4-dione > imidazolidine-2,4-dione (hydantoin). 
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5.4 Experimental 
General Experimental 
 Buffer preparation 
 
The preparation of all H2O and D2O phosphate buffers used in this chapter were explained in 
Chapter 4. The concentrations of the acid and basic components were calculated using the 
Henderson-Hasselbalch equation, taking into account the effect of ionic strength and 
temperature (37 °C) on the pKa. Stock solutions of 0.09-0.1 M of studied compounds were 
used containing 10% d3-ACN and 90 vol-% D2O-phosphate buffer for the H/D exchange 
process for compound 5.2, 5.4, 5.5 and 5.6. No overlap between the hydrogen attached to the 
stereogenic centre and water in 1H-NMR spectroscopy was found. 
 
General methods 
 
All non-deuterated solvents were HPLC grade obtained from commercial supplies and used 
without further purification. Deuterated ACN and DMSO were purchased from Fluorochem 
or Sigma Aldrich. Materials used were weighed on an analytical Fisher Brand PS-100 balance 
(Max 100 g, d = 0.1 mg). Volumes for preparing stock solutions were measured by Gilson 
research micropipettes. Aqueous stock solutions were centrifuged three times to avoid 
precipitation inside the stock solution. pH measurements for all concentrations of buffers in 
non-deuterated and deuterated-buffer conditions were carried out at 20 °C using a Hanna 
Instruments pH 210 pH meter. The pH meter was calibrated before each measurement with 
certified (traceable to NIST) buffers at pH 10.01+ 0.02 (at 20 °C) (from Fisher) and pH 4.00 + 
0.01 (at 20 °C) (from Reagecon). Kinetic experiments of racemisation were carried out on a 
Chirascan CD spectrometer equipped with a temperature-controlled sample holder for circular 
dichroism (temperature stability: ± 0.02 °C) in 1.00 cm path length quartz cuvettes, unless 
otherwise stated. Kinetic experiments of H/D exchange were carried out on a Bruker Avance 
400 and a Bruker Avance 500 NMR spectroscopy. Origin pro 9.0 and Mestrenova were used 
for data analysis. 
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4.4.1.5 Preparation of solutions  
 
Stock solutions of 0.05-0.06 M of 5.1 and 5.3 were prepared by dissolving the thiohydantoin 
in 10 % D2O and 90 % deuterated phosphate buffer. An ultrasonic bath sonicator was used to 
accelerate the dissolution process. Aqueous solutions of 5.1 and 5.3 were put in plastic 
Eppendorfs and centrifuged for 8 minutes at 13.3 rpm on a Jencons-pls Spectrafuge 24.D 
centrifuge. The remaining compounds were dissolved in d3-ACN or d6-DMSO and mixed 
with 90% D2O- phosphate buffer.  
 
4.4.1.6 Kinetic studies 
 
The temperature of 5.1-5.4 samples during kinetic experiments of H/D exchange was 
controlled in a water bath because the reaction was slow in comparison with the other 
compounds. However, the temperature of the NMR holder for the other compounds was set at 
37 °C because the reaction was fast.  
 
4.4.1.7 Data analysis 
 
1H-NMR data were analysed for all compounds by the Mestrenova NMR program and the 
areas were integrated. The relative areas for the asymmetric hydrogens for all compounds 
were plotted versus time and the pseudo-first-order rate constant of H/D exchange determined 
using Origin pro 9.0. 
 
 Kinetic equations 
 
To calculate the pseudo-first-order rate constants for H/D exchange of the studied 
compounds, the following equation was used: 
 
 
 
𝑅𝑡 = 𝑅𝑓𝑖𝑛 +  ∆𝑅 𝑒
−𝑘 × 𝑡 Equation 5. 1 
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Here, Rt is the relative area at time t, Rfin is the final relative area, ΔR represents the difference 
between the relative area at time zero and Rfin, and k is the observed pseudo-first-order rate 
constant of the hydrogen-deuterium exchange. 
To calculate the second-order rate constants for H/D exchange, the following equation was 
used:  
 
      buffer30
3
bufferODODobs
kODkODkkk     Equation 5. 2 
  
where k0 is the rate constant for the non-catalysed reaction, kOD
- and kD3O+ are the specific base 
and acid catalysed rate constants for H/D exchange, respectively, which can be obtained from 
the intercept (kin), kbuffer is the second-order rate constant for the buffer catalysis of H/D 
exchange, which is determined from the slope, and kobs is the observed rate constant of the 
reaction.  
 
4.4.1.8 Error calculation 
 
The errors of pseudo-first-order and second-order rate constants were provided by non-linear 
and linear equations in Origin Pro 9.0. The errors of krac/kdeut were calculated by using 
Equation 4.9 in Chapter 4 (vide supra). The weighted average and its error equation (for 
equations, see Chapter 4) were used for compound 5.5 after obtaining two non-linear graphs, 
which were corrected with and without the base line in 1H-NMR spectroscopy by the 
Mestrenova program. 
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6.1 General conclusions 
 
In the present work, the kinetics and mechanism of racemisation and H/D exchange of 
substituted 2-thiohydantoins (2-thioxoimidazolidin-4-ones), thiazolidine-2,4-diones and 
rhodanines (2-thioxothiazolidin-4-ones) have been studied under conditions mimicking 
physiological conditions. From the present work, the following conclusion can be drawn. 
First, 2-thioxoimidazolidin-4-one derivatives with substituents at the 1, 3 and/or 5-positions 
have been prepared as racemic and enantioenriched compounds (Chapter 2). Knoevenagel 
condensation worked successfully in reactions involving different aldehydes with the parent 
2-thioxoimidazolidin-4-ones to prepare the corresponding unsaturated 2-thioxoimidazolidin-
4-ones. Knoevenagel condensation also worked in the preparation of unsaturated 5-substituted 
thiazolidine-2,4-diones and 5-substituted 2-thioxothiazolidin-4-one derivatives. To prepare 
saturated 5-substituted 2-thioxoimidazolidin-4-ones, zinc and acetic acid were used to reduce 
the double bond to a single bond and prepare racemic 5-substituted 2-thioxoimidazolidin-4-
ones. The reduction process worked well for all unsaturated 2-thioxoimidazolidin-4-ones 
prepared, except for (Z)-5-(furan-2-ylmethylene)-2-thioxoimidazolidin-4-one which produces 
an unknown product. Zn/acetic acid was also a good agent to reduce (Z)-5-(pyridin-2-
ylmethylene)thiazolidine-2,4-dione but not (Z)-5-benzylidenethiazolidine-2,4-dione; the 
reason for this difference was unclear. As an alternative, LiBH4 in the presence of pyridine for 
catalytic reduction in THF was tried for (Z)-5-benzylidenethiazolidine-2,4-dione and was 
found to be successful. Our attempts to prepare enantioenriched 5-substituted 2-
thioxoimidazolidin-4-ones derivatives starting from enantiopure amino acids with thiourea 
failed because of the high temperature required for the reaction. Chiral HPLC was used for 
the separation of 5-(pyridin-2-ylmethyl)-2-thioxoimidazolidin-4-one R- and S- enantiomers. 
Several enantioenriched 5-substituted 1-acetyl-2-thioxoimidazolidin-4-one derivatives were 
synthesised from the corresponding amino acids with ammonium thiocyanate in the presence 
of acetic acid and acetic anhydride. N-acetyl substituted 2-thioxoimidazolidin-4-ones could be 
obtained with some enantiomeric excess. 
Second, during racemisation studies (Chapter 4) the buffer-catalysed hydrolysis of 2-
thioxoimidazolidin-4-one was observed. Kinetic studies of this process were described in 
Chapter 3. The acetyl substituent on the N-1 position of 5-substituted 1-acetyl-2-
thioxoimidazolidin-4-ones can be rapidly removed by acid or base. It was concluded that by 
using a base, such as sodium hydroxide and a buffer, the hydrolysis of 5-substituted 1-acetyl-
2-thioxoimidazolidin-4-ones produces 5-substituted 2-thioxoimidazolidin-4-ones and the 
223 
 
subsequent continued hydrolysis produces substituted 2-thioureidopropanoic acids. On the 
other hand, using acids, such as hydrochloric acid, produces 5-substituted 2-
thioxoimidazolidin-4-ones without continued hydrolysis. The substituents at the C-5 position 
change the rate constants for hydrolysis, depending on steric hindrance. It is also interesting to 
note that a phenyl substituent at the N-3 position increases the rate constant for the hydrolysis 
of 2-thioxoimidazolidin-4-ones derivatives.  
Third, in Chapter 4 the rate constants for the loss of the optical activity kɵ were determined 
directly using CD spectroscopy. The substituents at C-5 influenced the rate constants through 
steric hindrance and the presence of highly electronegative atoms and electron-withdrawing 
groups on the substituent. The kɵ were observed at different concentrations of buffer and were 
found to increase linearly with increasing concentration of buffers, suggesting general-base 
catalysed of racemisation. The comparison of kɵ in H2O- and D2O-phosphate buffer showed 
negligible solvent kinetic isotope effect, with the rate constants within the margin of error. 
The rate constants for racemisation, krac, were determined by subtracting the rate constant of 
hydrolysis khyd from the rate constants for the loss of optical activity kɵ. The sensitivity of the 
proton transfer for the nature of the buffer was studied using different buffers (acetate, 
phosphate and TRIS) and observing the rate constants kɵ and krac. The β-value of 0.21 ± 
0.0008 for 4.1 was obtained from the Brønsted plot, which suggests an early transition state. 
However, it was noted that the ionisation of the most acidic hydrogen at N-3 affects the value 
of β. Therefore, by using the pKa of the substituted 2-thioxoimidazolidin-4-ones, together with 
the pH, the rate constants of racemisation for the protonated (S)-1-acetyl-5-methyl-2-
thioxoimidazolidin-4-one were calculated and plotted versus the pKa of buffers. The resulting 
β-value of 0.51 ± 0.09 for the protonated (S)-1-acetyl-5-methyl-2-thioxoimidazolidin-4-one 
confirmed general-base catalysis of racemisation and suggests the proton is approximately 
halfway between the reactant and product in the transition state. The rate constants kɵ and krac 
in different concentrations of H2O- and D2O based phosphate buffers were also determined 
for the trisubstituted 2-thioxoimidazolidin-4-ones. Similar to the 5-substituted 1-acetyl-2-
thioxoimidazolidin-4-one derivatives, a negligible solvent kinetic isotope effect on the 
racemisation was found. The rate constants for racemisation of trisubstituted 2-
thioxoimidazolidin-4-ones were quite high in comparison with the rate constants for 
racemisation of 5-substituted 1-acetyl- tri-substituted 2-thioxoimidazolidin-4-ones. From the 
temperature dependence, the racemisation reaction of (R)-5-benzyl-3-phenyl-1-(pyridin-2-
ylmethyl)-2-thioxoimidazolidin-4-one, a positive enthalpy value and negative entropy value 
of activation was found for the loss of optical activity. Addition of 10 vol-% of a co-solvent 
224 
 
with phosphate buffer changed the rate constant kɵ in comparison with 100% aqueous 
solution. DMSO, TFE and methanol increase the rate constant of racemisation kɵ to 4.7. It 
was found that 5-substituted 2-thioxoimidazolidin-4-ones racemise fast, not only in buffer, 
but also in water and organic solvents.  
Fourth, the mechanism of racemisation for 5-substituted 1-acetyl-2-thioxoimidazolidin-4-ones 
was described in Chapter 5 by comparing kH/D (determined using 
1H-NMR spectroscopy) and 
kɵ (obtained using CD spectroscopy) in D2O based phosphate buffer. We found that kH/D/krac is 
close to unity, which confirms the SE1 mechanism rather than the SE2 mechanism for the 
racemisation of 5-substituted 1-acetyl-2-thioxoimidazolidin-4-ones. Therefore, as an 
alternative to studying the racemisation process, H/D exchange was studied for racemic 5-
substituted 2-thioxoimidazolidin-4-one derivatives assuming kH/D = krac. The H/D exchange 
process was studied for a variety of compounds with different substituents at the asymmetric 
carbon using 1H-NMR spectroscopy. Similar to our observations for racemisation, 
substituents at C-5 have a significant effect on the rate constants for H/D exchange. The rate 
constants kH/D for 5-substituted 2-thioxoimidazolidin-4-ones were high in comparison with the 
kH/D for 5-substituted 1-acetyl-2-thioxoimidazolidin-4-ones. The rate constant for H/D 
exchange of 5-((tetrahydrofuran-3-yl)methyl)-2-thioxoimidazolidin-4-one was the highest, 
with the lowest rate constant for H/D exchange found for 5-isopropyl-2-thioxoimidazolidin-4-
one. The phenyl substituent at the N-3 position slows down H/D exchange of 5-benzyl-3-
phenyl-2-thioxoimidazolidin-4-one in comparison with 5-benzyl-2-thioxoimidazolidin-4-one. 
Our reported data showed that kH/D was lower for 5-benzylthiazolidine-2,4-dione and 5-
(pyridin-2-ylmethyl)thiazolidine-2,4-dione than for the corresponding 5-substituted 2-
thioxoimidazolidin-4-ones (thiohydantoin). It can be concluded from comparison with 
previous reports such as those by Narduolo1, Reist et al.2 and Lazarus3 that the kH/D and krac of 
imidazolidine-2,4-dione (hydantoin) derivatives are lower than for thiazolidine-2,4-dione 
derivative (Scheme 6.1).  
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Scheme 6.1: Comparison of the rate constants for H/D exchange for 5-benzyl-2-
thioxoimidazolidin-4-one, 1-acetyl-5-benzyl-2-thioxoimidazolidin-4-one and 5-
benzylimidazolidine-2,4-dione 
 
The H/D exchange process was studied for 5-benzyl-2-thioxothiazolidin-4-one and 5-
(pyridin-2-ylmethyl)-2-thioxothiazolidin-4-one and loss of the hydrogen at the asymmetric 
carbon in less than 10 minutes was observed, corresponding to the fastest exchange measured 
in this study. The kH/D or krac can thus be ordered imidazolidine-2,4-dione (hydantoin) < 
thiazolidine-2,4-dione < 2-thioxoimidazolidin-4-one (thiohydantoin) < 2-thioxothiazolidin-4-
one (rhodanine) derivatives.  
 
6.2 Future work 
 
In order to complete the studies on 2-thioxoimidazolidin-4-ones (thiohydantoin), it would be 
interesting to synthesise enantioenriched 5-substituted 2-thioxoimidazolidin-4-ones by 
carrying out the reaction at low temperature. Alternatively, using chiral columns such as 
CHIRALPAK® or CHIRALCEL® to separate racemic 5-substituted 2-thioxoimidazolidin-4-
one and keeping the sample at very low temperature to avoid racemisation could also be 
attempted. We have already tried the Astec Chirobiotic T chiral column without success for 
the separation of several racemic 5-substituted 2-thioxoimidazolidin-4-ones, with the 
exception of 5-benzyl-2-thioxoimidazolidin-4-one and 5-(pyridin-2-ylmethyl)-2-
thioxoimidazolidin-4-one. The further preparation of enantioenriched tri-susbtituted 2-
thioxoimidazolidin-4-one might be carried out by the same procedure described in Chapter 2. 
Alternatively, enantioenriched N-acetylated 2-thiohydantoins could be prepared by hydrolysis 
under acidic conditions. The acidic solutions could be mixed rapidly, for example in a 
stopped-flow apparatus. Solvent kinetic isotope effects for the hydrolysis of substituted 2-
thiohydantoin could be carried out in H2O- and D2O based phosphate buffer. The effect of 
electron-donating and electron-withdrawing groups on the phenyl group attached to the 
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stereogenic centre of 2-thiohydantoin on racemisation and hydrolysis could be studied by 
constructing a Hammett plot.  
It might well be possible to determine racemisation rate constants for compounds such as 
those in Scheme 6.2 without need for optical resolution.  
 
Scheme 6.2: Synthesis and racemisation of (S)-5-((R)-phenylmethyl-d)-2-thioxoimidazolidin-
4-one 
 
The “racemisation” could then be followed through the different vicinal JHH for the different 
diastereoisomers. 
Lower concentrations of buffer would be useful to observe the rate constant of the H/D 
exchange of thioxothiazolidin-4-one (rhodanine) derivatives. It would also be possible to 
study the hydrolysis of imidazolidine-2,4-dione (hydantoin), thiazolidine-2,4-dione, 2-
thioxoimidazolidin-4-one (thiohydantoin) and 2-thioxothiazolidin-4-one (rhodanine) 
derivatives using 2D-NMR spectroscopy to confirm the exact structure of the hydrolysed 
product. Kinetic studies of racemisation of other 5-ring compounds similar to hydantoin 
derivatives would also be interesting, e.g. 2-thioxooxazolidin-4-ones and oxazolidine-2,4-
diones.  
Future work might involve a study of the binding between our synthesised product and DNA 
or protein. It would also be fascinating to study metal complexes formed between the 
synthesised compounds using by X-ray crystallography. Studying the enzyme catalysed 
racemisation process and comparing with the present results would also be of interest. 
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X-ray for compound 18 
 
 
Table 1.  Crystal data and structure refinement for compound 18 
Identification code  shelx 
Empirical formula  C9 H6 N2 O S2 
Formula weight  222.28 
Temperature  150 (2) K 
Wavelength  1.54184 Å 
Crystal system  Triclinic 
Space group  P -1 
Unit cell dimensions a = 3.8308 (2) Å a= 76.754(5) °. 
 b = 11.0036 (7) Å b= 88.094(5) °. 
 c = 11.3316 (7) Å g = 82.962(5) °. 
Volume 461.44(5)  Å3 
Z 2 
Density (calculated) 1.600 Mg/m3 
Absorption coefficient 4.942 mm-1 
F(000) 228 
Crystal size 0.333 x 0.046 x 0.042 mm3 
Theta range for data collection 4.008 to 73.763°. 
Index ranges -4<=h<=4, -13<=k<=13, -14<=l<=13 
Reflections collected 2747 
Independent reflections 1778 [R (int) = 0.0222] 
Completeness to theta = 67.684° 98.5 %  
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1778 / 0 / 127 
Goodness-of-fit on F2 1.042 
Final R indices [I>2sigma (I)] R1 = 0.0336, wR2 = 0.0881 
R indices (all data) R1 = 0.0355, wR2 = 0.0917 
Extinction coefficient n/a 
Largest diff. peak and hole 0.330 and -0.322 e.Å-3 
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Table 2.  Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2x 
103) 
For compound 18.  U (eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
___________________________________________________________________________ 
 X y z U(eq) 
___________________________________________________________________________ 
C(1) 3327(4) 3388(2) 6536(2) 23(1) 
C(2) 6463(4) 1994(2) 5485(2) 22(1) 
C(3) 5249(4) 1111(2) 6568(2) 21(1) 
C(4) 6048(4) -141(2) 6727(2) 22(1) 
C(5) 5084(4) -1067(2) 7789(2) 23(1) 
C(6) 6049(5) -2349(2) 7870(2) 28(1) 
C(7) 5165(5) -3195(2) 8913(2) 33(1) 
C(8) 3375(5) -2738(2) 9835(2) 32(1) 
C(9) 2494(5) -1444(2) 9672(2) 29(1) 
N(1) 5197(4) 3219(1) 5536(1) 24(1) 
N(2) 3305(4) -614(1) 8670(1) 25(1) 
O(1) 8324(3) 1738(1) 4667(1) 29(1) 
S(1) 1704(1) 4750(1) 6822(1) 28(1) 
S(2) 2849(1) 1944(1) 7532(1) 22(1) 
___________________________________________________________________________
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Table 3.   Bond lengths [Å] and angles [°] for compound 18 
_____________________________________________________ 
C(1)-N(1)  1.357(2) 
C(1)-S(1)  1.6482(17) 
C(1)-S(2)  1.7510(17) 
C(2)-O(1)  1.214(2) 
C(2)-N(1)  1.389(2) 
C(2)-C(3)  1.481(2) 
C(3)-C(4)  1.345(2) 
C(3)-S(2)  1.7508(17) 
C(4)-C(5)  1.457(2) 
C(4)-H(4)  0.9500 
C(5)-N(2)  1.344(2) 
C(5)-C(6)  1.397(2) 
C(6)-C(7)  1.387(3) 
C(6)-H(6)  0.9500 
C(7)-C(8)  1.386(3) 
C(7)-H(7)  0.9500 
C(8)-C(9)  1.394(3) 
C(8)-H(8)  0.9500 
C(9)-N(2)  1.338(2) 
C(9)-H(9)  0.9500 
N(1)-H(1)  0.8800 
 
N(1)-C(1)-S(1) 126.08(13) 
N(1)-C(1)-S(2) 110.97(12) 
S(1)-C(1)-S(2) 122.95(11) 
O(1)-C(2)-N(1) 122.98(15) 
O(1)-C(2)-C(3) 127.50(15) 
N(1)-C(2)-C(3) 109.50(14) 
C(4)-C(3)-C(2) 121.54(15) 
C(4)-C(3)-S(2) 128.27(13) 
C(2)-C(3)-S(2) 110.18(12) 
C(3)-C(4)-C(5) 124.83(16) 
C(3)-C(4)-H(4) 117.6 
C(5)-C(4)-H(4) 117.6 
N(2)-C(5)-C(6) 123.07(16) 
N(2)-C(5)-C(4) 116.47(15) 
C(6)-C(5)-C(4) 120.45(16) 
C(7)-C(6)-C(5) 118.51(17) 
 A5 
 
C(7)-C(6)-H(6) 120.7 
C(5)-C(6)-H(6) 120.7 
C(8)-C(7)-C(6) 118.92(17) 
C(8)-C(7)-H(7) 120.5 
C(6)-C(7)-H(7) 120.5 
C(7)-C(8)-C(9) 118.68(16) 
C(7)-C(8)-H(8) 120.7 
C(9)-C(8)-H(8) 120.7 
N(2)-C(9)-C(8) 123.25(17) 
N(2)-C(9)-H(9) 118.4 
C(8)-C(9)-H(9) 118.4 
C(1)-N(1)-C(2) 117.41(14) 
C(1)-N(1)-H(1) 121.3 
C(2)-N(1)-H(1) 121.3 
C(9)-N(2)-C(5) 117.56(15) 
C(3)-S(2)-C(1) 91.87(8) 
_____________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
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Table 4.   Anisotropic displacement parameters (Å
2
x 10
3
) for compound 18.  The anisotropic 
displacement factor exponent takes the form: -2p
2
[ h
2
a*
2
U11 + ... + 2 h k a* b* U12 ] 
___________________________________________________________________________
___ 
 U11 U22 U33 U23 U13 U12 
___________________________________________________________________________
___ 
C(1) 24(1)  22(1) 23(1)  -6(1) 3(1)  -2(1) 
C(2) 26(1)  21(1) 20(1)  -6(1) 2(1)  -3(1) 
C(3) 23(1)  21(1) 21(1)  -6(1) 3(1)  -3(1) 
C(4) 25(1)  21(1) 21(1)  -7(1) 4(1)  -2(1) 
C(5) 25(1)  21(1) 23(1)  -6(1) 0(1)  -3(1) 
C(6) 34(1)  23(1) 26(1)  -7(1) 3(1)  -2(1) 
C(7) 42(1)  20(1) 35(1)  -4(1) -1(1)  -3(1) 
C(8) 39(1)  29(1) 26(1)  0(1) 3(1)  -9(1) 
C(9) 35(1)  29(1) 22(1)  -5(1) 6(1)  -6(1) 
N(1) 30(1)  18(1) 23(1)  -4(1) 6(1)  -3(1) 
N(2) 28(1)  22(1) 24(1)  -5(1) 4(1)  -3(1) 
O(1) 38(1)  24(1) 25(1)  -7(1) 10(1)  -2(1) 
S(1) 34(1)  19(1) 32(1)  -9(1) 10(1)  -1(1) 
S(2) 25(1)  19(1) 21(1)  -6(1) 6(1)  -3(1) 
___________________________________________________________________________ 
 
Table 5.   Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2x 103) 
for compound 18. 
________________________________________________________________________________ 
 x  y  z  U(eq) 
___________________________________________________________________ 
H(4) 7335 -444 6101 27 
H(6) 7282 -2636 7225 33 
H(7) 5777 -4074 8995 39 
H(8) 2761 -3296 10562 38 
H(9) 1256 -1135 10304 35 
H(1) 5593 3860 4943 29 
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A.3.1 Kinetics and mechanism of base-catalysed hydrolysis of 5-substituted 1-acetyl-2-
thiohydantoins 
 
  
  
 
 
 
 
 
Figure a3.1: Hydrolysis of 3.1 at 286 nm in H2O-phosphate buffer at a) 0.045 M, b) 0.09 
M, c) 0.18 M, d) 0.27 M and e) 0.36 M total phosphate with ionic strength of 0.9 M I, pH 
7.4 at 37 °C. The squares (■) are the experimental points, and the red solid lines are the fits 
to pseudo-first-order kinetics. 
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Figure a3.2: Hydrolysis of 3.2 at 289 nm in H2O-phosphate buffer at a) 0.045 M, b) 0.09 
M, c) 0.18 M, d) 0.27 M and e) 0.36 M total phosphate with ionic strength of 0.9 M I, pH 
7.4 at 37 °C. The squares (■) are the experimental points, and the red solid lines are the fits 
to pseudo-first-order kinetics. 
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Figure a3.3: Hydrolysis of 3.3 at 291 nm in H2O-phosphate buffer at a) 0.045 M, b) 0.09 
M, c) 0.18 M, d) 0.27 M and e) 0.36 M total phosphate with ionic strength of 0.9 M I, pH 
7.4 at 37 °C. The squares (■) are the experimental points, and the red solid lines are the fits 
to pseudo-first-order kinetics. 
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Figure a3.4: Hydrolysis of 3.4 at 283 nm in H2O-phosphate buffer at a) 0.045 M, b) 0.09 
M, c) 0.18 M, d) 0.27 M and e) 0.36 M total phosphate with ionic strength of  0.9 M I,  pH 
7.4 at 37 °C. The squares (■) are the experimental points, and the red solid lines are the fits 
to pseudo-first-order kinetics. 
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Figure a3.5: Hydrolysis of 3.5 at 288 nm in H2O-phosphate buffer in a) 0.045 M, b) 0.09 
M, c) 0.18 M, d) 0.27 M and e) 0.36 M total phosphate with ionic strength of  0.9 M I,  pH 
7.4 at 37 °C. The squares (■) are the experimental points, and the red solid lines are the fits 
to pseudo first-order kinetics. 
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Figure a3.6: Hydrolysis of 3.6 at 290 nm in H2O-phosphate buffer in a) 0.045 M, b) 0.09 
M, c) 0.18 M, d) 0.27M and e) 0.36 M total phosphate with ionic strength of  0.9 M I,  pH 
7.4 at 37 °C. The squares (■) are the experimental points, and the red solid lines are the fits 
to pseudo-first-order kinetics. 
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Figure a3.7: Hydrolysis of 3.7 at 290 nm in H2O-phosphate buffer in a) 0.045 M, b) 0.09 
M, c) 0.18 M, d) 0.27 M and e) 0.36 M total phosphate with ionic strength of  0.9 M I,  pH 
7.4 at 37 °C. The squares (■) are the experimental points, and the red solid lines are the fits 
to pseudo-first-order kinetics. 
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Table a3.1: Pseudo-first-order rate constants of hydrolysis khyd determined by UV-visible 
spectroscopy of 1-acetyl-2-thioxoimidazolidin-4-one (3.1) in H2O-phosphate buffer at 0.36 
M, 0.27 M, 0.18 M, 0.09 M and 0.045 M total phosphate with ionic strength of 0.9 M I, pH 
7.4 at 37 °C. 
Buffer conc./M Basic phosphate 
buffer 
khyd H2O/ 10
-6 s-1  
0.045 0.036 14.2 ± 0.3 (± 0.02)a 
0.09 0.072 16.8 ± 0.3 (± 0.03)a 
0.18 0.14 21.1 ± 0.4 (± 0.05)a 
0.27 0.22 25.7 ± 0.5 (± 0.07)a 
0.36 0.29 35.2 ± 0.7 (± 0.07)a 
b) Where the error from the data fit is reported as less than 2% of the rate constant, an 
error of 2% was assumed. Values in brackets are the errors from the data fit which are 
less than 2%. 
 
 
Table a3.2: Pseudo-first-order rate constants of hydrolysis khyd determined by UV-visible  
spectroscopy of (S)-1-acetyl-5-benzyl-2-thioxoimidazolidin-4-one (3.2) in H2O-phosphate 
buffer at 0.36 M, 0.27 M, 0.18 M, 0.09 M and 0.045 M total phosphate with ionic strength of  
0.9 M I,  pH 7.4 at 37 °C. 
Buffer conc./M Basic phosphate buffer khyd H2O/ 10
-6 s-1 
0.045 0.036 5.0 ± 0.1 (± 0.008)a 
0.09 0.072 5.2 ± 0.1 (± 0.008)a 
0.18 0.14 5.9  ± 0.1 (± 0.004)a 
0.27 0.22 6.7 ± 0.1 (± 0.008)a 
0.36 0.29 7.6 ± 0.2 (± 0.007)a 
a) Where the error from the data fit is reported as less than 2% of the rate constant, an 
error of 2% was assumed. Values in brackets are the errors from the data fit which are 
less than 2%. 
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Table a3.3: Pseudo-first-order rate constants of hydrolysis khyd determined by UV-visible 
spectroscopy of 1-acetyl-5-phenyl-2-thioxoimidazolidin-4-one (3.3) in H2O-phosphate buffer 
at 0.36 M, 0.27 M, 0.18 M, 0.09 M and 0.045 M total phosphate with ionic strength of 0.9 M 
I, pH 7.4 and 37 °C. 
Buffer conc./M Basic phosphate buffer khyd H2O/ 10
-6 s-1  
0.045 0.036 5.3 ± 0.1 (± 0.003)a 
0.09 0.072 6.1 ± 0.1 (± 0.003)a 
0.18 0.14 7.6 ± 0.2 (± 0.003)a 
0.27 0.22 9.1 ± 0.2 (± 0.004)a 
0.36 0.29 10.4 ± 0.2 (± 0.01)a 
a) Where the error from the data fit is reported as less than 2% of the rate constant, an 
error of 2% was assumed. Values in brackets are the errors from the data fit which are 
less than 2%. 
 
Table a3.4: Pseudo-first-order rate constants of hydrolysis khyd determined by UV-visible  
spectroscopy of (S)-5-((1H-indol-3-yl)methyl)-1-acetyl-2-thioxoimidazolidin-4-one (3.4) in 
H2O-phosphate buffer at 0.36 M, 0.27 M, 0.18 M, 0.09 M and 0.045 M total phosphate with 
ionic strength of  0.9 M I,  pH 7.4 at 37 °C. 
Buffer conc./M Basic phosphate buffer khyd H2O/ 10
-6 s-1  
0.045 0.036 4.0 ± 0.08 (± 0.007)a 
0.09 0.072 4.5 ± 0.09 (± 0.005)a 
0.18 0.14 5.1 ± 0.1 (± 0.007)a 
0.27 0.22 5.8 ± 0.1 (± 0.006)a 
0.36 0.29 6.8 ± 0.1 (± 0.005)a 
a) Where the error from the data fit is reported as less than 2% of the rate constant, an 
error of 2% was assumed. Values in brackets are the errors from the data fit which are 
less than 2%. 
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Table a3.5: Pseudo-first-order rate constants of hydrolysis khyd determined by UV-visible  
spectroscopy of (S)-1-acetyl-5-isopropyl-2-thioxoimidazolidin-4-one  (3.5) in H2O- phosphate 
buffer at 0.36 M, 0.27 M, 0.18 M, 0.09 M and 0.045 M total phosphate with ionic strength of  
0.9 M I,  pH 7.4 at 37 °C. 
Buffer conc./M Basic phosphate buffer khyd H2O/ 10
-6 s-1  
0.045 0.036 5.7 ± 0.1 (± 0.003)a 
0.09 0.072 6.5 ± 0.1 (± 0.002)a 
0.18 0.14 8.0 ± 0.2 (± 0.004)a 
0.27 0.22 9.9 ± 0.2 (± 0.010)a 
0.36 0.29 11.8 ± 0.2 (± 0.020)a 
a) Where the error from the data fit is reported as less than 2% of the rate constant, an 
error of 2% was assumed. Values in brackets are the errors from the data fit which are 
less than 2%. 
 
 
Table a3.6:  Pseudo-first-order rate constants of hydrolysis khyd determined by UV-visible  
spectroscopy of (S)-1-acetyl-5-(2-(methylthio)ethyl)-2-thioxoimidazolidin-4-one (3.6) in 
H2O-phosphate buffer at 0.36 M, 0.27 M, 0.18 M, 0.09 M and 0.045 M total phosphate with 
ionic strength of  0.9 M I,  pH 7.4 at 37 °C. 
Buffer conc./M Basic phosphate buffer khyd H2O/ 10
-6 s-1  
0.045 0.036 7.7 ± 0.2 (± 0.007)a 
0.09 0.072 8.8 ± 0.2 (± 0.005)a 
0.18 0.14 10.9 ± 0.2 (± 0.008)a 
0.27 0.22 13.1 ± 0.3 (± 0.009)a 
0.36 0.29 15.7 ± 0.3 (± 0.010)a  
a) Where the error from the data fit is reported as less than 2% of the rate constant, an 
error of 2% was assumed. Values in brackets are the errors from the data fit which are 
less than 2%. 
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Table a3.7: Pseudo-first-order rate constants of hydrolysis khyd determined by UV-visible  
spectroscopy of (S)-1-acetyl-5-methyl-2-thioxoimidazolidin-4-one (3.7) in H2O-phosphate 
buffer at 0.36 M, 0.27 M, 0.18 M, 0.09 M and 0.045 M total phosphate with ionic strength of  
0.9 M I,  pH 7.4 at 37 °C.  
Buffer conc./M Basic phosphate buffer khyd H2O/ 10
-6 s-1  
0.045 0.036 10.9 ± 0.2 (± 0.010)a 
0.09 0.072 12.2 ± 0.2 (± 0.006)a 
0.18 0.14 14.5 ± 0.3 (± 0.007)a 
0.27 0.22 17.1 ± 0.3 (± 0.008)a 
0.36 0.29 20.3 ± 0.4 (± 0.020)a 
a) Where the error from the data fit is reported as less than 2% of the rate constant, an 
error of 2% was assumed. Values in brackets are the errors from the data fit which are 
less than 2%. 
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Figure a3.8: Observed rate constants of hydrolysis of a) 3.1, b) 3.2, c) 3.3, and d) 3.4 as a 
function of the concentration of the basic components of (H2O-based phosphate buffer at 37 
°C, 0.9 M I, pH 7.4, 0.36 M, 0.27 M, 0.18 M, 0.09, and 0.045 M. 
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Figure a3.9: Observed rate constants of hydrolysis of a) 3.5, b) 3.6, and c) 3.7 as a function 
of the concentration of the basic components of (H2O-based phosphate buffer at 37 °C, 0.9 
M I, pH 7.4, 0.36 M, 0.27 M, 0.18 M, 0.09 and 0.045 M. 
 
 
 
 
 
 
 
 
 
 
 
 
0.00 0.05 0.10 0.15 0.20 0.25 0.30
0.0
2.0x10
-6
4.0x10
-6
6.0x10
-6
8.0x10
-6
1.0x10
-5
1.2x10
-5 a) 
k
h
y
d
ro
ly
s
is
/s
-1
[HPO
4
2-
]/M
Equation y = a + b*x
Weight Instrumental
Residual Sum 
of Squares
2.69995
Pearson's r
0.99823
Adj. R-Square
0.99529
Value Standard Error
C1
Intercept 4.84183E-6 1.07376E-7
Slope 2.33361E-5 8.02275E-7
0.00 0.05 0.10 0.15 0.20 0.25 0.30
0.0
2.0x10
-6
4.0x10
-6
6.0x10
-6
8.0x10
-6
1.0x10
-5
1.2x10
-5
1.4x10
-5
1.6x10
-5
b) 
k
h
y
d
ro
ly
s
is
/ 
s
-1
[HPO
4
2-
]/M
Equation y = a + b*x
Weight Instrumental
Residual Sum 
of Squares
1.09128
Pearson's r
0.99926
Adj. R-Square
0.99803
Value Standard Error
C1
Intercept 6.60639E-6 9.18663E-8
Slope 3.06453E-5 6.80456E-7
0.00 0.05 0.10 0.15 0.20 0.25 0.30
0.0
2.0x10
-6
4.0x10
-6
6.0x10
-6
8.0x10
-6
1.0x10
-5
1.2x10
-5
1.4x10
-5
1.6x10
-5
1.8x10
-5
2.0x10
-5
c) 
k
h
y
d
ro
ly
si
s/
s-
1
[HPO
4
2-
]/M
Equation y = a + b*x
Weight Instrumental
Residual Sum of 
Squares
1.53282
Pearson's r
0.99826
Adj. R-Square
0.99535
Value Standard Error
A
Intercept 9.88794E-6 1.48219E-7
Slope 2.98729E-5 1.0202E-6
 A21 
 
A.3.2 Determination of the rate constant for hydrolysis of 1-acetyl-5-isopropyl-2-
thiohydantoin by NMR spectroscopy 
 
   
  
Figure a3.10: The hydrolysis process of 3.5 by using a) 0.008 M of D2O-phosphate buffer, 
0.8 M I, pH 7.4 at 37 °C  (using 80% of 0.01 M of D2O-phosphate buffer, 1 M I, pH 7.4 at 37 
°C, with 20% of d3-acetonitrile), and b) 0.36 M of D2O-phosphate buffer, 0.9 M I, pH 7.4 at 
37 °C (No d3-acetonitrile). (■) the relative area 3H of H3CCO decreased over time, and (●) 
the relative area of 3H of H3CCO (one hydrogen disappeared in regards with the integration) 
increased over time. The squares (●) and (■) are the experimental points, and the red solid 
lines are the fits to pseudo first-order kinetics. 
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A.3.3. Brønsted plot for hydrolysis of (S)-1-acetyl-5-methyl-2-thioxoimidazolidin-4-one 
 
   
 
  
Figure a3.11: Hydrolysis of 3.7 at 290 nm in H2O acetate buffer in a) 0.18 M, b) 0.27M 
and c) 0.36 M total acetate buffer with ionic strength of 0.9 M I, pH 7.4 at 37 °C. The 
squares (■) are the experimental points, and the red solid lines are the fits to pseudo-first-
order kinetics. 
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Figure a3.12: Hydrolysis of 3.7 at 290 nm in H2O TRIS buffer in a) 0.045 M, b) 0.09 M, c) 
0.18 M, d) 0.27M and e) 0.36 M total TRIS with ionic strength of  0.9 M I,  pH 8.2 at 37 
°C. The squares (■) are the experimental points, and the red solid lines are the fits to 
pseudo-first-order kinetics. 
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Figure a3.13: Hydrolysis of 3.7 at 290 nm in H2O methyl amine buffer in, a) 0.09 M, b) 
0.18 M, c) 0.27 M and d) 0.36 M total methyl amine with ionic strength of  0.9 M I,  pH 9.7 
at 37 °C. The squares (■) are the experimental points, and the red solid lines are the fits to 
pseudo-first-order kinetics. 
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Figure a3.14:  rate constants of hydrolysis of 3.7, in H2O a) acetate buffers, pH
25 5.0 b) 
phosphate buffer pH25 7.4, c) TRIS buffer pH25 8.2, and d) methyl amine buffer pH25 9.7 at 37 
°C plotted as a function of the concentration of basic buffer components considering values of 
pKa of a) 4.59 b) 6.8  c) 7.88 , and d) 10.4 
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Figure a3.15: Bronsted plot for the base-catalysed hydrolysis of 3.7. 
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A.3.4. Kinetics of acid and base-catalysed hydrolysis of 1-acetyl-5-phenyl-2-
thioxoimidazolidin-4-one 
 
   
 
  
   
 
 
  
Figure a3.16: Hydrolysis of 3.3 at 279 nm in a) 0.24 M, b) 0.48 M, c) 0.72 M, and d) 0.96 
M of HCl at 37 °C. The squares (■) are the experimental points, and the red solid lines are 
the fits to pseudo-first-order kinetics. 
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Figure a3.17: Hydrolysis of 3.3 at 290 nm in a) 0.0017 M, b) 0.0025 M, c) 0.0033 M, d) 
0.0042 M, and e) 0.005 M of NaOH at 37 °C. The squares (■) are the experimental points, 
and the red solid lines are the fits to pseudo-first-order kinetics. 
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Figure a3.18: Rate constants of hydrolysis of 3.7, in a) HCl, and b) NaOH plotted as a 
function of the concentration of HCl and NaOH, respectively at 37 °C. 
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A.3.5. Kinetics and mechanism of base-catalysed hydrolysis of 5-substituted 2-
thioxoimidazolidin-4-ones 
 
 
 
   
Figure a3.19: Hydrolysis of 3.8 at 259 nm in H2O-phosphate buffer at a) 0.045 M, b) 0.09 
M, c) 0.18 M, d) 0.27 M and e) 0.36 M total phosphate with ionic strength of 0.9 M I, pH 
7.4 at 37 °C. The squares (■) are the experimental points, and the red solid lines are the fits 
to pseudo-first-order kinetics. 
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Figure a3.20: Hydrolysis of 3.9 at 262 nm in H2O-phosphate buffer at a) 0.045 M, b) 0.09 
M, c) 0.18 M, d) 0.27 M and e) 0.36 M total phosphate with ionic strength of 0.9 M I, pH 
7.4 at 37 °C. The squares (■) are the experimental points, and the red solid lines are the fits 
to pseudo-first-order kinetics. 
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Figure a3.21: Hydrolysis of 3.10 at 262 nm in H2O phosphate buffer at a) 0.045 M, b) 0.09 
M, c) 0.18 M, d) 0.27 M and e) 0.36 M total phosphate with ionic strength of 0.9 M I, pH 
7.4 at 37 °C. The squares (■) are the experimental points, and the red solid lines are the fits 
to pseudo-first-order kinetics. 
 
 
 
0.0 6.0x10
4
1.2x10
5
1.8x10
5
2.4x10
5
3.0x10
5
3.6x10
5
0.0
0.2
0.4
0.6
0.8
1.0
a)
Data: Data1_B
Model: exponential_hiwaahmad
Weighting: 
A No weighting
  
Chi^2/DoF = 0.00001
R^2 =  0.99942
  
k 1.28694E-5 ±2.38904E-8
Af 0.4172 ±2.428E-4
delta_A 0.5669 ±4.332E-4
A
b
s
o
rb
a
n
c
e
t / s
0.0 6.0x10
4
1.2x10
5
1.8x10
5
2.4x10
5
3.0x10
5
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4 b)
Data: Data1_B
Model: exponential_hiwaahmad
Weighting: 
A No weighting
  
Chi^2/DoF = 0.00008
R^2 =  0.99812
  
k 1.35984E-5 ±4.93934E-8
Af 0.4059 ±6.967E-4
delta_A 0.7954 ±0.001142
A
b
s
o
rb
a
n
c
e
t / s
0.0 6.0x10
4
1.2x10
5
1.8x10
5
2.4x10
5
3.0x10
5
3.6x10
5
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
c)
Data: Data1_B
Model: exponential_hiwaahmad
Weighting: 
A No weighting
  
Chi^2/DoF = 0.00006
R^2 =  0.99856
  
k 1.36807E-5 ±3.69616E-8
Af 0.3994 ±4.649E-4
delta_A 0.8204 ±9.938E-4
A
b
s
o
rb
a
n
c
e
t / s
0.0 6.0x10
4
1.2x10
5
1.8x10
5
2.4x10
5
3.0x10
5
3.6x10
5
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4 d)
Data: Data1_B
Model: exponential_hiwaahmad
Weighting: 
A No weighting
  
Chi^2/DoF = 0.00003
R^2 =  0.99924
  
k 1.72453E-5 ±3.14329E-8
Af 0.3952 ±2.693E-4
delta_A 0.8411 ±7.886E-4
A
b
s
o
rb
a
n
c
e
t / s
0.0 6.0x10
4
1.2x10
5
1.8x10
5
2.4x10
5
3.0x10
5
3.6x10
5
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
e)
Data: Data1_B
Model: exponential_hiwaahmad
Weighting: 
A No weighting
  
Chi^2/DoF = 0.00003
R^2 =  0.99913
  
k 2.58142E-5 ±4.67753E-8
Af 0.4095 ±2.041E-4
delta_A 0.8445 ±9.097E-4
A
b
s
o
rb
a
n
c
e
t / s
 A33 
 
 
 
   
Figure a3.22: Hydrolysis of 3.11 at 262 nm in H2O-phosphate buffer at a) 0.045 M, b) 0.09 
M, c) 0.18 M, d) 0.27 M and e) 0.36 M total phosphate with ionic strength of 0.9 M I, pH 
7.4 at 37 °C. The squares (■) are the experimental points, and the red solid lines are the fits 
to pseudo-first-order kinetics. 
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Figure a3.23: Hydrolysis of 3.12 at 264 nm in H2O-phosphate buffer at a) 0.09 M, b) 0.18 
M, c) 0.27 M and d) 0.36 M total phosphate with ionic strength of 0.9 M I, pH 7.4 at 37 °C. 
The squares (■) are the experimental points, and the red solid lines are the fits to pseudo- 
first-order kinetics. 
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Figure a3.24: Hydrolysis of 3.13 at 264 nm in H2O-phosphate buffer at a) 0.045 M, b) 0.09 
M, c) 0.18 M, d) 0.27 M and e) 0.36 M total phosphate with ionic strength of 0.9 M I, pH 
7.4 at 37 °C. The squares (■) are the experimental points, and the red solid lines are the fits 
to pseudo-first-order kinetics. 
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Figure a3.25: Hydrolysis of 3.14 at 264 nm in H2O-phosphate buffer at a) 0.045 M, b) 0.09 
M, c) 0.18 M, d) 0.27 M and e) 0.36 M total phosphate with ionic strength of 0.9 M I, pH 
7.4 at 37 °C. The squares (■) are the experimental points, and the red solid lines are the fits 
to pseudo-first-order kinetics. 
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Figure a3.26: Hydrolysis of 3.15 at 262 nm in H2O-phosphate buffer at a) 0.045 M, b) 0.09 
M, c) 0.18 M, d) 0.27 M and e) 0.36 M total phosphate with ionic strength of 0.9 M I, pH 
7.4 at 37 °C. The squares (■) are the experimental points, and the red solid lines are the fits 
to pseudo-first-order kinetics. 
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Table a3.8: Pseudo-first-order rate constants od hydrolysis khydro determined by UV-visible 
spectroscopy for 2-thioxoimidazolidin-4-one (3.8) in H2O-phosphate buffer at 0.36 M, 0.27 
M, 0.18 M, 0.09 M and 0.045 M total phosphate with ionic strength of 0.9 M I, pH 7.4 and 37 
°C.  
Buffer conc./M Basic phosphate buffer/M k hyd H2O/ 10
-6 s-1  
0.045 0.036 24.2 ± 0.5 (± 0.08)a  
4.8300000E-07 
 
4.8300000E-07 
 
4.8300000E-07 
 
0.09 0.072 39.5 ± 0.8 (± 0.1)a 
0.18 0.14 44.9 ±  0.9 (± 0.2)a 
0.27 0.22 45.1 ± 0.9 (± 0.2)a 
0.36 0.29 57.8 ± 1.2 (± 0.2)a 
a) Where the error from the data fit is reported as less than 2% of the rate constant, an 
error of 2% was assumed. Values in brackets are the errors from the data fit which are 
less than 2%. 
 
 
Table a3.9: Pseudo-first-order rate constants od hydrolysis khydro determined by UV-visible 
spectroscopy for 5-benzyl-2-thioxoimidazolidin-4-one (3.9) in H2O-phosphate buffer at 0.36 
M, 0.27 M, 0.18 M, 0.09 M and 0.045 M total phosphate with ionic strength of 0.9 M I, pH 
7.4 and 37 °C. 
Buffer conc./M Basic phosphate buffer/M k hyd H2O/ 10
-6 s-1  
0.045 0.036 12.2 ± 0.2 (± 0.1)a 
 
4.8300000E-07 
 
4.8300000E-07 
 
4.8300000E-07 
 
0.09 0.072 17.5  ± 0.4 (± 0.06)a 
0.18 0.14 19.9 ± 0.4 (± 0.05)a 
0.27 0.22 25.9  ± 0.5 (± 0.04)a 
0.36 0.29 33.0 ± 0.7 (± 0.06)a 
a) Where the error from the data fit is reported as less than 2% of the rate constant, an 
error of 2% was assumed. Values in brackets are the errors from the data fit which are 
less than 2%. 
 
 
 
 
 A39 
 
Table a3.10: Pseudo-first-order rate constants od hydrolysis khyd determined by UV-visible  
spectroscopy for 5-(pyridin-2-ylmethyl)-2-thioxoimidazolidin-4-one (3.10) in H2O phosphate 
buffer at 0.36 M, 0.27 M, 0.18 M, 0.09 M and 0.045 M total phosphate with ionic strength of  
0.9 M I,  pH 7.4 and 37 °C. 
Buffer conc./M Basic phosphate buffer/M k hyd H2O/ 10
-6 s-1  
0.045 0.036 12.9  ± 0.3 (± 0.02)a 
 
4.8300000E-07 
 
4.8300000E-07 
 
4.8300000E-07 
 
0.09 0.072 13.6 ± 0.3 (± 0.05)a 
0.18 0.14 13.7 ± 0.3 (± 0.04)a 
 0.27 0.22 17.2 ± 0.4 (± 0.03)
a 
0.36 0.29 25.8  ± 0.5 (± 0.05)a 
 a) Where the error from the data fit is reported as less than 2% of the rate constant, an 
error of 2% was assumed. Values in brackets are the errors from the data fit which are 
less than 2%. 
 
Table a3.11: Pseudo-first-order rate constants od hydrolysis khyd determined by UV-visible  
spectroscopy for 5-((1-methyl-1H-pyrrol-2-yl)methyl)-2-thioxoimidazolidin-4-one (3.11) in 
H2O phosphate buffer at 0.36 M, 0.27 M, 0.18 M, 0.09 M total phosphate with ionic strength 
of  0.9 M I,  pH 7.4 and 37 °C.  
Buffer conc./M Basic phosphate buffer/M k hyd H2O/ 10
-6 s-1 
0.045 0.036 39.4 ± 0.8 (± 0.5)a 
 
4.8300000E-07 
 
4.8300000E-07 
 
4.8300000E-07 
 
0.09 0.072 41.5 ± 0.8 (± 0.5)a 
0.18 0.14 43.0 ± 0.9 (± 0.4)a 
 0.27 0.22 44.7 ± 0.9 (± 0.5)
a 
0.36 0.29 46.3  ± 0.9 (± 0.5)a 
 a) Where the error from the data fit is reported as less than 2% of the rate constant, an 
error of 2% was assumed. Values in brackets are the errors from the data fit which are 
less than 2%. 
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Table a3.12: Pseudo-first-order rate constants od hydrolysis khyd determined by UV-visible  
spectroscopy for 5-(4-methoxybenzyl)-2-thioxoimidazolidin-4-one (3.12) in H2O phosphate 
buffer at 0.36 M, 0.27 M, 0.18 M, and 0.09 M total phosphate with ionic strength of  0.9 M I,  
pH 7.4 and 37 °C.  
Buffer conc./M Basic phosphate buffer / M k hyd H2O/ 10
-6 s-1  
0.045 0.036  
4.8300000E-07 
 
4.8300000E-07 
 
4.8300000E-07 
 
0.09 0.072 7.9 ± 0.2 (± 0.04)a 
 0.18 0.14 10.2 ± 0.2 (± 0.05)
a 
 
 
0.27 0.22 11.3 ± 0.2 (± 0.06)a 
 0.36 0.29 11.4 ± 0.2 (± 0.04)
a 
 
 
a) Where the error from the data fit is reported as less than 2% of the rate constant, an 
error of 2% was assumed. Values in brackets are the errors from the data fit which are 
less than 2%. 
 
 
Table a3.13: Pseudo-first-order rate constants od hydrolysis khyd determined by UV-visible 
for 5-((tetrahydrofuran-3-yl)methyl)-2-thioxoimidazolidin-4-one (3.13) in H2O phosphate 
buffer at 0.36 M, 0.27 M, 0.18 M, 0.09 M and 0.045 M total with ionic strength of  0.9 M I,  
pH 7.4 and 37 °C.  
Buffer conc./M Basic phosphate buffer/M k hydro H2O/ 10
-6 s-1  
0.045 0.036 52.7 ± 1.1 (± 0.09)a 
4.8300000E-07 
 
4.8300000E-07 
 
4.8300000E-07 
 
0.09 0.072 54.0 ± 1.1 (± 0.1)a 
0.18 0.14 56.1 ± 1.1 (± 0.2)a 
 0.27 0.22 57.7 ± 1.2 (± 0.2)
a 
0.36 0.29 59.9 ± 1.2 (± 0.3)a 
 a) Where the error from the data fit is reported as less than 2% of the rate constant, an 
error of 2% was assumed. Values in brackets are the errors from the data fit which are 
less than 2%. 
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Table a3.14: Pseudo-first-order rate constants od hydrolysis khyd determined by UV-visible 
for 5-methyl-2-thioxoimidazolidin-4-one (3.14) in H2O phosphate buffer at 0.36 M, 0.27 M, 
0.18 M, 0.09 M and 0.045 M total phosphate with ionic strength of 0.9 M I, pH 7.4 at 37 °C.  
Buffer conc./M Basic phosphate buffer/M k hydro H2O/ 10
-6 s-1  
0.045 0.036 17.5 ± 0.4 (± 0.1)a 
4.8300000E-07 
 
4.8300000E-07 
 
4.8300000E-07 
 
0.09 0.072 22.0 ± 0.4 (± 0.1)a 
0.18 0.14 31.7 ± 0.6 (± 0.1)a 
 0.27 0.22 33.0 ± 0.7 (± 0.1)
a 
0.36 0.29 36.7 ± 0.7 (± 0.3)a  
a) Where the error from the data fit is reported as less than 2% of the rate constant, an 
error of 2% was assumed. Values in brackets are the errors from the data fit which are 
less than 2%. 
 
Table a3.15: Pseudo-first-order rate constants od hydrolysis khyd determined by UV-visible 
for 5-((1H-indol-3-yl)methyl)-2-thioxoimidazolidin-4-one (3.15) in H2O phosphate buffer at 
0.36, 0.27, 0.18, 0.09 and 0.045 M total phosphate with ionic strength of  0.9 M I,  pH 7.4 at 
37 °C.  
Buffer conc./M Basic phosphate buffer k hyd H2O/ 10
-6 s-1 M-1 
0.045 0.036 13.2 ± 0.3 (± 0.04)a 
4.8300000E-07 
 
4.8300000E-07 
 
4.8300000E-07 
 
0.09 0.072 14.2 ± 0.3 (± 0.04)a 
0.18 0.14 22.5 ± 0.5 (± 0.09)a 
 0.27 0.22 25.6 ± 0.5 (± 0.1)
a 
0.36 0.29 27.5  ± 0.6 (± 0.2)a 
 a) Where the error from the data fit is reported as less than 2% of the rate constant, an 
error of 2% was assumed. Values in brackets are the errors from the data fit which are 
less than 2%. 
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Figure a3.27: Observed rate constants of hydrolysis of a) 3.8, b) 3.9, c) 3.10, and d) 3.11 as a 
function of the concentration of the basic components of (H2O-based phosphate buffer at 37 
°C, 0.9 M I, pH 7.4, 0.36 M, 0.27 M, 0.18 M, 0.09, and 0.045 M. 
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Figure a3.28: Observed rate constants of hydrolysis of a) 3.12, b) 3.13, c) 3.14, and d) 3.15 as 
a function of the concentration of the basic components of (H2O-based phosphate buffer at 37 
°C, 0.9 M I, pH 7.4, 0.36 M, 0.27 M, 0.18 M, 0.09, and 0.045 M. 
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A.3.6. Kinetics and mechanism of base-catalysed hydrolysis of 3,5-di-substituted 2-
thiohydantoins 
 
 
 
   
Figure a3.29: Hydrolysis of 3.16 at 265 nm in H2O-phosphate buffer at a) 0.009 M, b) 0.018 
M, c) 0.027 M and d) 0.036 M, and e) 0.045 M total phosphate with ionic strength of 0.9 M 
I, pH 7.4 at 37 °C. The squares (■) are the experimental points, and the red solid lines are the 
fits to pseudo-first-order kinetics. 
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Table a3.16: Pseudo-first-order rate constants od hydrolysis khyd determined by UV-visible 
spectroscopy for 5-benzyl-3-phenyl-2-thioxoimidazolidin-4-one (3.16) in H2O-phosphate 
buffer at 0.009 M, 0.018 M, 0.027 M , 0.036 M and 0.045 M total phosphate and 0.0072 M, 
0.014 M, 0.021 M, 0.028 M and 0.035 M phosphate basic, respectively with ionic strength of  
0.9 M I,  pH 7.4 and 37 °C. 
Buffer conc./M Basic phosphate buffer k hydro H2O/ 10
-6 s-1  
0.009 0.0072 
 
29.5  ± 0.6 ( 0.03)a 
 
4.8300000E-07 
 
4.8300000E-07 
 
4.8300000E-07 
 
0.018 0.014 
 
31.2 ± 0.6 (0.05)a 
0.027 0.022 
 
39.4 ± 0.8 (0.05)a 
 0.036 0.029 
 
55.7 ± 1.1 (0.05)a 
0.045 0.036 
 
57.0 ± 1.1 (0.07)a 
 a) Where the error from the data fit is less than 2% of the error of the rate constants have 
been set to 2%. Values in brackets are the errors from the data fit which are less than 
2%. 
 
 
 
 
  
Figure a3.30: Observed rate constants of hydrolysis of 3.16 as a function of the concentration 
of the basic components of (H2O-based phosphate buffer at 37 °C, 0.9 M I, pH 7.4 at 37 °C. 
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Kinetics and mechanism for 
racemisation of substituted 2-
thiohydantoins 
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A4.1 Racemisation of 5-substituted 1-acetyl-2-thiohydantoins 
 
 
 
 
Figure a4.1: Change in ellipticity over time for solutions of 4.1 in H2O-phosphate buffer at 
a) 0.045 M, b) 0.09 M, c) 0.18 M, d) 0.27 M and e) 0.36 M total phosphate with ionic 
strength of 0.9 M I, pH 7.4 at 37 °C.  
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Figure a4.2: Change in ellipticity over time for solutions 4.1 in D2O-phosphate buffer at a) 
0.045 M, b) 0.09 M, c) 0.18 M, d) 0.27 M and e) 0.36 M total phosphate with ionic strength 
of 0.9 M I,  pH* 7.4 at 37 °C. 
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Figure a4.3: Change in ellipticity over time for solutions of 4.2 in H2O-phosphate buffer at a) 
0.045 M, b) 0.09 M, c) 0.18 M, d) 0.27 M and e) 0.36 M total phosphate with ionic strength of 
0.9 M I, pH 7.4 at 37 °C. 
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Figure a4.4: Change in ellipticity over time for solutions of 4.2 in D2O-phosphate buffer at a) 
0.045 M, b) 0.09 M, c) 0.18 M, d) 0.27 M and e) 0.36 M total phosphate with ionic strength of 
0.9 M I,  pH* 7.4 at 37 °C. 
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Figure a4.5: Change in ellipticity over time for solutions of 4.3 in H2O-phosphate buffer at a) 
0.045 M, b) 0.09 M, c) 0.18 M, d) 0.27 M and e) 0.36 M total phosphate with ionic strength of 
0.9 M I, pH 7.4 at 37 °C. 
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Figure a4.6: Change in ellipticity over time for solutions of 4.3 in D2O-phosphate buffer at a) 
0.045 M, b) 0.09 M, c) 0.18 M, d) 0.27 M and e) 0.36 M total phosphate with ionic strength of 
0.9 M I, pH 7.4 at 37 °C. 
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Figure a4.7: Change in ellipticity over time for solutions of 4.4 in H2O-phosphate buffer at a) 
0.045 M, b) 0.09 M, c) 0.18 M, d) 0.27 M and e) 0.36 M total phosphate with ionic strength of 
0.9 M I, pH 7.4 at 37 °C. 
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Figure a4.8: Change in ellipticity over time for solutions of 4.4 in D2O-phosphate buffer at a) 
0.045 M, b) 0.09 M, c) 0.18 M, d) 0.27 M and e) 0.36 M total phosphate with ionic strength of 
0.9 M I, pH 7.4 at 37 °C. 
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Figure a4.9: Change in ellipticity over time for solutions of 4.5 in H2O-phosphate buffer at a) 
0.045 M, b) 0.09 M, c) 0.18 M, d) 0.27 M and e) 0.36 M total phosphate with ionic strength of 
0.9 M I, pH 7.4 at 37 °C. 
 
 
 
 
 
 
 
220 240 260 280 300 320 340 360 380 400
-4
0
4
8
a)


m
il
li
d
eg
re
es
Wave length(nm)
220 240 260 280 300 320 340 360 380 400
-8
-4
0
4 b)


m
il
li
d
eg
re
es
wave length(nm)
220 240 260 280 300 320 340 360 380 400
-4
0
4
c)


m
il
li
d
eg
re
es
wave length(nm)
220 240 260 280 300 320 340 360 380 400
-4
0
4
d)


m
il
li
d
eg
re
es
Wave length(nm)
220 240 260 280 300 320 340 360 380 400
-4
0
4
8
e)


m
il
li
d
eg
re
es
Wave length(nm)
 A56 
 
 
 
Figure a4.10: Change in ellipticity over time for solutions of 4.5 in D2O-phosphate buffer at 
a) 0.045 M, b) 0.09 M, c) 0.18 M, d) 0.27 M and e) 0.36 M total phosphate with ionic strength 
of 0.9 M I,  pH* 7.4 at 37 °C. 
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Figure a4.11: The ellipticities of 4.1 at 262 nm versus time in H2O-phosphate buffer at a) 
0.045 M, b) 0.09 M, c) 0.18 M, d) 0.27 M and e) 0.36 M total phosphate with ionic strength of 
0.9 M I,  pH 7.4 at 37 °C. 
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Figure a4.12: The ellipticities of 4.1 at 262 nm versus time in D2O-phosphate buffer at a) 
0.09 M, b) 0.18 M, c) 0.27 M and d) 0.36 M total phosphate with ionic strength of 0.9 M I,  
pH* 7.4 at 37 °C. 
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Figure a4.13: The ellipticities of 4.2 at 265 nm versus time in H2O-phosphate buffer at a) 
0.045 M, b) 0.09 M, c) 0.18 M, d) 0.27 M and e) 0.36 M total phosphate with ionic strength of 
0.9 M I,  pH 7.4 at 37 °C. 
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Figure a4.14: The ellipticities of 4.2 at 265 nm versus time in D2O-phosphate buffer at a) 
0.09 M, b) 0.18 M, c) 0.27 M and d) 0.36 M total phosphate with ionic strength of 0.9 M I,  
pH* 7.4 at 37 °C. 
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Figure a4.15: The ellipticities of 4.3 at 268 nm versus time in H2O-phosphate buffer at a) 
0.045 M, b) 0.09 M, c) 0.18 M, d) 0.27 M and e) 0.36 M total phosphate with ionic strength of 
0.9 M I,  pH 7.4 at 37 °C. 
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Figure a4.16: The ellipticities of 4.3 at 268 nm versus time in D2O-phosphate buffer at a) 
0.09 M, b) 0.18 M, c) 0.27 M and d) 0.36 M total phosphate with ionic strength of 0.9 M I,  
pH* 7.4 at 37 °C. 
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Figure a4.17: The ellipticities of 4.3 at 290 nm versus time in H2O-phosphate buffer at a) 
0.045 M, b) 0.09 M, c) 0.18 M, d) 0.27 M and e) 0.36 M total phosphate with ionic strength of 
0.9 M I,  pH 7.4 at 37 °C. 
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Figure a4.18: The ellipticities of 4.4 at 290 nm versus time in D2O-phosphate buffer at a) 
0.09 M, b) 0.18 M, c) 0.27 M and d) 0.36 M total phosphate with ionic strength of 0.9 M I,  
pH* 7.4 at 37 °C. 
 
 
 
 
 
 
 
 
 
0.0 2.0x10
4
4.0x10
4
6.0x10
4
8.0x10
4
-8
-6
-4
-2
0
a)
Data: Data1_B
Model: exponential_hiwaahmad
Weighting: 
A No weighting
  
Chi^2/DoF = 0.04023
R^2 =  0.9899
  
k 5.709E-5 ±1.217E-6
Af -0.1776 ±0.0357
delta_A -7.758 ±0.0724


m
il
li
d
eg
re
es
 
t / s
0 1x10
4
2x10
4
3x10
4
4x10
4
5x10
4
6x10
4
7x10
4
-8
-7
-6
-5
-4
-3
-2
-1
0
1
b)
Data: Data1_B
Model: exponential_hiwaahmad
Weighting: 
A No weighting
  
Chi^2/DoF = 0.02686
R^2 =  0.99102
  
k 1.049E-4 ±2.174E-6
Af -0.3719 ±0.02504
delta_A -7.156 ±0.0775


m
il
li
d
eg
re
es
 
t / s
0.0 2.0x10
4
4.0x10
4
6.0x10
4
8.0x10
4
1.0x10
5
-8
-7
-6
-5
-4
-3
-2
-1
0
1
c)
Data: Data1_B
Model: exponential_hiwaahmad
Weighting: 
A No weighting
  
Chi^2/DoF = 0.04159
R^2 =  0.97379
  
k 1.539E-4 ±4.133E-6
Af -0.2565 ±0.01904
delta_A -6.842 ±0.1135

t / s
0.0 2.0x10
4
4.0x10
4
6.0x10
4
8.0x10
4
-8
-7
-6
-5
-4
-3
-2
-1
0 d)
Data: Data1_B
Model: exponential_hiwaahmad
Weighting: 
A No weighting
  
Chi^2/DoF = 0.03347
R^2 =  0.9781
  
k 2.259E-4 ±6.196E-6
Af -0.4979 ±0.01862
delta_A -7.034 ±0.1186


m
il
li
d
eg
re
es
 
t / s
 A65 
 
  
  
 
Figure a4.19: The ellipticities of 4.5 at 263 nm versus time in H2O-phosphate buffer at a) 
0.045 M, b) 0.09 M, c) 0.18 M, d) 0.27 M and e) 0.36 M total phosphate with ionic strength of 
0.9 M I,  pH 7.4 at 37 °C. 
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Figure a4.20: The ellipticities of 4.5 at 263 nm versus time in D2O-phosphate buffer at a) 
0.09 M, b) 0.18 M, c) 0.27 M and d) 0.36 M total phosphate with ionic strength of 0.9 M I,  
pH* 7.4 at 37 °C. 
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Table a4.1: Pseudo-first-order rate constants kɵ determined by CD spectroscopy of (S)-1-
acetyl-5-methyl-2-thioxoimidazolidin-4-one (4.1) in H2O- and D2O-phosphate buffer at 0.36 
M, 0.27 M, 0.18 M, 0.09 M and 0.045 M total phosphate and 0.29 M, 0.22 M, 0.14 M, 0.072 
M and 0.036 M phosphate basic, respectively with ionic strength of 0.9 M I, pH and pH* 7.4 
and 37 °C. 
Total buffer 
con./M 
 
kɵ (H2O)/ 
10-6 s-1 
kɵ (D2O) / 
10-6 s-1 
kH/kD 
0.045 43.7 ± 0.9 (± 0.7)(a   
0.09 72.9  ± 1.5 (± 0.9)(a 68.5  ±  1.4 (± 0.8)(a 1.06 ± 0.03 
0.18 123.6 ± 2.5 (± 1.5)(a 122.3  ± 2.5 (± 1.6)(a 1.01 ± 0.02 
0.27 174.0 ± 3.7 (± 3.6)(a 174.0 ± 3.7 (± 3.6)(a 1.00 ± 0.03 
0.36 251.5 ± 6.2 (± 5.4)(a 262.6 ± 5.3 (± 4.0)(a 0.96 ± 0.02 
c) Where the error from the data fit is reported as less than 2% of the rate constant, an 
error of 2% was assumed. Values in brackets are the errors from the data fit which are 
less than 2%. 
 
 
Table a4.2: Pseudo-first order rate constants kɵ determined by CD spectroscopy of (S)-1-
acetyl-5-benzyl-2-thioxoimidazolidin-4-one (4.2) in H2O- and D2O-phosphate buffer at 0.36 
M, 0.27 M, 0.18 M, 0.09 M and 0.045 M total phosphate and 0.29 M, 0.22 M, 0.14 M, 0.072 
M and 0.036 M phosphate basic, respectively with ionic strength of 0.9 M I, pH and pH* 7.4 
and 37 °C. 
Total buffer 
con./M 
 
kɵ (H2O)/ 
10-6 s-1 
kɵ (D2O)/ 
10-6 s-1 
kH/kD 
0.045 65.3 ± 1.3 (± 0.5)(a   
0.09 105.6 ± 2.1 (± 1.2)(a 105.3 ± 2.1 (± 1.0)(a 1.00 ± 0.03 
0.18 201.4 ± 4.0 (± 2.2)(a  205.0 ± 4.1 (± 2.3)(a 0.98 ± 0.03 
0.27 296.5 ± 5.9 (± 4.3)(a 334.7 ± 6.7 (± 5.0)(a 0.89 ± 0.03 
0.36 453.4 ± 9.1 (± 7.6)(a 458.7 ± 9.2 (± 7.4)(a 0.99 ± 0.03 
a) Where the error from the data fit is reported as less than 2% of the rate constant, an 
error of 2% was assumed. Values in brackets are the errors from the data fit which are 
less than 2%. 
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Table a4.3: Pseudo-first order rate constants kɵ determined by CD spectroscopy of (S)-1-
acetyl-5-isopropyl-2-thioxoimidazolidin-4-onein (4.3) H2O- and D2O-phosphate buffer at 
0.36 M, 0.27 M, 0.18 M, and 0.09 M total phosphate 0.29 M, 0.22 M, 0.14 M, 0.072 M and 
0.036 M phosphate basic, respectively with ionic strength of  0.9 M I,  pH and pH* 7.4 and 
37 °C. 
 
Total buffer 
con./M 
 
kɵ (H2O)/ 
10-6 s-1 
kɵ (D2O)/ 
10-6 s-1 
kH/kD 
0.09 11.6 ± 0.2 (± 0.2)(a   
0.18 14.3 ± 0.3 (± 0.1)(a 11.1 ± 0.2 (± 0.1)(a 1.29 ± 0.04 
0.27 19.2 ± 0.4 (± 0.2)(a 14.6 ± 0.3 (± 0.2)(a 1.32 ± 0.04 
0.36 26.2 ± 0.5 (± 0.3)(a 19.0 ± 0.4 (± 0.2)(a 1.38 ± 0.04 
a) Where the error from the data fit is reported as less than 2% of the rate constant, an 
error of 2% was assumed. Values in brackets are the errors from the data fit which are 
less than 2%. 
 
 
Table a4.4: Pseudo-first order rate constants kɵ determined by CD spectroscopy of (S)-5-
((1H-indol-3-yl)methyl)-1-acetyl-2-thioxoimidazolidin-4-one (4.4) in H2O- and D2O-
phosphate buffer at 0.36 M, 0.27 M, 0.18 M, 0.09 M and 0.045 M total phosphate 0.29, 0.22, 
0.14, 0.072 and 0.036 M phosphate basic, respectively with ionic strength of  0.9 M I,  pH 
and pH* 7.4 and 37 °C. 
 Total buffer 
con./M 
 
kɵ (H2O)/ 
10-6 s-1  
kɵ (D2O) / 
10-6 s-1 
kH/kD 
0.045 32.0 ± 0.6 (± 0.5)(a   
0.09 58.5 ± 1.2 (± 1.1)(a 57.1 ± 1.2 1.02 ± 0.03 
0.18 99.8 ± 2.0 (± 2.0)(a 104.9 ± 2.2 0.95 ± 0.03 
0.27 148.3 ± 3.5    153.9 ± 4.1 0.96 ± 0.04 
0.36 196.4 ± 5.8  225.9 ± 6.2 0.87 ± 0.04 
a) Where the error from the data fit is reported as less than 2% of the rate constant, an 
error of 2% was assumed. Values in brackets are the errors from the data fit which are 
less than 2%. 
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Table a4.5: Pseudo-first-order rate constants kɵ determined by CD spectroscopy of (S)-1-
acetyl-5-(2-(methylthio)ethyl)-2-thioxoimidazolidin-4-one (4.5) in H2O- and D2O-phosphate 
buffer at  0.36 M, 0.27 M, 0.18 M, 0.09 M and 0.045 M total phosphate 0.29 M, 0.22 M, 
0.14 M, 0.072 M and 0.036 M phosphate basic, respectively with ionic strength of  0.9 M I,  
pH and pH* 7.4 and 37 °C. 
 Total buffer 
con./M 
 
kɵ (H2O)/ 
10-6 s-1 
kɵ (D2O)/ 
10-6 s-1 
kH/kD 
0.045 134.3 ± 2.7(± 2.3)(a   
0.09 213.8 ± 4.3 (± 3.8)(a 214.0  ± 4.3 1.00 ± 0.02 
0.18 395.3 ± 10.2  430.3 ± 9.6 0.92 ± 0.02 
0.27 558.7 ± 15.8  642.9 ± 16.0 0.87 ± 0.02 
0.36 840.0 ± 23.9  869.9 ± 28.3 0.97 ± 0.03 
a) Where the error from the data fit is reported as less than 2% of the rate constant, an 
error of 2% was assumed. Values in brackets are the errors from the data fit which are 
less than 2%. 
 
 
  
Figure a4.21: Observed rate constants kɵ of (S)-1-acetyl-5-methyl-2-thioxoimidazolidin-4-
one (4.1) as a function of the concentration of the basic components of a) (H2O- based 
phosphate buffer at 37 °C, 0.9 M I, pH 7.4, 0.36 M, 0.27 M, 0.18 M, 0.09, and 0.045 M, and 
b) D2O-based phosphate buffer at 37 °C, 0.9 M I, pH
* 7.4, 0.36 M, 0.27 M, 0.18 M, and 0.09 
M. 
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Figure a4.22: Observed rate constants kɵ of (S)-1-acetyl-5-benzyl-2-thioxoimidazolidin-4-one 
(4.2)  as a function of the concentration of the basic components of a) (H2O- based phosphate 
buffer at 37 °C, 0.9 M I, pH 7.4, 0.36 M, 0.27 M, 0.18 M, 0.09, and 0.045 M, and b) D2O-
based phosphate buffer at 37 °C, 0.9 M I, pH* 7.4, 0.36 M, 0.27 M, 0.18 M, and 0.09 M. 
 
 
  
Figure a4.23: Observed rate constants kɵ of (S)-1-acetyl-5-isopropyl-2-thioxoimidazolidin-4-
onein (4.3)  as a function of the concentration of the basic components of a) (H2O- based 
phosphate buffer at 37 °C, 0.9 M I, pH 7.4, 0.36 M, 0.27 M, 0.18 M, and  0.09, and b) D2O-
based phosphate buffer at 37 °C, 0.9 M I, pH* 7.4, 0.36 M, 0.27 M, and  0.18 M. 
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Figure a4.24: Observed rate constants kɵ of (S)-5-((1H-indol-3-yl)methyl)-1-acetyl-2-
thioxoimidazolidin-4-one (4.4) as a function of the concentration of the basic components of 
a) (H2O- based phosphate buffer at 37 °C, 0.9 M I, pH 7.4, 0.36 M, 0.27 M, 0.18 M, 0.09, and 
0.045 M, and b) D2O-based phosphate buffer at 37 °C, 0.9 M I, pH
* 7.4, 0.36 M, 0.27 M, 0.18 
M, and 0.09 M. 
  
 
  
Figure a4.25: Observed rate constants kɵ of (S)-1-acetyl-5-(2-(methylthio)ethyl)-2-
thioxoimidazolidin-4-one (4.5) as a function of the concentration of the basic components of 
a) (H2O- based phosphate buffer at 37 °C, 0.9 M I, pH 7.4, 0.36 M, 0.27 M, 0.18 M, 0.09, and 
0.045 M, and b) D2O-based phosphate buffer at 37 °C, 0.9 M I, pH
* 7.4, 0.36 M, 0.27 M, 0.18 
M, and 0.09 M. 
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Figure a4.26: Observed rate constants of racemisation krac determined by Equation 4.5 for 
compounds a) 4.1, b) 4.2, c) 4.3, d) 4.4 and e) 4.5  as a function of the concentration of the 
basic components of (H2O-based total phosphate buffer at 37 °C, 0.9 M I, pH 7.4, 0.36 M, 
0.27 M, 0.18 M, 0.09, and 0.045 M. 
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Table a4.6: Second-order rate constants for buffer-catalysed kɵ, determined from Figures 
a4.21-a4.25 and krac obtained in Figure a4.26 and the combined uncatalysed, deuteroxide-
catalysed and hydronium-catalysed kin observed in Figures a4.21-a4.26 for 4.1-4.5 in H2O 
phosphate buffers, 0.9 M I, pH and pH 7.4 at 37 °C.  
Comp. 
kɵ 
/ 10-6 s-1 M-1 
kin 
/ 10-6 s-1 
krac,H2O 
/ 10-6M-1 s-1 
kin 
/ 10-6 s-1 
4.1 763 ± 29 16.5 ± 2.3 735 ± 30  
 
 
6.5 ± 2.5 
4.2 1356 ± 86 14 ± 6.7 1347 ± 86 
 
9.3 ± 6.7 
4.3 61.3 ± 9.4 6.6 ± 1.5 45.0 ± 9.0 
 
0.4 ± 1.7 
 4.4 646 ± 19.4 9.3 ± 1.4 636 ± 19 5.7 ± 1.4 
4.5 2495 ± 131 41.7 ± 9.0 2465 ± 131 
 
35.0 ± 9.0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 A74 
 
A4.2. Brønsted plot for proton transfer 
 
  
 
Figure a4.27: Observed rate constants of racemisation determined by Equation 4.5 for 4.1  a) 
acetate, b) phosphate, and  c) TRIS buffer as a function of the concentration of the basic 
components of (H2O-based buffer at 37 °C, 0.9 M I, pH 5.0, 7.4, and 8.2, respectively. 
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Table a4.7: The pKa , kɵ,  and  krac of 4.1 in acetate, phosphate, and TRIS buffers at 0.9 M I, 
pH 5.0, 7.4, 8.2 and 9.7, respectively. 
Buffers 
 
pKa 
kɵ (H2O) 
/ 10-6 s-1 M-1 
krac (H2O)  
/ 10-6 s-1 M-1 
Acetate 
0.0166 
4.59(a 246.0 ± 18.0 253.5 ± 13.0 
phosphate 6.8(b 763 ± 28 735 ± 30 
TRIS 
0.02496 
7.88(a 1381 ± 127 1248 ± 139 
 
 
 
 
Figure a4.28: Bronsted plot for the base-catalysed racemisation of a) deprotonated 4.1 data 
and b) protonated 4.1 data from Table h 4.7.  
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A4.3. Racemisation of tri-substituted 2-thiohydantoin 
  
  
 
Figure a4.29: Change in ellipticity over time for solutions of 4.7 in H2O-phosphate buffer at 
a) 0.009 M, b) 0.018 M, c) 0.027 M, d) 0.036 M and e) 0.045 M total phosphate with ionic 
strength of 0.9 M I, pH 7.4 at 37 °C. 
 
 
220 240 260 280 300 320
-16
-12
-8
-4
0
4
8
12
16
20


m
il
li
d
eg
re
es
 
Wave length (nm)
a)
220 240 260 280 300 320
-20
-16
-12
-8
-4
0
4
8
12
16
20 b)


m
il
li
d
eg
re
es
 
Wave length (nm)
220 240 260 280 300 320
-20
-16
-12
-8
-4
0
4
8
12
16
20 c)


m
il
li
d
eg
re
es
 
Wave length (nm)
220 240 260 280 300 320
-20
-16
-12
-8
-4
0
4
8
12
16
20 d)


m
il
li
d
eg
re
es
 
Wave length (nm)
220 240 260 280 300 320
-20
-16
-12
-8
-4
0
4
8
12
16
20 e)


m
il
li
d
eg
re
es
 
Wave length (nm)
 A77 
 
  
  
 
Figure a4.30: Change in ellipticity over time for solutions of 4.7 in D2O-phosphate buffer at 
a) 0.009 M, b) 0.018 M, c) 0.027 M, d) 0.036 M and e) 0.045 M total phosphate with ionic 
strength of 0.9 M I,  pH* 7.4 at 37 °C. 
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Figure a4.31: Change in ellipticity over time for solutions of 4.8 in H2O-phosphate buffer at 
a) 0.009 M, b) 0.018 M, c) 0.027 M, d) 0.036 M and e) 0.045 M total phosphate with ionic 
strength of 0.9 M I, pH 7.4 at 37 °C. 
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Figure a4.32: Change in ellipticity over time for solutions of 4.8 in D2O-phosphate buffer at 
a) 0.009 M, b) 0.018 M, c) 0.027 M, d) 0.036 M and e) 0.045 M total phosphate with ionic 
strength of 0.9 M I,  pH* 7.4 at 37 °C. 
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Figure a4.33: The ellipticities of 4.7 at 272 nm versus time in H2O-phosphate buffer at a) 
0.009 M, b) 0.018 M, c) 0.027 M, d) 0.036 M and e) 0.045 M total phosphate with ionic 
strength of 0.9 M I,  pH 7.4 at 37 °C. 
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Figure a4.34: The ellipticities of 4.7 at 272 nm versus time in D2O-phosphate buffer at a) 
0.009 M, b) 0.018 M, c) 0.027 M, d) 0.036 M and e) 0.045 M total phosphate with ionic 
strength of 0.9 M I,  pH* 7.4 at 37 °C. 
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Figure a4.35: The ellipticities of 4.8 at 271 nm in H2O-phosphate buffer at a) 0.009 M, b) 
0.018 M, c) 0.027 M, d) 0.036 M and e) 0.045 M total phosphate with ionic strength of 0.9 M 
I,  pH 7.4 at 37 °C. 
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Figure a4.36: The ellipticities of 4.8 at 271 nm in D2O-phosphate buffer at a) 0.009 M, b) 
0.018 M, c) 0.027 M, d) 0.036 M and e) 0.045 M total phosphate with ionic strength of 0.9 M 
I,  pH* 7.4 at 37 °C. 
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Figure a4.37: Observed rate constants of racemisation of (R)-5-benzyl-3-phenyl-1-(pyridin-
2-ylmethyl)-2-thioxoimidazolidin-4-one (4.7) at 272 nm as a function of the concentration of 
the basic components of a) (H2O- based phosphate buffer at 37 °C, 0.9 M I, pH 7.4, 0.045 M, 
0.036 M, 0.027 M, 0.018 M, and 0.09 and b) D2O-based phosphate buffer at 37 °C, 0.9 M I, 
pH* 7.4, 0.045 M, 0.036 M, 0.027 M, 0.018 M, and 0.09 M. 
 
 
 
Figure a4.38: Observed rate constants of racemisation of (S)-5-isopropyl-3-phenyl-1-
(pyridin-2-ylmethyl)-2-thioxoimidazolidin-4-one (4.8) at 271 nm as a function of the 
concentration of the basic components of a) (H2O- based phosphate buffer at 37 °C, 0.9 M I, 
pH 7.4, 0.045 M, 0.036 M, 0.027 M, 0.018 M, and 0.09 M and b) D2O-based phosphate buffer 
at 37 °C, 0.9 M I, pH* 7.4, 0.045 M, 0.036 M, 0.027 M, 0.018 M, and 0.09 M . 
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Table a4.8: Pseudo-first-order rate constants kɵ determined by CD spectroscopy of (R)-5-
benzyl-3-phenyl-1-(pyridin-2-ylmethyl)-2-thioxoimidazolidin-4-one (4.7) at 272 nm in H2O 
and D2O phosphate buffer at 0.045, 0.036 M, 0.027 M, 0.018 M, and 0.09 M total phosphate 
and 0.036, 0.029, 0.022, 0.014 and 0.0072 M phosphate basic, respectively with ionic strength 
of  0.9 M I,  pH and pH* 7.4 at 37 °C. 
Comp. 
(4.7) 
kɵ (H2O)/ 
10-6 s-1 
kɵ (D2O) / 
10-6 s-1 
kH/kD 
0.009 3005 ± 96  2703 ± 86    1.11 ± 0.05 
0.018 3147 ± 90  2894 ± 99 1.09 ± 0.05 
0.027 4060 ± 163  3670 ± 126 1.11± 0.06 
0.036 4460 ± 147  4130 ± 181 1.08 ± 0.06 
0.045 5360 ± 198  4890 ± 214 1.10 ± 0.06 
 
 
Table a4.9: Pseudo-first-order rate constants kɵ determined by CD spectroscopy of (S)-5-
isopropyl-3-phenyl-1-(pyridin-2-ylmethyl)-2-thioxoimidazolidin-4-one (4.8) at 271 nm in 
H2O and D2O-phosphate buffer at 0.045, 0.036 M, 0.027 M, 0.018 M, and 0.09 M total 
phosphate and 0.036, 0.029, 0.022, 0.014 and 0.0072 M phosphate basic, respectively with 
ionic strength of  0.9 M I,  pH and pH* 7.4 at 37 °C. 
Comp. 
(4.8) 
kɵ (H2O)/ 
10-6 s-1 
kɵ (D2O) / 
10-6 s-1 
kH/kD 
0.009 380.4 ± 7.2  327.3 ± 5.5     1.16 ± 0.03 
0.018 387.3  ± 7.9  375.3 ± 6.7  1.03 ± 0.03 
0.027 452.4 ± 11.3 395.9 ± 7.5  1.14 ± 0.04 
0.036 508.0 ± 10.7  433.0 ± 7.7  1.17 ± 0.03 
0.045 513.0 ± 13.8 462.5 ± 8.8  1.11 ± 0.04 
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A4.4. Racemisation of 5-substituted 2-thiohydantoins 
 
 
  
 
Figure a4.39: Chromatogram of compounds a) 4.15 and b) 4.16 by using 70 of Water and 
30% of methanol with the flow rate of 1.0 ml/ min at room temperature. The chiral column of 
Astec CHIROBIOTIC T, 25 cm x 4.6 mm, 5 μm particles. 
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A5.1 The hydrogen/deuterium exchange of 5-substituted 1-acetyl-2-
thiohydantoins 
 
  
Figure a5.1: Relative integration of 5.1 in D2O-phosphate buffer at a) 0.09 M, b) 0.18 M, c) 
0.27 M and d) 0.36 M total phosphate with ionic strength of 0.9 M I, pH* 7.4 at 37 °C 
obtained by 1H-NMR spectroscopy plotted versus time. The squares (■) are the experimental 
points, and the red solid lines are the fits to pseudo first-order kinetics. 
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Figure a5.2: Relative integration of 5.3 in D2O-phosphate buffer at a) 0.18 M, b) 0.27 M and 
c) 0.36 M total phosphate with ionic strength of 0.9 M I, pH* 7.4 at 37 °C obtained by 1H-
NMR spectroscopy plotted versus time. The squares (■) are the experimental points, and the 
red solid lines are the fits to pseudo-first-order kinetics. 
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Table a5.1:Pseudo-first-order rate constants kH/D determined by 
1H-NMR spectroscopy of (S)-
1-acetyl-5-methyl-2-thioxoimidazolidin-4-one (5.1) in D2O phosphate buffer at 0.36, 0.27, 
0.18, and 0.09 total phosphate and 0.29, 0.22, 0.14, and 0.072 M basic phosphate buffer, 
respectively with ionic strength of  0.9 M I,  pH* 7.4 and 37 °C. 
Total phosphate  Basic phosphate  kH/D (D2O)/ 
10-6 s-1 
0.09 0.072 83.5  ± 3.2 
0.18 0.14 144.4 ± 5.1 
0.27 0.22 210.9 ± 6.7 
0.36 0.29 274.0 ± 11.1 
 
 
Table a5.2: Pseudo-first-order rate constants kH/D determined by 
1H-NMR spectroscopy of 
(S)-1-acetyl-5-isopropyl-2-thioxoimidazolidin-4-one (5.3) in D2O-phosphate buffer at 0.36, 
0.27, and 0.18, total phosphate and 0.29, 0.22, and 0.14 basic phosphate buffer, respectively 
with ionic strength of  0.9 M I,  pH* 7.4 and 37 °C. 
Total phosphate  Basic phosphate  kH/D (D2O)/ 
10-6 s-1 
0.18 0.14 11.7 ± 0.2 (± 0.1)(a 
0.27 0.22 14.8 ± 0.3 (± 0.2)(a 
0.36 0.29 21.1 ± 0.4 
c) Where the error from the data fit is reported as less than 2% of the rate constant, an 
error of 2% was assumed. Values in brackets are the errors from the data fit which are 
less than 2%. 
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Figure a5.3:  Second-order rate constants for buffer-catalysed of H/D exchange by 1H-NMR 
spectroscopy of a) 5.1, and b) 5.3 in D2O-phosphate buffers, 0.9 M I, pH
* 7.4 at 37 °C. 
 
  
Figure a5.4: Relative integration of a) 5.2 and b) 5.4 in D2O-phosphate buffer at 0.09 M total 
phosphate with ionic strength of 0.9 M I, pH* 7.4 at 37 °C obtained by 1H-NMR spectroscopy 
plotted versus time by using 10% of d3-ACN. The squares (■) are the experimental points, 
and the red solid lines are the fits to pseudo-first-order kinetics. 
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Figure a5.5: Relative integration of 5.5 with a) correcting phase b) without correcting the 
phase of base line of 1H-NMR spectra by Mestrenova in D2O-phosphate buffer at 0.09 M total 
phosphate with ionic strength of 0.9 M I, pH* 7.4 at 37 °C obtained by 1H-NMR spectroscopy 
plotted versus time by using 10% of d3-ACN. The squares (■) are the experimental points, 
and the red solid lines are the fits to pseudo-first-order kinetics. The weight average equation 
(See Chapter 5) for rate constant of a) and b) was used to obtained the observed rate constant 
of H/D exchange and reported in Table 5.3.  
 
 
Figure a5.6: Relative integration of 5.6 in D2O-phosphate buffer at 0.09 M total phosphate 
with ionic strength of 0.9 M I, pH* 7.4 at 37 °C obtained by 1H-NMR spectroscopy plotted 
versus time by using 10% of d3-ACN. The squares (■) are the experimental points, and the 
red solid lines are the fits to pseudo-first-order kinetics. 
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A5.2. The H/D exchange process of 5-substituted 2-thiohydantoins 
 
 
 
  
Figure a5.7: Relative integration of a) 5.7, b) 5.8,  c) 5.9, and d) 5.10 in D2O-phosphate 
buffer at 0.009 M total phosphate with ionic strength of 0.9 M I, pH* 7.4 at 37 °C obtained by 
1H-NMR spectroscopy plotted versus time by using 10% of d3-ACN. The squares (■) are the 
experimental points, and the red solid lines are the fits to pseudo-first-order kinetics. 
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Figure a5.8: Relative integration of a) 5.11, b) 5.12, c) 5.13, and d) 5.14 in D2O-phosphate 
buffer at 0.009 M total phosphate with ionic strength of 0.9 M I, pH* 7.4 at 37 °C obtained by 
1H-NMR spectroscopy plotted versus time by using 10% of d3-ACN. The squares (■) are the 
experimental points, and the red solid lines are the fits to pseudo-first-order kinetics. 
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A5.3. The H/D exchange process of 3-phenyl-5-benzyl-2-thiohydantoin 
 
 
Figure a5.9: Relative integration of 5.15 in D2O-phosphate buffer at 0.008 M total phosphate 
with ionic strength of 0.8 M I, pH* 7.4 at 37 °C obtained by 1H-NMR spectroscopy plotted 
versus time by using 20% of d3-ACN. The squares (■) are the experimental points, and the 
red solid lines are the fits to pseudo-first-order kinetics. 
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A5.4. The H/D exchange process of 5-substituted thiazolidine-2,4-diones 
 
 
 
Figure a5.10: Relative integration of 5.21 in D2O-phosphate buffer at a) 0.09 M, b) 0.18 M, 
and c) 0.27 M total phosphate with ionic strength of 0.9 M I, pH* 7.4 at 37 °C obtained by 1H-
NMR spectroscopy plotted versus time. The squares (■) are the experimental points, and the 
red solid lines are the fits to pseudo-first-order kinetics. 
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Figure a5.11: Relative integration of 5.22 in D2O-phosphate buffer at a) 0.09 M, b) 0.18 M, 
and c) 0.27 M total phosphate with ionic strength of 0.9 M I, pH* 7.4 at 37 °C obtained by 1H-
NMR spectroscopy plotted versus time. The squares (■) are the experimental points, and the 
red solid lines are the fits to pseudo-first-order kinetics. 
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Figure a5.12:  Second-order rate constants for buffer-catalysed of H/D exchange by 1H-NMR 
spectroscopy of a) 5.21, and b) 5.22 in D2O-phosphate buffers, 0.9 M I, pH
* 7.4 at 37 °C. 
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